Red_ESRD,Medida,Puntaje_de_Medida,AÃ±o,Measure_id
1,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",5.11,2022,allmcFcovpatPq4_n
1,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",29.32,2022,allmcEcovpatPq4_n
1,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",43.76,2022,allmcEcovDeaPq4_n
1,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",38.2,2022,allmcEcovHosPq4_n
1,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",10.67,2022,nh_mcFcovpatPq4_n
1,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",49.16,2022,nh_mcEcovpatPq4_n
1,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",52.55,2022,nh_mcEcovDeaPq4_n
1,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",48.19,2022,nh_mcEcovHosPq4_n
1,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",64.78,2022,agey4_n
1,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.2,2022,age1y4_n
1,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",44.78,2022,age2y4_n
1,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",55.02,2022,age3y4_n
1,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",43.27,2022,dis1y4_n
1,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",24.49,2022,dis2y4_n
1,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",12.37,2022,dis3y4_n
1,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",19.5,2022,dis4y4_n
1,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.37,2022,dis5y4_n
1,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",17.56,2022,vin1y4_n
1,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",18.52,2022,vin2y4_n
1,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.7,2022,vin3y4_n
1,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",26.38,2022,vin4y4_n
1,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",23.85,2022,vin5y4_n
1,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",4.37,2022,rac1y4_n
1,"N: Prevalent Patients - Race: % African American, 12/31/2022",23.25,2022,rac2y4_n
1,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.39,2022,rac3y4_n
1,"N: Prevalent Patients - Race: % White, 12/31/2022",71.86,2022,rac4y4_n
1,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.14,2022,rac5y4_n
1,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",14.54,2022,eth1y4_n
1,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",85.36,2022,eth2y4_n
1,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.1,2022,eth3y4_n
1,"N: Prevalent Patients - Sex: % Female, 12/31/2022",40.68,2022,sexy4_n
1,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",15.32,2022,nrshomey4_n
1,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",4.85,2022,viny4_n
1,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",84.1,2022,modhdy4_n
1,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",3.62,2022,modhhdy4_n
1,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.63,2022,modcapdy4_n
1,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",10.44,2022,modccpdy4_n
1,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.2,2022,modothry4_n
1,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",66.07,2022,pahy4m_n
1,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",18.53,2022,CWunCa1y4_n
1,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",77.51,2022,CWunCa2y4_n
1,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.13,2022,CWunCa3y4_n
1,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",2.83,2022,CWunCamissy4_n
1,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
1,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.89,2022,CWavgUnCay4_n
1,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.43,2022,CWavgPy4_n
1,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.02,2022,CWP1y4_n
1,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",23.44,2022,CWP2y4_n
1,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",29.27,2022,CWP3y4_n
1,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",22.63,2022,CWP4y4_n
1,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",14.44,2022,CWP5y4_n
1,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",3.2,2022,CWPmissy4_n
1,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
1,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",1.92,2022,CWunCagt102y4_n
1,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",88.83,2022,CWptdenomy4m_n
1,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",777.1,2022,CWptmthdenomy4m_n
1,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",95.07,2022,serumphospatsy4m_n
1,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",825.48,2022,serumphospmy4m_n
1,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",88.83,2022,CWhcptdenomy4m_n
1,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",777.06,2022,CWhcptmthdenomy4m_n
1,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",61.23,2022,ppavfy4_n
1,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",14.12,2022,ppavgy4_n
1,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",22.71,2022,ppcathy4_n
1,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",1.94,2022,ppomy4_n
1,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",17.52,2022,ltcy4_n
1,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",15.3,2022,piavfy4_n
1,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",3.39,2022,piavgy4_n
1,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",77.83,2022,picathy4_n
1,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",3.49,2022,piomy4_n
1,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",16.3,2022,pifisty4_n
1,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",83.47,2022,phdvapty4m_n
1,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",716.53,2022,phdy4m_n
1,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",16.5,2022,ihdy4m_n
1,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",61.72,2022,sfry4_n
1,"N: VA infection - Average number of eligible PD patients, 2022",9.77,2022,pdpaty4m_n
1,"N: VA infection - Average number of eligible PD patient-months, 2022",68.74,2022,pdptmoy4m_n
1,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.6,2022,pd2inf100moy4_n
1,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",52.27,2022,ncmy4m_n
1,"N: Prevalent Comorbidities - Average % with Anemia, 2022",3.7,2022,clmanemy4_n
1,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.82,2022,clmhivaidmy4_n
1,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",2.15,2022,clmalcomy4_n
1,"N: Prevalent Comorbidities - Average % with Cancer, 2022",4.53,2022,clmcanmy4_n
1,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",0.84,2022,clmcamy4_n
1,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",24.0,2022,clmcdmy4_n
1,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",7.66,2022,clmcvdmy4_n
1,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",18.05,2022,clmcopdmy4_n
1,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",35.05,2022,clmchfmy4_n
1,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",37.67,2022,clmdiabmy4_n
1,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",1.68,2022,clmdrugmy4_n
1,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",3.55,2022,clmgtbmy4_n
1,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.5,2022,clmhepbmy4_n
1,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.67,2022,clmhepothmy4_n
1,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",20.9,2022,clmhypthymy4_n
1,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",19.37,2022,clminfmy4_n
1,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",30.74,2022,clmihdmy4_n
1,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",9.87,2022,clmmimy4_n
1,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",18.54,2022,clmpvdmy4_n
1,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",4.42,2022,clmpnemy4_n
1,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.52,2022,clmcntcomy4_n
1,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",4.33,2022,clminfvamy4_n
1,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.64,2022,clmmstinfmy4_n
1,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.4,2022,clmtbmy4_n
1,"N (AFS): Facility Information - Average number of patients, 2022",110.42,2022,allcnty4m_n
1,N (AFS): Facility Information - Average number of all patients on 12/31/2022,72.56,2022,endcnty4m_n
1,"N (AFS): Facility Information - Average % of patients transferred in, 2022",15.22,2022,transiny4_n
1,"N (AFS): Facility Information - Average % of patients transferred out, 2022",15.65,2022,transouty4_n
1,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,80.64,2022,medicarey4_n
1,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,9.1,2022,medpendy4_n
1,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,10.25,2022,nonmedy4_n
1,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.19,2022,cfc_N
1,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,5.84,2022,std_N
1,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",30.77,2022,p_age1y4_n
1,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",3.85,2022,p_age2y4_n
1,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",38.46,2022,p_age3y4_n
1,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",26.92,2022,p_age4y4_n
1,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",0.0,2022,p_dis1y4_n
1,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",3.85,2022,p_dis2y4_n
1,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",34.62,2022,p_dis3y4_n
1,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",42.31,2022,p_dis4y4_n
1,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
1,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
1,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",11.54,2022,p_dis7y4_n
1,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",7.69,2022,p_dis8y4_n
1,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",34.62,2022,p_vin1y4_n
1,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",30.77,2022,p_vin2y4_n
1,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",7.69,2022,p_vin3y4_n
1,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",7.69,2022,p_vin4y4_n
1,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",19.23,2022,p_vin5y4_n
1,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",7.69,2022,p_rac1y4_n
1,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",11.54,2022,p_rac2y4_n
1,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",3.85,2022,p_rac3y4_n
1,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",76.92,2022,p_rac4y4_n
1,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",0.0,2022,p_rac5y4_n
1,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",38.46,2022,p_eth1y4_n
1,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",61.54,2022,p_eth2y4_n
1,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
1,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",38.46,2022,p_sexy4_n
1,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",57.69,2022,p_modhdy4_n
1,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
1,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",7.69,2022,p_modcapdy4_n
1,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",34.62,2022,p_modccpdy4_n
1,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
1,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",28.57,2022,p_allmdcrmy4_n
1,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",33.33,2022,p_insmdcdmy4_n
1,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",4.76,2022,p_insempmy4_n
1,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",33.33,2022,p_insnonothmy4_n
1,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",23.81,2022,p_nephnomy4_n
1,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",28.57,2022,p_nephy6my4_n
1,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",4.76,2022,p_nephy612my4_n
1,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",33.33,2022,p_nephy12my4_n
1,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",9.52,2022,p_nephunkmissmy4_n
1,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",100.0,2022,p_ptinfymy4_n
1,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",0.0,2022,p_mefavfmy4_n
1,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
1,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",100.0,2022,p_mefcathmy4_n
1,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
1,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",6.25,2022,p_avfpresentmy4_n
1,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",21.24,2022,p_ppavfy4_n
1,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",61.14,2022,p_ltcy4_n
1,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",25.63,2022,p_WLy4_n
1,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",13.76,2022,p_WLlt10y4_n
1,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",38.51,2022,p_WL1017y4_n
1,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.71,2022,p_CWhdavgHGBy4_n
1,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",26.97,2022,p_CWhdhgb1y4_n
1,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",25.84,2022,p_CWhdhgb2y4_n
1,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",25.84,2022,p_CWhdhgb3y4_n
1,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",14.04,2022,p_CWhdhgb4y4_n
1,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",7.3,2022,p_CWhdhgb5y4_n
1,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.72,2022,p_CWpdavgHGBy4_n
1,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",27.78,2022,p_CWpdhgb1y4_n
1,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",18.89,2022,p_CWpdhgb2y4_n
1,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",16.67,2022,p_CWpdhgb3y4_n
1,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",21.11,2022,p_CWpdhgb4y4_n
1,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",15.56,2022,p_CWpdhgb5y4_n
1,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.21,2022,p_CWhdalby4_n
1,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",2.81,2022,p_CWhdalb1y4_n
1,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",5.62,2022,p_CWhdalb2y4_n
1,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",18.54,2022,p_CWhdalb3y4_n
1,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",65.17,2022,p_CWhdalb4y4_n
1,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",7.87,2022,p_CWhdalb5y4_n
1,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",4.13,2022,p_CWpdalby4_n
1,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",0.0,2022,p_CWpdalb1y4_n
1,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",2.22,2022,p_CWpdalb2y4_n
1,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",21.11,2022,p_CWpdalb3y4_n
1,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",54.44,2022,p_CWpdalb4y4_n
1,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",22.22,2022,p_CWpdalb5y4_n
1,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",76.67,2022,p_CWpdktvge18y4_n
1,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",97.59,2022,p_CWhdktvge12y4_n
1,"N: Patient Placement -  % of incident patients, 2022",18.51,2022,ppidy4_n
1,"N: Patient Placement -  % of patients continuing at facility, 2022",72.12,2022,ppcdy4_n
1,"N: Patient Placement -  % of patients that transfered into facility, 2022",9.37,2022,pptdy4_n
1,"N: End of Year Status - % of patients death attributed to this facility, 2022",14.84,2022,pdhdy4_n
1,"N: End of Year Status - % of patients death attributed to another facility, 2022",1.59,2022,pdody4_n
1,"N: End of Year Status - % of patients that received a transplant, 2022",3.65,2022,ptxdy4_n
1,"N: End of Year Status - % of patients alive in this facility, 2022",70.19,2022,pahdy4_n
1,"N: End of Year Status - % of patients alive in another facility, 2022",6.55,2022,paody4_n
1,"N: End of Year Status - % of patients other, 2022",3.19,2022,potdy4_n
1,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,61.39,2022,iuhemy4m_n
1,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.02,2022,iufreqy4m_n
1,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,61.37,2022,iunonfreqy4m_n
1,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.01,2022,iuothy4m_n
1,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.01,2022,iucapdy4m_n
1,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.02,2022,iuccpdy4m_n
1,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,2.43,2022,ihhemy4m_n
1,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.71,2022,ihfreqy4m_n
1,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,1.73,2022,ihnonfreqy4m_n
1,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
1,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,1.31,2022,ihcapdy4m_n
1,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,7.41,2022,ihccpdy4m_n
1,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",16.33,2022,staffy4m_n
1,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,5.53,2022,nurseFTy4m_n
1,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,5.39,2022,ptcareFTy4m_n
1,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,1.03,2022,dietFTy4m_n
1,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.08,2022,socwkFTy4m_n
1,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,1.5,2022,nursePTy4m_n
1,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.98,2022,ptcarePTy4m_n
1,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.43,2022,dietPTy4m_n
1,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.38,2022,socwkPTy4m_n
1,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,31.64,2022,vocrehaby4m_n
1,"N (AFS): Facility Information - Average % incident patients, 2022",16.87,2022,incpery4_n
1,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,32.04,2022,employedy4_n
1,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.94,2022,schooly4_n
1,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",52.99,2022,nh_ppavfy4_n
1,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",22.54,2022,nh_ltcy4_n
1,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",1.94,2022,nh_CWhdktv1y4_n
1,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",7.43,2022,nh_CWpdktv1y4_n
1,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",29.91,2022,nh_CWhdhgb1y4_n
1,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",81.2,2022,nh_CWhdesarxy4_n
1,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",26.39,2022,nh_CWpdhgb1y4_n
1,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",57.43,2022,nh_CWpdesarxy4_n
1,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",43.05,2022,nh_obdry4_n
1,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.09,2022,nh_smry4_n
1,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",43.03,2022,nh_wity4_n
1,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",271.31,2022,nh_obhtry4_n
1,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.39,2022,nh_shrty4_n
1,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",24.0,2022,nh_sepiy4_n
1,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",14.0,2022,nh_miiy4_n
1,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",52.98,2022,nh_achfy4_n
1,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",39.88,2022,nh_acdry4_n
1,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",3.16,2022,nh_acary4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",1.38,2022,nh_clmhivaidmy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",6.01,2022,nh_clminfvamy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",1.05,2022,nh_clmhepbmy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",2.92,2022,nh_clmhepothmy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",3.42,2022,nh_clmmstinfmy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",12.13,2022,nh_clmpnemy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.33,2022,nh_clmtbmy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",39.53,2022,nh_clminfmy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",1.93,2022,nh_clmcamy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",43.5,2022,nh_clmcdmy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",18.58,2022,nh_clmcvdmy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",59.81,2022,nh_clmchfmy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",51.49,2022,nh_clmihdmy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",15.6,2022,nh_clmmimy4_n
1,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",36.0,2022,nh_clmpvdmy4_n
1,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.05,2022,nh_age1y4_n
1,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",28.46,2022,nh_age2y4_n
1,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",71.49,2022,nh_age3y4_n
1,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",54.99,2022,nh_dis1y4_n
1,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",21.64,2022,nh_dis2y4_n
1,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",6.27,2022,nh_dis3y4_n
1,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",16.8,2022,nh_dis4y4_n
1,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.3,2022,nh_dis5y4_n
1,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",1.78,2022,nh_rac1y4_n
1,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",24.65,2022,nh_rac2y4_n
1,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",0.4,2022,nh_rac3y4_n
1,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",73.12,2022,nh_rac4y4_n
1,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.05,2022,nh_rac5y4_n
1,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",11.51,2022,nh_eth1y4_n
1,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",88.39,2022,nh_eth2y4_n
1,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.1,2022,nh_eth3y4_n
1,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",22.13,2022,nh_vin1y4_n
1,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",15.76,2022,nh_vin2y4_n
1,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",11.31,2022,nh_vin3y4_n
1,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",26.14,2022,nh_vin4y4_n
1,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",24.65,2022,nh_vin5y4_n
1,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",47.58,2022,nh_sexy4_n
1,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",95.55,2022,nh_modhdy4_n
1,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",1.28,2022,nh_modhhdy4_n
1,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.35,2022,nh_modcapdy4_n
1,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",2.37,2022,nh_modccpdy4_n
1,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.44,2022,nh_modothry4_n
1,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",85.44,2022,nh_allmdcrmy4_n
1,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",7.93,2022,nh_insmdcdmy4_n
1,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",2.21,2022,nh_insempmy4_n
1,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",4.42,2022,nh_insnonothmy4_n
1,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",9.23,2022,nh_mefavfmy4_n
1,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",2.47,2022,nh_mefgraftmy4_n
1,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",86.09,2022,nh_mefcathmy4_n
1,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",2.21,2022,nh_mefoumaccessmy4_n
1,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",19.25,2022,nh_avfpresentmy4_n
1,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",11.57,2022,nh_nephnomy4_n
1,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",17.69,2022,nh_nephy6my4_n
1,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",19.77,2022,nh_nephy612my4_n
1,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",35.76,2022,nh_nephy12my4_n
1,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",15.21,2022,nh_nephunkmissmy4_n
1,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",79.06,2022,nh_ptinfymy4_n
1,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",2.44,2022,alcomy4_n
1,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",16.15,2022,ashdmy4_n
1,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",22.49,2022,othcarmy4_n
1,"N (2728): Incident Patients  - Percent with cancer, 2022",8.31,2022,canmy4_n
1,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",27.23,2022,chfmy4_n
1,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",7.95,2022,cvamy4_n
1,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",41.52,2022,diabimy4_n
1,"N (2728): Incident Patients  - Percent with diabetes, 2022",59.28,2022,diabmy4_n
1,"N (2728): Incident Patients  - Percent drug dependent, 2022",2.11,2022,drugmy4_n
1,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",84.65,2022,hxhtmy4_n
1,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",4.49,2022,ambumy4_n
1,"N (2728): Incident Patients  - Percent inability to transfer, 2022",2.41,2022,transmy4_n
1,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",8.56,2022,copdmy4_n
1,"N (2728): Incident Patients  - Percent with PVD, 2022",10.91,2022,pvdmy4_n
1,"N (2728): Incident Patients  - Percent smoker, 2022",5.82,2022,smokmy4_n
1,"N (2728): Incident Patients  - Percent Hispanic, 2022",13.3,2022,ethmy4_n
1,"N (2728): Incident Patients  - Percent White, 2022",77.95,2022,whitemy4_n
1,"N (2728): Incident Patients  - Percent African American, 2022",17.01,2022,blackmy4_n
1,"N (2728): Incident Patients  - Percent Native American, 2022",0.8,2022,nativmy4_n
1,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",4.02,2022,asianmy4_n
1,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.22,2022,racoummy4_n
1,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",29.56,2022,cempmy4_n
1,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",38.87,2022,pempmy4_n
1,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",44.1,2022,dbprimy4_n
1,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",8.39,2022,gnprimy4_n
1,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",26.45,2022,htprimy4_n
1,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",21.05,2022,omprimy4_n
1,"N (2728): Incident Patients  - Percent female, 2022",39.89,2022,femmy4_n
1,"N (2728): Incident Patients  - Average age, 2022",65.45,2022,agemy4_n
1,"N (2728): Incident Patients  - Average serum albumin, 2022",3.5,2022,salbmy4_n
1,"N (2728): Incident Patients  - Average creatinine, 2022",6.75,2022,creamy4_n
1,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.21,2022,hgmy4_n
1,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",9.9,2022,gfrmy4_n
1,"N (2728): Incident Patients  - Average count of comorbidities, 2022",3.04,2022,cntcomy4_n
1,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",87.31,2022,pdmodMEFHDmy4_n
1,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",12.69,2022,pdmodMEFPDmy4_n
1,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
1,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",45.07,2022,insmdcrmy4_n
1,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",13.46,2022,insmdcdmy4_n
1,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",11.08,2022,insmdcrcdmy4_n
1,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",10.06,2022,insempmy4_n
1,"N (2728): Incident Patients  - Percent with no coverage, 2022",0.78,2022,insnonemy4_n
1,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",11.19,2022,insmdcromy4_n
1,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",8.37,2022,insmedomy4_n
1,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",22.05,2022,preepomy4_n
1,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",9.11,2022,nephnomy4_n
1,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",15.18,2022,nephy6my4_n
1,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",20.19,2022,nephy612my4_n
1,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",42.44,2022,nephy12my4_n
1,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",13.07,2022,nephunkmissmy4_n
1,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",85.21,2022,ptinfymy4_n
1,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",44.76,2022,ptxmedunfitmy4_n
1,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
1,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
1,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",8.99,2022,ptxdeclinemy4_n
1,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",55.24,2022,ptxnotassessmy4_n
1,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",16.47,2022,mefavfmy4_n
1,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",3.14,2022,mefgraftmy4_n
1,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",80.01,2022,mefcathmy4_n
1,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.38,2022,mefoumaccessmy4_n
1,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",27.25,2022,avfpresentmy4_n
1,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",27.8,2022,bmimmy4_n
1,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",28.25,2022,bmifmy4_n
1,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",2.71,2022,ptinfnmy4m_n
1,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",16.0,2022,hemomy4m_n
1,"N (2728): Incident Patients  - Average Number of forms returned, 2022",18.32,2022,nmy4m_n
1,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",89.8,2019,rdsmzm_n
1,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",59.71,2019,dyzm_n
1,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",11.94,2019,deazm_n
1,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",13.67,2019,exdzm_n
1,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.08,2019,dudzm_n
1,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",0.87,2019,smrz_n
1,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",36.42,2019,witz_n
1,"N: All Patient Mortality - % of deaths from infection, 2019-2022",14.17,2019,infz_n
1,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",43.24,2019,cardz_n
1,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.56,2019,livz_n
1,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",18.02,2019,fynmzm_n
1,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",10.91,2019,fydyzm_n
1,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.83,2019,fydeazm_n
1,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",3.29,2019,fyexdzm_n
1,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",0.86,2019,fysmrz_n
1,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",36.14,2019,fywitz_n
1,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",11.78,2019,fyinfz_n
1,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",39.21,2019,fycardiacz_n
1,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",3.53,2019,fylivz_n
1,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",73.32,2019,rdshzm_n
1,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",73.1,2019,htazm_n
1,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",74.02,2019,extzm_n
1,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",583.24,2019,hdzm_n
1,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",602.38,2019,exhdzm_n
1,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",47.49,2019,hdyzm_n
1,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",0.99,2019,shrtz_n
1,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.97,2019,shrdz_n
1,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.71,2019,lenz_n
1,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",9.45,2019,onez_n
1,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",9.35,2019,miiz_n
1,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",12.96,2019,sepiz_n
1,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",32.51,2019,achfz_n
1,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",23.37,2019,acdrz_n
1,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.28,2019,acarz_n
1,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",86.13,2019,ipedz_n
1,"N: ED30 - Average annual index discharges, 2019-22",46.17,2019,ed30indexzm_n
1,"N: ED30- Average annual number of ED visits, 2019-22",7.17,2019,ed30obszm_n
1,"N: ED30 - Average annual expected ED visits, 2019-22",7.42,2019,ed30expzm_n
1,"N: ED30: Standardized Ratio of ED30, 2019-22",1.0,2019,ed30z_n
1,"N SRR -  Standardized Readmission Ratio, 2022",1.04,2022,srry4_n
1,"N: SRR - Average index discharges, 2022",74.61,2022,indexmy4_n
1,"N: SRR - Average number of readmissions, 2022",19.68,2022,readmmy4_n
1,"N: SRR - Average expected readmissions, 2022",19.74,2022,srrexpmy4_n
1,Pt included in SEDR analysis,54.29,2019,rdsezm_n
1,Total number of ED Visits,50.31,2019,hedzm_n
1,Expected number of ED events,52.76,2019,exedzm_n
1,Years at risk for ED visit rate,34.96,2019,edyrzm_n
1,Years at risk for ED visit rate,29363.19,2019,edyrz_n
1,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",0.95,2019,sedrz_n
1,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",60.86,2019,rdstzm_n
1,"N: STR - Average number of patients (per year in average facility), 2019-2022",66.45,2019,rdsalltzm_n
1,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",2.54,2019,txzm_n
1,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",2.91,2019,txallzm_n
1,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",40.53,2019,txyzm_n
1,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",2.15,2019,cadalltzm_n
1,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.8,2019,livealltzm_n
1,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",1.85,2019,extxzm_n
1,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",1.37,2019,strz_n
1,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",65.23,2022,pppwpty4m_n
1,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",30.2,2022,WLy4_n
1,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",44.08,2022,WLlt40y4_n
1,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",28.84,2022,WL4074y4_n
1,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",31.56,2022,WLmaley4_n
1,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",28.09,2022,WLfemy4_n
1,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",29.39,2022,WLwhhy4_n
1,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",29.5,2022,WLwhnhy4_n
1,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",29.43,2022,WLbly4_n
1,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",46.69,2022,WLasy4_n
1,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",24.02,2022,WLnay4_n
1,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",33.98,2022,WLothy4_n
1,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",25.01,2022,WLDMy4_n
1,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",34.1,2022,WLnodmy4_n
1,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",29.12,2022,WLnotxy4_n
1,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",41.09,2022,WLtxy4_n
1,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",26.34,2022,WLVCat1y4_n
1,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",37.06,2022,WLVCat2y4_n
1,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",28.1,2022,WLVCat3y4_n
1,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",548.92,2022,pppwpmy4m_n
1,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",30.26,2022,pppwy4_n
1,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",10.07,2019,swrptzm_n
1,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",7.75,2019,swrpyzm_n
1,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",1.31,2019,swrwlzm_n
1,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.66,2019,swrexwlzm_n
1,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",1.98,2019,swrz_n
1,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",86.99,2021,FVfy3_n
1,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",7.65,2021,FVdeclinedfy3_n
1,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.11,2021,FVovndfy3_n
1,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",5.36,2021,FVothrsnfy3_n
1,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",73.57,2022,FVhy4_n
1,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",74.72,2022,FVmcarehy4_n
1,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",73.96,2022,FVmahy4_n
1,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",75.07,2022,FVmpphy4_n
1,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",72.73,2022,FVdualhy4_n
1,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",75.38,2022,FVmsphy4_n
1,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",68.05,2022,FVnonmcarehy4_n
1,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",67.86,2022,FVlt18hy4_n
1,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",66.96,2022,FV1839hy4_n
1,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",71.71,2022,FV4064hy4_n
1,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",73.73,2022,FV6574hy4_n
1,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",77.6,2022,FV75uphy4_n
1,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",73.29,2022,FVmalehy4_n
1,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",74.04,2022,FVfemhy4_n
1,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",80.84,2022,FVashy4_n
1,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",66.67,2022,FVnahy4_n
1,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",75.17,2022,FVwhhy4_n
1,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",50.0,2022,FVrothhy4_n
1,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",67.4,2022,FVblkhy4_n
1,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",73.24,2022,FVhisphy4_n
1,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",64.26,2022,FVVCat1hy4_n
1,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",75.13,2022,FVVCat2hy4_n
1,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",76.96,2022,FVVCat3hy4_n
1,"N: Influenza - Average number of patients treated on 12/31, 2022",68.94,2022,eFVy4m_n
1,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",0.67,2022,medrsnfy4m_N
1,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.67,2022,CWhdavgHGBy4_n
1,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",23.95,2022,CWhdhgb1y4_n
1,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",35.48,2022,CWhdhgb2y4_n
1,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",27.47,2022,CWhdhgb3y4_n
1,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",10.8,2022,CWhdhgb4y4_n
1,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.3,2022,CWhdhgb5y4_n
1,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",76.09,2022,CWhdesarxy4_n
1,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.88,2022,CWpdavgHGBy4_n
1,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",23.73,2022,CWpdhgb1y4_n
1,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",28.09,2022,CWpdhgb2y4_n
1,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",25.04,2022,CWpdhgb3y4_n
1,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",18.57,2022,CWpdhgb4y4_n
1,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",4.57,2022,CWpdhgb5y4_n
1,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",54.74,2022,CWpdesarxy4_n
1,"N: HD HGB (Adult) - Average number of eligible patients, 2022",78.45,2022,CWhdptdenomy4m_n
1,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",685.96,2022,CWhdptmthdenomy4m_n
1,"N: PD HGB (Adult) - Average number of eligible patients, 2022",19.89,2022,CWpdptdenomy4m_n
1,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",149.92,2022,CWpdptmthdenomy4m_n
1,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",40.28,2022,rdstfy4m_n
1,"N: STrR (Adult) - Average Patient Years at Risk, 2022",24.37,2022,tfyy4m_n
1,"N: STrR (Adult) - Average Number of Transfusions, 2022",7.03,2022,tfy4m_n
1,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",8.28,2022,extfy4m_n
1,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.85,2022,strry4_n
1,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.88,2022,CWhdalby4_n
1,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",2.33,2022,CWhdalb1y4_n
1,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",9.62,2022,CWhdalb2y4_n
1,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",39.96,2022,CWhdalb3y4_n
1,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",45.25,2022,CWhdalb4y4_n
1,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",2.85,2022,CWhdalb5y4_n
1,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",51.9,2022,CWhdalblt4y4_n
1,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.57,2022,CWhdavgufry4_n
1,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",86.87,2022,CWhdufr1y4_n
1,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",7.25,2022,CWhdufr2y4_n
1,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",3.49,2022,CWhdufrmissy4_n
1,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.38,2022,CWhdufrgt20y4_n
1,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.67,2022,CWpdalby4_n
1,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",6.2,2022,CWpdalb1y4_n
1,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",21.15,2022,CWpdalb2y4_n
1,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",41.78,2022,CWpdalb3y4_n
1,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",26.42,2022,CWpdalb4y4_n
1,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",4.45,2022,CWpdalb5y4_n
1,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",69.13,2022,CWpdalblt4y4_n
1,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",78.45,2022,CWhddenomy4m_n
1,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",685.96,2022,CWhdmthdenomy4m_n
1,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",19.89,2022,CWpddenomy4m_n
1,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",149.92,2022,CWpdmthdenomy4m_n
1,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.2,2022,CWpdavgktvy4_n
1,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",5.82,2022,CWpdktv1y4_n
1,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",69.42,2022,CWpdktv2y4_n
1,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",21.55,2022,CWpdktv3y4_n
1,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",3.21,2022,CWpdktv4y4_n
1,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.61,2022,CWhdavgktvy4_n
1,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",1.58,2022,CWhdktv1y4_n
1,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",74.85,2022,CWhdktv2y4_n
1,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",21.9,2022,CWhdktv3y4_n
1,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.67,2022,CWhdktv4y4_n
1,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",74.03,2022,CWhdktvptsy4m_N
1,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",642.01,2022,CWhdktvptmthy4m_N
2,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",5.27,2022,allmcFcovpatPq4_n
2,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",32.94,2022,allmcEcovpatPq4_n
2,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",42.01,2022,allmcEcovDeaPq4_n
2,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",42.31,2022,allmcEcovHosPq4_n
2,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",9.7,2022,nh_mcFcovpatPq4_n
2,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",50.33,2022,nh_mcEcovpatPq4_n
2,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",51.44,2022,nh_mcEcovDeaPq4_n
2,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",51.82,2022,nh_mcEcovHosPq4_n
2,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",64.79,2022,agey4_n
2,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.15,2022,age1y4_n
2,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",45.47,2022,age2y4_n
2,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",54.39,2022,age3y4_n
2,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",41.72,2022,dis1y4_n
2,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",30.04,2022,dis2y4_n
2,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",10.3,2022,dis3y4_n
2,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",17.26,2022,dis4y4_n
2,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.68,2022,dis5y4_n
2,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",16.45,2022,vin1y4_n
2,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",17.77,2022,vin2y4_n
2,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.28,2022,vin3y4_n
2,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",25.84,2022,vin4y4_n
2,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",26.66,2022,vin5y4_n
2,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",9.1,2022,rac1y4_n
2,"N: Prevalent Patients - Race: % African American, 12/31/2022",37.92,2022,rac2y4_n
2,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.9,2022,rac3y4_n
2,"N: Prevalent Patients - Race: % White, 12/31/2022",51.62,2022,rac4y4_n
2,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.46,2022,rac5y4_n
2,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",18.7,2022,eth1y4_n
2,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",81.09,2022,eth2y4_n
2,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.2,2022,eth3y4_n
2,"N: Prevalent Patients - Sex: % Female, 12/31/2022",41.32,2022,sexy4_n
2,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",16.97,2022,nrshomey4_n
2,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",5.1,2022,viny4_n
2,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",90.43,2022,modhdy4_n
2,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",2.49,2022,modhhdy4_n
2,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.0,2022,modcapdy4_n
2,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",5.98,2022,modccpdy4_n
2,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.1,2022,modothry4_n
2,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",67.25,2022,pahy4m_n
2,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",17.78,2022,CWunCa1y4_n
2,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",76.73,2022,CWunCa2y4_n
2,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.28,2022,CWunCa3y4_n
2,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",4.21,2022,CWunCamissy4_n
2,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
2,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.91,2022,CWavgUnCay4_n
2,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.29,2022,CWavgPy4_n
2,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",8.85,2022,CWP1y4_n
2,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",24.37,2022,CWP2y4_n
2,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",27.77,2022,CWP3y4_n
2,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",21.88,2022,CWP4y4_n
2,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",12.51,2022,CWP5y4_n
2,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",4.62,2022,CWPmissy4_n
2,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
2,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",2.84,2022,CWunCagt102y4_n
2,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",93.44,2022,CWptdenomy4m_n
2,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",798.97,2022,CWptmthdenomy4m_n
2,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",99.89,2022,serumphospatsy4m_n
2,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",846.24,2022,serumphospmy4m_n
2,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",93.69,2022,CWhcptdenomy4m_n
2,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",801.17,2022,CWhcptmthdenomy4m_n
2,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",63.76,2022,ppavfy4_n
2,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",11.16,2022,ppavgy4_n
2,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",21.42,2022,ppcathy4_n
2,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",3.66,2022,ppomy4_n
2,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",17.66,2022,ltcy4_n
2,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",13.27,2022,piavfy4_n
2,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",2.88,2022,piavgy4_n
2,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",78.31,2022,picathy4_n
2,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",5.54,2022,piomy4_n
2,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",14.04,2022,pifisty4_n
2,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",92.77,2022,phdvapty4m_n
2,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",781.4,2022,phdy4m_n
2,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",17.68,2022,ihdy4m_n
2,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",63.33,2022,sfry4_n
2,"N: VA infection - Average number of eligible PD patients, 2022",8.73,2022,pdpaty4m_n
2,"N: VA infection - Average number of eligible PD patient-months, 2022",64.78,2022,pdptmoy4m_n
2,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",3.51,2022,pd2inf100moy4_n
2,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",52.82,2022,ncmy4m_n
2,"N: Prevalent Comorbidities - Average % with Anemia, 2022",3.97,2022,clmanemy4_n
2,"N: Prevalent Comorbidities - Average % with AIDS, 2022",1.42,2022,clmhivaidmy4_n
2,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.3,2022,clmalcomy4_n
2,"N: Prevalent Comorbidities - Average % with Cancer, 2022",4.9,2022,clmcanmy4_n
2,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",0.82,2022,clmcamy4_n
2,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",21.84,2022,clmcdmy4_n
2,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",8.34,2022,clmcvdmy4_n
2,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",16.83,2022,clmcopdmy4_n
2,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",33.7,2022,clmchfmy4_n
2,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",38.59,2022,clmdiabmy4_n
2,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",1.07,2022,clmdrugmy4_n
2,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",3.3,2022,clmgtbmy4_n
2,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.72,2022,clmhepbmy4_n
2,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",2.02,2022,clmhepothmy4_n
2,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",16.61,2022,clmhypthymy4_n
2,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",20.24,2022,clminfmy4_n
2,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",31.76,2022,clmihdmy4_n
2,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",10.44,2022,clmmimy4_n
2,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",18.48,2022,clmpvdmy4_n
2,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",3.95,2022,clmpnemy4_n
2,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.47,2022,clmcntcomy4_n
2,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",4.73,2022,clminfvamy4_n
2,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.32,2022,clmmstinfmy4_n
2,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.41,2022,clmtbmy4_n
2,"N (AFS): Facility Information - Average number of patients, 2022",121.68,2022,allcnty4m_n
2,N (AFS): Facility Information - Average number of all patients on 12/31/2022,77.34,2022,endcnty4m_n
2,"N (AFS): Facility Information - Average % of patients transferred in, 2022",18.86,2022,transiny4_n
2,"N (AFS): Facility Information - Average % of patients transferred out, 2022",19.74,2022,transouty4_n
2,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,76.06,2022,medicarey4_n
2,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,11.97,2022,medpendy4_n
2,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,11.97,2022,nonmedy4_n
2,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.15,2022,cfc_N
2,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,3.82,2022,std_N
2,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",36.11,2022,p_age1y4_n
2,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",11.11,2022,p_age2y4_n
2,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",27.78,2022,p_age3y4_n
2,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",25.0,2022,p_age4y4_n
2,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",8.33,2022,p_dis1y4_n
2,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",0.0,2022,p_dis2y4_n
2,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",36.11,2022,p_dis3y4_n
2,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",33.33,2022,p_dis4y4_n
2,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
2,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
2,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",16.67,2022,p_dis7y4_n
2,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",5.56,2022,p_dis8y4_n
2,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",33.33,2022,p_vin1y4_n
2,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",13.89,2022,p_vin2y4_n
2,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",22.22,2022,p_vin3y4_n
2,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",19.44,2022,p_vin4y4_n
2,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",11.11,2022,p_vin5y4_n
2,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",2.78,2022,p_rac1y4_n
2,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",36.11,2022,p_rac2y4_n
2,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",0.0,2022,p_rac3y4_n
2,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",61.11,2022,p_rac4y4_n
2,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",0.0,2022,p_rac5y4_n
2,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",25.0,2022,p_eth1y4_n
2,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",75.0,2022,p_eth2y4_n
2,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
2,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",50.0,2022,p_sexy4_n
2,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",58.33,2022,p_modhdy4_n
2,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
2,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.0,2022,p_modcapdy4_n
2,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",41.67,2022,p_modccpdy4_n
2,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
2,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",34.38,2022,p_allmdcrmy4_n
2,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",37.5,2022,p_insmdcdmy4_n
2,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",18.75,2022,p_insempmy4_n
2,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",9.38,2022,p_insnonothmy4_n
2,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",9.38,2022,p_nephnomy4_n
2,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",28.13,2022,p_nephy6my4_n
2,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",15.63,2022,p_nephy612my4_n
2,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",34.38,2022,p_nephy12my4_n
2,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",12.5,2022,p_nephunkmissmy4_n
2,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",90.63,2022,p_ptinfymy4_n
2,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",3.85,2022,p_mefavfmy4_n
2,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
2,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",96.15,2022,p_mefcathmy4_n
2,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
2,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",3.85,2022,p_avfpresentmy4_n
2,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",17.31,2022,p_ppavfy4_n
2,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",60.58,2022,p_ltcy4_n
2,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",34.78,2022,p_WLy4_n
2,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",29.38,2022,p_WLlt10y4_n
2,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",52.53,2022,p_WL1017y4_n
2,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.42,2022,p_CWhdavgHGBy4_n
2,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",26.55,2022,p_CWhdhgb1y4_n
2,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",28.36,2022,p_CWhdhgb2y4_n
2,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",25.82,2022,p_CWhdhgb3y4_n
2,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",6.18,2022,p_CWhdhgb4y4_n
2,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",13.09,2022,p_CWhdhgb5y4_n
2,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.24,2022,p_CWpdavgHGBy4_n
2,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",17.65,2022,p_CWpdhgb1y4_n
2,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",22.35,2022,p_CWpdhgb2y4_n
2,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",19.41,2022,p_CWpdhgb3y4_n
2,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",20.59,2022,p_CWpdhgb4y4_n
2,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",20.0,2022,p_CWpdhgb5y4_n
2,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.09,2022,p_CWhdalby4_n
2,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",1.82,2022,p_CWhdalb1y4_n
2,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",3.64,2022,p_CWhdalb2y4_n
2,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",21.09,2022,p_CWhdalb3y4_n
2,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",60.0,2022,p_CWhdalb4y4_n
2,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",13.45,2022,p_CWhdalb5y4_n
2,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.73,2022,p_CWpdalby4_n
2,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",4.71,2022,p_CWpdalb1y4_n
2,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",15.88,2022,p_CWpdalb2y4_n
2,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",31.18,2022,p_CWpdalb3y4_n
2,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",25.88,2022,p_CWpdalb4y4_n
2,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",22.35,2022,p_CWpdalb5y4_n
2,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",91.18,2022,p_CWpdktvge18y4_n
2,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",79.51,2022,p_CWhdktvge12y4_n
2,"N: Patient Placement -  % of incident patients, 2022",17.21,2022,ppidy4_n
2,"N: Patient Placement -  % of patients continuing at facility, 2022",71.32,2022,ppcdy4_n
2,"N: Patient Placement -  % of patients that transfered into facility, 2022",11.48,2022,pptdy4_n
2,"N: End of Year Status - % of patients death attributed to this facility, 2022",12.88,2022,pdhdy4_n
2,"N: End of Year Status - % of patients death attributed to another facility, 2022",2.41,2022,pdody4_n
2,"N: End of Year Status - % of patients that received a transplant, 2022",3.93,2022,ptxdy4_n
2,"N: End of Year Status - % of patients alive in this facility, 2022",68.43,2022,pahdy4_n
2,"N: End of Year Status - % of patients alive in another facility, 2022",8.1,2022,paody4_n
2,"N: End of Year Status - % of patients other, 2022",4.25,2022,potdy4_n
2,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,70.27,2022,iuhemy4m_n
2,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.01,2022,iufreqy4m_n
2,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,70.26,2022,iunonfreqy4m_n
2,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.0,2022,iuothy4m_n
2,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
2,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
2,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,1.84,2022,ihhemy4m_n
2,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.32,2022,ihfreqy4m_n
2,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,1.52,2022,ihnonfreqy4m_n
2,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
2,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.79,2022,ihcapdy4m_n
2,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,4.44,2022,ihccpdy4m_n
2,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",17.32,2022,staffy4m_n
2,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,6.37,2022,nurseFTy4m_n
2,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,5.79,2022,ptcareFTy4m_n
2,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,1.04,2022,dietFTy4m_n
2,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.05,2022,socwkFTy4m_n
2,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,1.42,2022,nursePTy4m_n
2,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.9,2022,ptcarePTy4m_n
2,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.42,2022,dietPTy4m_n
2,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.34,2022,socwkPTy4m_n
2,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,35.52,2022,vocrehaby4m_n
2,"N (AFS): Facility Information - Average % incident patients, 2022",15.42,2022,incpery4_n
2,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,27.45,2022,employedy4_n
2,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.86,2022,schooly4_n
2,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",51.21,2022,nh_ppavfy4_n
2,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",24.45,2022,nh_ltcy4_n
2,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",4.15,2022,nh_CWhdktv1y4_n
2,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",9.82,2022,nh_CWpdktv1y4_n
2,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",32.26,2022,nh_CWhdhgb1y4_n
2,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",77.26,2022,nh_CWhdesarxy4_n
2,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",32.4,2022,nh_CWpdhgb1y4_n
2,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",55.09,2022,nh_CWpdesarxy4_n
2,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",38.83,2022,nh_obdry4_n
2,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.1,2022,nh_smry4_n
2,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",16.82,2022,nh_wity4_n
2,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",277.22,2022,nh_obhtry4_n
2,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.43,2022,nh_shrty4_n
2,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",25.27,2022,nh_sepiy4_n
2,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",13.37,2022,nh_miiy4_n
2,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",45.39,2022,nh_achfy4_n
2,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",32.46,2022,nh_acdry4_n
2,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",3.36,2022,nh_acary4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",2.13,2022,nh_clmhivaidmy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",8.7,2022,nh_clminfvamy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",1.09,2022,nh_clmhepbmy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",3.67,2022,nh_clmhepothmy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",3.5,2022,nh_clmmstinfmy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",10.31,2022,nh_clmpnemy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.57,2022,nh_clmtbmy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",40.7,2022,nh_clminfmy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.22,2022,nh_clmcamy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",39.0,2022,nh_clmcdmy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",19.04,2022,nh_clmcvdmy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",54.62,2022,nh_clmchfmy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",50.33,2022,nh_clmihdmy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",17.51,2022,nh_clmmimy4_n
2,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",35.48,2022,nh_clmpvdmy4_n
2,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
2,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",29.21,2022,nh_age2y4_n
2,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",70.79,2022,nh_age3y4_n
2,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",48.46,2022,nh_dis1y4_n
2,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",28.73,2022,nh_dis2y4_n
2,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",4.78,2022,nh_dis3y4_n
2,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",16.56,2022,nh_dis4y4_n
2,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",1.46,2022,nh_dis5y4_n
2,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",6.75,2022,nh_rac1y4_n
2,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",41.07,2022,nh_rac2y4_n
2,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",0.82,2022,nh_rac3y4_n
2,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",50.94,2022,nh_rac4y4_n
2,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.43,2022,nh_rac5y4_n
2,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",15.96,2022,nh_eth1y4_n
2,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",83.68,2022,nh_eth2y4_n
2,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.36,2022,nh_eth3y4_n
2,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",20.93,2022,nh_vin1y4_n
2,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",17.26,2022,nh_vin2y4_n
2,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",11.45,2022,nh_vin3y4_n
2,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",25.4,2022,nh_vin4y4_n
2,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",24.96,2022,nh_vin5y4_n
2,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",44.65,2022,nh_sexy4_n
2,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",95.06,2022,nh_modhdy4_n
2,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",3.77,2022,nh_modhhdy4_n
2,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.17,2022,nh_modcapdy4_n
2,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",0.82,2022,nh_modccpdy4_n
2,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.19,2022,nh_modothry4_n
2,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",83.75,2022,nh_allmdcrmy4_n
2,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",10.54,2022,nh_insmdcdmy4_n
2,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",1.51,2022,nh_insempmy4_n
2,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",4.2,2022,nh_insnonothmy4_n
2,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",8.91,2022,nh_mefavfmy4_n
2,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",1.38,2022,nh_mefgraftmy4_n
2,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",88.46,2022,nh_mefcathmy4_n
2,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",1.25,2022,nh_mefoumaccessmy4_n
2,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",20.58,2022,nh_avfpresentmy4_n
2,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",17.25,2022,nh_nephnomy4_n
2,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",15.31,2022,nh_nephy6my4_n
2,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",11.29,2022,nh_nephy612my4_n
2,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",20.89,2022,nh_nephy12my4_n
2,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",35.26,2022,nh_nephunkmissmy4_n
2,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",81.99,2022,nh_ptinfymy4_n
2,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",1.04,2022,alcomy4_n
2,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",14.69,2022,ashdmy4_n
2,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",18.78,2022,othcarmy4_n
2,"N (2728): Incident Patients  - Percent with cancer, 2022",8.16,2022,canmy4_n
2,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",27.41,2022,chfmy4_n
2,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",8.68,2022,cvamy4_n
2,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",34.55,2022,diabimy4_n
2,"N (2728): Incident Patients  - Percent with diabetes, 2022",59.44,2022,diabmy4_n
2,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.23,2022,drugmy4_n
2,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",87.3,2022,hxhtmy4_n
2,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",5.39,2022,ambumy4_n
2,"N (2728): Incident Patients  - Percent inability to transfer, 2022",4.04,2022,transmy4_n
2,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",8.15,2022,copdmy4_n
2,"N (2728): Incident Patients  - Percent with PVD, 2022",7.48,2022,pvdmy4_n
2,"N (2728): Incident Patients  - Percent smoker, 2022",4.07,2022,smokmy4_n
2,"N (2728): Incident Patients  - Percent Hispanic, 2022",17.44,2022,ethmy4_n
2,"N (2728): Incident Patients  - Percent White, 2022",57.74,2022,whitemy4_n
2,"N (2728): Incident Patients  - Percent African American, 2022",30.67,2022,blackmy4_n
2,"N (2728): Incident Patients  - Percent Native American, 2022",2.16,2022,nativmy4_n
2,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",8.83,2022,asianmy4_n
2,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.59,2022,racoummy4_n
2,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",26.35,2022,cempmy4_n
2,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",36.9,2022,pempmy4_n
2,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",41.9,2022,dbprimy4_n
2,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",6.73,2022,gnprimy4_n
2,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",29.06,2022,htprimy4_n
2,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",22.31,2022,omprimy4_n
2,"N (2728): Incident Patients  - Percent female, 2022",40.27,2022,femmy4_n
2,"N (2728): Incident Patients  - Average age, 2022",65.44,2022,agemy4_n
2,"N (2728): Incident Patients  - Average serum albumin, 2022",3.38,2022,salbmy4_n
2,"N (2728): Incident Patients  - Average creatinine, 2022",6.83,2022,creamy4_n
2,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.12,2022,hgmy4_n
2,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",10.15,2022,gfrmy4_n
2,"N (2728): Incident Patients  - Average count of comorbidities, 2022",2.9,2022,cntcomy4_n
2,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",91.98,2022,pdmodMEFHDmy4_n
2,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",8.02,2022,pdmodMEFPDmy4_n
2,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
2,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",41.08,2022,insmdcrmy4_n
2,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",20.6,2022,insmdcdmy4_n
2,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",12.03,2022,insmdcrcdmy4_n
2,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",9.42,2022,insempmy4_n
2,"N (2728): Incident Patients  - Percent with no coverage, 2022",0.42,2022,insnonemy4_n
2,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",9.84,2022,insmdcromy4_n
2,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",6.61,2022,insmedomy4_n
2,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",15.53,2022,preepomy4_n
2,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",15.41,2022,nephnomy4_n
2,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",15.38,2022,nephy6my4_n
2,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",16.64,2022,nephy612my4_n
2,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",31.72,2022,nephy12my4_n
2,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",20.86,2022,nephunkmissmy4_n
2,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",90.14,2022,ptinfymy4_n
2,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",64.83,2022,ptxmedunfitmy4_n
2,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
2,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
2,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",16.72,2022,ptxdeclinemy4_n
2,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",32.97,2022,ptxnotassessmy4_n
2,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",14.59,2022,mefavfmy4_n
2,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",2.52,2022,mefgraftmy4_n
2,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",82.3,2022,mefcathmy4_n
2,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.59,2022,mefoumaccessmy4_n
2,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",29.18,2022,avfpresentmy4_n
2,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",26.93,2022,bmimmy4_n
2,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",27.93,2022,bmifmy4_n
2,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",1.8,2022,ptinfnmy4m_n
2,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",16.76,2022,hemomy4m_n
2,"N (2728): Incident Patients  - Average Number of forms returned, 2022",18.22,2022,nmy4m_n
2,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",99.87,2019,rdsmzm_n
2,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",64.89,2019,dyzm_n
2,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",11.79,2019,deazm_n
2,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",12.92,2019,exdzm_n
2,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.06,2019,dudzm_n
2,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",0.91,2019,smrz_n
2,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",19.54,2019,witz_n
2,"N: All Patient Mortality - % of deaths from infection, 2019-2022",12.4,2019,infz_n
2,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",51.46,2019,cardz_n
2,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.37,2019,livz_n
2,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",19.45,2019,fynmzm_n
2,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",11.62,2019,fydyzm_n
2,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",3.14,2019,fydeazm_n
2,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",3.16,2019,fyexdzm_n
2,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",0.99,2019,fysmrz_n
2,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",20.77,2019,fywitz_n
2,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",11.31,2019,fyinfz_n
2,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",48.41,2019,fycardiacz_n
2,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",2.38,2019,fylivz_n
2,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",80.88,2019,rdshzm_n
2,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",80.22,2019,htazm_n
2,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",76.4,2019,extzm_n
2,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",680.26,2019,hdzm_n
2,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",624.39,2019,exhdzm_n
2,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",51.4,2019,hdyzm_n
2,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",1.05,2019,shrtz_n
2,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",1.09,2019,shrdz_n
2,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",8.16,2019,lenz_n
2,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",9.08,2019,onez_n
2,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",8.67,2019,miiz_n
2,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",14.14,2019,sepiz_n
2,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",30.62,2019,achfz_n
2,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",21.16,2019,acdrz_n
2,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.55,2019,acarz_n
2,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",88.6,2019,ipedz_n
2,"N: ED30 - Average annual index discharges, 2019-22",47.95,2019,ed30indexzm_n
2,"N: ED30- Average annual number of ED visits, 2019-22",5.92,2019,ed30obszm_n
2,"N: ED30 - Average annual expected ED visits, 2019-22",7.65,2019,ed30expzm_n
2,"N: ED30: Standardized Ratio of ED30, 2019-22",0.85,2019,ed30z_n
2,"N SRR -  Standardized Readmission Ratio, 2022",1.1,2022,srry4_n
2,"N: SRR - Average index discharges, 2022",80.21,2022,indexmy4_n
2,"N: SRR - Average number of readmissions, 2022",21.53,2022,readmmy4_n
2,"N: SRR - Average expected readmissions, 2022",20.92,2022,srrexpmy4_n
2,Pt included in SEDR analysis,58.03,2019,rdsezm_n
2,Total number of ED Visits,41.31,2019,hedzm_n
2,Expected number of ED events,52.4,2019,exedzm_n
2,Years at risk for ED visit rate,36.31,2019,edyrzm_n
2,Years at risk for ED visit rate,53880.54,2019,edyrz_n
2,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",0.79,2019,sedrz_n
2,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",68.22,2019,rdstzm_n
2,"N: STR - Average number of patients (per year in average facility), 2019-2022",74.12,2019,rdsalltzm_n
2,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",2.87,2019,txzm_n
2,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",3.25,2019,txallzm_n
2,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",44.57,2019,txyzm_n
2,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",2.58,2019,cadalltzm_n
2,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.77,2019,livealltzm_n
2,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",2.05,2019,extxzm_n
2,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",1.4,2019,strz_n
2,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",65.09,2022,pppwpty4m_n
2,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",23.97,2022,WLy4_n
2,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",36.33,2022,WLlt40y4_n
2,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",22.7,2022,WL4074y4_n
2,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",24.95,2022,WLmaley4_n
2,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",22.43,2022,WLfemy4_n
2,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",26.19,2022,WLwhhy4_n
2,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",20.16,2022,WLwhnhy4_n
2,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",23.82,2022,WLbly4_n
2,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",33.47,2022,WLasy4_n
2,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",27.11,2022,WLnay4_n
2,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",25.38,2022,WLothy4_n
2,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",21.12,2022,WLDMy4_n
2,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",25.94,2022,WLnodmy4_n
2,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",22.56,2022,WLnotxy4_n
2,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",38.41,2022,WLtxy4_n
2,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",19.45,2022,WLVCat1y4_n
2,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",29.15,2022,WLVCat2y4_n
2,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",24.24,2022,WLVCat3y4_n
2,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",552.53,2022,pppwpmy4m_n
2,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",22.45,2022,pppwy4_n
2,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",11.03,2019,swrptzm_n
2,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",8.61,2019,swrpyzm_n
2,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",1.28,2019,swrwlzm_n
2,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.8,2019,swrexwlzm_n
2,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",1.6,2019,swrz_n
2,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",75.73,2021,FVfy3_n
2,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",10.83,2021,FVdeclinedfy3_n
2,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.16,2021,FVovndfy3_n
2,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",13.44,2021,FVothrsnfy3_n
2,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",61.02,2022,FVhy4_n
2,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",62.79,2022,FVmcarehy4_n
2,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",63.11,2022,FVmahy4_n
2,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",62.5,2022,FVmpphy4_n
2,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",60.54,2022,FVdualhy4_n
2,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",63.01,2022,FVmsphy4_n
2,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",53.25,2022,FVnonmcarehy4_n
2,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",47.37,2022,FVlt18hy4_n
2,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",55.31,2022,FV1839hy4_n
2,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",58.38,2022,FV4064hy4_n
2,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",61.99,2022,FV6574hy4_n
2,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",65.06,2022,FV75uphy4_n
2,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",60.98,2022,FVmalehy4_n
2,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",61.03,2022,FVfemhy4_n
2,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",69.17,2022,FVashy4_n
2,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",57.25,2022,FVnahy4_n
2,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",64.42,2022,FVwhhy4_n
2,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",45.0,2022,FVrothhy4_n
2,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",54.6,2022,FVblkhy4_n
2,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",61.25,2022,FVhisphy4_n
2,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",49.86,2022,FVVCat1hy4_n
2,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",61.27,2022,FVVCat2hy4_n
2,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",65.64,2022,FVVCat3hy4_n
2,"N: Influenza - Average number of patients treated on 12/31, 2022",70.76,2022,eFVy4m_n
2,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",0.71,2022,medrsnfy4m_N
2,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.63,2022,CWhdavgHGBy4_n
2,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",25.13,2022,CWhdhgb1y4_n
2,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",33.2,2022,CWhdhgb2y4_n
2,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",26.95,2022,CWhdhgb3y4_n
2,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",10.83,2022,CWhdhgb4y4_n
2,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.89,2022,CWhdhgb5y4_n
2,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",77.63,2022,CWhdesarxy4_n
2,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.81,2022,CWpdavgHGBy4_n
2,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",24.74,2022,CWpdhgb1y4_n
2,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",28.58,2022,CWpdhgb2y4_n
2,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",25.87,2022,CWpdhgb3y4_n
2,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",16.89,2022,CWpdhgb4y4_n
2,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.91,2022,CWpdhgb5y4_n
2,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",53.65,2022,CWpdesarxy4_n
2,"N: HD HGB (Adult) - Average number of eligible patients, 2022",87.95,2022,CWhdptdenomy4m_n
2,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",749.23,2022,CWhdptmthdenomy4m_n
2,"N: PD HGB (Adult) - Average number of eligible patients, 2022",17.65,2022,CWpdptdenomy4m_n
2,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",136.57,2022,CWpdptmthdenomy4m_n
2,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",41.28,2022,rdstfy4m_n
2,"N: STrR (Adult) - Average Patient Years at Risk, 2022",23.94,2022,tfyy4m_n
2,"N: STrR (Adult) - Average Number of Transfusions, 2022",9.09,2022,tfy4m_n
2,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",8.3,2022,extfy4m_n
2,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",1.1,2022,strry4_n
2,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.86,2022,CWhdalby4_n
2,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",2.62,2022,CWhdalb1y4_n
2,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",10.25,2022,CWhdalb2y4_n
2,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",39.37,2022,CWhdalb3y4_n
2,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",43.02,2022,CWhdalb4y4_n
2,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",4.74,2022,CWhdalb5y4_n
2,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",52.23,2022,CWhdalblt4y4_n
2,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.6,2022,CWhdavgufry4_n
2,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",86.63,2022,CWhdufr1y4_n
2,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",6.65,2022,CWhdufr2y4_n
2,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",4.92,2022,CWhdufrmissy4_n
2,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",1.8,2022,CWhdufrgt20y4_n
2,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.65,2022,CWpdalby4_n
2,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",7.08,2022,CWpdalb1y4_n
2,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",21.7,2022,CWpdalb2y4_n
2,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",42.73,2022,CWpdalb3y4_n
2,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",24.42,2022,CWpdalb4y4_n
2,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",4.07,2022,CWpdalb5y4_n
2,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",71.51,2022,CWpdalblt4y4_n
2,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",87.95,2022,CWhddenomy4m_n
2,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",749.23,2022,CWhdmthdenomy4m_n
2,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",17.65,2022,CWpddenomy4m_n
2,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",136.57,2022,CWpdmthdenomy4m_n
2,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.24,2022,CWpdavgktvy4_n
2,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",6.27,2022,CWpdktv1y4_n
2,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",65.42,2022,CWpdktv2y4_n
2,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",23.48,2022,CWpdktv3y4_n
2,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",4.82,2022,CWpdktv4y4_n
2,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.59,2022,CWhdavgktvy4_n
2,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",2.78,2022,CWhdktv1y4_n
2,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",74.59,2022,CWhdktv2y4_n
2,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",19.41,2022,CWhdktv3y4_n
2,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",3.21,2022,CWhdktv4y4_n
2,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",85.69,2022,CWhdktvptsy4m_N
2,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",726.53,2022,CWhdktvptmthy4m_N
3,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",3.76,2022,allmcFcovpatPq4_n
3,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",25.77,2022,allmcEcovpatPq4_n
3,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",35.88,2022,allmcEcovDeaPq4_n
3,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",37.52,2022,allmcEcovHosPq4_n
3,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",10.08,2022,nh_mcFcovpatPq4_n
3,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",48.86,2022,nh_mcEcovpatPq4_n
3,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",50.0,2022,nh_mcEcovDeaPq4_n
3,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",48.11,2022,nh_mcEcovHosPq4_n
3,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",65.25,2022,agey4_n
3,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.08,2022,age1y4_n
3,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",44.49,2022,age2y4_n
3,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",55.43,2022,age3y4_n
3,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",46.55,2022,dis1y4_n
3,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",31.85,2022,dis2y4_n
3,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",8.61,2022,dis3y4_n
3,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",12.69,2022,dis4y4_n
3,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.3,2022,dis5y4_n
3,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",16.14,2022,vin1y4_n
3,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",17.88,2022,vin2y4_n
3,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.95,2022,vin3y4_n
3,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",26.73,2022,vin4y4_n
3,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",25.31,2022,vin5y4_n
3,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",4.74,2022,rac1y4_n
3,"N: Prevalent Patients - Race: % African American, 12/31/2022",28.66,2022,rac2y4_n
3,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.15,2022,rac3y4_n
3,"N: Prevalent Patients - Race: % White, 12/31/2022",66.2,2022,rac4y4_n
3,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.25,2022,rac5y4_n
3,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",42.52,2022,eth1y4_n
3,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",57.39,2022,eth2y4_n
3,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.09,2022,eth3y4_n
3,"N: Prevalent Patients - Sex: % Female, 12/31/2022",39.77,2022,sexy4_n
3,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",12.96,2022,nrshomey4_n
3,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",4.84,2022,viny4_n
3,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",88.91,2022,modhdy4_n
3,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",1.8,2022,modhhdy4_n
3,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.72,2022,modcapdy4_n
3,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",8.43,2022,modccpdy4_n
3,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.14,2022,modothry4_n
3,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",70.3,2022,pahy4m_n
3,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",16.21,2022,CWunCa1y4_n
3,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",80.32,2022,CWunCa2y4_n
3,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",0.87,2022,CWunCa3y4_n
3,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",2.6,2022,CWunCamissy4_n
3,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
3,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.94,2022,CWavgUnCay4_n
3,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.17,2022,CWavgPy4_n
3,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",8.94,2022,CWP1y4_n
3,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",26.33,2022,CWP2y4_n
3,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",30.83,2022,CWP3y4_n
3,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",20.79,2022,CWP4y4_n
3,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",10.45,2022,CWP5y4_n
3,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",2.65,2022,CWPmissy4_n
3,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
3,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",1.9,2022,CWunCagt102y4_n
3,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",93.48,2022,CWptdenomy4m_n
3,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",827.98,2022,CWptmthdenomy4m_n
3,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",99.4,2022,serumphospatsy4m_n
3,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",875.34,2022,serumphospmy4m_n
3,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",93.48,2022,CWhcptdenomy4m_n
3,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",827.97,2022,CWhcptmthdenomy4m_n
3,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",54.31,2022,ppavfy4_n
3,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",19.61,2022,ppavgy4_n
3,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",23.88,2022,ppcathy4_n
3,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",2.2,2022,ppomy4_n
3,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",19.34,2022,ltcy4_n
3,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",10.58,2022,piavfy4_n
3,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",4.57,2022,piavgy4_n
3,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",80.81,2022,picathy4_n
3,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",4.04,2022,piomy4_n
3,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",11.22,2022,pifisty4_n
3,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",90.77,2022,phdvapty4m_n
3,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",792.29,2022,phdy4m_n
3,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",16.82,2022,ihdy4m_n
3,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",56.14,2022,sfry4_n
3,"N: VA infection - Average number of eligible PD patients, 2022",7.77,2022,pdpaty4m_n
3,"N: VA infection - Average number of eligible PD patient-months, 2022",55.64,2022,pdptmoy4m_n
3,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",1.75,2022,pd2inf100moy4_n
3,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",57.1,2022,ncmy4m_n
3,"N: Prevalent Comorbidities - Average % with Anemia, 2022",1.96,2022,clmanemy4_n
3,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.84,2022,clmhivaidmy4_n
3,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",0.96,2022,clmalcomy4_n
3,"N: Prevalent Comorbidities - Average % with Cancer, 2022",3.64,2022,clmcanmy4_n
3,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",0.73,2022,clmcamy4_n
3,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",17.44,2022,clmcdmy4_n
3,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",6.62,2022,clmcvdmy4_n
3,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",12.75,2022,clmcopdmy4_n
3,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",28.05,2022,clmchfmy4_n
3,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",36.84,2022,clmdiabmy4_n
3,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",0.65,2022,clmdrugmy4_n
3,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",2.65,2022,clmgtbmy4_n
3,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.3,2022,clmhepbmy4_n
3,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.31,2022,clmhepothmy4_n
3,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",16.34,2022,clmhypthymy4_n
3,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",17.05,2022,clminfmy4_n
3,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",26.26,2022,clmihdmy4_n
3,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",6.9,2022,clmmimy4_n
3,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",15.44,2022,clmpvdmy4_n
3,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",2.43,2022,clmpnemy4_n
3,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.05,2022,clmcntcomy4_n
3,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",4.86,2022,clminfvamy4_n
3,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.04,2022,clmmstinfmy4_n
3,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.17,2022,clmtbmy4_n
3,"N (AFS): Facility Information - Average number of patients, 2022",115.63,2022,allcnty4m_n
3,N (AFS): Facility Information - Average number of all patients on 12/31/2022,79.32,2022,endcnty4m_n
3,"N (AFS): Facility Information - Average % of patients transferred in, 2022",14.16,2022,transiny4_n
3,"N (AFS): Facility Information - Average % of patients transferred out, 2022",14.74,2022,transouty4_n
3,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,82.28,2022,medicarey4_n
3,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,6.77,2022,medpendy4_n
3,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,10.94,2022,nonmedy4_n
3,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.27,2022,cfc_N
3,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,5.47,2022,std_N
3,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",14.29,2022,p_age1y4_n
3,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",0.0,2022,p_age2y4_n
3,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",21.43,2022,p_age3y4_n
3,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",64.29,2022,p_age4y4_n
3,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",0.0,2022,p_dis1y4_n
3,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",0.0,2022,p_dis2y4_n
3,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",28.57,2022,p_dis3y4_n
3,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",42.86,2022,p_dis4y4_n
3,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
3,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
3,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",28.57,2022,p_dis7y4_n
3,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",0.0,2022,p_dis8y4_n
3,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",28.57,2022,p_vin1y4_n
3,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",35.71,2022,p_vin2y4_n
3,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",14.29,2022,p_vin3y4_n
3,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",7.14,2022,p_vin4y4_n
3,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",14.29,2022,p_vin5y4_n
3,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",0.0,2022,p_rac1y4_n
3,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",21.43,2022,p_rac2y4_n
3,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",0.0,2022,p_rac3y4_n
3,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",78.57,2022,p_rac4y4_n
3,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",0.0,2022,p_rac5y4_n
3,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",71.43,2022,p_eth1y4_n
3,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",28.57,2022,p_eth2y4_n
3,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
3,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",21.43,2022,p_sexy4_n
3,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",50.0,2022,p_modhdy4_n
3,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
3,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.0,2022,p_modcapdy4_n
3,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",50.0,2022,p_modccpdy4_n
3,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
3,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",55.56,2022,p_allmdcrmy4_n
3,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",27.78,2022,p_insmdcdmy4_n
3,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",11.11,2022,p_insempmy4_n
3,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",5.56,2022,p_insnonothmy4_n
3,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",27.78,2022,p_nephnomy4_n
3,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",11.11,2022,p_nephy6my4_n
3,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",11.11,2022,p_nephy612my4_n
3,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",33.33,2022,p_nephy12my4_n
3,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",16.67,2022,p_nephunkmissmy4_n
3,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",88.89,2022,p_ptinfymy4_n
3,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",0.0,2022,p_mefavfmy4_n
3,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",6.67,2022,p_mefgraftmy4_n
3,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",93.33,2022,p_mefcathmy4_n
3,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
3,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",6.67,2022,p_avfpresentmy4_n
3,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",19.12,2022,p_ppavfy4_n
3,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",61.76,2022,p_ltcy4_n
3,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",30.51,2022,p_WLy4_n
3,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",23.68,2022,p_WLlt10y4_n
3,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",32.37,2022,p_WL1017y4_n
3,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.87,2022,p_CWhdavgHGBy4_n
3,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",12.07,2022,p_CWhdhgb1y4_n
3,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",37.93,2022,p_CWhdhgb2y4_n
3,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",46.55,2022,p_CWhdhgb3y4_n
3,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",3.45,2022,p_CWhdhgb4y4_n
3,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",0.0,2022,p_CWhdhgb5y4_n
3,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.28,2022,p_CWpdavgHGBy4_n
3,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",17.53,2022,p_CWpdhgb1y4_n
3,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",23.71,2022,p_CWpdhgb2y4_n
3,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",16.49,2022,p_CWpdhgb3y4_n
3,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",32.99,2022,p_CWpdhgb4y4_n
3,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",9.28,2022,p_CWpdhgb5y4_n
3,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.33,2022,p_CWhdalby4_n
3,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",0.0,2022,p_CWhdalb1y4_n
3,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",0.0,2022,p_CWhdalb2y4_n
3,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",8.62,2022,p_CWhdalb3y4_n
3,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",91.38,2022,p_CWhdalb4y4_n
3,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",0.0,2022,p_CWhdalb5y4_n
3,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.94,2022,p_CWpdalby4_n
3,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",4.12,2022,p_CWpdalb1y4_n
3,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",6.19,2022,p_CWpdalb2y4_n
3,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",32.99,2022,p_CWpdalb3y4_n
3,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",47.42,2022,p_CWpdalb4y4_n
3,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",9.28,2022,p_CWpdalb5y4_n
3,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",90.72,2022,p_CWpdktvge18y4_n
3,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",100.0,2022,p_CWhdktvge12y4_n
3,"N: Patient Placement -  % of incident patients, 2022",17.21,2022,ppidy4_n
3,"N: Patient Placement -  % of patients continuing at facility, 2022",73.07,2022,ppcdy4_n
3,"N: Patient Placement -  % of patients that transfered into facility, 2022",9.72,2022,pptdy4_n
3,"N: End of Year Status - % of patients death attributed to this facility, 2022",14.0,2022,pdhdy4_n
3,"N: End of Year Status - % of patients death attributed to another facility, 2022",1.6,2022,pdody4_n
3,"N: End of Year Status - % of patients that received a transplant, 2022",2.87,2022,ptxdy4_n
3,"N: End of Year Status - % of patients alive in this facility, 2022",71.46,2022,pahdy4_n
3,"N: End of Year Status - % of patients alive in another facility, 2022",7.11,2022,paody4_n
3,"N: End of Year Status - % of patients other, 2022",2.95,2022,potdy4_n
3,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,70.83,2022,iuhemy4m_n
3,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.02,2022,iufreqy4m_n
3,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,70.81,2022,iunonfreqy4m_n
3,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.01,2022,iuothy4m_n
3,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
3,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
3,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,1.31,2022,ihhemy4m_n
3,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.64,2022,ihfreqy4m_n
3,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,0.67,2022,ihnonfreqy4m_n
3,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
3,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.62,2022,ihcapdy4m_n
3,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,6.54,2022,ihccpdy4m_n
3,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",17.44,2022,staffy4m_n
3,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,8.41,2022,nurseFTy4m_n
3,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,4.37,2022,ptcareFTy4m_n
3,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,1.25,2022,dietFTy4m_n
3,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.27,2022,socwkFTy4m_n
3,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.92,2022,nursePTy4m_n
3,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.6,2022,ptcarePTy4m_n
3,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.28,2022,dietPTy4m_n
3,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.33,2022,socwkPTy4m_n
3,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,35.76,2022,vocrehaby4m_n
3,"N (AFS): Facility Information - Average % incident patients, 2022",15.93,2022,incpery4_n
3,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,26.88,2022,employedy4_n
3,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,1.13,2022,schooly4_n
3,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",47.82,2022,nh_ppavfy4_n
3,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",20.47,2022,nh_ltcy4_n
3,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",1.53,2022,nh_CWhdktv1y4_n
3,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",6.46,2022,nh_CWpdktv1y4_n
3,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",28.2,2022,nh_CWhdhgb1y4_n
3,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",82.12,2022,nh_CWhdesarxy4_n
3,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",28.46,2022,nh_CWpdhgb1y4_n
3,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",59.52,2022,nh_CWpdesarxy4_n
3,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",41.38,2022,nh_obdry4_n
3,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.11,2022,nh_smry4_n
3,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",30.37,2022,nh_wity4_n
3,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",282.05,2022,nh_obhtry4_n
3,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.51,2022,nh_shrty4_n
3,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",25.19,2022,nh_sepiy4_n
3,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",11.02,2022,nh_miiy4_n
3,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",47.69,2022,nh_achfy4_n
3,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",38.27,2022,nh_acdry4_n
3,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",4.18,2022,nh_acary4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",1.48,2022,nh_clmhivaidmy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",9.03,2022,nh_clminfvamy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",0.56,2022,nh_clmhepbmy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",3.66,2022,nh_clmhepothmy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",3.33,2022,nh_clmmstinfmy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",7.55,2022,nh_clmpnemy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.19,2022,nh_clmtbmy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",39.95,2022,nh_clminfmy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.31,2022,nh_clmcamy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",41.99,2022,nh_clmcdmy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",18.56,2022,nh_clmcvdmy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",56.06,2022,nh_clmchfmy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",51.67,2022,nh_clmihdmy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",12.5,2022,nh_clmmimy4_n
3,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",35.83,2022,nh_clmpvdmy4_n
3,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.04,2022,nh_age1y4_n
3,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",29.73,2022,nh_age2y4_n
3,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",70.23,2022,nh_age3y4_n
3,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",45.31,2022,nh_dis1y4_n
3,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",35.98,2022,nh_dis2y4_n
3,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",4.69,2022,nh_dis3y4_n
3,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",13.72,2022,nh_dis4y4_n
3,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.3,2022,nh_dis5y4_n
3,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",4.27,2022,nh_rac1y4_n
3,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",41.39,2022,nh_rac2y4_n
3,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",0.13,2022,nh_rac3y4_n
3,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",54.05,2022,nh_rac4y4_n
3,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.17,2022,nh_rac5y4_n
3,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",12.63,2022,nh_eth1y4_n
3,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",87.25,2022,nh_eth2y4_n
3,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.13,2022,nh_eth3y4_n
3,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",22.17,2022,nh_vin1y4_n
3,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",14.82,2022,nh_vin2y4_n
3,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",11.28,2022,nh_vin3y4_n
3,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",25.42,2022,nh_vin4y4_n
3,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",26.31,2022,nh_vin5y4_n
3,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",45.52,2022,nh_sexy4_n
3,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",96.79,2022,nh_modhdy4_n
3,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",0.21,2022,nh_modhhdy4_n
3,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.08,2022,nh_modcapdy4_n
3,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",2.62,2022,nh_modccpdy4_n
3,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.3,2022,nh_modothry4_n
3,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",84.64,2022,nh_allmdcrmy4_n
3,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",8.38,2022,nh_insmdcdmy4_n
3,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",2.58,2022,nh_insempmy4_n
3,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",4.4,2022,nh_insnonothmy4_n
3,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",6.34,2022,nh_mefavfmy4_n
3,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",3.44,2022,nh_mefgraftmy4_n
3,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",88.61,2022,nh_mefcathmy4_n
3,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",1.61,2022,nh_mefoumaccessmy4_n
3,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",17.62,2022,nh_avfpresentmy4_n
3,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",16.76,2022,nh_nephnomy4_n
3,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",25.99,2022,nh_nephy6my4_n
3,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",16.97,2022,nh_nephy612my4_n
3,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",18.47,2022,nh_nephy12my4_n
3,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",21.8,2022,nh_nephunkmissmy4_n
3,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",88.18,2022,nh_ptinfymy4_n
3,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",1.48,2022,alcomy4_n
3,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",18.3,2022,ashdmy4_n
3,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",24.41,2022,othcarmy4_n
3,"N (2728): Incident Patients  - Percent with cancer, 2022",7.67,2022,canmy4_n
3,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",25.63,2022,chfmy4_n
3,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",8.46,2022,cvamy4_n
3,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",43.74,2022,diabimy4_n
3,"N (2728): Incident Patients  - Percent with diabetes, 2022",64.81,2022,diabmy4_n
3,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.02,2022,drugmy4_n
3,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",89.58,2022,hxhtmy4_n
3,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",8.83,2022,ambumy4_n
3,"N (2728): Incident Patients  - Percent inability to transfer, 2022",5.84,2022,transmy4_n
3,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",6.08,2022,copdmy4_n
3,"N (2728): Incident Patients  - Percent with PVD, 2022",14.16,2022,pvdmy4_n
3,"N (2728): Incident Patients  - Percent smoker, 2022",4.45,2022,smokmy4_n
3,"N (2728): Incident Patients  - Percent Hispanic, 2022",38.81,2022,ethmy4_n
3,"N (2728): Incident Patients  - Percent White, 2022",67.29,2022,whitemy4_n
3,"N (2728): Incident Patients  - Percent African American, 2022",25.8,2022,blackmy4_n
3,"N (2728): Incident Patients  - Percent Native American, 2022",0.76,2022,nativmy4_n
3,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",5.73,2022,asianmy4_n
3,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.41,2022,racoummy4_n
3,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",26.29,2022,cempmy4_n
3,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",35.48,2022,pempmy4_n
3,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",45.91,2022,dbprimy4_n
3,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",5.14,2022,gnprimy4_n
3,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",32.73,2022,htprimy4_n
3,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",16.21,2022,omprimy4_n
3,"N (2728): Incident Patients  - Percent female, 2022",39.38,2022,femmy4_n
3,"N (2728): Incident Patients  - Average age, 2022",65.5,2022,agemy4_n
3,"N (2728): Incident Patients  - Average serum albumin, 2022",3.38,2022,salbmy4_n
3,"N (2728): Incident Patients  - Average creatinine, 2022",6.35,2022,creamy4_n
3,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.46,2022,hgmy4_n
3,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",10.73,2022,gfrmy4_n
3,"N (2728): Incident Patients  - Average count of comorbidities, 2022",3.24,2022,cntcomy4_n
3,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",90.28,2022,pdmodMEFHDmy4_n
3,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",9.72,2022,pdmodMEFPDmy4_n
3,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
3,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",52.6,2022,insmdcrmy4_n
3,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",14.49,2022,insmdcdmy4_n
3,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",4.9,2022,insmdcrcdmy4_n
3,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",11.18,2022,insempmy4_n
3,"N (2728): Incident Patients  - Percent with no coverage, 2022",1.66,2022,insnonemy4_n
3,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",6.86,2022,insmdcromy4_n
3,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",8.3,2022,insmedomy4_n
3,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",17.41,2022,preepomy4_n
3,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",18.39,2022,nephnomy4_n
3,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",19.11,2022,nephy6my4_n
3,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",19.44,2022,nephy612my4_n
3,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",28.7,2022,nephy12my4_n
3,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",14.36,2022,nephunkmissmy4_n
3,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",94.51,2022,ptinfymy4_n
3,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",62.3,2022,ptxmedunfitmy4_n
3,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
3,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
3,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",11.11,2022,ptxdeclinemy4_n
3,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",36.11,2022,ptxnotassessmy4_n
3,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",11.59,2022,mefavfmy4_n
3,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",4.2,2022,mefgraftmy4_n
3,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",83.97,2022,mefcathmy4_n
3,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.24,2022,mefoumaccessmy4_n
3,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",23.75,2022,avfpresentmy4_n
3,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",27.15,2022,bmimmy4_n
3,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",27.63,2022,bmifmy4_n
3,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",0.99,2022,ptinfnmy4m_n
3,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",16.31,2022,hemomy4m_n
3,"N (2728): Incident Patients  - Average Number of forms returned, 2022",18.07,2022,nmy4m_n
3,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",97.44,2019,rdsmzm_n
3,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",65.4,2019,dyzm_n
3,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",12.4,2019,deazm_n
3,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",13.23,2019,exdzm_n
3,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.07,2019,dudzm_n
3,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",0.94,2019,smrz_n
3,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",19.14,2019,witz_n
3,"N: All Patient Mortality - % of deaths from infection, 2019-2022",15.75,2019,infz_n
3,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",57.03,2019,cardz_n
3,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",2.07,2019,livz_n
3,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",18.86,2019,fynmzm_n
3,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",11.29,2019,fydyzm_n
3,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",3.2,2019,fydeazm_n
3,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",3.16,2019,fyexdzm_n
3,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",1.01,2019,fysmrz_n
3,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",21.3,2019,fywitz_n
3,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",14.64,2019,fyinfz_n
3,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",52.8,2019,fycardiacz_n
3,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",3.17,2019,fylivz_n
3,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",80.83,2019,rdshzm_n
3,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",72.57,2019,htazm_n
3,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",71.17,2019,extzm_n
3,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",603.69,2019,hdzm_n
3,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",587.12,2019,exhdzm_n
3,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",52.97,2019,hdyzm_n
3,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",1.02,2019,shrtz_n
3,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",1.03,2019,shrdz_n
3,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",8.04,2019,lenz_n
3,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",7.56,2019,onez_n
3,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",6.53,2019,miiz_n
3,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",11.27,2019,sepiz_n
3,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",25.8,2019,achfz_n
3,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",17.3,2019,acdrz_n
3,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.39,2019,acarz_n
3,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",90.3,2019,ipedz_n
3,"N: ED30 - Average annual index discharges, 2019-22",37.28,2019,ed30indexzm_n
3,"N: ED30- Average annual number of ED visits, 2019-22",4.46,2019,ed30obszm_n
3,"N: ED30 - Average annual expected ED visits, 2019-22",5.59,2019,ed30expzm_n
3,"N: ED30: Standardized Ratio of ED30, 2019-22",0.83,2019,ed30z_n
3,"N SRR -  Standardized Readmission Ratio, 2022",1.16,2022,srry4_n
3,"N: SRR - Average index discharges, 2022",72.71,2022,indexmy4_n
3,"N: SRR - Average number of readmissions, 2022",18.95,2022,readmmy4_n
3,"N: SRR - Average expected readmissions, 2022",17.21,2022,srrexpmy4_n
3,Pt included in SEDR analysis,48.72,2019,rdsezm_n
3,Total number of ED Visits,33.46,2019,hedzm_n
3,Expected number of ED events,42.13,2019,exedzm_n
3,Years at risk for ED visit rate,30.59,2019,edyrzm_n
3,Years at risk for ED visit rate,32675.03,2019,edyrz_n
3,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",0.79,2019,sedrz_n
3,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",67.17,2019,rdstzm_n
3,"N: STR - Average number of patients (per year in average facility), 2019-2022",71.9,2019,rdsalltzm_n
3,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",2.07,2019,txzm_n
3,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",2.31,2019,txallzm_n
3,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",45.37,2019,txyzm_n
3,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.75,2019,cadalltzm_n
3,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.59,2019,livealltzm_n
3,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",2.04,2019,extxzm_n
3,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",1.02,2019,strz_n
3,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",68.7,2022,pppwpty4m_n
3,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",17.6,2022,WLy4_n
3,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",30.19,2022,WLlt40y4_n
3,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",16.59,2022,WL4074y4_n
3,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",18.8,2022,WLmaley4_n
3,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",15.67,2022,WLfemy4_n
3,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",10.83,2022,WLwhhy4_n
3,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",22.93,2022,WLwhnhy4_n
3,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",21.12,2022,WLbly4_n
3,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",32.3,2022,WLasy4_n
3,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",20.2,2022,WLnay4_n
3,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",22.31,2022,WLothy4_n
3,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",13.09,2022,WLDMy4_n
3,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",21.6,2022,WLnodmy4_n
3,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",16.42,2022,WLnotxy4_n
3,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",33.44,2022,WLtxy4_n
3,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",14.6,2022,WLVCat1y4_n
3,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",22.31,2022,WLVCat2y4_n
3,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",16.39,2022,WLVCat3y4_n
3,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",593.16,2022,pppwpmy4m_n
3,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",20.38,2022,pppwy4_n
3,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",11.4,2019,swrptzm_n
3,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",8.99,2019,swrpyzm_n
3,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.94,2019,swrwlzm_n
3,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.78,2019,swrexwlzm_n
3,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",1.21,2019,swrz_n
3,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",87.81,2021,FVfy3_n
3,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",6.77,2021,FVdeclinedfy3_n
3,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.08,2021,FVovndfy3_n
3,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",5.41,2021,FVothrsnfy3_n
3,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",76.69,2022,FVhy4_n
3,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",77.49,2022,FVmcarehy4_n
3,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",81.16,2022,FVmahy4_n
3,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",74.27,2022,FVmpphy4_n
3,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",71.47,2022,FVdualhy4_n
3,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",70.83,2022,FVmsphy4_n
3,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",71.62,2022,FVnonmcarehy4_n
3,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",62.5,2022,FVlt18hy4_n
3,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",70.17,2022,FV1839hy4_n
3,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",74.12,2022,FV4064hy4_n
3,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",78.87,2022,FV6574hy4_n
3,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",79.0,2022,FV75uphy4_n
3,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",76.81,2022,FVmalehy4_n
3,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",76.22,2022,FVfemhy4_n
3,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",77.11,2022,FVashy4_n
3,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",53.85,2022,FVnahy4_n
3,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",80.35,2022,FVwhhy4_n
3,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",52.08,2022,FVrothhy4_n
3,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",68.12,2022,FVblkhy4_n
3,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",85.18,2022,FVhisphy4_n
3,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",64.79,2022,FVVCat1hy4_n
3,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",76.61,2022,FVVCat2hy4_n
3,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",81.43,2022,FVVCat3hy4_n
3,"N: Influenza - Average number of patients treated on 12/31, 2022",72.94,2022,eFVy4m_n
3,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",1.0,2022,medrsnfy4m_N
3,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.77,2022,CWhdavgHGBy4_n
3,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",19.88,2022,CWhdhgb1y4_n
3,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",36.99,2022,CWhdhgb2y4_n
3,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",29.56,2022,CWhdhgb3y4_n
3,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",11.44,2022,CWhdhgb4y4_n
3,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.14,2022,CWhdhgb5y4_n
3,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",76.5,2022,CWhdesarxy4_n
3,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.94,2022,CWpdavgHGBy4_n
3,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",21.01,2022,CWpdhgb1y4_n
3,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",29.98,2022,CWpdhgb2y4_n
3,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",27.96,2022,CWpdhgb3y4_n
3,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",18.52,2022,CWpdhgb4y4_n
3,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.53,2022,CWpdhgb5y4_n
3,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",57.81,2022,CWpdesarxy4_n
3,"N: HD HGB (Adult) - Average number of eligible patients, 2022",85.98,2022,CWhdptdenomy4m_n
3,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",757.84,2022,CWhdptmthdenomy4m_n
3,"N: PD HGB (Adult) - Average number of eligible patients, 2022",17.02,2022,CWpdptdenomy4m_n
3,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",133.67,2022,CWpdptmthdenomy4m_n
3,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",33.19,2022,rdstfy4m_n
3,"N: STrR (Adult) - Average Patient Years at Risk, 2022",19.34,2022,tfyy4m_n
3,"N: STrR (Adult) - Average Number of Transfusions, 2022",5.86,2022,tfy4m_n
3,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",6.66,2022,extfy4m_n
3,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.88,2022,strry4_n
3,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.88,2022,CWhdalby4_n
3,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",2.52,2022,CWhdalb1y4_n
3,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",9.25,2022,CWhdalb2y4_n
3,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",39.17,2022,CWhdalb3y4_n
3,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",46.09,2022,CWhdalb4y4_n
3,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",2.96,2022,CWhdalb5y4_n
3,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",50.95,2022,CWhdalblt4y4_n
3,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.32,2022,CWhdavgufry4_n
3,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",89.48,2022,CWhdufr1y4_n
3,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",5.78,2022,CWhdufr2y4_n
3,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",3.24,2022,CWhdufrmissy4_n
3,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",1.5,2022,CWhdufrgt20y4_n
3,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.67,2022,CWpdalby4_n
3,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",6.01,2022,CWpdalb1y4_n
3,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",22.15,2022,CWpdalb2y4_n
3,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",42.84,2022,CWpdalb3y4_n
3,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",26.51,2022,CWpdalb4y4_n
3,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",2.49,2022,CWpdalb5y4_n
3,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",71.0,2022,CWpdalblt4y4_n
3,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",85.98,2022,CWhddenomy4m_n
3,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",757.84,2022,CWhdmthdenomy4m_n
3,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",17.02,2022,CWpddenomy4m_n
3,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",133.67,2022,CWpdmthdenomy4m_n
3,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.3,2022,CWpdavgktvy4_n
3,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",3.29,2022,CWpdktv1y4_n
3,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",66.87,2022,CWpdktv2y4_n
3,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",27.95,2022,CWpdktv3y4_n
3,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.89,2022,CWpdktv4y4_n
3,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.63,2022,CWhdavgktvy4_n
3,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",1.05,2022,CWhdktv1y4_n
3,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",73.06,2022,CWhdktv2y4_n
3,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",24.35,2022,CWhdktv3y4_n
3,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.54,2022,CWhdktv4y4_n
3,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",83.75,2022,CWhdktvptsy4m_N
3,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",722.06,2022,CWhdktvptmthy4m_N
4,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",4.09,2022,allmcFcovpatPq4_n
4,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",27.71,2022,allmcEcovpatPq4_n
4,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",36.44,2022,allmcEcovDeaPq4_n
4,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",35.96,2022,allmcEcovHosPq4_n
4,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",8.07,2022,nh_mcFcovpatPq4_n
4,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",44.31,2022,nh_mcEcovpatPq4_n
4,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",39.53,2022,nh_mcEcovDeaPq4_n
4,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",45.0,2022,nh_mcEcovHosPq4_n
4,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",63.89,2022,agey4_n
4,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.26,2022,age1y4_n
4,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",47.01,2022,age2y4_n
4,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",52.74,2022,age3y4_n
4,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",41.99,2022,dis1y4_n
4,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",29.74,2022,dis2y4_n
4,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",10.57,2022,dis3y4_n
4,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",17.4,2022,dis4y4_n
4,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.3,2022,dis5y4_n
4,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",16.32,2022,vin1y4_n
4,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",18.37,2022,vin2y4_n
4,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.67,2022,vin3y4_n
4,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.98,2022,vin4y4_n
4,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",26.66,2022,vin5y4_n
4,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",2.71,2022,rac1y4_n
4,"N: Prevalent Patients - Race: % African American, 12/31/2022",37.62,2022,rac2y4_n
4,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.22,2022,rac3y4_n
4,"N: Prevalent Patients - Race: % White, 12/31/2022",59.34,2022,rac4y4_n
4,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.11,2022,rac5y4_n
4,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",7.46,2022,eth1y4_n
4,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",92.45,2022,eth2y4_n
4,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.09,2022,eth3y4_n
4,"N: Prevalent Patients - Sex: % Female, 12/31/2022",40.73,2022,sexy4_n
4,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",14.79,2022,nrshomey4_n
4,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",5.07,2022,viny4_n
4,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",84.03,2022,modhdy4_n
4,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",3.65,2022,modhhdy4_n
4,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.37,2022,modcapdy4_n
4,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",10.79,2022,modccpdy4_n
4,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.17,2022,modothry4_n
4,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",48.23,2022,pahy4m_n
4,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",19.18,2022,CWunCa1y4_n
4,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",76.48,2022,CWunCa2y4_n
4,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.2,2022,CWunCa3y4_n
4,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",3.1,2022,CWunCamissy4_n
4,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.04,2022,CWunCaOoRy4_n
4,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.87,2022,CWavgUnCay4_n
4,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.36,2022,CWavgPy4_n
4,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.91,2022,CWP1y4_n
4,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",24.25,2022,CWP2y4_n
4,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",28.77,2022,CWP3y4_n
4,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",21.94,2022,CWP4y4_n
4,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",13.65,2022,CWP5y4_n
4,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",3.48,2022,CWPmissy4_n
4,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
4,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",2.27,2022,CWunCagt102y4_n
4,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",66.51,2022,CWptdenomy4m_n
4,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",564.74,2022,CWptmthdenomy4m_n
4,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",70.9,2022,serumphospatsy4m_n
4,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",597.42,2022,serumphospmy4m_n
4,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",66.51,2022,CWhcptdenomy4m_n
4,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",564.72,2022,CWhcptmthdenomy4m_n
4,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",58.2,2022,ppavfy4_n
4,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",16.46,2022,ppavgy4_n
4,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",23.02,2022,ppcathy4_n
4,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",2.32,2022,ppomy4_n
4,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",18.06,2022,ltcy4_n
4,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",13.51,2022,piavfy4_n
4,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",3.35,2022,piavgy4_n
4,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",78.07,2022,picathy4_n
4,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",5.07,2022,piomy4_n
4,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",14.33,2022,pifisty4_n
4,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",62.71,2022,phdvapty4m_n
4,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",522.79,2022,phdy4m_n
4,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",11.23,2022,ihdy4m_n
4,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",58.59,2022,sfry4_n
4,"N: VA infection - Average number of eligible PD patients, 2022",8.25,2022,pdpaty4m_n
4,"N: VA infection - Average number of eligible PD patient-months, 2022",58.71,2022,pdptmoy4m_n
4,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.7,2022,pd2inf100moy4_n
4,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",38.85,2022,ncmy4m_n
4,"N: Prevalent Comorbidities - Average % with Anemia, 2022",2.94,2022,clmanemy4_n
4,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.88,2022,clmhivaidmy4_n
4,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.44,2022,clmalcomy4_n
4,"N: Prevalent Comorbidities - Average % with Cancer, 2022",4.16,2022,clmcanmy4_n
4,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",0.88,2022,clmcamy4_n
4,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",22.67,2022,clmcdmy4_n
4,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",8.0,2022,clmcvdmy4_n
4,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",17.08,2022,clmcopdmy4_n
4,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",34.52,2022,clmchfmy4_n
4,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",36.83,2022,clmdiabmy4_n
4,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",1.4,2022,clmdrugmy4_n
4,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",2.96,2022,clmgtbmy4_n
4,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.4,2022,clmhepbmy4_n
4,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",2.19,2022,clmhepothmy4_n
4,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",25.22,2022,clmhypthymy4_n
4,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",18.53,2022,clminfmy4_n
4,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",28.96,2022,clmihdmy4_n
4,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",6.93,2022,clmmimy4_n
4,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",18.35,2022,clmpvdmy4_n
4,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",3.54,2022,clmpnemy4_n
4,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.45,2022,clmcntcomy4_n
4,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",5.01,2022,clminfvamy4_n
4,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.63,2022,clmmstinfmy4_n
4,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.2,2022,clmtbmy4_n
4,"N (AFS): Facility Information - Average number of patients, 2022",82.92,2022,allcnty4m_n
4,N (AFS): Facility Information - Average number of all patients on 12/31/2022,52.83,2022,endcnty4m_n
4,"N (AFS): Facility Information - Average % of patients transferred in, 2022",17.9,2022,transiny4_n
4,"N (AFS): Facility Information - Average % of patients transferred out, 2022",18.39,2022,transouty4_n
4,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,83.06,2022,medicarey4_n
4,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,8.07,2022,medpendy4_n
4,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,8.87,2022,nonmedy4_n
4,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.09,2022,cfc_N
4,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,2.61,2022,std_N
4,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",36.96,2022,p_age1y4_n
4,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",15.22,2022,p_age2y4_n
4,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",21.74,2022,p_age3y4_n
4,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",26.09,2022,p_age4y4_n
4,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",2.17,2022,p_dis1y4_n
4,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",0.0,2022,p_dis2y4_n
4,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",39.13,2022,p_dis3y4_n
4,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",19.57,2022,p_dis4y4_n
4,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
4,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
4,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",21.74,2022,p_dis7y4_n
4,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",17.39,2022,p_dis8y4_n
4,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",32.61,2022,p_vin1y4_n
4,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",15.22,2022,p_vin2y4_n
4,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",15.22,2022,p_vin3y4_n
4,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",15.22,2022,p_vin4y4_n
4,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",21.74,2022,p_vin5y4_n
4,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",2.17,2022,p_rac1y4_n
4,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",26.09,2022,p_rac2y4_n
4,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",0.0,2022,p_rac3y4_n
4,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",71.74,2022,p_rac4y4_n
4,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",0.0,2022,p_rac5y4_n
4,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",8.7,2022,p_eth1y4_n
4,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",91.3,2022,p_eth2y4_n
4,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
4,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",45.65,2022,p_sexy4_n
4,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",43.48,2022,p_modhdy4_n
4,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
4,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.0,2022,p_modcapdy4_n
4,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",50.0,2022,p_modccpdy4_n
4,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",6.52,2022,p_modothry4_n
4,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",19.23,2022,p_allmdcrmy4_n
4,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",23.08,2022,p_insmdcdmy4_n
4,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",11.54,2022,p_insempmy4_n
4,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",46.15,2022,p_insnonothmy4_n
4,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",23.08,2022,p_nephnomy4_n
4,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",23.08,2022,p_nephy6my4_n
4,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",26.92,2022,p_nephy612my4_n
4,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",19.23,2022,p_nephy12my4_n
4,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",7.69,2022,p_nephunkmissmy4_n
4,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",84.62,2022,p_ptinfymy4_n
4,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",0.0,2022,p_mefavfmy4_n
4,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",11.76,2022,p_mefgraftmy4_n
4,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",88.24,2022,p_mefcathmy4_n
4,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
4,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",0.0,2022,p_avfpresentmy4_n
4,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",6.49,2022,p_ppavfy4_n
4,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",78.24,2022,p_ltcy4_n
4,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",47.63,2022,p_WLy4_n
4,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",36.86,2022,p_WLlt10y4_n
4,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",60.91,2022,p_WL1017y4_n
4,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.99,2022,p_CWhdavgHGBy4_n
4,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",15.52,2022,p_CWhdhgb1y4_n
4,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",20.69,2022,p_CWhdhgb2y4_n
4,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",25.0,2022,p_CWhdhgb3y4_n
4,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",17.67,2022,p_CWhdhgb4y4_n
4,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",21.12,2022,p_CWhdhgb5y4_n
4,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.79,2022,p_CWpdavgHGBy4_n
4,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",18.75,2022,p_CWpdhgb1y4_n
4,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",18.42,2022,p_CWpdhgb2y4_n
4,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",21.05,2022,p_CWpdhgb3y4_n
4,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",12.5,2022,p_CWpdhgb4y4_n
4,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",29.28,2022,p_CWpdhgb5y4_n
4,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.11,2022,p_CWhdalby4_n
4,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",2.59,2022,p_CWhdalb1y4_n
4,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",2.16,2022,p_CWhdalb2y4_n
4,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",18.1,2022,p_CWhdalb3y4_n
4,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",53.88,2022,p_CWhdalb4y4_n
4,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",23.28,2022,p_CWhdalb5y4_n
4,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.67,2022,p_CWpdalby4_n
4,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",8.88,2022,p_CWpdalb1y4_n
4,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",14.14,2022,p_CWpdalb2y4_n
4,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",21.05,2022,p_CWpdalb3y4_n
4,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",24.34,2022,p_CWpdalb4y4_n
4,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",31.58,2022,p_CWpdalb5y4_n
4,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",63.49,2022,p_CWpdktvge18y4_n
4,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",77.39,2022,p_CWhdktvge12y4_n
4,"N: Patient Placement -  % of incident patients, 2022",16.67,2022,ppidy4_n
4,"N: Patient Placement -  % of patients continuing at facility, 2022",70.99,2022,ppcdy4_n
4,"N: Patient Placement -  % of patients that transfered into facility, 2022",12.34,2022,pptdy4_n
4,"N: End of Year Status - % of patients death attributed to this facility, 2022",13.99,2022,pdhdy4_n
4,"N: End of Year Status - % of patients death attributed to another facility, 2022",2.13,2022,pdody4_n
4,"N: End of Year Status - % of patients that received a transplant, 2022",3.17,2022,ptxdy4_n
4,"N: End of Year Status - % of patients alive in this facility, 2022",68.45,2022,pahdy4_n
4,"N: End of Year Status - % of patients alive in another facility, 2022",9.15,2022,paody4_n
4,"N: End of Year Status - % of patients other, 2022",3.11,2022,potdy4_n
4,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,44.53,2022,iuhemy4m_n
4,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.0,2022,iufreqy4m_n
4,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,44.53,2022,iunonfreqy4m_n
4,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.01,2022,iuothy4m_n
4,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
4,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
4,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,1.75,2022,ihhemy4m_n
4,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.44,2022,ihfreqy4m_n
4,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,1.31,2022,ihnonfreqy4m_n
4,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
4,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.78,2022,ihcapdy4m_n
4,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,5.76,2022,ihccpdy4m_n
4,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",12.26,2022,staffy4m_n
4,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,3.56,2022,nurseFTy4m_n
4,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,4.78,2022,ptcareFTy4m_n
4,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,0.92,2022,dietFTy4m_n
4,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,0.92,2022,socwkFTy4m_n
4,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.64,2022,nursePTy4m_n
4,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.65,2022,ptcarePTy4m_n
4,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.42,2022,dietPTy4m_n
4,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.39,2022,socwkPTy4m_n
4,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,24.83,2022,vocrehaby4m_n
4,"N (AFS): Facility Information - Average % incident patients, 2022",15.08,2022,incpery4_n
4,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,27.43,2022,employedy4_n
4,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.66,2022,schooly4_n
4,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",46.44,2022,nh_ppavfy4_n
4,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",25.27,2022,nh_ltcy4_n
4,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",2.91,2022,nh_CWhdktv1y4_n
4,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",10.33,2022,nh_CWpdktv1y4_n
4,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",28.14,2022,nh_CWhdhgb1y4_n
4,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",77.33,2022,nh_CWhdesarxy4_n
4,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",28.56,2022,nh_CWpdhgb1y4_n
4,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",53.33,2022,nh_CWpdesarxy4_n
4,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",41.93,2022,nh_obdry4_n
4,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.05,2022,nh_smry4_n
4,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",32.45,2022,nh_wity4_n
4,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",268.52,2022,nh_obhtry4_n
4,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.41,2022,nh_shrty4_n
4,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",21.85,2022,nh_sepiy4_n
4,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",9.96,2022,nh_miiy4_n
4,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",49.56,2022,nh_achfy4_n
4,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",36.7,2022,nh_acdry4_n
4,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",3.01,2022,nh_acary4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",0.67,2022,nh_clmhivaidmy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",8.71,2022,nh_clminfvamy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",0.71,2022,nh_clmhepbmy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",3.73,2022,nh_clmhepothmy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",3.64,2022,nh_clmmstinfmy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",9.3,2022,nh_clmpnemy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.25,2022,nh_clmtbmy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",38.84,2022,nh_clminfmy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",1.8,2022,nh_clmcamy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",41.1,2022,nh_clmcdmy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",17.93,2022,nh_clmcvdmy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",57.23,2022,nh_clmchfmy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",47.38,2022,nh_clmihdmy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",11.9,2022,nh_clmmimy4_n
4,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",36.28,2022,nh_clmpvdmy4_n
4,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
4,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",28.9,2022,nh_age2y4_n
4,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",71.1,2022,nh_age3y4_n
4,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",52.03,2022,nh_dis1y4_n
4,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",26.85,2022,nh_dis2y4_n
4,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",5.88,2022,nh_dis3y4_n
4,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",14.56,2022,nh_dis4y4_n
4,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.68,2022,nh_dis5y4_n
4,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",1.21,2022,nh_rac1y4_n
4,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",35.23,2022,nh_rac2y4_n
4,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",0.08,2022,nh_rac3y4_n
4,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",63.37,2022,nh_rac4y4_n
4,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.11,2022,nh_rac5y4_n
4,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",4.36,2022,nh_eth1y4_n
4,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",95.41,2022,nh_eth2y4_n
4,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.23,2022,nh_eth3y4_n
4,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",20.14,2022,nh_vin1y4_n
4,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",15.7,2022,nh_vin2y4_n
4,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",12.44,2022,nh_vin3y4_n
4,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.16,2022,nh_vin4y4_n
4,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",27.57,2022,nh_vin5y4_n
4,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",48.46,2022,nh_sexy4_n
4,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",89.87,2022,nh_modhdy4_n
4,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",7.93,2022,nh_modhhdy4_n
4,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.11,2022,nh_modcapdy4_n
4,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",1.67,2022,nh_modccpdy4_n
4,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.42,2022,nh_modothry4_n
4,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",88.83,2022,nh_allmdcrmy4_n
4,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",5.86,2022,nh_insmdcdmy4_n
4,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",2.39,2022,nh_insempmy4_n
4,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",2.93,2022,nh_insnonothmy4_n
4,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",6.4,2022,nh_mefavfmy4_n
4,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",1.74,2022,nh_mefgraftmy4_n
4,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",89.37,2022,nh_mefcathmy4_n
4,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",2.49,2022,nh_mefoumaccessmy4_n
4,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",17.03,2022,nh_avfpresentmy4_n
4,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",15.08,2022,nh_nephnomy4_n
4,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",20.28,2022,nh_nephy6my4_n
4,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",18.98,2022,nh_nephy612my4_n
4,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",27.22,2022,nh_nephy12my4_n
4,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",18.44,2022,nh_nephunkmissmy4_n
4,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",90.35,2022,nh_ptinfymy4_n
4,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",1.45,2022,alcomy4_n
4,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",14.93,2022,ashdmy4_n
4,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",24.6,2022,othcarmy4_n
4,"N (2728): Incident Patients  - Percent with cancer, 2022",8.78,2022,canmy4_n
4,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",28.81,2022,chfmy4_n
4,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",9.22,2022,cvamy4_n
4,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",40.44,2022,diabimy4_n
4,"N (2728): Incident Patients  - Percent with diabetes, 2022",60.18,2022,diabmy4_n
4,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.4,2022,drugmy4_n
4,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",85.0,2022,hxhtmy4_n
4,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",5.37,2022,ambumy4_n
4,"N (2728): Incident Patients  - Percent inability to transfer, 2022",2.56,2022,transmy4_n
4,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",9.09,2022,copdmy4_n
4,"N (2728): Incident Patients  - Percent with PVD, 2022",7.93,2022,pvdmy4_n
4,"N (2728): Incident Patients  - Percent smoker, 2022",7.11,2022,smokmy4_n
4,"N (2728): Incident Patients  - Percent Hispanic, 2022",6.33,2022,ethmy4_n
4,"N (2728): Incident Patients  - Percent White, 2022",67.11,2022,whitemy4_n
4,"N (2728): Incident Patients  - Percent African American, 2022",29.17,2022,blackmy4_n
4,"N (2728): Incident Patients  - Percent Native American, 2022",0.76,2022,nativmy4_n
4,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",2.72,2022,asianmy4_n
4,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.25,2022,racoummy4_n
4,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",29.39,2022,cempmy4_n
4,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",39.28,2022,pempmy4_n
4,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",44.01,2022,dbprimy4_n
4,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",6.46,2022,gnprimy4_n
4,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",28.48,2022,htprimy4_n
4,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",21.06,2022,omprimy4_n
4,"N (2728): Incident Patients  - Percent female, 2022",38.77,2022,femmy4_n
4,"N (2728): Incident Patients  - Average age, 2022",64.76,2022,agemy4_n
4,"N (2728): Incident Patients  - Average serum albumin, 2022",3.43,2022,salbmy4_n
4,"N (2728): Incident Patients  - Average creatinine, 2022",6.53,2022,creamy4_n
4,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.37,2022,hgmy4_n
4,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",10.6,2022,gfrmy4_n
4,"N (2728): Incident Patients  - Average count of comorbidities, 2022",3.07,2022,cntcomy4_n
4,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",85.74,2022,pdmodMEFHDmy4_n
4,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",14.26,2022,pdmodMEFPDmy4_n
4,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
4,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",51.78,2022,insmdcrmy4_n
4,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",13.55,2022,insmdcdmy4_n
4,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",6.57,2022,insmdcrcdmy4_n
4,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",12.79,2022,insempmy4_n
4,"N (2728): Incident Patients  - Percent with no coverage, 2022",0.87,2022,insnonemy4_n
4,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",9.07,2022,insmdcromy4_n
4,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",5.37,2022,insmedomy4_n
4,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",19.85,2022,preepomy4_n
4,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",11.9,2022,nephnomy4_n
4,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",18.69,2022,nephy6my4_n
4,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",19.14,2022,nephy612my4_n
4,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",37.37,2022,nephy12my4_n
4,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",12.9,2022,nephunkmissmy4_n
4,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",94.47,2022,ptinfymy4_n
4,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",41.53,2022,ptxmedunfitmy4_n
4,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
4,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
4,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",13.31,2022,ptxdeclinemy4_n
4,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",47.98,2022,ptxnotassessmy4_n
4,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",14.97,2022,mefavfmy4_n
4,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",3.2,2022,mefgraftmy4_n
4,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",81.44,2022,mefcathmy4_n
4,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.39,2022,mefoumaccessmy4_n
4,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",25.81,2022,avfpresentmy4_n
4,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",28.3,2022,bmimmy4_n
4,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",29.26,2022,bmifmy4_n
4,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",0.69,2022,ptinfnmy4m_n
4,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",10.72,2022,hemomy4m_n
4,"N (2728): Incident Patients  - Average Number of forms returned, 2022",12.5,2022,nmy4m_n
4,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",69.09,2019,rdsmzm_n
4,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",44.84,2019,dyzm_n
4,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",9.19,2019,deazm_n
4,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",10.23,2019,exdzm_n
4,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.06,2019,dudzm_n
4,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",0.9,2019,smrz_n
4,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",27.92,2019,witz_n
4,"N: All Patient Mortality - % of deaths from infection, 2019-2022",9.42,2019,infz_n
4,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",42.91,2019,cardz_n
4,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.29,2019,livz_n
4,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",13.37,2019,fynmzm_n
4,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",7.97,2019,fydyzm_n
4,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.31,2019,fydeazm_n
4,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.49,2019,fyexdzm_n
4,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",0.93,2019,fysmrz_n
4,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",29.55,2019,fywitz_n
4,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",9.46,2019,fyinfz_n
4,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",37.2,2019,fycardiacz_n
4,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",2.2,2019,fylivz_n
4,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",56.71,2019,rdshzm_n
4,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",55.57,2019,htazm_n
4,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",54.49,2019,extzm_n
4,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",451.47,2019,hdzm_n
4,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",447.55,2019,exhdzm_n
4,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",36.11,2019,hdyzm_n
4,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",1.02,2019,shrtz_n
4,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",1.01,2019,shrdz_n
4,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.8,2019,lenz_n
4,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",8.52,2019,onez_n
4,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",6.55,2019,miiz_n
4,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",12.2,2019,sepiz_n
4,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",32.35,2019,achfz_n
4,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",23.42,2019,acdrz_n
4,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.41,2019,acarz_n
4,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",86.78,2019,ipedz_n
4,"N: ED30 - Average annual index discharges, 2019-22",30.77,2019,ed30indexzm_n
4,"N: ED30- Average annual number of ED visits, 2019-22",4.18,2019,ed30obszm_n
4,"N: ED30 - Average annual expected ED visits, 2019-22",5.11,2019,ed30expzm_n
4,"N: ED30: Standardized Ratio of ED30, 2019-22",0.86,2019,ed30z_n
4,"N SRR -  Standardized Readmission Ratio, 2022",1.03,2022,srry4_n
4,"N: SRR - Average index discharges, 2022",53.06,2022,indexmy4_n
4,"N: SRR - Average number of readmissions, 2022",13.96,2022,readmmy4_n
4,"N: SRR - Average expected readmissions, 2022",14.49,2022,srrexpmy4_n
4,Pt included in SEDR analysis,36.3,2019,rdsezm_n
4,Total number of ED Visits,29.61,2019,hedzm_n
4,Expected number of ED events,34.53,2019,exedzm_n
4,Years at risk for ED visit rate,23.05,2019,edyrzm_n
4,Years at risk for ED visit rate,35310.72,2019,edyrz_n
4,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",0.86,2019,sedrz_n
4,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",48.28,2019,rdstzm_n
4,"N: STR - Average number of patients (per year in average facility), 2019-2022",52.83,2019,rdsalltzm_n
4,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",1.68,2019,txzm_n
4,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",1.92,2019,txallzm_n
4,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",31.35,2019,txyzm_n
4,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.47,2019,cadalltzm_n
4,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.49,2019,livealltzm_n
4,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",1.46,2019,extxzm_n
4,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",1.15,2019,strz_n
4,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",49.81,2022,pppwpty4m_n
4,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",23.4,2022,WLy4_n
4,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",34.91,2022,WLlt40y4_n
4,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",22.17,2022,WL4074y4_n
4,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",24.8,2022,WLmaley4_n
4,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",21.23,2022,WLfemy4_n
4,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",22.89,2022,WLwhhy4_n
4,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",21.18,2022,WLwhnhy4_n
4,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",25.22,2022,WLbly4_n
4,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",36.64,2022,WLasy4_n
4,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",29.34,2022,WLnay4_n
4,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",9.47,2022,WLothy4_n
4,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",19.42,2022,WLDMy4_n
4,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",26.25,2022,WLnodmy4_n
4,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",22.08,2022,WLnotxy4_n
4,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",36.71,2022,WLtxy4_n
4,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",19.47,2022,WLVCat1y4_n
4,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",29.17,2022,WLVCat2y4_n
4,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",22.76,2022,WLVCat3y4_n
4,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",415.73,2022,pppwpmy4m_n
4,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",21.62,2022,pppwy4_n
4,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",7.89,2019,swrptzm_n
4,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",6.13,2019,swrpyzm_n
4,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.81,2019,swrwlzm_n
4,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.54,2019,swrexwlzm_n
4,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",1.52,2019,swrz_n
4,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",83.26,2021,FVfy3_n
4,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",9.08,2021,FVdeclinedfy3_n
4,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.1,2021,FVovndfy3_n
4,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",7.66,2021,FVothrsnfy3_n
4,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",66.35,2022,FVhy4_n
4,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",68.1,2022,FVmcarehy4_n
4,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",68.59,2022,FVmahy4_n
4,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",68.0,2022,FVmpphy4_n
4,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",67.25,2022,FVdualhy4_n
4,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",66.26,2022,FVmsphy4_n
4,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",56.84,2022,FVnonmcarehy4_n
4,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",32.0,2022,FVlt18hy4_n
4,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",59.17,2022,FV1839hy4_n
4,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",63.44,2022,FV4064hy4_n
4,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",68.33,2022,FV6574hy4_n
4,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",71.06,2022,FV75uphy4_n
4,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",65.89,2022,FVmalehy4_n
4,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",67.02,2022,FVfemhy4_n
4,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",72.02,2022,FVashy4_n
4,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",36.96,2022,FVnahy4_n
4,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",67.5,2022,FVwhhy4_n
4,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",46.43,2022,FVrothhy4_n
4,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",64.34,2022,FVblkhy4_n
4,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",69.84,2022,FVhisphy4_n
4,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",54.62,2022,FVVCat1hy4_n
4,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",66.9,2022,FVVCat2hy4_n
4,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",71.01,2022,FVVCat3hy4_n
4,"N: Influenza - Average number of patients treated on 12/31, 2022",49.91,2022,eFVy4m_n
4,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",0.58,2022,medrsnfy4m_N
4,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.7,2022,CWhdavgHGBy4_n
4,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",23.21,2022,CWhdhgb1y4_n
4,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",34.42,2022,CWhdhgb2y4_n
4,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",28.33,2022,CWhdhgb3y4_n
4,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",11.38,2022,CWhdhgb4y4_n
4,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.67,2022,CWhdhgb5y4_n
4,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",76.97,2022,CWhdesarxy4_n
4,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.84,2022,CWpdavgHGBy4_n
4,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",24.51,2022,CWpdhgb1y4_n
4,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",28.43,2022,CWpdhgb2y4_n
4,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",25.23,2022,CWpdhgb3y4_n
4,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",18.2,2022,CWpdhgb4y4_n
4,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.64,2022,CWpdhgb5y4_n
4,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",54.23,2022,CWpdesarxy4_n
4,"N: HD HGB (Adult) - Average number of eligible patients, 2022",59.77,2022,CWhdptdenomy4m_n
4,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",504.47,2022,CWhdptmthdenomy4m_n
4,"N: PD HGB (Adult) - Average number of eligible patients, 2022",16.87,2022,CWpdptdenomy4m_n
4,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",128.39,2022,CWpdptmthdenomy4m_n
4,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",26.4,2022,rdstfy4m_n
4,"N: STrR (Adult) - Average Patient Years at Risk, 2022",15.55,2022,tfyy4m_n
4,"N: STrR (Adult) - Average Number of Transfusions, 2022",4.98,2022,tfy4m_n
4,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",5.16,2022,extfy4m_n
4,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.96,2022,strry4_n
4,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.89,2022,CWhdalby4_n
4,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",2.17,2022,CWhdalb1y4_n
4,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",9.1,2022,CWhdalb2y4_n
4,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",38.57,2022,CWhdalb3y4_n
4,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",46.23,2022,CWhdalb4y4_n
4,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",3.93,2022,CWhdalb5y4_n
4,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",49.84,2022,CWhdalblt4y4_n
4,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.31,2022,CWhdavgufry4_n
4,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",87.94,2022,CWhdufr1y4_n
4,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",6.07,2022,CWhdufr2y4_n
4,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",3.69,2022,CWhdufrmissy4_n
4,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.3,2022,CWhdufrgt20y4_n
4,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.66,2022,CWpdalby4_n
4,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",6.78,2022,CWpdalb1y4_n
4,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",21.82,2022,CWpdalb2y4_n
4,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",40.93,2022,CWpdalb3y4_n
4,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",26.85,2022,CWpdalb4y4_n
4,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",3.62,2022,CWpdalb5y4_n
4,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",69.53,2022,CWpdalblt4y4_n
4,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",59.77,2022,CWhddenomy4m_n
4,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",504.47,2022,CWhdmthdenomy4m_n
4,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",16.87,2022,CWpddenomy4m_n
4,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",128.39,2022,CWpdmthdenomy4m_n
4,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.23,2022,CWpdavgktvy4_n
4,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",6.78,2022,CWpdktv1y4_n
4,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",66.13,2022,CWpdktv2y4_n
4,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",24.01,2022,CWpdktv3y4_n
4,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",3.09,2022,CWpdktv4y4_n
4,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.6,2022,CWhdavgktvy4_n
4,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",2.36,2022,CWhdktv1y4_n
4,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",74.7,2022,CWhdktv2y4_n
4,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",20.88,2022,CWhdktv3y4_n
4,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",2.06,2022,CWhdktv4y4_n
4,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",58.39,2022,CWhdktvptsy4m_N
4,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",487.27,2022,CWhdktvptmthy4m_N
5,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",3.58,2022,allmcFcovpatPq4_n
5,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",26.58,2022,allmcEcovpatPq4_n
5,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",36.71,2022,allmcEcovDeaPq4_n
5,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",35.67,2022,allmcEcovHosPq4_n
5,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",7.7,2022,nh_mcFcovpatPq4_n
5,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",44.47,2022,nh_mcEcovpatPq4_n
5,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",46.45,2022,nh_mcEcovDeaPq4_n
5,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",43.4,2022,nh_mcEcovHosPq4_n
5,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",63.48,2022,agey4_n
5,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.12,2022,age1y4_n
5,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",48.55,2022,age2y4_n
5,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",51.33,2022,age3y4_n
5,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",38.29,2022,dis1y4_n
5,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",37.88,2022,dis2y4_n
5,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",8.31,2022,dis3y4_n
5,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",14.63,2022,dis4y4_n
5,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.88,2022,dis5y4_n
5,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",16.88,2022,vin1y4_n
5,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",18.04,2022,vin2y4_n
5,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.2,2022,vin3y4_n
5,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.5,2022,vin4y4_n
5,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",27.38,2022,vin5y4_n
5,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",4.22,2022,rac1y4_n
5,"N: Prevalent Patients - Race: % African American, 12/31/2022",58.27,2022,rac2y4_n
5,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.24,2022,rac3y4_n
5,"N: Prevalent Patients - Race: % White, 12/31/2022",37.05,2022,rac4y4_n
5,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.23,2022,rac5y4_n
5,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",5.75,2022,eth1y4_n
5,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",94.07,2022,eth2y4_n
5,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.18,2022,eth3y4_n
5,"N: Prevalent Patients - Sex: % Female, 12/31/2022",42.39,2022,sexy4_n
5,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",14.5,2022,nrshomey4_n
5,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",5.09,2022,viny4_n
5,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",83.44,2022,modhdy4_n
5,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",4.59,2022,modhhdy4_n
5,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.34,2022,modcapdy4_n
5,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",10.49,2022,modccpdy4_n
5,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.13,2022,modothry4_n
5,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",54.04,2022,pahy4m_n
5,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",18.9,2022,CWunCa1y4_n
5,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",76.61,2022,CWunCa2y4_n
5,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.05,2022,CWunCa3y4_n
5,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",3.44,2022,CWunCamissy4_n
5,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
5,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.89,2022,CWavgUnCay4_n
5,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.45,2022,CWavgPy4_n
5,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.45,2022,CWP1y4_n
5,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",22.98,2022,CWP2y4_n
5,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",28.99,2022,CWP3y4_n
5,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",21.49,2022,CWP4y4_n
5,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",15.25,2022,CWP5y4_n
5,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",3.84,2022,CWPmissy4_n
5,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
5,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",2.38,2022,CWunCagt102y4_n
5,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",74.88,2022,CWptdenomy4m_n
5,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",632.83,2022,CWptmthdenomy4m_n
5,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",79.97,2022,serumphospatsy4m_n
5,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",670.68,2022,serumphospmy4m_n
5,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",74.88,2022,CWhcptdenomy4m_n
5,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",632.81,2022,CWhcptmthdenomy4m_n
5,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",56.97,2022,ppavfy4_n
5,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",16.84,2022,ppavgy4_n
5,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",23.89,2022,ppcathy4_n
5,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",2.31,2022,ppomy4_n
5,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",18.67,2022,ltcy4_n
5,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",11.22,2022,piavfy4_n
5,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",3.4,2022,piavgy4_n
5,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",81.69,2022,picathy4_n
5,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",3.69,2022,piomy4_n
5,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",11.66,2022,pifisty4_n
5,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",71.64,2022,phdvapty4m_n
5,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",594.18,2022,phdy4m_n
5,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",13.22,2022,ihdy4m_n
5,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",58.04,2022,sfry4_n
5,"N: VA infection - Average number of eligible PD patients, 2022",9.69,2022,pdpaty4m_n
5,"N: VA infection - Average number of eligible PD patient-months, 2022",69.67,2022,pdptmoy4m_n
5,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.44,2022,pd2inf100moy4_n
5,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",42.35,2022,ncmy4m_n
5,"N: Prevalent Comorbidities - Average % with Anemia, 2022",3.64,2022,clmanemy4_n
5,"N: Prevalent Comorbidities - Average % with AIDS, 2022",1.27,2022,clmhivaidmy4_n
5,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.25,2022,clmalcomy4_n
5,"N: Prevalent Comorbidities - Average % with Cancer, 2022",3.62,2022,clmcanmy4_n
5,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",1.0,2022,clmcamy4_n
5,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",19.98,2022,clmcdmy4_n
5,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",8.18,2022,clmcvdmy4_n
5,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",15.27,2022,clmcopdmy4_n
5,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",31.11,2022,clmchfmy4_n
5,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",34.75,2022,clmdiabmy4_n
5,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",0.83,2022,clmdrugmy4_n
5,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",3.08,2022,clmgtbmy4_n
5,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.52,2022,clmhepbmy4_n
5,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",2.03,2022,clmhepothmy4_n
5,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",22.07,2022,clmhypthymy4_n
5,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",18.31,2022,clminfmy4_n
5,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",25.55,2022,clmihdmy4_n
5,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",8.14,2022,clmmimy4_n
5,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",16.51,2022,clmpvdmy4_n
5,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",3.44,2022,clmpnemy4_n
5,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.27,2022,clmcntcomy4_n
5,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",4.85,2022,clminfvamy4_n
5,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.48,2022,clmmstinfmy4_n
5,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.21,2022,clmtbmy4_n
5,"N (AFS): Facility Information - Average number of patients, 2022",97.2,2022,allcnty4m_n
5,N (AFS): Facility Information - Average number of all patients on 12/31/2022,61.26,2022,endcnty4m_n
5,"N (AFS): Facility Information - Average % of patients transferred in, 2022",19.34,2022,transiny4_n
5,"N (AFS): Facility Information - Average % of patients transferred out, 2022",19.4,2022,transouty4_n
5,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,79.48,2022,medicarey4_n
5,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,9.24,2022,medpendy4_n
5,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,11.27,2022,nonmedy4_n
5,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.12,2022,cfc_N
5,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,6.62,2022,std_N
5,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",27.59,2022,p_age1y4_n
5,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",13.79,2022,p_age2y4_n
5,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",20.69,2022,p_age3y4_n
5,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",37.93,2022,p_age4y4_n
5,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",0.0,2022,p_dis1y4_n
5,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",0.0,2022,p_dis2y4_n
5,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",37.93,2022,p_dis3y4_n
5,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",31.03,2022,p_dis4y4_n
5,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
5,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
5,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",24.14,2022,p_dis7y4_n
5,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",6.9,2022,p_dis8y4_n
5,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",34.48,2022,p_vin1y4_n
5,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",41.38,2022,p_vin2y4_n
5,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",10.34,2022,p_vin3y4_n
5,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",3.45,2022,p_vin4y4_n
5,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",10.34,2022,p_vin5y4_n
5,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",0.0,2022,p_rac1y4_n
5,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",55.17,2022,p_rac2y4_n
5,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",3.45,2022,p_rac3y4_n
5,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",37.93,2022,p_rac4y4_n
5,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",3.45,2022,p_rac5y4_n
5,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",13.79,2022,p_eth1y4_n
5,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",86.21,2022,p_eth2y4_n
5,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
5,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",37.93,2022,p_sexy4_n
5,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",62.07,2022,p_modhdy4_n
5,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
5,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.0,2022,p_modcapdy4_n
5,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",37.93,2022,p_modccpdy4_n
5,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
5,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",6.9,2022,p_allmdcrmy4_n
5,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",48.28,2022,p_insmdcdmy4_n
5,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",34.48,2022,p_insempmy4_n
5,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",10.34,2022,p_insnonothmy4_n
5,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",13.79,2022,p_nephnomy4_n
5,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",24.14,2022,p_nephy6my4_n
5,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",17.24,2022,p_nephy612my4_n
5,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",37.93,2022,p_nephy12my4_n
5,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",6.9,2022,p_nephunkmissmy4_n
5,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",93.1,2022,p_ptinfymy4_n
5,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",0.0,2022,p_mefavfmy4_n
5,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
5,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",100.0,2022,p_mefcathmy4_n
5,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
5,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",0.0,2022,p_avfpresentmy4_n
5,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",14.62,2022,p_ppavfy4_n
5,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",64.82,2022,p_ltcy4_n
5,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",28.05,2022,p_WLy4_n
5,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",23.85,2022,p_WLlt10y4_n
5,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",35.11,2022,p_WL1017y4_n
5,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.16,2022,p_CWhdavgHGBy4_n
5,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",17.65,2022,p_CWhdhgb1y4_n
5,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",18.63,2022,p_CWhdhgb2y4_n
5,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",39.22,2022,p_CWhdhgb3y4_n
5,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",22.06,2022,p_CWhdhgb4y4_n
5,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.45,2022,p_CWhdhgb5y4_n
5,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.5,2022,p_CWpdavgHGBy4_n
5,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",10.97,2022,p_CWpdhgb1y4_n
5,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",16.13,2022,p_CWpdhgb2y4_n
5,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",27.1,2022,p_CWpdhgb3y4_n
5,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",27.74,2022,p_CWpdhgb4y4_n
5,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",18.06,2022,p_CWpdhgb5y4_n
5,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.14,2022,p_CWhdalby4_n
5,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",0.0,2022,p_CWhdalb1y4_n
5,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",3.92,2022,p_CWhdalb2y4_n
5,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",21.57,2022,p_CWhdalb3y4_n
5,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",71.08,2022,p_CWhdalb4y4_n
5,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",3.43,2022,p_CWhdalb5y4_n
5,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.76,2022,p_CWpdalby4_n
5,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",3.23,2022,p_CWpdalb1y4_n
5,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",19.35,2022,p_CWpdalb2y4_n
5,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",25.16,2022,p_CWpdalb3y4_n
5,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",32.26,2022,p_CWpdalb4y4_n
5,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",20.0,2022,p_CWpdalb5y4_n
5,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",70.32,2022,p_CWpdktvge18y4_n
5,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",90.72,2022,p_CWhdktvge12y4_n
5,"N: Patient Placement -  % of incident patients, 2022",17.32,2022,ppidy4_n
5,"N: Patient Placement -  % of patients continuing at facility, 2022",70.23,2022,ppcdy4_n
5,"N: Patient Placement -  % of patients that transfered into facility, 2022",12.45,2022,pptdy4_n
5,"N: End of Year Status - % of patients death attributed to this facility, 2022",13.99,2022,pdhdy4_n
5,"N: End of Year Status - % of patients death attributed to another facility, 2022",2.28,2022,pdody4_n
5,"N: End of Year Status - % of patients that received a transplant, 2022",3.03,2022,ptxdy4_n
5,"N: End of Year Status - % of patients alive in this facility, 2022",68.58,2022,pahdy4_n
5,"N: End of Year Status - % of patients alive in another facility, 2022",8.52,2022,paody4_n
5,"N: End of Year Status - % of patients other, 2022",3.6,2022,potdy4_n
5,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,51.3,2022,iuhemy4m_n
5,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.01,2022,iufreqy4m_n
5,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,51.3,2022,iunonfreqy4m_n
5,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.02,2022,iuothy4m_n
5,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
5,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
5,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,2.7,2022,ihhemy4m_n
5,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.6,2022,ihfreqy4m_n
5,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,2.1,2022,ihnonfreqy4m_n
5,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
5,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.88,2022,ihcapdy4m_n
5,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,6.34,2022,ihccpdy4m_n
5,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",13.75,2022,staffy4m_n
5,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,3.43,2022,nurseFTy4m_n
5,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,6.2,2022,ptcareFTy4m_n
5,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,1.08,2022,dietFTy4m_n
5,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.06,2022,socwkFTy4m_n
5,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.6,2022,nursePTy4m_n
5,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.84,2022,ptcarePTy4m_n
5,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.28,2022,dietPTy4m_n
5,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.26,2022,socwkPTy4m_n
5,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,30.22,2022,vocrehaby4m_n
5,"N (AFS): Facility Information - Average % incident patients, 2022",15.44,2022,incpery4_n
5,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,32.6,2022,employedy4_n
5,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.72,2022,schooly4_n
5,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",44.2,2022,nh_ppavfy4_n
5,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",25.63,2022,nh_ltcy4_n
5,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",2.89,2022,nh_CWhdktv1y4_n
5,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",8.24,2022,nh_CWpdktv1y4_n
5,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",33.83,2022,nh_CWhdhgb1y4_n
5,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",78.1,2022,nh_CWhdesarxy4_n
5,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",30.28,2022,nh_CWpdhgb1y4_n
5,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",53.13,2022,nh_CWpdesarxy4_n
5,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",42.37,2022,nh_obdry4_n
5,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.29,2022,nh_smry4_n
5,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",19.98,2022,nh_wity4_n
5,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",257.15,2022,nh_obhtry4_n
5,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.39,2022,nh_shrty4_n
5,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",23.52,2022,nh_sepiy4_n
5,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",10.92,2022,nh_miiy4_n
5,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",45.45,2022,nh_achfy4_n
5,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",32.65,2022,nh_acdry4_n
5,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",4.11,2022,nh_acary4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",2.05,2022,nh_clmhivaidmy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",8.93,2022,nh_clminfvamy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",0.98,2022,nh_clmhepbmy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",4.01,2022,nh_clmhepothmy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",4.64,2022,nh_clmmstinfmy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",9.4,2022,nh_clmpnemy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.16,2022,nh_clmtbmy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",40.08,2022,nh_clminfmy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.49,2022,nh_clmcamy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",39.63,2022,nh_clmcdmy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",21.87,2022,nh_clmcvdmy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",55.85,2022,nh_clmchfmy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",44.49,2022,nh_clmihdmy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",15.4,2022,nh_clmmimy4_n
5,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",35.75,2022,nh_clmpvdmy4_n
5,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
5,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",32.13,2022,nh_age2y4_n
5,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",67.87,2022,nh_age3y4_n
5,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",46.99,2022,nh_dis1y4_n
5,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",34.12,2022,nh_dis2y4_n
5,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",4.11,2022,nh_dis3y4_n
5,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",12.93,2022,nh_dis4y4_n
5,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",1.85,2022,nh_dis5y4_n
5,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",2.55,2022,nh_rac1y4_n
5,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",58.19,2022,nh_rac2y4_n
5,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",0.25,2022,nh_rac3y4_n
5,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",38.79,2022,nh_rac4y4_n
5,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.22,2022,nh_rac5y4_n
5,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",2.43,2022,nh_eth1y4_n
5,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",97.23,2022,nh_eth2y4_n
5,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.34,2022,nh_eth3y4_n
5,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",23.01,2022,nh_vin1y4_n
5,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",14.92,2022,nh_vin2y4_n
5,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",11.36,2022,nh_vin3y4_n
5,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",23.31,2022,nh_vin4y4_n
5,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",27.4,2022,nh_vin5y4_n
5,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",50.04,2022,nh_sexy4_n
5,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",88.89,2022,nh_modhdy4_n
5,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",8.68,2022,nh_modhhdy4_n
5,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.14,2022,nh_modcapdy4_n
5,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",2.07,2022,nh_modccpdy4_n
5,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.22,2022,nh_modothry4_n
5,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",83.98,2022,nh_allmdcrmy4_n
5,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",8.82,2022,nh_insmdcdmy4_n
5,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",2.82,2022,nh_insempmy4_n
5,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",4.38,2022,nh_insnonothmy4_n
5,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",5.79,2022,nh_mefavfmy4_n
5,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",2.54,2022,nh_mefgraftmy4_n
5,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",89.06,2022,nh_mefcathmy4_n
5,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",2.61,2022,nh_mefoumaccessmy4_n
5,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",11.22,2022,nh_avfpresentmy4_n
5,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",12.99,2022,nh_nephnomy4_n
5,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",21.67,2022,nh_nephy6my4_n
5,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",16.58,2022,nh_nephy612my4_n
5,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",18.35,2022,nh_nephy12my4_n
5,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",30.42,2022,nh_nephunkmissmy4_n
5,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",91.67,2022,nh_ptinfymy4_n
5,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",1.46,2022,alcomy4_n
5,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",8.08,2022,ashdmy4_n
5,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",19.06,2022,othcarmy4_n
5,"N (2728): Incident Patients  - Percent with cancer, 2022",6.04,2022,canmy4_n
5,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",24.15,2022,chfmy4_n
5,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",7.66,2022,cvamy4_n
5,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",39.12,2022,diabimy4_n
5,"N (2728): Incident Patients  - Percent with diabetes, 2022",61.07,2022,diabmy4_n
5,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.9,2022,drugmy4_n
5,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",86.21,2022,hxhtmy4_n
5,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",5.52,2022,ambumy4_n
5,"N (2728): Incident Patients  - Percent inability to transfer, 2022",3.08,2022,transmy4_n
5,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",7.2,2022,copdmy4_n
5,"N (2728): Incident Patients  - Percent with PVD, 2022",5.33,2022,pvdmy4_n
5,"N (2728): Incident Patients  - Percent smoker, 2022",7.52,2022,smokmy4_n
5,"N (2728): Incident Patients  - Percent Hispanic, 2022",4.26,2022,ethmy4_n
5,"N (2728): Incident Patients  - Percent White, 2022",46.53,2022,whitemy4_n
5,"N (2728): Incident Patients  - Percent African American, 2022",48.16,2022,blackmy4_n
5,"N (2728): Incident Patients  - Percent Native American, 2022",0.72,2022,nativmy4_n
5,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",4.31,2022,asianmy4_n
5,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.28,2022,racoummy4_n
5,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",31.26,2022,cempmy4_n
5,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",39.66,2022,pempmy4_n
5,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",39.47,2022,dbprimy4_n
5,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",5.46,2022,gnprimy4_n
5,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",36.67,2022,htprimy4_n
5,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",18.41,2022,omprimy4_n
5,"N (2728): Incident Patients  - Percent female, 2022",42.47,2022,femmy4_n
5,"N (2728): Incident Patients  - Average age, 2022",64.12,2022,agemy4_n
5,"N (2728): Incident Patients  - Average serum albumin, 2022",3.43,2022,salbmy4_n
5,"N (2728): Incident Patients  - Average creatinine, 2022",6.6,2022,creamy4_n
5,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.26,2022,hgmy4_n
5,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",10.76,2022,gfrmy4_n
5,"N (2728): Incident Patients  - Average count of comorbidities, 2022",2.83,2022,cntcomy4_n
5,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",85.93,2022,pdmodMEFHDmy4_n
5,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",14.07,2022,pdmodMEFPDmy4_n
5,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
5,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",48.71,2022,insmdcrmy4_n
5,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",13.11,2022,insmdcdmy4_n
5,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",5.85,2022,insmdcrcdmy4_n
5,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",12.74,2022,insempmy4_n
5,"N (2728): Incident Patients  - Percent with no coverage, 2022",1.81,2022,insnonemy4_n
5,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",10.41,2022,insmdcromy4_n
5,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",7.37,2022,insmedomy4_n
5,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",14.06,2022,preepomy4_n
5,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",13.19,2022,nephnomy4_n
5,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",17.06,2022,nephy6my4_n
5,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",20.71,2022,nephy612my4_n
5,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",28.57,2022,nephy12my4_n
5,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",20.47,2022,nephunkmissmy4_n
5,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",95.0,2022,ptinfymy4_n
5,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",36.79,2022,ptxmedunfitmy4_n
5,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
5,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
5,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",10.69,2022,ptxdeclinemy4_n
5,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",57.55,2022,ptxnotassessmy4_n
5,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",11.55,2022,mefavfmy4_n
5,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",3.46,2022,mefgraftmy4_n
5,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",84.63,2022,mefcathmy4_n
5,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.37,2022,mefoumaccessmy4_n
5,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",20.35,2022,avfpresentmy4_n
5,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",27.82,2022,bmimmy4_n
5,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",29.0,2022,bmifmy4_n
5,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",0.71,2022,ptinfnmy4m_n
5,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",12.25,2022,hemomy4m_n
5,"N (2728): Incident Patients  - Average Number of forms returned, 2022",14.26,2022,nmy4m_n
5,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",77.1,2019,rdsmzm_n
5,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",49.75,2019,dyzm_n
5,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",9.58,2019,deazm_n
5,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",9.35,2019,exdzm_n
5,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.05,2019,dudzm_n
5,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",1.02,2019,smrz_n
5,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",18.97,2019,witz_n
5,"N: All Patient Mortality - % of deaths from infection, 2019-2022",8.97,2019,infz_n
5,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",39.36,2019,cardz_n
5,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.11,2019,livz_n
5,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",14.03,2019,fynmzm_n
5,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",8.49,2019,fydyzm_n
5,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.26,2019,fydeazm_n
5,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.18,2019,fyexdzm_n
5,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",1.04,2019,fysmrz_n
5,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",20.52,2019,fywitz_n
5,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",7.72,2019,fyinfz_n
5,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",36.94,2019,fycardiacz_n
5,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",1.99,2019,fylivz_n
5,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",62.16,2019,rdshzm_n
5,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",52.88,2019,htazm_n
5,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",57.08,2019,extzm_n
5,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",420.68,2019,hdzm_n
5,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",467.11,2019,exhdzm_n
5,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",39.01,2019,hdyzm_n
5,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",0.93,2019,shrtz_n
5,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.9,2019,shrdz_n
5,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.65,2019,lenz_n
5,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",8.89,2019,onez_n
5,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",7.11,2019,miiz_n
5,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",13.06,2019,sepiz_n
5,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",29.1,2019,achfz_n
5,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",19.75,2019,acdrz_n
5,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.62,2019,acarz_n
5,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",87.58,2019,ipedz_n
5,"N: ED30 - Average annual index discharges, 2019-22",35.4,2019,ed30indexzm_n
5,"N: ED30- Average annual number of ED visits, 2019-22",5.94,2019,ed30obszm_n
5,"N: ED30 - Average annual expected ED visits, 2019-22",5.83,2019,ed30expzm_n
5,"N: ED30: Standardized Ratio of ED30, 2019-22",1.06,2019,ed30z_n
5,"N SRR -  Standardized Readmission Ratio, 2022",0.98,2022,srry4_n
5,"N: SRR - Average index discharges, 2022",50.57,2022,indexmy4_n
5,"N: SRR - Average number of readmissions, 2022",12.89,2022,readmmy4_n
5,"N: SRR - Average expected readmissions, 2022",13.75,2022,srrexpmy4_n
5,Pt included in SEDR analysis,48.09,2019,rdsezm_n
5,Total number of ED Visits,46.45,2019,hedzm_n
5,Expected number of ED events,44.79,2019,exedzm_n
5,Years at risk for ED visit rate,30.04,2019,edyrzm_n
5,Years at risk for ED visit rate,57324.41,2019,edyrz_n
5,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",1.04,2019,sedrz_n
5,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",55.56,2019,rdstzm_n
5,"N: STR - Average number of patients (per year in average facility), 2019-2022",60.17,2019,rdsalltzm_n
5,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",2.0,2019,txzm_n
5,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",2.25,2019,txallzm_n
5,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",35.86,2019,txyzm_n
5,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.85,2019,cadalltzm_n
5,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.44,2019,livealltzm_n
5,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",1.68,2019,extxzm_n
5,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",1.19,2019,strz_n
5,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",56.16,2022,pppwpty4m_n
5,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",17.11,2022,WLy4_n
5,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",25.36,2022,WLlt40y4_n
5,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",16.26,2022,WL4074y4_n
5,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",18.42,2022,WLmaley4_n
5,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",15.19,2022,WLfemy4_n
5,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",16.51,2022,WLwhhy4_n
5,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",16.1,2022,WLwhnhy4_n
5,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",16.87,2022,WLbly4_n
5,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",29.37,2022,WLasy4_n
5,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",20.78,2022,WLnay4_n
5,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",17.68,2022,WLothy4_n
5,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",15.06,2022,WLDMy4_n
5,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",18.37,2022,WLnodmy4_n
5,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",16.29,2022,WLnotxy4_n
5,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",26.24,2022,WLtxy4_n
5,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",15.59,2022,WLVCat1y4_n
5,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",22.14,2022,WLVCat2y4_n
5,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",14.44,2022,WLVCat3y4_n
5,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",469.67,2022,pppwpmy4m_n
5,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",16.9,2022,pppwy4_n
5,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",8.88,2019,swrptzm_n
5,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",7.05,2019,swrpyzm_n
5,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.75,2019,swrwlzm_n
5,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.7,2019,swrexwlzm_n
5,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",1.07,2019,swrz_n
5,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",82.29,2021,FVfy3_n
5,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",7.62,2021,FVdeclinedfy3_n
5,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.11,2021,FVovndfy3_n
5,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",10.09,2021,FVothrsnfy3_n
5,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",78.55,2022,FVhy4_n
5,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",79.87,2022,FVmcarehy4_n
5,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",81.95,2022,FVmahy4_n
5,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",79.22,2022,FVmpphy4_n
5,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",76.62,2022,FVdualhy4_n
5,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",76.91,2022,FVmsphy4_n
5,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",71.0,2022,FVnonmcarehy4_n
5,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",66.67,2022,FVlt18hy4_n
5,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",67.38,2022,FV1839hy4_n
5,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",75.86,2022,FV4064hy4_n
5,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",80.79,2022,FV6574hy4_n
5,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",83.13,2022,FV75uphy4_n
5,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",77.94,2022,FVmalehy4_n
5,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",79.04,2022,FVfemhy4_n
5,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",83.41,2022,FVashy4_n
5,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",61.54,2022,FVnahy4_n
5,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",80.74,2022,FVwhhy4_n
5,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",60.94,2022,FVrothhy4_n
5,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",76.66,2022,FVblkhy4_n
5,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",82.99,2022,FVhisphy4_n
5,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",70.46,2022,FVVCat1hy4_n
5,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",78.32,2022,FVVCat2hy4_n
5,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",81.81,2022,FVVCat3hy4_n
5,"N: Influenza - Average number of patients treated on 12/31, 2022",56.21,2022,eFVy4m_n
5,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",2.17,2022,medrsnfy4m_N
5,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.64,2022,CWhdavgHGBy4_n
5,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",25.57,2022,CWhdhgb1y4_n
5,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",33.37,2022,CWhdhgb2y4_n
5,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",27.21,2022,CWhdhgb3y4_n
5,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",11.07,2022,CWhdhgb4y4_n
5,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.78,2022,CWhdhgb5y4_n
5,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",74.28,2022,CWhdesarxy4_n
5,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.81,2022,CWpdavgHGBy4_n
5,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",24.86,2022,CWpdhgb1y4_n
5,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",26.92,2022,CWpdhgb2y4_n
5,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",25.44,2022,CWpdhgb3y4_n
5,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",16.9,2022,CWpdhgb4y4_n
5,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",5.87,2022,CWpdhgb5y4_n
5,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",53.67,2022,CWpdesarxy4_n
5,"N: HD HGB (Adult) - Average number of eligible patients, 2022",67.99,2022,CWhdptdenomy4m_n
5,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",571.66,2022,CWhdptmthdenomy4m_n
5,"N: PD HGB (Adult) - Average number of eligible patients, 2022",20.08,2022,CWpdptdenomy4m_n
5,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",154.6,2022,CWpdptmthdenomy4m_n
5,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",35.93,2022,rdstfy4m_n
5,"N: STrR (Adult) - Average Patient Years at Risk, 2022",21.42,2022,tfyy4m_n
5,"N: STrR (Adult) - Average Number of Transfusions, 2022",6.54,2022,tfy4m_n
5,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",6.99,2022,extfy4m_n
5,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.94,2022,strry4_n
5,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.9,2022,CWhdalby4_n
5,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",2.11,2022,CWhdalb1y4_n
5,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",8.68,2022,CWhdalb2y4_n
5,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",37.78,2022,CWhdalb3y4_n
5,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",46.84,2022,CWhdalb4y4_n
5,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",4.59,2022,CWhdalb5y4_n
5,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",48.57,2022,CWhdalblt4y4_n
5,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.59,2022,CWhdavgufry4_n
5,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",86.62,2022,CWhdufr1y4_n
5,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",7.73,2022,CWhdufr2y4_n
5,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",3.37,2022,CWhdufrmissy4_n
5,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.28,2022,CWhdufrgt20y4_n
5,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.67,2022,CWpdalby4_n
5,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",6.16,2022,CWpdalb1y4_n
5,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",21.16,2022,CWpdalb2y4_n
5,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",41.48,2022,CWpdalb3y4_n
5,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",25.56,2022,CWpdalb4y4_n
5,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",5.64,2022,CWpdalb5y4_n
5,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",68.8,2022,CWpdalblt4y4_n
5,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",67.99,2022,CWhddenomy4m_n
5,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",571.66,2022,CWhdmthdenomy4m_n
5,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",20.08,2022,CWpddenomy4m_n
5,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",154.6,2022,CWpdmthdenomy4m_n
5,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.2,2022,CWpdavgktvy4_n
5,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",5.47,2022,CWpdktv1y4_n
5,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",67.25,2022,CWpdktv2y4_n
5,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",22.49,2022,CWpdktv3y4_n
5,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",4.79,2022,CWpdktv4y4_n
5,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.57,2022,CWhdavgktvy4_n
5,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",1.95,2022,CWhdktv1y4_n
5,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",78.98,2022,CWhdktv2y4_n
5,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",17.46,2022,CWhdktv3y4_n
5,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.6,2022,CWhdktv4y4_n
5,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",65.38,2022,CWhdktvptsy4m_N
5,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",543.37,2022,CWhdktvptmthy4m_N
6,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",2.46,2022,allmcFcovpatPq4_n
6,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",26.2,2022,allmcEcovpatPq4_n
6,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",35.64,2022,allmcEcovDeaPq4_n
6,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",33.95,2022,allmcEcovHosPq4_n
6,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",5.86,2022,nh_mcFcovpatPq4_n
6,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",45.26,2022,nh_mcEcovpatPq4_n
6,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",44.84,2022,nh_mcEcovDeaPq4_n
6,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",42.62,2022,nh_mcEcovHosPq4_n
6,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",61.87,2022,agey4_n
6,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.22,2022,age1y4_n
6,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",52.95,2022,age2y4_n
6,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",46.83,2022,age3y4_n
6,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",39.04,2022,dis1y4_n
6,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",39.27,2022,dis2y4_n
6,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",8.97,2022,dis3y4_n
6,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",12.27,2022,dis4y4_n
6,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.46,2022,dis5y4_n
6,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",16.09,2022,vin1y4_n
6,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",17.14,2022,vin2y4_n
6,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.01,2022,vin3y4_n
6,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.51,2022,vin4y4_n
6,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",29.25,2022,vin5y4_n
6,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",2.02,2022,rac1y4_n
6,"N: Prevalent Patients - Race: % African American, 12/31/2022",64.91,2022,rac2y4_n
6,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.68,2022,rac3y4_n
6,"N: Prevalent Patients - Race: % White, 12/31/2022",32.27,2022,rac4y4_n
6,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.12,2022,rac5y4_n
6,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",4.76,2022,eth1y4_n
6,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",95.15,2022,eth2y4_n
6,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.09,2022,eth3y4_n
6,"N: Prevalent Patients - Sex: % Female, 12/31/2022",44.03,2022,sexy4_n
6,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",10.45,2022,nrshomey4_n
6,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",5.26,2022,viny4_n
6,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",83.7,2022,modhdy4_n
6,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",3.4,2022,modhhdy4_n
6,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.99,2022,modcapdy4_n
6,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",11.76,2022,modccpdy4_n
6,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.15,2022,modothry4_n
6,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",54.45,2022,pahy4m_n
6,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",19.16,2022,CWunCa1y4_n
6,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",76.87,2022,CWunCa2y4_n
6,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.14,2022,CWunCa3y4_n
6,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",2.82,2022,CWunCamissy4_n
6,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
6,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.89,2022,CWavgUnCay4_n
6,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.53,2022,CWavgPy4_n
6,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.76,2022,CWP1y4_n
6,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",21.76,2022,CWP2y4_n
6,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",27.11,2022,CWP3y4_n
6,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",23.4,2022,CWP4y4_n
6,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",16.76,2022,CWP5y4_n
6,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",3.21,2022,CWPmissy4_n
6,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
6,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",1.68,2022,CWunCagt102y4_n
6,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",74.99,2022,CWptdenomy4m_n
6,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",644.73,2022,CWptmthdenomy4m_n
6,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",79.79,2022,serumphospatsy4m_n
6,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",680.86,2022,serumphospmy4m_n
6,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",74.98,2022,CWhcptdenomy4m_n
6,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",644.7,2022,CWhcptmthdenomy4m_n
6,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",56.53,2022,ppavfy4_n
6,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",21.89,2022,ppavgy4_n
6,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",19.54,2022,ppcathy4_n
6,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",2.04,2022,ppomy4_n
6,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",14.63,2022,ltcy4_n
6,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",12.44,2022,piavfy4_n
6,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",4.87,2022,piavgy4_n
6,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",78.68,2022,picathy4_n
6,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",4.01,2022,piomy4_n
6,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",12.99,2022,pifisty4_n
6,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",71.57,2022,phdvapty4m_n
6,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",606.42,2022,phdy4m_n
6,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",12.48,2022,ihdy4m_n
6,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",55.49,2022,sfry4_n
6,"N: VA infection - Average number of eligible PD patients, 2022",10.92,2022,pdpaty4m_n
6,"N: VA infection - Average number of eligible PD patient-months, 2022",76.58,2022,pdptmoy4m_n
6,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.75,2022,pd2inf100moy4_n
6,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",46.43,2022,ncmy4m_n
6,"N: Prevalent Comorbidities - Average % with Anemia, 2022",3.16,2022,clmanemy4_n
6,"N: Prevalent Comorbidities - Average % with AIDS, 2022",1.07,2022,clmhivaidmy4_n
6,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.23,2022,clmalcomy4_n
6,"N: Prevalent Comorbidities - Average % with Cancer, 2022",3.2,2022,clmcanmy4_n
6,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",0.94,2022,clmcamy4_n
6,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",17.2,2022,clmcdmy4_n
6,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",7.47,2022,clmcvdmy4_n
6,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",14.1,2022,clmcopdmy4_n
6,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",30.68,2022,clmchfmy4_n
6,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",33.68,2022,clmdiabmy4_n
6,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",0.93,2022,clmdrugmy4_n
6,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",3.02,2022,clmgtbmy4_n
6,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.61,2022,clmhepbmy4_n
6,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.37,2022,clmhepothmy4_n
6,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",23.54,2022,clmhypthymy4_n
6,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",16.72,2022,clminfmy4_n
6,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",23.37,2022,clmihdmy4_n
6,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",6.19,2022,clmmimy4_n
6,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",14.89,2022,clmpvdmy4_n
6,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",3.0,2022,clmpnemy4_n
6,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.13,2022,clmcntcomy4_n
6,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",4.78,2022,clminfvamy4_n
6,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.35,2022,clmmstinfmy4_n
6,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.13,2022,clmtbmy4_n
6,"N (AFS): Facility Information - Average number of patients, 2022",94.09,2022,allcnty4m_n
6,N (AFS): Facility Information - Average number of all patients on 12/31/2022,61.96,2022,endcnty4m_n
6,"N (AFS): Facility Information - Average % of patients transferred in, 2022",17.46,2022,transiny4_n
6,"N (AFS): Facility Information - Average % of patients transferred out, 2022",17.38,2022,transouty4_n
6,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,87.91,2022,medicarey4_n
6,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,5.57,2022,medpendy4_n
6,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,6.52,2022,nonmedy4_n
6,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.15,2022,cfc_N
6,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,3.14,2022,std_N
6,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",23.71,2022,p_age1y4_n
6,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",17.53,2022,p_age2y4_n
6,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",27.84,2022,p_age3y4_n
6,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",30.93,2022,p_age4y4_n
6,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",1.03,2022,p_dis1y4_n
6,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",6.19,2022,p_dis2y4_n
6,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",29.9,2022,p_dis3y4_n
6,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",32.99,2022,p_dis4y4_n
6,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
6,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
6,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",25.77,2022,p_dis7y4_n
6,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",4.12,2022,p_dis8y4_n
6,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",18.56,2022,p_vin1y4_n
6,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",30.93,2022,p_vin2y4_n
6,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",18.56,2022,p_vin3y4_n
6,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",19.59,2022,p_vin4y4_n
6,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",12.37,2022,p_vin5y4_n
6,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",4.12,2022,p_rac1y4_n
6,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",50.52,2022,p_rac2y4_n
6,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",3.09,2022,p_rac3y4_n
6,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",42.27,2022,p_rac4y4_n
6,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",0.0,2022,p_rac5y4_n
6,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",13.4,2022,p_eth1y4_n
6,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",86.6,2022,p_eth2y4_n
6,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
6,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",37.11,2022,p_sexy4_n
6,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",46.39,2022,p_modhdy4_n
6,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
6,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.0,2022,p_modcapdy4_n
6,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",53.61,2022,p_modccpdy4_n
6,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
6,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",8.33,2022,p_allmdcrmy4_n
6,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",66.67,2022,p_insmdcdmy4_n
6,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",11.11,2022,p_insempmy4_n
6,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",13.89,2022,p_insnonothmy4_n
6,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",22.22,2022,p_nephnomy4_n
6,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",11.11,2022,p_nephy6my4_n
6,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",16.67,2022,p_nephy612my4_n
6,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",44.44,2022,p_nephy12my4_n
6,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",5.56,2022,p_nephunkmissmy4_n
6,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",94.44,2022,p_ptinfymy4_n
6,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",0.0,2022,p_mefavfmy4_n
6,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
6,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",100.0,2022,p_mefcathmy4_n
6,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
6,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",0.0,2022,p_avfpresentmy4_n
6,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",17.74,2022,p_ppavfy4_n
6,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",65.34,2022,p_ltcy4_n
6,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",28.16,2022,p_WLy4_n
6,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",18.93,2022,p_WLlt10y4_n
6,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",35.57,2022,p_WL1017y4_n
6,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.73,2022,p_CWhdavgHGBy4_n
6,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",24.47,2022,p_CWhdhgb1y4_n
6,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",28.52,2022,p_CWhdhgb2y4_n
6,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",28.35,2022,p_CWhdhgb3y4_n
6,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",15.49,2022,p_CWhdhgb4y4_n
6,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.17,2022,p_CWhdhgb5y4_n
6,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.66,2022,p_CWpdavgHGBy4_n
6,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",31.7,2022,p_CWpdhgb1y4_n
6,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",21.44,2022,p_CWpdhgb2y4_n
6,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",19.45,2022,p_CWpdhgb3y4_n
6,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",17.15,2022,p_CWpdhgb4y4_n
6,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",10.26,2022,p_CWpdhgb5y4_n
6,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.11,2022,p_CWhdalby4_n
6,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",0.35,2022,p_CWhdalb1y4_n
6,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",3.87,2022,p_CWhdalb2y4_n
6,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",24.65,2022,p_CWhdalb3y4_n
6,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",67.25,2022,p_CWhdalb4y4_n
6,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",3.87,2022,p_CWhdalb5y4_n
6,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.68,2022,p_CWpdalby4_n
6,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",11.79,2022,p_CWpdalb1y4_n
6,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",17.3,2022,p_CWpdalb2y4_n
6,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",22.82,2022,p_CWpdalb3y4_n
6,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",33.54,2022,p_CWpdalb4y4_n
6,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",14.55,2022,p_CWpdalb5y4_n
6,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",75.34,2022,p_CWpdktvge18y4_n
6,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",94.38,2022,p_CWhdktvge12y4_n
6,"N: Patient Placement -  % of incident patients, 2022",16.23,2022,ppidy4_n
6,"N: Patient Placement -  % of patients continuing at facility, 2022",71.38,2022,ppcdy4_n
6,"N: Patient Placement -  % of patients that transfered into facility, 2022",12.39,2022,pptdy4_n
6,"N: End of Year Status - % of patients death attributed to this facility, 2022",13.21,2022,pdhdy4_n
6,"N: End of Year Status - % of patients death attributed to another facility, 2022",1.85,2022,pdody4_n
6,"N: End of Year Status - % of patients that received a transplant, 2022",2.83,2022,ptxdy4_n
6,"N: End of Year Status - % of patients alive in this facility, 2022",68.89,2022,pahdy4_n
6,"N: End of Year Status - % of patients alive in another facility, 2022",9.08,2022,paody4_n
6,"N: End of Year Status - % of patients other, 2022",4.15,2022,potdy4_n
6,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,52.32,2022,iuhemy4m_n
6,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.02,2022,iufreqy4m_n
6,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,52.3,2022,iunonfreqy4m_n
6,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.0,2022,iuothy4m_n
6,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
6,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
6,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,1.93,2022,ihhemy4m_n
6,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.65,2022,ihfreqy4m_n
6,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,1.27,2022,ihnonfreqy4m_n
6,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
6,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.71,2022,ihcapdy4m_n
6,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,7.0,2022,ihccpdy4m_n
6,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",13.15,2022,staffy4m_n
6,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,3.8,2022,nurseFTy4m_n
6,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,5.42,2022,ptcareFTy4m_n
6,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,0.98,2022,dietFTy4m_n
6,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.0,2022,socwkFTy4m_n
6,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.67,2022,nursePTy4m_n
6,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.66,2022,ptcarePTy4m_n
6,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.31,2022,dietPTy4m_n
6,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.31,2022,socwkPTy4m_n
6,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,32.62,2022,vocrehaby4m_n
6,"N (AFS): Facility Information - Average % incident patients, 2022",14.63,2022,incpery4_n
6,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,23.9,2022,employedy4_n
6,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.94,2022,schooly4_n
6,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",46.7,2022,nh_ppavfy4_n
6,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",19.78,2022,nh_ltcy4_n
6,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",3.07,2022,nh_CWhdktv1y4_n
6,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",10.86,2022,nh_CWpdktv1y4_n
6,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",33.17,2022,nh_CWhdhgb1y4_n
6,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",79.95,2022,nh_CWhdesarxy4_n
6,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",29.77,2022,nh_CWpdhgb1y4_n
6,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",56.38,2022,nh_CWpdesarxy4_n
6,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",40.95,2022,nh_obdry4_n
6,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.23,2022,nh_smry4_n
6,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",26.87,2022,nh_wity4_n
6,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",264.52,2022,nh_obhtry4_n
6,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.49,2022,nh_shrty4_n
6,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",23.38,2022,nh_sepiy4_n
6,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",9.54,2022,nh_miiy4_n
6,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",49.31,2022,nh_achfy4_n
6,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",33.16,2022,nh_acdry4_n
6,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",4.02,2022,nh_acary4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",1.5,2022,nh_clmhivaidmy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",8.36,2022,nh_clminfvamy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",1.57,2022,nh_clmhepbmy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",3.21,2022,nh_clmhepothmy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",3.73,2022,nh_clmmstinfmy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",9.5,2022,nh_clmpnemy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.23,2022,nh_clmtbmy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",38.56,2022,nh_clminfmy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.55,2022,nh_clmcamy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",37.08,2022,nh_clmcdmy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",22.59,2022,nh_clmcvdmy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",57.48,2022,nh_clmchfmy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",43.52,2022,nh_clmihdmy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",11.05,2022,nh_clmmimy4_n
6,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",35.28,2022,nh_clmpvdmy4_n
6,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.02,2022,nh_age1y4_n
6,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",33.23,2022,nh_age2y4_n
6,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",66.75,2022,nh_age3y4_n
6,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",50.17,2022,nh_dis1y4_n
6,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",34.75,2022,nh_dis2y4_n
6,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",4.09,2022,nh_dis3y4_n
6,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",10.46,2022,nh_dis4y4_n
6,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.52,2022,nh_dis5y4_n
6,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",0.61,2022,nh_rac1y4_n
6,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",64.9,2022,nh_rac2y4_n
6,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",0.45,2022,nh_rac3y4_n
6,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",33.95,2022,nh_rac4y4_n
6,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.09,2022,nh_rac5y4_n
6,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",2.17,2022,nh_eth1y4_n
6,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",97.77,2022,nh_eth2y4_n
6,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.06,2022,nh_eth3y4_n
6,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",19.09,2022,nh_vin1y4_n
6,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",13.95,2022,nh_vin2y4_n
6,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",12.13,2022,nh_vin3y4_n
6,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.59,2022,nh_vin4y4_n
6,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",30.24,2022,nh_vin5y4_n
6,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",50.58,2022,nh_sexy4_n
6,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",96.75,2022,nh_modhdy4_n
6,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",1.41,2022,nh_modhhdy4_n
6,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.06,2022,nh_modcapdy4_n
6,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",1.56,2022,nh_modccpdy4_n
6,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.22,2022,nh_modothry4_n
6,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",89.29,2022,nh_allmdcrmy4_n
6,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",4.14,2022,nh_insmdcdmy4_n
6,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",1.52,2022,nh_insempmy4_n
6,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",5.05,2022,nh_insnonothmy4_n
6,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",6.76,2022,nh_mefavfmy4_n
6,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",3.83,2022,nh_mefgraftmy4_n
6,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",87.46,2022,nh_mefcathmy4_n
6,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",1.95,2022,nh_mefoumaccessmy4_n
6,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",15.58,2022,nh_avfpresentmy4_n
6,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",18.26,2022,nh_nephnomy4_n
6,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",18.38,2022,nh_nephy6my4_n
6,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",16.86,2022,nh_nephy612my4_n
6,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",24.28,2022,nh_nephy12my4_n
6,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",22.22,2022,nh_nephunkmissmy4_n
6,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",87.22,2022,nh_ptinfymy4_n
6,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",1.78,2022,alcomy4_n
6,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",9.65,2022,ashdmy4_n
6,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",18.2,2022,othcarmy4_n
6,"N (2728): Incident Patients  - Percent with cancer, 2022",6.58,2022,canmy4_n
6,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",28.19,2022,chfmy4_n
6,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",9.43,2022,cvamy4_n
6,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",41.03,2022,diabimy4_n
6,"N (2728): Incident Patients  - Percent with diabetes, 2022",62.82,2022,diabmy4_n
6,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.81,2022,drugmy4_n
6,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",88.35,2022,hxhtmy4_n
6,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",5.64,2022,ambumy4_n
6,"N (2728): Incident Patients  - Percent inability to transfer, 2022",2.9,2022,transmy4_n
6,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",8.2,2022,copdmy4_n
6,"N (2728): Incident Patients  - Percent with PVD, 2022",7.21,2022,pvdmy4_n
6,"N (2728): Incident Patients  - Percent smoker, 2022",7.6,2022,smokmy4_n
6,"N (2728): Incident Patients  - Percent Hispanic, 2022",4.36,2022,ethmy4_n
6,"N (2728): Incident Patients  - Percent White, 2022",41.27,2022,whitemy4_n
6,"N (2728): Incident Patients  - Percent African American, 2022",55.23,2022,blackmy4_n
6,"N (2728): Incident Patients  - Percent Native American, 2022",1.03,2022,nativmy4_n
6,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",2.25,2022,asianmy4_n
6,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.22,2022,racoummy4_n
6,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",25.02,2022,cempmy4_n
6,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",35.71,2022,pempmy4_n
6,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",40.04,2022,dbprimy4_n
6,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",5.42,2022,gnprimy4_n
6,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",39.22,2022,htprimy4_n
6,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",15.32,2022,omprimy4_n
6,"N (2728): Incident Patients  - Percent female, 2022",44.4,2022,femmy4_n
6,"N (2728): Incident Patients  - Average age, 2022",62.88,2022,agemy4_n
6,"N (2728): Incident Patients  - Average serum albumin, 2022",3.36,2022,salbmy4_n
6,"N (2728): Incident Patients  - Average creatinine, 2022",6.98,2022,creamy4_n
6,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.15,2022,hgmy4_n
6,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",10.34,2022,gfrmy4_n
6,"N (2728): Incident Patients  - Average count of comorbidities, 2022",2.99,2022,cntcomy4_n
6,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",84.81,2022,pdmodMEFHDmy4_n
6,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",15.19,2022,pdmodMEFPDmy4_n
6,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
6,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",48.4,2022,insmdcrmy4_n
6,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",8.37,2022,insmdcdmy4_n
6,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",6.54,2022,insmdcrcdmy4_n
6,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",11.88,2022,insempmy4_n
6,"N (2728): Incident Patients  - Percent with no coverage, 2022",7.28,2022,insnonemy4_n
6,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",8.72,2022,insmdcromy4_n
6,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",8.8,2022,insmedomy4_n
6,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",14.36,2022,preepomy4_n
6,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",15.57,2022,nephnomy4_n
6,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",16.27,2022,nephy6my4_n
6,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",19.33,2022,nephy612my4_n
6,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",32.05,2022,nephy12my4_n
6,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",16.78,2022,nephunkmissmy4_n
6,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",92.28,2022,ptinfymy4_n
6,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",29.94,2022,ptxmedunfitmy4_n
6,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
6,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
6,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",8.14,2022,ptxdeclinemy4_n
6,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",69.1,2022,ptxnotassessmy4_n
6,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",13.26,2022,mefavfmy4_n
6,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",4.57,2022,mefgraftmy4_n
6,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",81.96,2022,mefcathmy4_n
6,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.21,2022,mefoumaccessmy4_n
6,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",24.37,2022,avfpresentmy4_n
6,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",28.12,2022,bmimmy4_n
6,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",29.36,2022,bmifmy4_n
6,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",1.06,2022,ptinfnmy4m_n
6,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",11.61,2022,hemomy4m_n
6,"N (2728): Incident Patients  - Average Number of forms returned, 2022",13.69,2022,nmy4m_n
6,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",78.96,2019,rdsmzm_n
6,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",51.98,2019,dyzm_n
6,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",9.6,2019,deazm_n
6,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",9.36,2019,exdzm_n
6,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.06,2019,dudzm_n
6,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",1.03,2019,smrz_n
6,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",21.17,2019,witz_n
6,"N: All Patient Mortality - % of deaths from infection, 2019-2022",9.79,2019,infz_n
6,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",45.63,2019,cardz_n
6,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.05,2019,livz_n
6,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",13.59,2019,fynmzm_n
6,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",8.32,2019,fydyzm_n
6,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.1,2019,fydeazm_n
6,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.01,2019,fyexdzm_n
6,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",1.05,2019,fysmrz_n
6,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",22.78,2019,fywitz_n
6,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",9.04,2019,fyinfz_n
6,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",41.45,2019,fycardiacz_n
6,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",1.92,2019,fylivz_n
6,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",68.52,2019,rdshzm_n
6,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",58.8,2019,htazm_n
6,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",61.15,2019,extzm_n
6,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",474.45,2019,hdzm_n
6,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",495.13,2019,exhdzm_n
6,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",44.31,2019,hdyzm_n
6,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",0.96,2019,shrtz_n
6,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.96,2019,shrdz_n
6,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.74,2019,lenz_n
6,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",8.03,2019,onez_n
6,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",5.63,2019,miiz_n
6,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",11.4,2019,sepiz_n
6,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",28.64,2019,achfz_n
6,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",17.29,2019,acdrz_n
6,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.8,2019,acarz_n
6,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",84.89,2019,ipedz_n
6,"N: ED30 - Average annual index discharges, 2019-22",33.61,2019,ed30indexzm_n
6,"N: ED30- Average annual number of ED visits, 2019-22",5.88,2019,ed30obszm_n
6,"N: ED30 - Average annual expected ED visits, 2019-22",5.47,2019,ed30expzm_n
6,"N: ED30: Standardized Ratio of ED30, 2019-22",1.1,2019,ed30z_n
6,"N SRR -  Standardized Readmission Ratio, 2022",1.02,2022,srry4_n
6,"N: SRR - Average index discharges, 2022",55.57,2022,indexmy4_n
6,"N: SRR - Average number of readmissions, 2022",14.02,2022,readmmy4_n
6,"N: SRR - Average expected readmissions, 2022",14.41,2022,srrexpmy4_n
6,Pt included in SEDR analysis,45.85,2019,rdsezm_n
6,Total number of ED Visits,46.92,2019,hedzm_n
6,Expected number of ED events,43.88,2019,exedzm_n
6,Years at risk for ED visit rate,28.95,2019,edyrzm_n
6,Years at risk for ED visit rate,96335.5,2019,edyrz_n
6,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",1.07,2019,sedrz_n
6,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",60.91,2019,rdstzm_n
6,"N: STR - Average number of patients (per year in average facility), 2019-2022",64.76,2019,rdsalltzm_n
6,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",1.69,2019,txzm_n
6,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",1.87,2019,txallzm_n
6,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",40.18,2019,txyzm_n
6,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.59,2019,cadalltzm_n
6,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.3,2019,livealltzm_n
6,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",1.96,2019,extxzm_n
6,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",0.86,2019,strz_n
6,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",62.25,2022,pppwpty4m_n
6,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",15.1,2022,WLy4_n
6,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",22.78,2022,WLlt40y4_n
6,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",14.22,2022,WL4074y4_n
6,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",16.04,2022,WLmaley4_n
6,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",13.81,2022,WLfemy4_n
6,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",16.2,2022,WLwhhy4_n
6,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",15.12,2022,WLwhnhy4_n
6,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",14.86,2022,WLbly4_n
6,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",21.09,2022,WLasy4_n
6,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",13.78,2022,WLnay4_n
6,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",11.44,2022,WLothy4_n
6,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",12.89,2022,WLDMy4_n
6,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",16.48,2022,WLnodmy4_n
6,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",14.1,2022,WLnotxy4_n
6,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",29.7,2022,WLtxy4_n
6,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",11.53,2022,WLVCat1y4_n
6,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",20.85,2022,WLVCat2y4_n
6,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",14.0,2022,WLVCat3y4_n
6,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",521.72,2022,pppwpmy4m_n
6,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",14.41,2022,pppwy4_n
6,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",9.64,2019,swrptzm_n
6,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",7.76,2019,swrpyzm_n
6,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.67,2019,swrwlzm_n
6,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.79,2019,swrexwlzm_n
6,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",0.86,2019,swrz_n
6,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",82.47,2021,FVfy3_n
6,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",9.88,2021,FVdeclinedfy3_n
6,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.13,2021,FVovndfy3_n
6,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",7.66,2021,FVothrsnfy3_n
6,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",75.73,2022,FVhy4_n
6,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",76.64,2022,FVmcarehy4_n
6,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",77.54,2022,FVmahy4_n
6,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",76.24,2022,FVmpphy4_n
6,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",75.6,2022,FVdualhy4_n
6,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",73.22,2022,FVmsphy4_n
6,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",66.35,2022,FVnonmcarehy4_n
6,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",71.7,2022,FVlt18hy4_n
6,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",63.0,2022,FV1839hy4_n
6,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",73.36,2022,FV4064hy4_n
6,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",78.86,2022,FV6574hy4_n
6,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",80.8,2022,FV75uphy4_n
6,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",75.1,2022,FVmalehy4_n
6,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",76.18,2022,FVfemhy4_n
6,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",78.32,2022,FVashy4_n
6,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",83.07,2022,FVnahy4_n
6,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",77.54,2022,FVwhhy4_n
6,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",66.13,2022,FVrothhy4_n
6,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",74.43,2022,FVblkhy4_n
6,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",78.43,2022,FVhisphy4_n
6,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",65.01,2022,FVVCat1hy4_n
6,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",75.04,2022,FVVCat2hy4_n
6,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",80.04,2022,FVVCat3hy4_n
6,"N: Influenza - Average number of patients treated on 12/31, 2022",57.27,2022,eFVy4m_n
6,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",1.46,2022,medrsnfy4m_N
6,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.66,2022,CWhdavgHGBy4_n
6,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",25.21,2022,CWhdhgb1y4_n
6,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",33.39,2022,CWhdhgb2y4_n
6,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",27.51,2022,CWhdhgb3y4_n
6,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",11.58,2022,CWhdhgb4y4_n
6,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.31,2022,CWhdhgb5y4_n
6,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",75.34,2022,CWhdesarxy4_n
6,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.91,2022,CWpdavgHGBy4_n
6,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",23.25,2022,CWpdhgb1y4_n
6,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",27.59,2022,CWpdhgb2y4_n
6,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",26.22,2022,CWpdhgb3y4_n
6,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",19.69,2022,CWpdhgb4y4_n
6,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.25,2022,CWpdhgb5y4_n
6,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",54.05,2022,CWpdesarxy4_n
6,"N: HD HGB (Adult) - Average number of eligible patients, 2022",67.95,2022,CWhdptdenomy4m_n
6,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",582.76,2022,CWhdptmthdenomy4m_n
6,"N: PD HGB (Adult) - Average number of eligible patients, 2022",22.29,2022,CWpdptdenomy4m_n
6,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",170.72,2022,CWpdptmthdenomy4m_n
6,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",30.62,2022,rdstfy4m_n
6,"N: STrR (Adult) - Average Patient Years at Risk, 2022",17.95,2022,tfyy4m_n
6,"N: STrR (Adult) - Average Number of Transfusions, 2022",5.97,2022,tfy4m_n
6,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",5.87,2022,extfy4m_n
6,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",1.02,2022,strry4_n
6,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.9,2022,CWhdalby4_n
6,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",1.94,2022,CWhdalb1y4_n
6,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",8.43,2022,CWhdalb2y4_n
6,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",38.84,2022,CWhdalb3y4_n
6,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",47.09,2022,CWhdalb4y4_n
6,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",3.7,2022,CWhdalb5y4_n
6,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",49.21,2022,CWhdalblt4y4_n
6,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.6,2022,CWhdavgufry4_n
6,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",85.31,2022,CWhdufr1y4_n
6,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",7.82,2022,CWhdufr2y4_n
6,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",4.32,2022,CWhdufrmissy4_n
6,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.55,2022,CWhdufrgt20y4_n
6,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.66,2022,CWpdalby4_n
6,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",6.0,2022,CWpdalb1y4_n
6,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",22.5,2022,CWpdalb2y4_n
6,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",43.65,2022,CWpdalb3y4_n
6,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",24.8,2022,CWpdalb4y4_n
6,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",3.05,2022,CWpdalb5y4_n
6,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",72.15,2022,CWpdalblt4y4_n
6,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",67.95,2022,CWhddenomy4m_n
6,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",582.76,2022,CWhdmthdenomy4m_n
6,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",22.29,2022,CWpddenomy4m_n
6,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",170.72,2022,CWpdmthdenomy4m_n
6,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.23,2022,CWpdavgktvy4_n
6,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",5.23,2022,CWpdktv1y4_n
6,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",69.33,2022,CWpdktv2y4_n
6,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",23.08,2022,CWpdktv3y4_n
6,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",2.37,2022,CWpdktv4y4_n
6,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.61,2022,CWhdavgktvy4_n
6,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",2.19,2022,CWhdktv1y4_n
6,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",72.87,2022,CWhdktv2y4_n
6,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",23.04,2022,CWhdktv3y4_n
6,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.91,2022,CWhdktv4y4_n
6,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",65.87,2022,CWhdktvptsy4m_N
6,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",560.7,2022,CWhdktvptmthy4m_N
7,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",2.27,2022,allmcFcovpatPq4_n
7,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",27.16,2022,allmcEcovpatPq4_n
7,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",34.44,2022,allmcEcovDeaPq4_n
7,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",34.04,2022,allmcEcovHosPq4_n
7,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",5.48,2022,nh_mcFcovpatPq4_n
7,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",44.22,2022,nh_mcEcovpatPq4_n
7,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",43.47,2022,nh_mcEcovDeaPq4_n
7,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",43.76,2022,nh_mcEcovHosPq4_n
7,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",64.04,2022,agey4_n
7,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.22,2022,age1y4_n
7,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",46.94,2022,age2y4_n
7,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",52.85,2022,age3y4_n
7,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",39.19,2022,dis1y4_n
7,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",37.66,2022,dis2y4_n
7,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",7.87,2022,dis3y4_n
7,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",14.43,2022,dis4y4_n
7,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.84,2022,dis5y4_n
7,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",17.72,2022,vin1y4_n
7,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",19.57,2022,vin2y4_n
7,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.68,2022,vin3y4_n
7,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.71,2022,vin4y4_n
7,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",24.31,2022,vin5y4_n
7,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",2.82,2022,rac1y4_n
7,"N: Prevalent Patients - Race: % African American, 12/31/2022",39.53,2022,rac2y4_n
7,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.24,2022,rac3y4_n
7,"N: Prevalent Patients - Race: % White, 12/31/2022",57.2,2022,rac4y4_n
7,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.22,2022,rac5y4_n
7,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",20.75,2022,eth1y4_n
7,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",79.14,2022,eth2y4_n
7,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.11,2022,eth3y4_n
7,"N: Prevalent Patients - Sex: % Female, 12/31/2022",40.98,2022,sexy4_n
7,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",12.56,2022,nrshomey4_n
7,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",4.69,2022,viny4_n
7,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",83.64,2022,modhdy4_n
7,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",3.75,2022,modhhdy4_n
7,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.04,2022,modcapdy4_n
7,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",11.41,2022,modccpdy4_n
7,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.15,2022,modothry4_n
7,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",53.58,2022,pahy4m_n
7,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",16.25,2022,CWunCa1y4_n
7,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",78.32,2022,CWunCa2y4_n
7,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.13,2022,CWunCa3y4_n
7,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",4.29,2022,CWunCamissy4_n
7,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
7,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.94,2022,CWavgUnCay4_n
7,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.44,2022,CWavgPy4_n
7,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",6.99,2022,CWP1y4_n
7,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",22.88,2022,CWP2y4_n
7,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",29.55,2022,CWP3y4_n
7,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",21.0,2022,CWP4y4_n
7,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",14.86,2022,CWP5y4_n
7,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",4.71,2022,CWPmissy4_n
7,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
7,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",2.7,2022,CWunCagt102y4_n
7,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",77.37,2022,CWptdenomy4m_n
7,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",622.01,2022,CWptmthdenomy4m_n
7,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",82.91,2022,serumphospatsy4m_n
7,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",662.25,2022,serumphospmy4m_n
7,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",77.36,2022,CWhcptdenomy4m_n
7,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",621.98,2022,CWhcptmthdenomy4m_n
7,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",53.72,2022,ppavfy4_n
7,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",17.31,2022,ppavgy4_n
7,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",25.13,2022,ppcathy4_n
7,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",3.83,2022,ppomy4_n
7,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",20.24,2022,ltcy4_n
7,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",8.35,2022,piavfy4_n
7,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",2.28,2022,piavgy4_n
7,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",84.08,2022,picathy4_n
7,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",5.3,2022,piomy4_n
7,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",8.97,2022,pifisty4_n
7,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",74.13,2022,phdvapty4m_n
7,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",585.78,2022,phdy4m_n
7,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",14.39,2022,ihdy4m_n
7,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",54.25,2022,sfry4_n
7,"N: VA infection - Average number of eligible PD patients, 2022",9.66,2022,pdpaty4m_n
7,"N: VA infection - Average number of eligible PD patient-months, 2022",64.53,2022,pdptmoy4m_n
7,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.35,2022,pd2inf100moy4_n
7,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",44.54,2022,ncmy4m_n
7,"N: Prevalent Comorbidities - Average % with Anemia, 2022",4.34,2022,clmanemy4_n
7,"N: Prevalent Comorbidities - Average % with AIDS, 2022",1.53,2022,clmhivaidmy4_n
7,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.48,2022,clmalcomy4_n
7,"N: Prevalent Comorbidities - Average % with Cancer, 2022",4.22,2022,clmcanmy4_n
7,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",1.05,2022,clmcamy4_n
7,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",22.79,2022,clmcdmy4_n
7,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",8.91,2022,clmcvdmy4_n
7,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",16.5,2022,clmcopdmy4_n
7,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",35.73,2022,clmchfmy4_n
7,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",42.05,2022,clmdiabmy4_n
7,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",2.17,2022,clmdrugmy4_n
7,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",3.4,2022,clmgtbmy4_n
7,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.57,2022,clmhepbmy4_n
7,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.7,2022,clmhepothmy4_n
7,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",25.37,2022,clmhypthymy4_n
7,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",20.76,2022,clminfmy4_n
7,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",31.92,2022,clmihdmy4_n
7,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",9.98,2022,clmmimy4_n
7,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",20.07,2022,clmpvdmy4_n
7,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",3.53,2022,clmpnemy4_n
7,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.66,2022,clmcntcomy4_n
7,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",5.87,2022,clminfvamy4_n
7,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.67,2022,clmmstinfmy4_n
7,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.18,2022,clmtbmy4_n
7,"N (AFS): Facility Information - Average number of patients, 2022",99.42,2022,allcnty4m_n
7,N (AFS): Facility Information - Average number of all patients on 12/31/2022,59.9,2022,endcnty4m_n
7,"N (AFS): Facility Information - Average % of patients transferred in, 2022",21.84,2022,transiny4_n
7,"N (AFS): Facility Information - Average % of patients transferred out, 2022",22.44,2022,transouty4_n
7,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,84.24,2022,medicarey4_n
7,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,8.07,2022,medpendy4_n
7,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,7.7,2022,nonmedy4_n
7,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.04,2022,cfc_N
7,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,3.08,2022,std_N
7,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",31.25,2022,p_age1y4_n
7,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",17.19,2022,p_age2y4_n
7,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",25.0,2022,p_age3y4_n
7,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",26.56,2022,p_age4y4_n
7,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",1.56,2022,p_dis1y4_n
7,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",6.25,2022,p_dis2y4_n
7,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",17.19,2022,p_dis3y4_n
7,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",40.63,2022,p_dis4y4_n
7,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
7,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
7,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",29.69,2022,p_dis7y4_n
7,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",4.69,2022,p_dis8y4_n
7,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",26.56,2022,p_vin1y4_n
7,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",23.44,2022,p_vin2y4_n
7,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",9.38,2022,p_vin3y4_n
7,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",21.88,2022,p_vin4y4_n
7,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",18.75,2022,p_vin5y4_n
7,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",0.0,2022,p_rac1y4_n
7,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",39.06,2022,p_rac2y4_n
7,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",1.56,2022,p_rac3y4_n
7,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",59.38,2022,p_rac4y4_n
7,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",0.0,2022,p_rac5y4_n
7,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",23.44,2022,p_eth1y4_n
7,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",75.0,2022,p_eth2y4_n
7,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",1.56,2022,p_eth3y4_n
7,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",45.31,2022,p_sexy4_n
7,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",45.31,2022,p_modhdy4_n
7,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",1.56,2022,p_modhhdy4_n
7,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.56,2022,p_modcapdy4_n
7,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",50.0,2022,p_modccpdy4_n
7,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",1.56,2022,p_modothry4_n
7,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",37.04,2022,p_allmdcrmy4_n
7,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",40.74,2022,p_insmdcdmy4_n
7,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",11.11,2022,p_insempmy4_n
7,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",11.11,2022,p_insnonothmy4_n
7,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",20.37,2022,p_nephnomy4_n
7,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",31.48,2022,p_nephy6my4_n
7,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",16.67,2022,p_nephy612my4_n
7,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",18.52,2022,p_nephy12my4_n
7,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",12.96,2022,p_nephunkmissmy4_n
7,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",94.44,2022,p_ptinfymy4_n
7,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",7.5,2022,p_mefavfmy4_n
7,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",2.5,2022,p_mefgraftmy4_n
7,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",90.0,2022,p_mefcathmy4_n
7,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
7,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",7.5,2022,p_avfpresentmy4_n
7,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",13.35,2022,p_ppavfy4_n
7,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",70.78,2022,p_ltcy4_n
7,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",25.23,2022,p_WLy4_n
7,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",19.61,2022,p_WLlt10y4_n
7,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",32.59,2022,p_WL1017y4_n
7,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.66,2022,p_CWhdavgHGBy4_n
7,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",18.54,2022,p_CWhdhgb1y4_n
7,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",33.43,2022,p_CWhdhgb2y4_n
7,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",35.11,2022,p_CWhdhgb3y4_n
7,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",8.43,2022,p_CWhdhgb4y4_n
7,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",4.49,2022,p_CWhdhgb5y4_n
7,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.36,2022,p_CWpdavgHGBy4_n
7,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",33.33,2022,p_CWpdhgb1y4_n
7,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",28.31,2022,p_CWpdhgb2y4_n
7,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",16.67,2022,p_CWpdhgb3y4_n
7,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",10.32,2022,p_CWpdhgb4y4_n
7,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",11.38,2022,p_CWpdhgb5y4_n
7,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",3.9,2022,p_CWhdalby4_n
7,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",6.74,2022,p_CWhdalb1y4_n
7,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",8.43,2022,p_CWhdalb2y4_n
7,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",25.0,2022,p_CWhdalb3y4_n
7,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",55.34,2022,p_CWhdalb4y4_n
7,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",4.49,2022,p_CWhdalb5y4_n
7,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.6,2022,p_CWpdalby4_n
7,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",16.67,2022,p_CWpdalb1y4_n
7,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",13.49,2022,p_CWpdalb2y4_n
7,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",31.48,2022,p_CWpdalb3y4_n
7,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",26.98,2022,p_CWpdalb4y4_n
7,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",11.38,2022,p_CWpdalb5y4_n
7,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",59.26,2022,p_CWpdktvge18y4_n
7,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",92.76,2022,p_CWhdktvge12y4_n
7,"N: Patient Placement -  % of incident patients, 2022",17.71,2022,ppidy4_n
7,"N: Patient Placement -  % of patients continuing at facility, 2022",66.78,2022,ppcdy4_n
7,"N: Patient Placement -  % of patients that transfered into facility, 2022",15.51,2022,pptdy4_n
7,"N: End of Year Status - % of patients death attributed to this facility, 2022",13.69,2022,pdhdy4_n
7,"N: End of Year Status - % of patients death attributed to another facility, 2022",2.56,2022,pdody4_n
7,"N: End of Year Status - % of patients that received a transplant, 2022",3.23,2022,ptxdy4_n
7,"N: End of Year Status - % of patients alive in this facility, 2022",65.18,2022,pahdy4_n
7,"N: End of Year Status - % of patients alive in another facility, 2022",11.43,2022,paody4_n
7,"N: End of Year Status - % of patients other, 2022",3.9,2022,potdy4_n
7,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,50.25,2022,iuhemy4m_n
7,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.03,2022,iufreqy4m_n
7,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,50.22,2022,iunonfreqy4m_n
7,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.0,2022,iuothy4m_n
7,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
7,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
7,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,2.12,2022,ihhemy4m_n
7,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.59,2022,ihfreqy4m_n
7,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,1.53,2022,ihnonfreqy4m_n
7,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
7,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.72,2022,ihcapdy4m_n
7,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,6.81,2022,ihccpdy4m_n
7,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",12.88,2022,staffy4m_n
7,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,3.8,2022,nurseFTy4m_n
7,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,5.36,2022,ptcareFTy4m_n
7,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,0.97,2022,dietFTy4m_n
7,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,0.98,2022,socwkFTy4m_n
7,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.62,2022,nursePTy4m_n
7,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.53,2022,ptcarePTy4m_n
7,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.33,2022,dietPTy4m_n
7,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.27,2022,socwkPTy4m_n
7,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,28.0,2022,vocrehaby4m_n
7,"N (AFS): Facility Information - Average % incident patients, 2022",15.66,2022,incpery4_n
7,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,27.82,2022,employedy4_n
7,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.91,2022,schooly4_n
7,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",41.2,2022,nh_ppavfy4_n
7,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",26.94,2022,nh_ltcy4_n
7,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",2.55,2022,nh_CWhdktv1y4_n
7,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",8.02,2022,nh_CWpdktv1y4_n
7,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",31.75,2022,nh_CWhdhgb1y4_n
7,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",79.89,2022,nh_CWhdesarxy4_n
7,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",27.53,2022,nh_CWpdhgb1y4_n
7,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",58.77,2022,nh_CWpdesarxy4_n
7,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",44.58,2022,nh_obdry4_n
7,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.25,2022,nh_smry4_n
7,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",20.64,2022,nh_wity4_n
7,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",346.75,2022,nh_obhtry4_n
7,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.74,2022,nh_shrty4_n
7,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",25.09,2022,nh_sepiy4_n
7,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",15.08,2022,nh_miiy4_n
7,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",52.05,2022,nh_achfy4_n
7,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",39.11,2022,nh_acdry4_n
7,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",4.77,2022,nh_acary4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",1.99,2022,nh_clmhivaidmy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",10.62,2022,nh_clminfvamy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",1.06,2022,nh_clmhepbmy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",3.26,2022,nh_clmhepothmy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",4.75,2022,nh_clmmstinfmy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",9.88,2022,nh_clmpnemy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.03,2022,nh_clmtbmy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",44.34,2022,nh_clminfmy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.38,2022,nh_clmcamy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",45.57,2022,nh_clmcdmy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",23.31,2022,nh_clmcvdmy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",62.84,2022,nh_clmchfmy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",56.13,2022,nh_clmihdmy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",19.38,2022,nh_clmmimy4_n
7,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",41.29,2022,nh_clmpvdmy4_n
7,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
7,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",29.11,2022,nh_age2y4_n
7,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",70.89,2022,nh_age3y4_n
7,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",48.12,2022,nh_dis1y4_n
7,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",36.18,2022,nh_dis2y4_n
7,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",3.38,2022,nh_dis3y4_n
7,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",11.21,2022,nh_dis4y4_n
7,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",1.11,2022,nh_dis5y4_n
7,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",1.73,2022,nh_rac1y4_n
7,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",40.7,2022,nh_rac2y4_n
7,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",0.22,2022,nh_rac3y4_n
7,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",57.24,2022,nh_rac4y4_n
7,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.11,2022,nh_rac5y4_n
7,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",14.46,2022,nh_eth1y4_n
7,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",85.51,2022,nh_eth2y4_n
7,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.03,2022,nh_eth3y4_n
7,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",23.48,2022,nh_vin1y4_n
7,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",16.54,2022,nh_vin2y4_n
7,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",11.81,2022,nh_vin3y4_n
7,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",25.18,2022,nh_vin4y4_n
7,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",22.99,2022,nh_vin5y4_n
7,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",46.93,2022,nh_sexy4_n
7,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",91.01,2022,nh_modhdy4_n
7,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",7.09,2022,nh_modhhdy4_n
7,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.14,2022,nh_modcapdy4_n
7,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",1.6,2022,nh_modccpdy4_n
7,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.16,2022,nh_modothry4_n
7,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",87.8,2022,nh_allmdcrmy4_n
7,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",5.89,2022,nh_insmdcdmy4_n
7,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",1.16,2022,nh_insempmy4_n
7,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",5.15,2022,nh_insnonothmy4_n
7,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",3.86,2022,nh_mefavfmy4_n
7,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",1.23,2022,nh_mefgraftmy4_n
7,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",93.44,2022,nh_mefcathmy4_n
7,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",1.47,2022,nh_mefoumaccessmy4_n
7,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",12.39,2022,nh_avfpresentmy4_n
7,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",21.15,2022,nh_nephnomy4_n
7,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",26.73,2022,nh_nephy6my4_n
7,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",15.27,2022,nh_nephy612my4_n
7,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",13.55,2022,nh_nephy12my4_n
7,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",23.3,2022,nh_nephunkmissmy4_n
7,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",84.86,2022,nh_ptinfymy4_n
7,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",1.45,2022,alcomy4_n
7,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",9.37,2022,ashdmy4_n
7,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",25.38,2022,othcarmy4_n
7,"N (2728): Incident Patients  - Percent with cancer, 2022",7.67,2022,canmy4_n
7,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",25.98,2022,chfmy4_n
7,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",8.33,2022,cvamy4_n
7,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",40.58,2022,diabimy4_n
7,"N (2728): Incident Patients  - Percent with diabetes, 2022",60.98,2022,diabmy4_n
7,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.15,2022,drugmy4_n
7,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",88.45,2022,hxhtmy4_n
7,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",7.7,2022,ambumy4_n
7,"N (2728): Incident Patients  - Percent inability to transfer, 2022",3.85,2022,transmy4_n
7,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",8.33,2022,copdmy4_n
7,"N (2728): Incident Patients  - Percent with PVD, 2022",6.83,2022,pvdmy4_n
7,"N (2728): Incident Patients  - Percent smoker, 2022",5.21,2022,smokmy4_n
7,"N (2728): Incident Patients  - Percent Hispanic, 2022",19.47,2022,ethmy4_n
7,"N (2728): Incident Patients  - Percent White, 2022",65.44,2022,whitemy4_n
7,"N (2728): Incident Patients  - Percent African American, 2022",30.54,2022,blackmy4_n
7,"N (2728): Incident Patients  - Percent Native American, 2022",0.74,2022,nativmy4_n
7,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",2.91,2022,asianmy4_n
7,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.38,2022,racoummy4_n
7,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",28.13,2022,cempmy4_n
7,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",36.82,2022,pempmy4_n
7,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",37.76,2022,dbprimy4_n
7,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",4.42,2022,gnprimy4_n
7,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",39.74,2022,htprimy4_n
7,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",18.08,2022,omprimy4_n
7,"N (2728): Incident Patients  - Percent female, 2022",39.19,2022,femmy4_n
7,"N (2728): Incident Patients  - Average age, 2022",65.41,2022,agemy4_n
7,"N (2728): Incident Patients  - Average serum albumin, 2022",3.43,2022,salbmy4_n
7,"N (2728): Incident Patients  - Average creatinine, 2022",6.18,2022,creamy4_n
7,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.38,2022,hgmy4_n
7,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",11.26,2022,gfrmy4_n
7,"N (2728): Incident Patients  - Average count of comorbidities, 2022",3.01,2022,cntcomy4_n
7,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",86.33,2022,pdmodMEFHDmy4_n
7,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",13.67,2022,pdmodMEFPDmy4_n
7,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
7,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",54.09,2022,insmdcrmy4_n
7,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",8.38,2022,insmdcdmy4_n
7,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",5.38,2022,insmdcrcdmy4_n
7,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",9.29,2022,insempmy4_n
7,"N (2728): Incident Patients  - Percent with no coverage, 2022",3.57,2022,insnonemy4_n
7,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",7.33,2022,insmdcromy4_n
7,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",11.97,2022,insmedomy4_n
7,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",15.45,2022,preepomy4_n
7,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",17.94,2022,nephnomy4_n
7,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",23.05,2022,nephy6my4_n
7,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",19.14,2022,nephy612my4_n
7,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",23.02,2022,nephy12my4_n
7,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",16.86,2022,nephunkmissmy4_n
7,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",94.03,2022,ptinfymy4_n
7,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",39.55,2022,ptxmedunfitmy4_n
7,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
7,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
7,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",7.71,2022,ptxdeclinemy4_n
7,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",55.38,2022,ptxnotassessmy4_n
7,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",8.87,2022,mefavfmy4_n
7,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",1.75,2022,mefgraftmy4_n
7,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",89.03,2022,mefcathmy4_n
7,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.35,2022,mefoumaccessmy4_n
7,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",18.97,2022,avfpresentmy4_n
7,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",27.53,2022,bmimmy4_n
7,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",28.23,2022,bmifmy4_n
7,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",0.92,2022,ptinfnmy4m_n
7,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",13.3,2022,hemomy4m_n
7,"N (2728): Incident Patients  - Average Number of forms returned, 2022",15.4,2022,nmy4m_n
7,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",79.7,2019,rdsmzm_n
7,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",49.64,2019,dyzm_n
7,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",10.14,2019,deazm_n
7,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",9.95,2019,exdzm_n
7,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.06,2019,dudzm_n
7,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",1.02,2019,smrz_n
7,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",18.92,2019,witz_n
7,"N: All Patient Mortality - % of deaths from infection, 2019-2022",7.21,2019,infz_n
7,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",48.47,2019,cardz_n
7,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.36,2019,livz_n
7,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",15.85,2019,fynmzm_n
7,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",9.57,2019,fydyzm_n
7,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.71,2019,fydeazm_n
7,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.63,2019,fyexdzm_n
7,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",1.03,2019,fysmrz_n
7,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",20.77,2019,fywitz_n
7,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",5.91,2019,fyinfz_n
7,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",42.4,2019,fycardiacz_n
7,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",1.86,2019,fylivz_n
7,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",67.96,2019,rdshzm_n
7,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",71.27,2019,htazm_n
7,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",61.32,2019,extzm_n
7,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",573.46,2019,hdzm_n
7,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",500.7,2019,exhdzm_n
7,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",41.53,2019,hdyzm_n
7,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",1.16,2019,shrtz_n
7,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",1.15,2019,shrdz_n
7,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.72,2019,lenz_n
7,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",9.18,2019,onez_n
7,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",7.95,2019,miiz_n
7,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",13.26,2019,sepiz_n
7,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",31.15,2019,achfz_n
7,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",21.2,2019,acdrz_n
7,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",3.16,2019,acarz_n
7,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",91.46,2019,ipedz_n
7,"N: ED30 - Average annual index discharges, 2019-22",37.54,2019,ed30indexzm_n
7,"N: ED30- Average annual number of ED visits, 2019-22",5.18,2019,ed30obszm_n
7,"N: ED30 - Average annual expected ED visits, 2019-22",6.28,2019,ed30expzm_n
7,"N: ED30: Standardized Ratio of ED30, 2019-22",0.86,2019,ed30z_n
7,"N SRR -  Standardized Readmission Ratio, 2022",1.12,2022,srry4_n
7,"N: SRR - Average index discharges, 2022",71.65,2022,indexmy4_n
7,"N: SRR - Average number of readmissions, 2022",20.38,2022,readmmy4_n
7,"N: SRR - Average expected readmissions, 2022",19.2,2022,srrexpmy4_n
7,Pt included in SEDR analysis,42.93,2019,rdsezm_n
7,Total number of ED Visits,34.23,2019,hedzm_n
7,Expected number of ED events,40.09,2019,exedzm_n
7,Years at risk for ED visit rate,25.71,2019,edyrzm_n
7,Years at risk for ED visit rate,57278.98,2019,edyrz_n
7,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",0.85,2019,sedrz_n
7,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",55.99,2019,rdstzm_n
7,"N: STR - Average number of patients (per year in average facility), 2019-2022",59.95,2019,rdsalltzm_n
7,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",1.84,2019,txzm_n
7,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",2.03,2019,txallzm_n
7,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",35.16,2019,txyzm_n
7,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.76,2019,cadalltzm_n
7,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.29,2019,livealltzm_n
7,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",1.66,2019,extxzm_n
7,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",1.11,2019,strz_n
7,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",59.64,2022,pppwpty4m_n
7,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",12.92,2022,WLy4_n
7,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",21.27,2022,WLlt40y4_n
7,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",12.04,2022,WL4074y4_n
7,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",13.72,2022,WLmaley4_n
7,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",11.74,2022,WLfemy4_n
7,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",13.01,2022,WLwhhy4_n
7,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",13.16,2022,WLwhnhy4_n
7,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",12.25,2022,WLbly4_n
7,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",19.76,2022,WLasy4_n
7,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",8.12,2022,WLnay4_n
7,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",15.65,2022,WLothy4_n
7,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",9.77,2022,WLDMy4_n
7,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",14.94,2022,WLnodmy4_n
7,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",11.91,2022,WLnotxy4_n
7,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",26.35,2022,WLtxy4_n
7,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",9.47,2022,WLVCat1y4_n
7,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",17.94,2022,WLVCat2y4_n
7,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",12.48,2022,WLVCat3y4_n
7,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",472.87,2022,pppwpmy4m_n
7,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",13.15,2022,pppwy4_n
7,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",10.02,2019,swrptzm_n
7,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",8.11,2019,swrpyzm_n
7,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.63,2019,swrwlzm_n
7,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.79,2019,swrexwlzm_n
7,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",0.8,2019,swrz_n
7,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",74.55,2021,FVfy3_n
7,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",12.99,2021,FVdeclinedfy3_n
7,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.1,2021,FVovndfy3_n
7,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",12.47,2021,FVothrsnfy3_n
7,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",72.22,2022,FVhy4_n
7,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",73.17,2022,FVmcarehy4_n
7,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",74.07,2022,FVmahy4_n
7,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",72.63,2022,FVmpphy4_n
7,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",70.52,2022,FVdualhy4_n
7,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",70.87,2022,FVmsphy4_n
7,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",63.4,2022,FVnonmcarehy4_n
7,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",29.17,2022,FVlt18hy4_n
7,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",59.41,2022,FV1839hy4_n
7,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",69.13,2022,FV4064hy4_n
7,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",74.44,2022,FV6574hy4_n
7,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",76.68,2022,FV75uphy4_n
7,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",71.84,2022,FVmalehy4_n
7,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",71.89,2022,FVfemhy4_n
7,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",75.49,2022,FVashy4_n
7,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",62.22,2022,FVnahy4_n
7,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",73.8,2022,FVwhhy4_n
7,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",51.25,2022,FVrothhy4_n
7,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",68.93,2022,FVblkhy4_n
7,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",71.94,2022,FVhisphy4_n
7,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",61.75,2022,FVVCat1hy4_n
7,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",72.43,2022,FVVCat2hy4_n
7,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",76.32,2022,FVVCat3hy4_n
7,"N: Influenza - Average number of patients treated on 12/31, 2022",57.67,2022,eFVy4m_n
7,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",2.82,2022,medrsnfy4m_N
7,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.64,2022,CWhdavgHGBy4_n
7,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",24.34,2022,CWhdhgb1y4_n
7,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",34.37,2022,CWhdhgb2y4_n
7,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",27.0,2022,CWhdhgb3y4_n
7,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",10.55,2022,CWhdhgb4y4_n
7,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.74,2022,CWhdhgb5y4_n
7,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",77.64,2022,CWhdesarxy4_n
7,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.88,2022,CWpdavgHGBy4_n
7,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",23.1,2022,CWpdhgb1y4_n
7,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",28.43,2022,CWpdhgb2y4_n
7,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",25.96,2022,CWpdhgb3y4_n
7,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",18.14,2022,CWpdhgb4y4_n
7,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",4.37,2022,CWpdhgb5y4_n
7,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",56.98,2022,CWpdesarxy4_n
7,"N: HD HGB (Adult) - Average number of eligible patients, 2022",70.01,2022,CWhdptdenomy4m_n
7,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",559.83,2022,CWhdptmthdenomy4m_n
7,"N: PD HGB (Adult) - Average number of eligible patients, 2022",19.68,2022,CWpdptdenomy4m_n
7,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",141.7,2022,CWpdptmthdenomy4m_n
7,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",29.78,2022,rdstfy4m_n
7,"N: STrR (Adult) - Average Patient Years at Risk, 2022",16.22,2022,tfyy4m_n
7,"N: STrR (Adult) - Average Number of Transfusions, 2022",6.38,2022,tfy4m_n
7,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",5.42,2022,extfy4m_n
7,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",1.18,2022,strry4_n
7,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.92,2022,CWhdalby4_n
7,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",1.73,2022,CWhdalb1y4_n
7,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",7.69,2022,CWhdalb2y4_n
7,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",36.63,2022,CWhdalb3y4_n
7,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",48.81,2022,CWhdalb4y4_n
7,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",5.13,2022,CWhdalb5y4_n
7,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",46.06,2022,CWhdalblt4y4_n
7,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.55,2022,CWhdavgufry4_n
7,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",86.36,2022,CWhdufr1y4_n
7,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",6.73,2022,CWhdufr2y4_n
7,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",4.6,2022,CWhdufrmissy4_n
7,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.31,2022,CWhdufrgt20y4_n
7,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.69,2022,CWpdalby4_n
7,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",5.05,2022,CWpdalb1y4_n
7,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",20.24,2022,CWpdalb2y4_n
7,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",43.28,2022,CWpdalb3y4_n
7,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",27.14,2022,CWpdalb4y4_n
7,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",4.29,2022,CWpdalb5y4_n
7,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",68.57,2022,CWpdalblt4y4_n
7,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",70.01,2022,CWhddenomy4m_n
7,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",559.83,2022,CWhdmthdenomy4m_n
7,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",19.68,2022,CWpddenomy4m_n
7,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",141.7,2022,CWpdmthdenomy4m_n
7,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.3,2022,CWpdavgktvy4_n
7,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",4.67,2022,CWpdktv1y4_n
7,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",64.08,2022,CWpdktv2y4_n
7,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",27.34,2022,CWpdktv3y4_n
7,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",3.92,2022,CWpdktv4y4_n
7,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.58,2022,CWhdavgktvy4_n
7,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",1.81,2022,CWhdktv1y4_n
7,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",76.5,2022,CWhdktv2y4_n
7,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",18.94,2022,CWhdktv3y4_n
7,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",2.74,2022,CWhdktv4y4_n
7,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",67.55,2022,CWhdktvptsy4m_N
7,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",532.25,2022,CWhdktvptmthy4m_N
8,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",2.17,2022,allmcFcovpatPq4_n
8,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",25.65,2022,allmcEcovpatPq4_n
8,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",34.36,2022,allmcEcovDeaPq4_n
8,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",31.8,2022,allmcEcovHosPq4_n
8,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",4.62,2022,nh_mcFcovpatPq4_n
8,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",40.75,2022,nh_mcEcovpatPq4_n
8,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",41.79,2022,nh_mcEcovDeaPq4_n
8,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",37.67,2022,nh_mcEcovHosPq4_n
8,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",61.45,2022,agey4_n
8,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.29,2022,age1y4_n
8,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",53.72,2022,age2y4_n
8,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",45.99,2022,age3y4_n
8,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",39.55,2022,dis1y4_n
8,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",40.2,2022,dis2y4_n
8,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",7.88,2022,dis3y4_n
8,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",12.02,2022,dis4y4_n
8,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.35,2022,dis5y4_n
8,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",16.92,2022,vin1y4_n
8,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",18.6,2022,vin2y4_n
8,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.42,2022,vin3y4_n
8,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.5,2022,vin4y4_n
8,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",26.57,2022,vin5y4_n
8,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",1.04,2022,rac1y4_n
8,"N: Prevalent Patients - Race: % African American, 12/31/2022",59.71,2022,rac2y4_n
8,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.5,2022,rac3y4_n
8,"N: Prevalent Patients - Race: % White, 12/31/2022",38.59,2022,rac4y4_n
8,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.16,2022,rac5y4_n
8,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",2.51,2022,eth1y4_n
8,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",97.39,2022,eth2y4_n
8,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.1,2022,eth3y4_n
8,"N: Prevalent Patients - Sex: % Female, 12/31/2022",44.87,2022,sexy4_n
8,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",11.49,2022,nrshomey4_n
8,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",4.95,2022,viny4_n
8,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",83.6,2022,modhdy4_n
8,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",3.9,2022,modhhdy4_n
8,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.08,2022,modcapdy4_n
8,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",11.2,2022,modccpdy4_n
8,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.22,2022,modothry4_n
8,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",50.24,2022,pahy4m_n
8,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",18.06,2022,CWunCa1y4_n
8,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",78.69,2022,CWunCa2y4_n
8,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.14,2022,CWunCa3y4_n
8,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",2.11,2022,CWunCamissy4_n
8,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
8,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.92,2022,CWavgUnCay4_n
8,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.59,2022,CWavgPy4_n
8,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.69,2022,CWP1y4_n
8,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",21.31,2022,CWP2y4_n
8,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",26.3,2022,CWP3y4_n
8,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",24.09,2022,CWP4y4_n
8,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",18.14,2022,CWP5y4_n
8,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",2.47,2022,CWPmissy4_n
8,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
8,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",1.31,2022,CWunCagt102y4_n
8,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",69.58,2022,CWptdenomy4m_n
8,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",595.69,2022,CWptmthdenomy4m_n
8,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",74.5,2022,serumphospatsy4m_n
8,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",631.77,2022,serumphospmy4m_n
8,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",69.57,2022,CWhcptdenomy4m_n
8,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",595.66,2022,CWhcptmthdenomy4m_n
8,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",56.09,2022,ppavfy4_n
8,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",21.05,2022,ppavgy4_n
8,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",21.49,2022,ppcathy4_n
8,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",1.36,2022,ppomy4_n
8,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",15.62,2022,ltcy4_n
8,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",10.82,2022,piavfy4_n
8,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",4.13,2022,piavgy4_n
8,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",80.97,2022,picathy4_n
8,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",4.08,2022,piomy4_n
8,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",11.33,2022,pifisty4_n
8,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",66.07,2022,phdvapty4m_n
8,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",560.7,2022,phdy4m_n
8,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",12.16,2022,ihdy4m_n
8,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",55.91,2022,sfry4_n
8,"N: VA infection - Average number of eligible PD patients, 2022",13.38,2022,pdpaty4m_n
8,"N: VA infection - Average number of eligible PD patient-months, 2022",96.28,2022,pdptmoy4m_n
8,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.69,2022,pd2inf100moy4_n
8,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",42.51,2022,ncmy4m_n
8,"N: Prevalent Comorbidities - Average % with Anemia, 2022",2.35,2022,clmanemy4_n
8,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.81,2022,clmhivaidmy4_n
8,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.06,2022,clmalcomy4_n
8,"N: Prevalent Comorbidities - Average % with Cancer, 2022",3.1,2022,clmcanmy4_n
8,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",0.99,2022,clmcamy4_n
8,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",16.81,2022,clmcdmy4_n
8,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",7.4,2022,clmcvdmy4_n
8,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",13.9,2022,clmcopdmy4_n
8,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",28.9,2022,clmchfmy4_n
8,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",33.97,2022,clmdiabmy4_n
8,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",1.09,2022,clmdrugmy4_n
8,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",2.7,2022,clmgtbmy4_n
8,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.35,2022,clmhepbmy4_n
8,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.34,2022,clmhepothmy4_n
8,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",18.55,2022,clmhypthymy4_n
8,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",17.12,2022,clminfmy4_n
8,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",23.06,2022,clmihdmy4_n
8,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",6.59,2022,clmmimy4_n
8,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",14.7,2022,clmpvdmy4_n
8,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",3.17,2022,clmpnemy4_n
8,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.04,2022,clmcntcomy4_n
8,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",4.78,2022,clminfvamy4_n
8,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.25,2022,clmmstinfmy4_n
8,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.08,2022,clmtbmy4_n
8,"N (AFS): Facility Information - Average number of patients, 2022",87.76,2022,allcnty4m_n
8,N (AFS): Facility Information - Average number of all patients on 12/31/2022,56.59,2022,endcnty4m_n
8,"N (AFS): Facility Information - Average % of patients transferred in, 2022",16.96,2022,transiny4_n
8,"N (AFS): Facility Information - Average % of patients transferred out, 2022",17.11,2022,transouty4_n
8,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,88.18,2022,medicarey4_n
8,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,7.34,2022,medpendy4_n
8,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,4.48,2022,nonmedy4_n
8,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.23,2022,cfc_N
8,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,4.15,2022,std_N
8,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",34.25,2022,p_age1y4_n
8,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",20.55,2022,p_age2y4_n
8,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",24.66,2022,p_age3y4_n
8,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",20.55,2022,p_age4y4_n
8,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",0.0,2022,p_dis1y4_n
8,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",4.11,2022,p_dis2y4_n
8,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",36.99,2022,p_dis3y4_n
8,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",34.25,2022,p_dis4y4_n
8,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
8,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
8,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",20.55,2022,p_dis7y4_n
8,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",4.11,2022,p_dis8y4_n
8,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",21.92,2022,p_vin1y4_n
8,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",21.92,2022,p_vin2y4_n
8,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",30.14,2022,p_vin3y4_n
8,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",13.7,2022,p_vin4y4_n
8,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",12.33,2022,p_vin5y4_n
8,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",1.37,2022,p_rac1y4_n
8,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",53.42,2022,p_rac2y4_n
8,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",0.0,2022,p_rac3y4_n
8,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",43.84,2022,p_rac4y4_n
8,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",1.37,2022,p_rac5y4_n
8,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",6.85,2022,p_eth1y4_n
8,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",91.78,2022,p_eth2y4_n
8,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",1.37,2022,p_eth3y4_n
8,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",39.73,2022,p_sexy4_n
8,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",49.32,2022,p_modhdy4_n
8,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",1.37,2022,p_modhhdy4_n
8,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.37,2022,p_modcapdy4_n
8,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",47.95,2022,p_modccpdy4_n
8,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
8,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",0.0,2022,p_allmdcrmy4_n
8,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",57.5,2022,p_insmdcdmy4_n
8,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",27.5,2022,p_insempmy4_n
8,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",15.0,2022,p_insnonothmy4_n
8,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",5.0,2022,p_nephnomy4_n
8,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",35.0,2022,p_nephy6my4_n
8,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",15.0,2022,p_nephy612my4_n
8,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",42.5,2022,p_nephy12my4_n
8,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",2.5,2022,p_nephunkmissmy4_n
8,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",100.0,2022,p_ptinfymy4_n
8,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",14.29,2022,p_mefavfmy4_n
8,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
8,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",85.71,2022,p_mefcathmy4_n
8,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
8,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",14.29,2022,p_avfpresentmy4_n
8,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",15.02,2022,p_ppavfy4_n
8,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",61.43,2022,p_ltcy4_n
8,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",20.35,2022,p_WLy4_n
8,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",16.88,2022,p_WLlt10y4_n
8,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",38.14,2022,p_WL1017y4_n
8,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.5,2022,p_CWhdavgHGBy4_n
8,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",24.03,2022,p_CWhdhgb1y4_n
8,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",16.02,2022,p_CWhdhgb2y4_n
8,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",17.48,2022,p_CWhdhgb3y4_n
8,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",11.17,2022,p_CWhdhgb4y4_n
8,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",31.31,2022,p_CWhdhgb5y4_n
8,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.89,2022,p_CWpdavgHGBy4_n
8,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",27.06,2022,p_CWpdhgb1y4_n
8,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",19.95,2022,p_CWpdhgb2y4_n
8,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",14.91,2022,p_CWpdhgb3y4_n
8,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",20.18,2022,p_CWpdhgb4y4_n
8,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",17.89,2022,p_CWpdhgb5y4_n
8,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",3.91,2022,p_CWhdalby4_n
8,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",2.18,2022,p_CWhdalb1y4_n
8,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",5.34,2022,p_CWhdalb2y4_n
8,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",26.21,2022,p_CWhdalb3y4_n
8,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",34.71,2022,p_CWhdalb4y4_n
8,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",31.55,2022,p_CWhdalb5y4_n
8,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.64,2022,p_CWpdalby4_n
8,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",8.26,2022,p_CWpdalb1y4_n
8,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",16.74,2022,p_CWpdalb2y4_n
8,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",33.49,2022,p_CWpdalb3y4_n
8,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",22.71,2022,p_CWpdalb4y4_n
8,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",18.81,2022,p_CWpdalb5y4_n
8,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",59.17,2022,p_CWpdktvge18y4_n
8,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",75.07,2022,p_CWhdktvge12y4_n
8,"N: Patient Placement -  % of incident patients, 2022",17.4,2022,ppidy4_n
8,"N: Patient Placement -  % of patients continuing at facility, 2022",70.49,2022,ppcdy4_n
8,"N: Patient Placement -  % of patients that transfered into facility, 2022",12.11,2022,pptdy4_n
8,"N: End of Year Status - % of patients death attributed to this facility, 2022",14.33,2022,pdhdy4_n
8,"N: End of Year Status - % of patients death attributed to another facility, 2022",2.19,2022,pdody4_n
8,"N: End of Year Status - % of patients that received a transplant, 2022",2.54,2022,ptxdy4_n
8,"N: End of Year Status - % of patients alive in this facility, 2022",68.2,2022,pahdy4_n
8,"N: End of Year Status - % of patients alive in another facility, 2022",8.6,2022,paody4_n
8,"N: End of Year Status - % of patients other, 2022",4.13,2022,potdy4_n
8,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,47.59,2022,iuhemy4m_n
8,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.02,2022,iufreqy4m_n
8,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,47.56,2022,iunonfreqy4m_n
8,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.0,2022,iuothy4m_n
8,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
8,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
8,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,2.02,2022,ihhemy4m_n
8,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.57,2022,ihfreqy4m_n
8,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,1.45,2022,ihnonfreqy4m_n
8,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
8,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.67,2022,ihcapdy4m_n
8,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,6.31,2022,ihccpdy4m_n
8,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",12.57,2022,staffy4m_n
8,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,3.81,2022,nurseFTy4m_n
8,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,4.75,2022,ptcareFTy4m_n
8,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,1.21,2022,dietFTy4m_n
8,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.19,2022,socwkFTy4m_n
8,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.66,2022,nursePTy4m_n
8,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.46,2022,ptcarePTy4m_n
8,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.24,2022,dietPTy4m_n
8,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.24,2022,socwkPTy4m_n
8,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,30.38,2022,vocrehaby4m_n
8,"N (AFS): Facility Information - Average % incident patients, 2022",15.56,2022,incpery4_n
8,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,21.71,2022,employedy4_n
8,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,1.04,2022,schooly4_n
8,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",45.35,2022,nh_ppavfy4_n
8,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",22.16,2022,nh_ltcy4_n
8,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",2.91,2022,nh_CWhdktv1y4_n
8,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",8.64,2022,nh_CWpdktv1y4_n
8,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",32.71,2022,nh_CWhdhgb1y4_n
8,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",79.57,2022,nh_CWhdesarxy4_n
8,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",29.48,2022,nh_CWpdhgb1y4_n
8,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",55.47,2022,nh_CWpdesarxy4_n
8,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",44.91,2022,nh_obdry4_n
8,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.25,2022,nh_smry4_n
8,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",26.74,2022,nh_wity4_n
8,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",267.15,2022,nh_obhtry4_n
8,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.48,2022,nh_shrty4_n
8,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",24.31,2022,nh_sepiy4_n
8,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",11.19,2022,nh_miiy4_n
8,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",46.36,2022,nh_achfy4_n
8,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",32.19,2022,nh_acdry4_n
8,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",5.34,2022,nh_acary4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",0.79,2022,nh_clmhivaidmy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",8.58,2022,nh_clminfvamy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",1.05,2022,nh_clmhepbmy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",2.6,2022,nh_clmhepothmy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",3.69,2022,nh_clmmstinfmy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",9.75,2022,nh_clmpnemy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.23,2022,nh_clmtbmy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",40.42,2022,nh_clminfmy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.63,2022,nh_clmcamy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",37.52,2022,nh_clmcdmy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",21.08,2022,nh_clmcvdmy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",54.57,2022,nh_clmchfmy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",43.77,2022,nh_clmihdmy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",12.61,2022,nh_clmmimy4_n
8,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",33.2,2022,nh_clmpvdmy4_n
8,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
8,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",35.04,2022,nh_age2y4_n
8,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",64.96,2022,nh_age3y4_n
8,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",50.05,2022,nh_dis1y4_n
8,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",35.64,2022,nh_dis2y4_n
8,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",3.72,2022,nh_dis3y4_n
8,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",10.14,2022,nh_dis4y4_n
8,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.46,2022,nh_dis5y4_n
8,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",0.35,2022,nh_rac1y4_n
8,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",54.82,2022,nh_rac2y4_n
8,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",0.18,2022,nh_rac3y4_n
8,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",44.51,2022,nh_rac4y4_n
8,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.14,2022,nh_rac5y4_n
8,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",1.4,2022,nh_eth1y4_n
8,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",98.53,2022,nh_eth2y4_n
8,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.07,2022,nh_eth3y4_n
8,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",20.73,2022,nh_vin1y4_n
8,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",16.27,2022,nh_vin2y4_n
8,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",11.79,2022,nh_vin3y4_n
8,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.97,2022,nh_vin4y4_n
8,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",26.24,2022,nh_vin5y4_n
8,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",51.49,2022,nh_sexy4_n
8,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",96.39,2022,nh_modhdy4_n
8,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",1.33,2022,nh_modhhdy4_n
8,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.14,2022,nh_modcapdy4_n
8,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",1.65,2022,nh_modccpdy4_n
8,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.49,2022,nh_modothry4_n
8,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",88.46,2022,nh_allmdcrmy4_n
8,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",5.33,2022,nh_insmdcdmy4_n
8,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",0.79,2022,nh_insempmy4_n
8,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",5.42,2022,nh_insnonothmy4_n
8,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",5.77,2022,nh_mefavfmy4_n
8,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",1.4,2022,nh_mefgraftmy4_n
8,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",88.11,2022,nh_mefcathmy4_n
8,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",4.72,2022,nh_mefoumaccessmy4_n
8,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",12.24,2022,nh_avfpresentmy4_n
8,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",17.83,2022,nh_nephnomy4_n
8,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",20.19,2022,nh_nephy6my4_n
8,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",15.03,2022,nh_nephy612my4_n
8,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",21.07,2022,nh_nephy12my4_n
8,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",25.87,2022,nh_nephunkmissmy4_n
8,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",89.69,2022,nh_ptinfymy4_n
8,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",1.59,2022,alcomy4_n
8,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",9.76,2022,ashdmy4_n
8,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",18.96,2022,othcarmy4_n
8,"N (2728): Incident Patients  - Percent with cancer, 2022",5.98,2022,canmy4_n
8,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",26.93,2022,chfmy4_n
8,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",9.08,2022,cvamy4_n
8,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",39.39,2022,diabimy4_n
8,"N (2728): Incident Patients  - Percent with diabetes, 2022",62.04,2022,diabmy4_n
8,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.67,2022,drugmy4_n
8,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",89.31,2022,hxhtmy4_n
8,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",6.88,2022,ambumy4_n
8,"N (2728): Incident Patients  - Percent inability to transfer, 2022",3.6,2022,transmy4_n
8,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",8.82,2022,copdmy4_n
8,"N (2728): Incident Patients  - Percent with PVD, 2022",6.27,2022,pvdmy4_n
8,"N (2728): Incident Patients  - Percent smoker, 2022",8.71,2022,smokmy4_n
8,"N (2728): Incident Patients  - Percent Hispanic, 2022",2.14,2022,ethmy4_n
8,"N (2728): Incident Patients  - Percent White, 2022",48.04,2022,whitemy4_n
8,"N (2728): Incident Patients  - Percent African American, 2022",49.64,2022,blackmy4_n
8,"N (2728): Incident Patients  - Percent Native American, 2022",0.85,2022,nativmy4_n
8,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",1.29,2022,asianmy4_n
8,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.18,2022,racoummy4_n
8,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",23.45,2022,cempmy4_n
8,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",30.94,2022,pempmy4_n
8,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",39.6,2022,dbprimy4_n
8,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",4.87,2022,gnprimy4_n
8,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",39.56,2022,htprimy4_n
8,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",15.97,2022,omprimy4_n
8,"N (2728): Incident Patients  - Percent female, 2022",45.22,2022,femmy4_n
8,"N (2728): Incident Patients  - Average age, 2022",62.43,2022,agemy4_n
8,"N (2728): Incident Patients  - Average serum albumin, 2022",3.36,2022,salbmy4_n
8,"N (2728): Incident Patients  - Average creatinine, 2022",6.67,2022,creamy4_n
8,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.24,2022,hgmy4_n
8,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",10.53,2022,gfrmy4_n
8,"N (2728): Incident Patients  - Average count of comorbidities, 2022",2.99,2022,cntcomy4_n
8,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",82.62,2022,pdmodMEFHDmy4_n
8,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",17.38,2022,pdmodMEFPDmy4_n
8,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
8,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",49.73,2022,insmdcrmy4_n
8,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",8.23,2022,insmdcdmy4_n
8,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",7.36,2022,insmdcrcdmy4_n
8,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",11.22,2022,insempmy4_n
8,"N (2728): Incident Patients  - Percent with no coverage, 2022",6.41,2022,insnonemy4_n
8,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",8.49,2022,insmdcromy4_n
8,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",8.58,2022,insmedomy4_n
8,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",11.26,2022,preepomy4_n
8,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",15.89,2022,nephnomy4_n
8,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",16.01,2022,nephy6my4_n
8,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",19.69,2022,nephy612my4_n
8,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",28.28,2022,nephy12my4_n
8,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",20.13,2022,nephunkmissmy4_n
8,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",91.61,2022,ptinfymy4_n
8,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",24.05,2022,ptxmedunfitmy4_n
8,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
8,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
8,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",9.76,2022,ptxdeclinemy4_n
8,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",74.32,2022,ptxnotassessmy4_n
8,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",11.57,2022,mefavfmy4_n
8,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",3.69,2022,mefgraftmy4_n
8,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",84.48,2022,mefcathmy4_n
8,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.26,2022,mefoumaccessmy4_n
8,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",20.8,2022,avfpresentmy4_n
8,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",28.14,2022,bmimmy4_n
8,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",29.38,2022,bmifmy4_n
8,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",1.17,2022,ptinfnmy4m_n
8,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",11.51,2022,hemomy4m_n
8,"N (2728): Incident Patients  - Average Number of forms returned, 2022",13.93,2022,nmy4m_n
8,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",73.32,2019,rdsmzm_n
8,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",48.01,2019,dyzm_n
8,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",9.86,2019,deazm_n
8,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",9.54,2019,exdzm_n
8,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.07,2019,dudzm_n
8,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",1.03,2019,smrz_n
8,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",20.61,2019,witz_n
8,"N: All Patient Mortality - % of deaths from infection, 2019-2022",12.0,2019,infz_n
8,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",51.83,2019,cardz_n
8,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.57,2019,livz_n
8,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",13.89,2019,fynmzm_n
8,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",8.3,2019,fydyzm_n
8,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.48,2019,fydeazm_n
8,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.28,2019,fyexdzm_n
8,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",1.09,2019,fysmrz_n
8,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",22.48,2019,fywitz_n
8,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",10.93,2019,fyinfz_n
8,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",45.8,2019,fycardiacz_n
8,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",2.78,2019,fylivz_n
8,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",63.12,2019,rdshzm_n
8,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",54.33,2019,htazm_n
8,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",56.61,2019,extzm_n
8,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",437.42,2019,hdzm_n
8,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",458.99,2019,exhdzm_n
8,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",40.62,2019,hdyzm_n
8,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",0.96,2019,shrtz_n
8,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.95,2019,shrdz_n
8,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.74,2019,lenz_n
8,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",8.98,2019,onez_n
8,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",6.47,2019,miiz_n
8,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",12.23,2019,sepiz_n
8,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",27.88,2019,achfz_n
8,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",17.54,2019,acdrz_n
8,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",3.29,2019,acarz_n
8,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",85.52,2019,ipedz_n
8,"N: ED30 - Average annual index discharges, 2019-22",30.72,2019,ed30indexzm_n
8,"N: ED30- Average annual number of ED visits, 2019-22",5.31,2019,ed30obszm_n
8,"N: ED30 - Average annual expected ED visits, 2019-22",5.18,2019,ed30expzm_n
8,"N: ED30: Standardized Ratio of ED30, 2019-22",1.07,2019,ed30z_n
8,"N SRR -  Standardized Readmission Ratio, 2022",1.02,2022,srry4_n
8,"N: SRR - Average index discharges, 2022",50.32,2022,indexmy4_n
8,"N: SRR - Average number of readmissions, 2022",12.78,2022,readmmy4_n
8,"N: SRR - Average expected readmissions, 2022",13.3,2022,srrexpmy4_n
8,Pt included in SEDR analysis,42.63,2019,rdsezm_n
8,Total number of ED Visits,43.54,2019,hedzm_n
8,Expected number of ED events,41.09,2019,exedzm_n
8,Years at risk for ED visit rate,26.96,2019,edyrzm_n
8,Years at risk for ED visit rate,54468.61,2019,edyrz_n
8,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",1.06,2019,sedrz_n
8,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",57.02,2019,rdstzm_n
8,"N: STR - Average number of patients (per year in average facility), 2019-2022",60.46,2019,rdsalltzm_n
8,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",1.46,2019,txzm_n
8,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",1.62,2019,txallzm_n
8,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",37.43,2019,txyzm_n
8,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.4,2019,cadalltzm_n
8,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.24,2019,livealltzm_n
8,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",1.84,2019,extxzm_n
8,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",0.8,2019,strz_n
8,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",57.95,2022,pppwpty4m_n
8,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",14.48,2022,WLy4_n
8,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",21.51,2022,WLlt40y4_n
8,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",13.67,2022,WL4074y4_n
8,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",16.29,2022,WLmaley4_n
8,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",12.16,2022,WLfemy4_n
8,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",17.53,2022,WLwhhy4_n
8,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",14.69,2022,WLwhnhy4_n
8,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",14.26,2022,WLbly4_n
8,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",21.14,2022,WLasy4_n
8,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",6.48,2022,WLnay4_n
8,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",10.6,2022,WLothy4_n
8,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",11.71,2022,WLDMy4_n
8,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",16.25,2022,WLnodmy4_n
8,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",13.61,2022,WLnotxy4_n
8,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",28.15,2022,WLtxy4_n
8,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",11.21,2022,WLVCat1y4_n
8,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",19.94,2022,WLVCat2y4_n
8,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",13.42,2022,WLVCat3y4_n
8,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",483.82,2022,pppwpmy4m_n
8,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",13.71,2022,pppwy4_n
8,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",9.89,2019,swrptzm_n
8,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",7.84,2019,swrpyzm_n
8,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.66,2019,swrwlzm_n
8,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.77,2019,swrexwlzm_n
8,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",0.85,2019,swrz_n
8,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",83.89,2021,FVfy3_n
8,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",9.4,2021,FVdeclinedfy3_n
8,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.14,2021,FVovndfy3_n
8,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",6.71,2021,FVothrsnfy3_n
8,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",75.63,2022,FVhy4_n
8,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",76.78,2022,FVmcarehy4_n
8,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",77.33,2022,FVmahy4_n
8,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",76.86,2022,FVmpphy4_n
8,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",76.4,2022,FVdualhy4_n
8,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",73.2,2022,FVmsphy4_n
8,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",65.94,2022,FVnonmcarehy4_n
8,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",55.17,2022,FVlt18hy4_n
8,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",65.9,2022,FV1839hy4_n
8,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",74.07,2022,FV4064hy4_n
8,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",78.26,2022,FV6574hy4_n
8,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",79.74,2022,FV75uphy4_n
8,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",75.23,2022,FVmalehy4_n
8,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",76.05,2022,FVfemhy4_n
8,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",79.49,2022,FVashy4_n
8,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",82.98,2022,FVnahy4_n
8,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",76.0,2022,FVwhhy4_n
8,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",60.0,2022,FVrothhy4_n
8,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",75.24,2022,FVblkhy4_n
8,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",80.37,2022,FVhisphy4_n
8,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",63.04,2022,FVVCat1hy4_n
8,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",75.94,2022,FVVCat2hy4_n
8,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",80.96,2022,FVVCat3hy4_n
8,"N: Influenza - Average number of patients treated on 12/31, 2022",52.84,2022,eFVy4m_n
8,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",0.65,2022,medrsnfy4m_N
8,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.66,2022,CWhdavgHGBy4_n
8,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",25.58,2022,CWhdhgb1y4_n
8,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",33.27,2022,CWhdhgb2y4_n
8,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",27.89,2022,CWhdhgb3y4_n
8,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",11.68,2022,CWhdhgb4y4_n
8,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",1.58,2022,CWhdhgb5y4_n
8,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",74.35,2022,CWhdesarxy4_n
8,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.03,2022,CWpdavgHGBy4_n
8,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",21.39,2022,CWpdhgb1y4_n
8,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",26.78,2022,CWpdhgb2y4_n
8,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",27.03,2022,CWpdhgb3y4_n
8,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",21.96,2022,CWpdhgb4y4_n
8,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.84,2022,CWpdhgb5y4_n
8,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",49.5,2022,CWpdesarxy4_n
8,"N: HD HGB (Adult) - Average number of eligible patients, 2022",62.53,2022,CWhdptdenomy4m_n
8,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",537.71,2022,CWhdptmthdenomy4m_n
8,"N: PD HGB (Adult) - Average number of eligible patients, 2022",26.85,2022,CWpdptdenomy4m_n
8,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",204.12,2022,CWpdptmthdenomy4m_n
8,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",29.9,2022,rdstfy4m_n
8,"N: STrR (Adult) - Average Patient Years at Risk, 2022",17.72,2022,tfyy4m_n
8,"N: STrR (Adult) - Average Number of Transfusions, 2022",6.68,2022,tfy4m_n
8,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",5.86,2022,extfy4m_n
8,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",1.14,2022,strry4_n
8,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.9,2022,CWhdalby4_n
8,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",2.09,2022,CWhdalb1y4_n
8,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",8.54,2022,CWhdalb2y4_n
8,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",38.65,2022,CWhdalb3y4_n
8,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",48.05,2022,CWhdalb4y4_n
8,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",2.66,2022,CWhdalb5y4_n
8,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",49.28,2022,CWhdalblt4y4_n
8,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.66,2022,CWhdavgufry4_n
8,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",86.58,2022,CWhdufr1y4_n
8,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",7.46,2022,CWhdufr2y4_n
8,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",3.42,2022,CWhdufrmissy4_n
8,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.53,2022,CWhdufrgt20y4_n
8,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.64,2022,CWpdalby4_n
8,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",7.01,2022,CWpdalb1y4_n
8,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",22.98,2022,CWpdalb2y4_n
8,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",42.85,2022,CWpdalb3y4_n
8,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",24.41,2022,CWpdalb4y4_n
8,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",2.75,2022,CWpdalb5y4_n
8,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",72.84,2022,CWpdalblt4y4_n
8,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",62.53,2022,CWhddenomy4m_n
8,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",537.71,2022,CWhdmthdenomy4m_n
8,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",26.85,2022,CWpddenomy4m_n
8,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",204.12,2022,CWpdmthdenomy4m_n
8,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.28,2022,CWpdavgktvy4_n
8,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",4.52,2022,CWpdktv1y4_n
8,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",67.08,2022,CWpdktv2y4_n
8,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",26.41,2022,CWpdktv3y4_n
8,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.99,2022,CWpdktv4y4_n
8,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.64,2022,CWhdavgktvy4_n
8,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",2.09,2022,CWhdktv1y4_n
8,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",69.2,2022,CWhdktv2y4_n
8,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",27.35,2022,CWhdktv3y4_n
8,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.36,2022,CWhdktv4y4_n
8,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",60.64,2022,CWhdktvptsy4m_N
8,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",519.11,2022,CWhdktvptmthy4m_N
9,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",3.6,2022,allmcFcovpatPq4_n
9,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",25.98,2022,allmcEcovpatPq4_n
9,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",34.69,2022,allmcEcovDeaPq4_n
9,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",34.8,2022,allmcEcovHosPq4_n
9,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",8.57,2022,nh_mcFcovpatPq4_n
9,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",42.56,2022,nh_mcEcovpatPq4_n
9,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",46.08,2022,nh_mcEcovDeaPq4_n
9,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",42.16,2022,nh_mcEcovHosPq4_n
9,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",63.29,2022,agey4_n
9,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.23,2022,age1y4_n
9,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",48.22,2022,age2y4_n
9,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",51.55,2022,age3y4_n
9,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",44.17,2022,dis1y4_n
9,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",29.01,2022,dis2y4_n
9,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",9.83,2022,dis3y4_n
9,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",16.43,2022,dis4y4_n
9,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.56,2022,dis5y4_n
9,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",18.94,2022,vin1y4_n
9,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",19.51,2022,vin2y4_n
9,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.75,2022,vin3y4_n
9,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",23.55,2022,vin4y4_n
9,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",24.26,2022,vin5y4_n
9,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",1.5,2022,rac1y4_n
9,"N: Prevalent Patients - Race: % African American, 12/31/2022",33.98,2022,rac2y4_n
9,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.21,2022,rac3y4_n
9,"N: Prevalent Patients - Race: % White, 12/31/2022",64.18,2022,rac4y4_n
9,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.12,2022,rac5y4_n
9,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",4.51,2022,eth1y4_n
9,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",95.4,2022,eth2y4_n
9,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.08,2022,eth3y4_n
9,"N: Prevalent Patients - Sex: % Female, 12/31/2022",42.14,2022,sexy4_n
9,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",18.17,2022,nrshomey4_n
9,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",4.71,2022,viny4_n
9,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",80.91,2022,modhdy4_n
9,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",4.95,2022,modhhdy4_n
9,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.44,2022,modcapdy4_n
9,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",12.45,2022,modccpdy4_n
9,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.25,2022,modothry4_n
9,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",43.49,2022,pahy4m_n
9,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",18.7,2022,CWunCa1y4_n
9,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",77.32,2022,CWunCa2y4_n
9,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.18,2022,CWunCa3y4_n
9,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",2.8,2022,CWunCamissy4_n
9,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
9,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.89,2022,CWavgUnCay4_n
9,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.51,2022,CWavgPy4_n
9,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.05,2022,CWP1y4_n
9,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",22.68,2022,CWP2y4_n
9,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",28.04,2022,CWP3y4_n
9,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",22.96,2022,CWP4y4_n
9,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",16.06,2022,CWP5y4_n
9,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",3.22,2022,CWPmissy4_n
9,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
9,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",1.87,2022,CWunCagt102y4_n
9,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",61.92,2022,CWptdenomy4m_n
9,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",509.21,2022,CWptmthdenomy4m_n
9,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",66.54,2022,serumphospatsy4m_n
9,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",542.92,2022,serumphospmy4m_n
9,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",61.92,2022,CWhcptdenomy4m_n
9,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",509.2,2022,CWhcptmthdenomy4m_n
9,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",54.52,2022,ppavfy4_n
9,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",17.7,2022,ppavgy4_n
9,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",25.54,2022,ppcathy4_n
9,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",2.23,2022,ppomy4_n
9,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",19.41,2022,ltcy4_n
9,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",10.51,2022,piavfy4_n
9,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",3.21,2022,piavgy4_n
9,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",82.15,2022,picathy4_n
9,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",4.12,2022,piomy4_n
9,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",11.13,2022,pifisty4_n
9,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",58.36,2022,phdvapty4m_n
9,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",471.05,2022,phdy4m_n
9,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",12.16,2022,ihdy4m_n
9,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",56.25,2022,sfry4_n
9,"N: VA infection - Average number of eligible PD patients, 2022",8.41,2022,pdpaty4m_n
9,"N: VA infection - Average number of eligible PD patient-months, 2022",58.18,2022,pdptmoy4m_n
9,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.43,2022,pd2inf100moy4_n
9,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",35.63,2022,ncmy4m_n
9,"N: Prevalent Comorbidities - Average % with Anemia, 2022",3.15,2022,clmanemy4_n
9,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.51,2022,clmhivaidmy4_n
9,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.48,2022,clmalcomy4_n
9,"N: Prevalent Comorbidities - Average % with Cancer, 2022",3.94,2022,clmcanmy4_n
9,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",1.03,2022,clmcamy4_n
9,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",22.63,2022,clmcdmy4_n
9,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",8.1,2022,clmcvdmy4_n
9,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",19.57,2022,clmcopdmy4_n
9,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",36.1,2022,clmchfmy4_n
9,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",38.9,2022,clmdiabmy4_n
9,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",1.22,2022,clmdrugmy4_n
9,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",3.68,2022,clmgtbmy4_n
9,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.33,2022,clmhepbmy4_n
9,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.62,2022,clmhepothmy4_n
9,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",21.78,2022,clmhypthymy4_n
9,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",19.59,2022,clminfmy4_n
9,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",30.08,2022,clmihdmy4_n
9,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",7.47,2022,clmmimy4_n
9,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",17.95,2022,clmpvdmy4_n
9,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",4.05,2022,clmpnemy4_n
9,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.51,2022,clmcntcomy4_n
9,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",5.56,2022,clminfvamy4_n
9,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.86,2022,clmmstinfmy4_n
9,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.12,2022,clmtbmy4_n
9,"N (AFS): Facility Information - Average number of patients, 2022",79.86,2022,allcnty4m_n
9,N (AFS): Facility Information - Average number of all patients on 12/31/2022,48.92,2022,endcnty4m_n
9,"N (AFS): Facility Information - Average % of patients transferred in, 2022",19.48,2022,transiny4_n
9,"N (AFS): Facility Information - Average % of patients transferred out, 2022",19.57,2022,transouty4_n
9,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,84.22,2022,medicarey4_n
9,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,7.56,2022,medpendy4_n
9,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,8.22,2022,nonmedy4_n
9,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.05,2022,cfc_N
9,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,2.08,2022,std_N
9,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",21.54,2022,p_age1y4_n
9,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",9.23,2022,p_age2y4_n
9,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",38.46,2022,p_age3y4_n
9,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",30.77,2022,p_age4y4_n
9,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",1.54,2022,p_dis1y4_n
9,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",1.54,2022,p_dis2y4_n
9,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",27.69,2022,p_dis3y4_n
9,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",33.85,2022,p_dis4y4_n
9,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
9,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
9,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",13.85,2022,p_dis7y4_n
9,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",21.54,2022,p_dis8y4_n
9,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",32.31,2022,p_vin1y4_n
9,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",30.77,2022,p_vin2y4_n
9,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",9.23,2022,p_vin3y4_n
9,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",16.92,2022,p_vin4y4_n
9,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",10.77,2022,p_vin5y4_n
9,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",0.0,2022,p_rac1y4_n
9,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",40.0,2022,p_rac2y4_n
9,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",0.0,2022,p_rac3y4_n
9,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",56.92,2022,p_rac4y4_n
9,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",3.08,2022,p_rac5y4_n
9,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",6.15,2022,p_eth1y4_n
9,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",93.85,2022,p_eth2y4_n
9,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
9,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",41.54,2022,p_sexy4_n
9,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",49.23,2022,p_modhdy4_n
9,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
9,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.54,2022,p_modcapdy4_n
9,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",49.23,2022,p_modccpdy4_n
9,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
9,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",18.18,2022,p_allmdcrmy4_n
9,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",50.0,2022,p_insmdcdmy4_n
9,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",22.73,2022,p_insempmy4_n
9,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",9.09,2022,p_insnonothmy4_n
9,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",40.91,2022,p_nephnomy4_n
9,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",20.45,2022,p_nephy6my4_n
9,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",13.64,2022,p_nephy612my4_n
9,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",15.91,2022,p_nephy12my4_n
9,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",9.09,2022,p_nephunkmissmy4_n
9,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",70.45,2022,p_ptinfymy4_n
9,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",14.81,2022,p_mefavfmy4_n
9,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
9,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",85.19,2022,p_mefcathmy4_n
9,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
9,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",18.52,2022,p_avfpresentmy4_n
9,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",14.78,2022,p_ppavfy4_n
9,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",67.21,2022,p_ltcy4_n
9,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",26.35,2022,p_WLy4_n
9,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",30.41,2022,p_WLlt10y4_n
9,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",25.05,2022,p_WL1017y4_n
9,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.14,2022,p_CWhdavgHGBy4_n
9,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",12.47,2022,p_CWhdhgb1y4_n
9,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",20.78,2022,p_CWhdhgb2y4_n
9,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",31.69,2022,p_CWhdhgb3y4_n
9,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",20.26,2022,p_CWhdhgb4y4_n
9,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",14.81,2022,p_CWhdhgb5y4_n
9,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.5,2022,p_CWpdavgHGBy4_n
9,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",24.27,2022,p_CWpdhgb1y4_n
9,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",20.47,2022,p_CWpdhgb2y4_n
9,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",21.93,2022,p_CWpdhgb3y4_n
9,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",10.23,2022,p_CWpdhgb4y4_n
9,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",23.1,2022,p_CWpdhgb5y4_n
9,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.02,2022,p_CWhdalby4_n
9,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",1.56,2022,p_CWhdalb1y4_n
9,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",6.75,2022,p_CWhdalb2y4_n
9,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",24.68,2022,p_CWhdalb3y4_n
9,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",51.95,2022,p_CWhdalb4y4_n
9,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",15.06,2022,p_CWhdalb5y4_n
9,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.61,2022,p_CWpdalby4_n
9,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",9.06,2022,p_CWpdalb1y4_n
9,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",18.71,2022,p_CWpdalb2y4_n
9,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",19.59,2022,p_CWpdalb3y4_n
9,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",23.98,2022,p_CWpdalb4y4_n
9,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",28.65,2022,p_CWpdalb5y4_n
9,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",68.42,2022,p_CWpdktvge18y4_n
9,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",83.98,2022,p_CWhdktvge12y4_n
9,"N: Patient Placement -  % of incident patients, 2022",18.8,2022,ppidy4_n
9,"N: Patient Placement -  % of patients continuing at facility, 2022",68.59,2022,ppcdy4_n
9,"N: Patient Placement -  % of patients that transfered into facility, 2022",12.62,2022,pptdy4_n
9,"N: End of Year Status - % of patients death attributed to this facility, 2022",16.01,2022,pdhdy4_n
9,"N: End of Year Status - % of patients death attributed to another facility, 2022",2.47,2022,pdody4_n
9,"N: End of Year Status - % of patients that received a transplant, 2022",2.95,2022,ptxdy4_n
9,"N: End of Year Status - % of patients alive in this facility, 2022",66.08,2022,pahdy4_n
9,"N: End of Year Status - % of patients alive in another facility, 2022",8.75,2022,paody4_n
9,"N: End of Year Status - % of patients other, 2022",3.74,2022,potdy4_n
9,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,39.75,2022,iuhemy4m_n
9,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.01,2022,iufreqy4m_n
9,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,39.74,2022,iunonfreqy4m_n
9,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.01,2022,iuothy4m_n
9,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
9,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
9,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,2.45,2022,ihhemy4m_n
9,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.75,2022,ihfreqy4m_n
9,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,1.7,2022,ihnonfreqy4m_n
9,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
9,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.77,2022,ihcapdy4m_n
9,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,5.94,2022,ihccpdy4m_n
9,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",11.39,2022,staffy4m_n
9,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,3.44,2022,nurseFTy4m_n
9,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,4.14,2022,ptcareFTy4m_n
9,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,1.03,2022,dietFTy4m_n
9,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.02,2022,socwkFTy4m_n
9,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.61,2022,nursePTy4m_n
9,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.53,2022,ptcarePTy4m_n
9,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.33,2022,dietPTy4m_n
9,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.29,2022,socwkPTy4m_n
9,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,23.68,2022,vocrehaby4m_n
9,"N (AFS): Facility Information - Average % incident patients, 2022",16.63,2022,incpery4_n
9,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,25.55,2022,employedy4_n
9,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.89,2022,schooly4_n
9,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",42.91,2022,nh_ppavfy4_n
9,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",25.53,2022,nh_ltcy4_n
9,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",2.74,2022,nh_CWhdktv1y4_n
9,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",6.45,2022,nh_CWpdktv1y4_n
9,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",30.16,2022,nh_CWhdhgb1y4_n
9,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",78.55,2022,nh_CWhdesarxy4_n
9,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",27.22,2022,nh_CWpdhgb1y4_n
9,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",53.19,2022,nh_CWpdesarxy4_n
9,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",46.96,2022,nh_obdry4_n
9,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.15,2022,nh_smry4_n
9,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",27.93,2022,nh_wity4_n
9,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",282.96,2022,nh_obhtry4_n
9,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.49,2022,nh_shrty4_n
9,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",22.7,2022,nh_sepiy4_n
9,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",10.04,2022,nh_miiy4_n
9,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",51.02,2022,nh_achfy4_n
9,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",36.39,2022,nh_acdry4_n
9,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",3.51,2022,nh_acary4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",0.46,2022,nh_clmhivaidmy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",10.05,2022,nh_clminfvamy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",0.55,2022,nh_clmhepbmy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",2.91,2022,nh_clmhepothmy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",4.5,2022,nh_clmmstinfmy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",9.86,2022,nh_clmpnemy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.15,2022,nh_clmtbmy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",41.48,2022,nh_clminfmy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.12,2022,nh_clmcamy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",43.05,2022,nh_clmcdmy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",18.38,2022,nh_clmcvdmy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",62.08,2022,nh_clmchfmy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",49.8,2022,nh_clmihdmy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",13.07,2022,nh_clmmimy4_n
9,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",35.38,2022,nh_clmpvdmy4_n
9,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
9,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",33.67,2022,nh_age2y4_n
9,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",66.33,2022,nh_age3y4_n
9,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",54.74,2022,nh_dis1y4_n
9,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",24.29,2022,nh_dis2y4_n
9,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",5.07,2022,nh_dis3y4_n
9,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",14.59,2022,nh_dis4y4_n
9,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",1.31,2022,nh_dis5y4_n
9,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",0.58,2022,nh_rac1y4_n
9,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",32.43,2022,nh_rac2y4_n
9,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",0.25,2022,nh_rac3y4_n
9,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",66.64,2022,nh_rac4y4_n
9,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.1,2022,nh_rac5y4_n
9,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",2.97,2022,nh_eth1y4_n
9,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",96.89,2022,nh_eth2y4_n
9,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.14,2022,nh_eth3y4_n
9,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",23.96,2022,nh_vin1y4_n
9,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",17.27,2022,nh_vin2y4_n
9,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",11.11,2022,nh_vin3y4_n
9,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",25.41,2022,nh_vin4y4_n
9,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",22.25,2022,nh_vin5y4_n
9,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",50.41,2022,nh_sexy4_n
9,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",85.95,2022,nh_modhdy4_n
9,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",10.48,2022,nh_modhhdy4_n
9,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.27,2022,nh_modcapdy4_n
9,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",2.91,2022,nh_modccpdy4_n
9,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.39,2022,nh_modothry4_n
9,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",84.38,2022,nh_allmdcrmy4_n
9,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",10.09,2022,nh_insmdcdmy4_n
9,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",2.05,2022,nh_insempmy4_n
9,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",3.47,2022,nh_insnonothmy4_n
9,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",5.34,2022,nh_mefavfmy4_n
9,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",2.19,2022,nh_mefgraftmy4_n
9,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",89.5,2022,nh_mefcathmy4_n
9,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",2.97,2022,nh_mefoumaccessmy4_n
9,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",11.87,2022,nh_avfpresentmy4_n
9,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",12.37,2022,nh_nephnomy4_n
9,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",27.49,2022,nh_nephy6my4_n
9,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",18.49,2022,nh_nephy612my4_n
9,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",21.23,2022,nh_nephy12my4_n
9,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",20.41,2022,nh_nephunkmissmy4_n
9,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",87.63,2022,nh_ptinfymy4_n
9,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",2.13,2022,alcomy4_n
9,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",12.66,2022,ashdmy4_n
9,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",26.5,2022,othcarmy4_n
9,"N (2728): Incident Patients  - Percent with cancer, 2022",8.62,2022,canmy4_n
9,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",30.41,2022,chfmy4_n
9,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",9.99,2022,cvamy4_n
9,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",44.58,2022,diabimy4_n
9,"N (2728): Incident Patients  - Percent with diabetes, 2022",63.78,2022,diabmy4_n
9,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.89,2022,drugmy4_n
9,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",86.56,2022,hxhtmy4_n
9,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",7.86,2022,ambumy4_n
9,"N (2728): Incident Patients  - Percent inability to transfer, 2022",3.84,2022,transmy4_n
9,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",12.5,2022,copdmy4_n
9,"N (2728): Incident Patients  - Percent with PVD, 2022",8.74,2022,pvdmy4_n
9,"N (2728): Incident Patients  - Percent smoker, 2022",10.62,2022,smokmy4_n
9,"N (2728): Incident Patients  - Percent Hispanic, 2022",3.2,2022,ethmy4_n
9,"N (2728): Incident Patients  - Percent White, 2022",72.43,2022,whitemy4_n
9,"N (2728): Incident Patients  - Percent African American, 2022",25.42,2022,blackmy4_n
9,"N (2728): Incident Patients  - Percent Native American, 2022",0.55,2022,nativmy4_n
9,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",1.39,2022,asianmy4_n
9,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.21,2022,racoummy4_n
9,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",24.91,2022,cempmy4_n
9,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",33.6,2022,pempmy4_n
9,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",45.58,2022,dbprimy4_n
9,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",5.99,2022,gnprimy4_n
9,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",29.09,2022,htprimy4_n
9,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",19.34,2022,omprimy4_n
9,"N (2728): Incident Patients  - Percent female, 2022",40.97,2022,femmy4_n
9,"N (2728): Incident Patients  - Average age, 2022",64.38,2022,agemy4_n
9,"N (2728): Incident Patients  - Average serum albumin, 2022",3.46,2022,salbmy4_n
9,"N (2728): Incident Patients  - Average creatinine, 2022",5.92,2022,creamy4_n
9,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.46,2022,hgmy4_n
9,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",11.49,2022,gfrmy4_n
9,"N (2728): Incident Patients  - Average count of comorbidities, 2022",3.31,2022,cntcomy4_n
9,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",85.27,2022,pdmodMEFHDmy4_n
9,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",14.73,2022,pdmodMEFPDmy4_n
9,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
9,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",51.59,2022,insmdcrmy4_n
9,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",15.02,2022,insmdcdmy4_n
9,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",7.45,2022,insmdcrcdmy4_n
9,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",10.43,2022,insempmy4_n
9,"N (2728): Incident Patients  - Percent with no coverage, 2022",1.05,2022,insnonemy4_n
9,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",9.09,2022,insmdcromy4_n
9,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",5.38,2022,insmedomy4_n
9,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",20.41,2022,preepomy4_n
9,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",11.39,2022,nephnomy4_n
9,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",22.87,2022,nephy6my4_n
9,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",20.99,2022,nephy612my4_n
9,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",30.97,2022,nephy12my4_n
9,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",13.78,2022,nephunkmissmy4_n
9,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",93.34,2022,ptinfymy4_n
9,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",49.2,2022,ptxmedunfitmy4_n
9,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
9,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
9,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",5.53,2022,ptxdeclinemy4_n
9,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",41.35,2022,ptxnotassessmy4_n
9,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",11.56,2022,mefavfmy4_n
9,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",2.73,2022,mefgraftmy4_n
9,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",85.39,2022,mefcathmy4_n
9,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.32,2022,mefoumaccessmy4_n
9,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",19.53,2022,avfpresentmy4_n
9,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",28.73,2022,bmimmy4_n
9,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",29.97,2022,bmifmy4_n
9,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",0.88,2022,ptinfnmy4m_n
9,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",11.27,2022,hemomy4m_n
9,"N (2728): Incident Patients  - Average Number of forms returned, 2022",13.22,2022,nmy4m_n
9,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",65.42,2019,rdsmzm_n
9,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",41.46,2019,dyzm_n
9,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",9.54,2019,deazm_n
9,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",10.11,2019,exdzm_n
9,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.04,2019,dudzm_n
9,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",0.94,2019,smrz_n
9,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",26.56,2019,witz_n
9,"N: All Patient Mortality - % of deaths from infection, 2019-2022",7.72,2019,infz_n
9,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",41.62,2019,cardz_n
9,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.09,2019,livz_n
9,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",13.7,2019,fynmzm_n
9,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",8.03,2019,fydyzm_n
9,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.66,2019,fydeazm_n
9,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.77,2019,fyexdzm_n
9,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",0.96,2019,fysmrz_n
9,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",27.01,2019,fywitz_n
9,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",7.34,2019,fyinfz_n
9,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",36.47,2019,fycardiacz_n
9,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",1.78,2019,fylivz_n
9,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",54.67,2019,rdshzm_n
9,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",52.8,2019,htazm_n
9,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",51.62,2019,extzm_n
9,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",408.92,2019,hdzm_n
9,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",422.26,2019,exhdzm_n
9,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",34.04,2019,hdyzm_n
9,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",1.02,2019,shrtz_n
9,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.97,2019,shrdz_n
9,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.44,2019,lenz_n
9,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",8.29,2019,onez_n
9,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",6.9,2019,miiz_n
9,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",13.03,2019,sepiz_n
9,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",32.89,2019,achfz_n
9,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",22.37,2019,acdrz_n
9,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.73,2019,acarz_n
9,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",81.83,2019,ipedz_n
9,"N: ED30 - Average annual index discharges, 2019-22",27.05,2019,ed30indexzm_n
9,"N: ED30- Average annual number of ED visits, 2019-22",4.64,2019,ed30obszm_n
9,"N: ED30 - Average annual expected ED visits, 2019-22",4.56,2019,ed30expzm_n
9,"N: ED30: Standardized Ratio of ED30, 2019-22",1.06,2019,ed30z_n
9,"N SRR -  Standardized Readmission Ratio, 2022",1.03,2022,srry4_n
9,"N: SRR - Average index discharges, 2022",49.0,2022,indexmy4_n
9,"N: SRR - Average number of readmissions, 2022",13.11,2022,readmmy4_n
9,"N: SRR - Average expected readmissions, 2022",13.55,2022,srrexpmy4_n
9,Pt included in SEDR analysis,33.29,2019,rdsezm_n
9,Total number of ED Visits,33.14,2019,hedzm_n
9,Expected number of ED events,31.3,2019,exedzm_n
9,Years at risk for ED visit rate,19.9,2019,edyrzm_n
9,Years at risk for ED visit rate,53637.93,2019,edyrz_n
9,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",1.06,2019,sedrz_n
9,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",47.28,2019,rdstzm_n
9,"N: STR - Average number of patients (per year in average facility), 2019-2022",50.93,2019,rdsalltzm_n
9,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",1.51,2019,txzm_n
9,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",1.71,2019,txallzm_n
9,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",29.91,2019,txyzm_n
9,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.4,2019,cadalltzm_n
9,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.34,2019,livealltzm_n
9,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",1.41,2019,extxzm_n
9,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",1.07,2019,strz_n
9,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",46.56,2022,pppwpty4m_n
9,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",12.62,2022,WLy4_n
9,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",21.84,2022,WLlt40y4_n
9,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",11.59,2022,WL4074y4_n
9,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",13.68,2022,WLmaley4_n
9,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",11.07,2022,WLfemy4_n
9,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",13.47,2022,WLwhhy4_n
9,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",12.23,2022,WLwhnhy4_n
9,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",12.63,2022,WLbly4_n
9,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",24.48,2022,WLasy4_n
9,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",10.68,2022,WLnay4_n
9,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",10.36,2022,WLothy4_n
9,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",10.4,2022,WLDMy4_n
9,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",14.34,2022,WLnodmy4_n
9,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",11.52,2022,WLnotxy4_n
9,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",25.52,2022,WLtxy4_n
9,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",11.13,2022,WLVCat1y4_n
9,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",16.82,2022,WLVCat2y4_n
9,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",10.7,2022,WLVCat3y4_n
9,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",377.41,2022,pppwpmy4m_n
9,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",12.07,2022,pppwy4_n
9,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",8.57,2019,swrptzm_n
9,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",6.78,2019,swrpyzm_n
9,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.64,2019,swrwlzm_n
9,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.61,2019,swrexwlzm_n
9,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",1.05,2019,swrz_n
9,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",82.25,2021,FVfy3_n
9,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",11.4,2021,FVdeclinedfy3_n
9,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.09,2021,FVovndfy3_n
9,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",6.35,2021,FVothrsnfy3_n
9,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",74.5,2022,FVhy4_n
9,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",75.87,2022,FVmcarehy4_n
9,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",75.94,2022,FVmahy4_n
9,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",76.21,2022,FVmpphy4_n
9,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",73.08,2022,FVdualhy4_n
9,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",73.61,2022,FVmsphy4_n
9,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",64.6,2022,FVnonmcarehy4_n
9,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",75.71,2022,FVlt18hy4_n
9,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",62.38,2022,FV1839hy4_n
9,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",71.69,2022,FV4064hy4_n
9,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",76.47,2022,FV6574hy4_n
9,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",79.52,2022,FV75uphy4_n
9,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",73.56,2022,FVmalehy4_n
9,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",75.25,2022,FVfemhy4_n
9,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",82.26,2022,FVashy4_n
9,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",57.75,2022,FVnahy4_n
9,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",77.38,2022,FVwhhy4_n
9,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",54.76,2022,FVrothhy4_n
9,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",68.12,2022,FVblkhy4_n
9,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",77.61,2022,FVhisphy4_n
9,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",65.89,2022,FVVCat1hy4_n
9,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",74.44,2022,FVVCat2hy4_n
9,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",78.55,2022,FVVCat3hy4_n
9,"N: Influenza - Average number of patients treated on 12/31, 2022",46.2,2022,eFVy4m_n
9,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",1.34,2022,medrsnfy4m_N
9,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.71,2022,CWhdavgHGBy4_n
9,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",23.82,2022,CWhdhgb1y4_n
9,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",33.43,2022,CWhdhgb2y4_n
9,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",27.97,2022,CWhdhgb3y4_n
9,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",12.36,2022,CWhdhgb4y4_n
9,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.43,2022,CWhdhgb5y4_n
9,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",75.23,2022,CWhdesarxy4_n
9,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.07,2022,CWpdavgHGBy4_n
9,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",21.03,2022,CWpdhgb1y4_n
9,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",26.73,2022,CWpdhgb2y4_n
9,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",26.71,2022,CWpdhgb3y4_n
9,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",23.06,2022,CWpdhgb4y4_n
9,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.47,2022,CWpdhgb5y4_n
9,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",48.25,2022,CWpdesarxy4_n
9,"N: HD HGB (Adult) - Average number of eligible patients, 2022",55.13,2022,CWhdptdenomy4m_n
9,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",450.98,2022,CWhdptmthdenomy4m_n
9,"N: PD HGB (Adult) - Average number of eligible patients, 2022",19.17,2022,CWpdptdenomy4m_n
9,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",143.4,2022,CWpdptmthdenomy4m_n
9,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",22.65,2022,rdstfy4m_n
9,"N: STrR (Adult) - Average Patient Years at Risk, 2022",12.65,2022,tfyy4m_n
9,"N: STrR (Adult) - Average Number of Transfusions, 2022",4.22,2022,tfy4m_n
9,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",4.35,2022,extfy4m_n
9,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.97,2022,strry4_n
9,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.86,2022,CWhdalby4_n
9,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",2.39,2022,CWhdalb1y4_n
9,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",10.27,2022,CWhdalb2y4_n
9,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",41.43,2022,CWhdalb3y4_n
9,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",42.23,2022,CWhdalb4y4_n
9,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",3.69,2022,CWhdalb5y4_n
9,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",54.08,2022,CWhdalblt4y4_n
9,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.43,2022,CWhdavgufry4_n
9,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",86.54,2022,CWhdufr1y4_n
9,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",7.2,2022,CWhdufr2y4_n
9,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",3.48,2022,CWhdufrmissy4_n
9,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.78,2022,CWhdufrgt20y4_n
9,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.63,2022,CWpdalby4_n
9,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",7.5,2022,CWpdalb1y4_n
9,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",23.61,2022,CWpdalb2y4_n
9,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",42.72,2022,CWpdalb3y4_n
9,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",23.79,2022,CWpdalb4y4_n
9,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",2.39,2022,CWpdalb5y4_n
9,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",73.83,2022,CWpdalblt4y4_n
9,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",55.13,2022,CWhddenomy4m_n
9,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",450.98,2022,CWhdmthdenomy4m_n
9,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",19.17,2022,CWpddenomy4m_n
9,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",143.4,2022,CWpdmthdenomy4m_n
9,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.28,2022,CWpdavgktvy4_n
9,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",4.13,2022,CWpdktv1y4_n
9,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",67.76,2022,CWpdktv2y4_n
9,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",26.39,2022,CWpdktv3y4_n
9,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.72,2022,CWpdktv4y4_n
9,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.6,2022,CWhdavgktvy4_n
9,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",1.98,2022,CWhdktv1y4_n
9,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",74.58,2022,CWhdktv2y4_n
9,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",21.43,2022,CWhdktv3y4_n
9,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",2.0,2022,CWhdktv4y4_n
9,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",52.83,2022,CWhdktvptsy4m_N
9,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",427.53,2022,CWhdktvptmthy4m_N
10,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",4.28,2022,allmcFcovpatPq4_n
10,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",31.13,2022,allmcEcovpatPq4_n
10,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",40.25,2022,allmcEcovDeaPq4_n
10,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",38.96,2022,allmcEcovHosPq4_n
10,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",8.94,2022,nh_mcFcovpatPq4_n
10,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",48.17,2022,nh_mcEcovpatPq4_n
10,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",48.01,2022,nh_mcEcovDeaPq4_n
10,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",46.03,2022,nh_mcEcovHosPq4_n
10,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",63.87,2022,agey4_n
10,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.13,2022,age1y4_n
10,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",47.26,2022,age2y4_n
10,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",52.62,2022,age3y4_n
10,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",40.94,2022,dis1y4_n
10,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",36.78,2022,dis2y4_n
10,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",8.33,2022,dis3y4_n
10,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",13.0,2022,dis4y4_n
10,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.95,2022,dis5y4_n
10,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",16.99,2022,vin1y4_n
10,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",18.24,2022,vin2y4_n
10,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.2,2022,vin3y4_n
10,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.92,2022,vin4y4_n
10,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",26.65,2022,vin5y4_n
10,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",5.1,2022,rac1y4_n
10,"N: Prevalent Patients - Race: % African American, 12/31/2022",38.13,2022,rac2y4_n
10,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.1,2022,rac3y4_n
10,"N: Prevalent Patients - Race: % White, 12/31/2022",56.44,2022,rac4y4_n
10,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.23,2022,rac5y4_n
10,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",17.63,2022,eth1y4_n
10,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",82.19,2022,eth2y4_n
10,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.18,2022,eth3y4_n
10,"N: Prevalent Patients - Sex: % Female, 12/31/2022",41.84,2022,sexy4_n
10,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",16.27,2022,nrshomey4_n
10,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",4.99,2022,viny4_n
10,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",79.66,2022,modhdy4_n
10,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",6.98,2022,modhhdy4_n
10,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.76,2022,modcapdy4_n
10,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",11.5,2022,modccpdy4_n
10,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.09,2022,modothry4_n
10,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",49.3,2022,pahy4m_n
10,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",19.03,2022,CWunCa1y4_n
10,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",76.21,2022,CWunCa2y4_n
10,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",0.9,2022,CWunCa3y4_n
10,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",3.86,2022,CWunCamissy4_n
10,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
10,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.88,2022,CWavgUnCay4_n
10,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.42,2022,CWavgPy4_n
10,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.75,2022,CWP1y4_n
10,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",23.3,2022,CWP2y4_n
10,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",28.14,2022,CWP3y4_n
10,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",21.79,2022,CWP4y4_n
10,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",14.71,2022,CWP5y4_n
10,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",4.31,2022,CWPmissy4_n
10,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
10,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",2.42,2022,CWunCagt102y4_n
10,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",69.48,2022,CWptdenomy4m_n
10,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",576.35,2022,CWptmthdenomy4m_n
10,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",74.17,2022,serumphospatsy4m_n
10,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",611.05,2022,serumphospmy4m_n
10,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",69.48,2022,CWhcptdenomy4m_n
10,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",576.33,2022,CWhcptmthdenomy4m_n
10,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",53.96,2022,ppavfy4_n
10,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",17.05,2022,ppavgy4_n
10,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",25.71,2022,ppcathy4_n
10,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",3.27,2022,ppomy4_n
10,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",21.08,2022,ltcy4_n
10,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",9.86,2022,piavfy4_n
10,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",3.04,2022,piavgy4_n
10,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",83.05,2022,picathy4_n
10,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",4.05,2022,piomy4_n
10,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",10.11,2022,pifisty4_n
10,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",66.56,2022,phdvapty4m_n
10,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",546.63,2022,phdy4m_n
10,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",12.67,2022,ihdy4m_n
10,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",55.88,2022,sfry4_n
10,"N: VA infection - Average number of eligible PD patients, 2022",11.47,2022,pdpaty4m_n
10,"N: VA infection - Average number of eligible PD patient-months, 2022",84.92,2022,pdptmoy4m_n
10,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.47,2022,pd2inf100moy4_n
10,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",38.22,2022,ncmy4m_n
10,"N: Prevalent Comorbidities - Average % with Anemia, 2022",3.63,2022,clmanemy4_n
10,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.74,2022,clmhivaidmy4_n
10,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.43,2022,clmalcomy4_n
10,"N: Prevalent Comorbidities - Average % with Cancer, 2022",4.27,2022,clmcanmy4_n
10,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",0.97,2022,clmcamy4_n
10,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",22.41,2022,clmcdmy4_n
10,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",8.52,2022,clmcvdmy4_n
10,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",16.6,2022,clmcopdmy4_n
10,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",35.09,2022,clmchfmy4_n
10,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",38.35,2022,clmdiabmy4_n
10,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",0.88,2022,clmdrugmy4_n
10,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",3.39,2022,clmgtbmy4_n
10,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.4,2022,clmhepbmy4_n
10,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.12,2022,clmhepothmy4_n
10,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",26.23,2022,clmhypthymy4_n
10,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",19.39,2022,clminfmy4_n
10,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",30.36,2022,clmihdmy4_n
10,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",8.32,2022,clmmimy4_n
10,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",17.91,2022,clmpvdmy4_n
10,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",4.19,2022,clmpnemy4_n
10,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.51,2022,clmcntcomy4_n
10,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",5.12,2022,clminfvamy4_n
10,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.63,2022,clmmstinfmy4_n
10,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.34,2022,clmtbmy4_n
10,"N (AFS): Facility Information - Average number of patients, 2022",92.2,2022,allcnty4m_n
10,N (AFS): Facility Information - Average number of all patients on 12/31/2022,55.37,2022,endcnty4m_n
10,"N (AFS): Facility Information - Average % of patients transferred in, 2022",21.48,2022,transiny4_n
10,"N (AFS): Facility Information - Average % of patients transferred out, 2022",22.79,2022,transouty4_n
10,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,76.83,2022,medicarey4_n
10,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,10.46,2022,medpendy4_n
10,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,12.74,2022,nonmedy4_n
10,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.13,2022,cfc_N
10,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,2.74,2022,std_N
10,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",18.18,2022,p_age1y4_n
10,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",4.55,2022,p_age2y4_n
10,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",18.18,2022,p_age3y4_n
10,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",59.09,2022,p_age4y4_n
10,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",0.0,2022,p_dis1y4_n
10,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",0.0,2022,p_dis2y4_n
10,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",45.45,2022,p_dis3y4_n
10,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",36.36,2022,p_dis4y4_n
10,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
10,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
10,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",18.18,2022,p_dis7y4_n
10,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",0.0,2022,p_dis8y4_n
10,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",13.64,2022,p_vin1y4_n
10,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",36.36,2022,p_vin2y4_n
10,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",0.0,2022,p_vin3y4_n
10,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",22.73,2022,p_vin4y4_n
10,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",27.27,2022,p_vin5y4_n
10,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",0.0,2022,p_rac1y4_n
10,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",36.36,2022,p_rac2y4_n
10,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",4.55,2022,p_rac3y4_n
10,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",59.09,2022,p_rac4y4_n
10,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",0.0,2022,p_rac5y4_n
10,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",27.27,2022,p_eth1y4_n
10,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",72.73,2022,p_eth2y4_n
10,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
10,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",36.36,2022,p_sexy4_n
10,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",27.27,2022,p_modhdy4_n
10,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",4.55,2022,p_modhhdy4_n
10,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.0,2022,p_modcapdy4_n
10,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",68.18,2022,p_modccpdy4_n
10,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
10,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",30.0,2022,p_allmdcrmy4_n
10,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",40.0,2022,p_insmdcdmy4_n
10,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",20.0,2022,p_insempmy4_n
10,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",10.0,2022,p_insnonothmy4_n
10,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",25.0,2022,p_nephnomy4_n
10,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",5.0,2022,p_nephy6my4_n
10,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",15.0,2022,p_nephy612my4_n
10,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",15.0,2022,p_nephy12my4_n
10,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",40.0,2022,p_nephunkmissmy4_n
10,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",100.0,2022,p_ptinfymy4_n
10,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",0.0,2022,p_mefavfmy4_n
10,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
10,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",100.0,2022,p_mefcathmy4_n
10,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
10,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",0.0,2022,p_avfpresentmy4_n
10,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",20.51,2022,p_ppavfy4_n
10,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",60.68,2022,p_ltcy4_n
10,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",53.89,2022,p_WLy4_n
10,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",46.08,2022,p_WLlt10y4_n
10,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",61.11,2022,p_WL1017y4_n
10,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.64,2022,p_CWhdavgHGBy4_n
10,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",28.57,2022,p_CWhdhgb1y4_n
10,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",23.81,2022,p_CWhdhgb2y4_n
10,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",30.48,2022,p_CWhdhgb3y4_n
10,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",13.33,2022,p_CWhdhgb4y4_n
10,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.81,2022,p_CWhdhgb5y4_n
10,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.57,2022,p_CWpdavgHGBy4_n
10,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",33.01,2022,p_CWpdhgb1y4_n
10,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",25.73,2022,p_CWpdhgb2y4_n
10,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",13.11,2022,p_CWpdhgb3y4_n
10,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",19.42,2022,p_CWpdhgb4y4_n
10,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",8.74,2022,p_CWpdhgb5y4_n
10,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.06,2022,p_CWhdalby4_n
10,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",2.86,2022,p_CWhdalb1y4_n
10,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",7.62,2022,p_CWhdalb2y4_n
10,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",20.95,2022,p_CWhdalb3y4_n
10,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",64.76,2022,p_CWhdalb4y4_n
10,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",3.81,2022,p_CWhdalb5y4_n
10,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.84,2022,p_CWpdalby4_n
10,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",3.88,2022,p_CWpdalb1y4_n
10,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",13.59,2022,p_CWpdalb2y4_n
10,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",34.47,2022,p_CWpdalb3y4_n
10,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",38.83,2022,p_CWpdalb4y4_n
10,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",9.22,2022,p_CWpdalb5y4_n
10,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",83.01,2022,p_CWpdktvge18y4_n
10,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",81.61,2022,p_CWhdktvge12y4_n
10,"N: Patient Placement -  % of incident patients, 2022",17.09,2022,ppidy4_n
10,"N: Patient Placement -  % of patients continuing at facility, 2022",69.91,2022,ppcdy4_n
10,"N: Patient Placement -  % of patients that transfered into facility, 2022",13.0,2022,pptdy4_n
10,"N: End of Year Status - % of patients death attributed to this facility, 2022",13.2,2022,pdhdy4_n
10,"N: End of Year Status - % of patients death attributed to another facility, 2022",2.6,2022,pdody4_n
10,"N: End of Year Status - % of patients that received a transplant, 2022",4.12,2022,ptxdy4_n
10,"N: End of Year Status - % of patients alive in this facility, 2022",67.13,2022,pahdy4_n
10,"N: End of Year Status - % of patients alive in another facility, 2022",9.18,2022,paody4_n
10,"N: End of Year Status - % of patients other, 2022",3.76,2022,potdy4_n
10,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,44.01,2022,iuhemy4m_n
10,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.02,2022,iufreqy4m_n
10,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,43.99,2022,iunonfreqy4m_n
10,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.0,2022,iuothy4m_n
10,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
10,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
10,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,3.83,2022,ihhemy4m_n
10,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.67,2022,ihfreqy4m_n
10,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,3.15,2022,ihnonfreqy4m_n
10,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
10,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,1.11,2022,ihcapdy4m_n
10,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,6.41,2022,ihccpdy4m_n
10,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",12.62,2022,staffy4m_n
10,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,3.39,2022,nurseFTy4m_n
10,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,5.38,2022,ptcareFTy4m_n
10,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,0.91,2022,dietFTy4m_n
10,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.15,2022,socwkFTy4m_n
10,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.57,2022,nursePTy4m_n
10,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.58,2022,ptcarePTy4m_n
10,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.33,2022,dietPTy4m_n
10,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.31,2022,socwkPTy4m_n
10,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,26.91,2022,vocrehaby4m_n
10,"N (AFS): Facility Information - Average % incident patients, 2022",15.28,2022,incpery4_n
10,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,31.03,2022,employedy4_n
10,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.66,2022,schooly4_n
10,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",39.82,2022,nh_ppavfy4_n
10,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",29.1,2022,nh_ltcy4_n
10,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",2.31,2022,nh_CWhdktv1y4_n
10,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",8.95,2022,nh_CWpdktv1y4_n
10,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",31.85,2022,nh_CWhdhgb1y4_n
10,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",75.41,2022,nh_CWhdesarxy4_n
10,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",29.69,2022,nh_CWpdhgb1y4_n
10,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",57.19,2022,nh_CWpdesarxy4_n
10,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",42.3,2022,nh_obdry4_n
10,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.16,2022,nh_smry4_n
10,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",16.96,2022,nh_wity4_n
10,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",289.79,2022,nh_obhtry4_n
10,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.54,2022,nh_shrty4_n
10,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",24.37,2022,nh_sepiy4_n
10,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",11.68,2022,nh_miiy4_n
10,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",50.13,2022,nh_achfy4_n
10,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",37.08,2022,nh_acdry4_n
10,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",4.2,2022,nh_acary4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",1.02,2022,nh_clmhivaidmy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",9.37,2022,nh_clminfvamy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",0.94,2022,nh_clmhepbmy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",2.49,2022,nh_clmhepothmy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",3.97,2022,nh_clmmstinfmy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",10.51,2022,nh_clmpnemy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.33,2022,nh_clmtbmy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",40.86,2022,nh_clminfmy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.41,2022,nh_clmcamy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",42.7,2022,nh_clmcdmy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",18.45,2022,nh_clmcvdmy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",60.78,2022,nh_clmchfmy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",50.76,2022,nh_clmihdmy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",15.87,2022,nh_clmmimy4_n
10,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",34.89,2022,nh_clmpvdmy4_n
10,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
10,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",32.64,2022,nh_age2y4_n
10,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",67.36,2022,nh_age3y4_n
10,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",48.96,2022,nh_dis1y4_n
10,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",34.58,2022,nh_dis2y4_n
10,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",3.39,2022,nh_dis3y4_n
10,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",11.23,2022,nh_dis4y4_n
10,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",1.84,2022,nh_dis5y4_n
10,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",3.74,2022,nh_rac1y4_n
10,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",38.36,2022,nh_rac2y4_n
10,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",0.14,2022,nh_rac3y4_n
10,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",57.72,2022,nh_rac4y4_n
10,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.04,2022,nh_rac5y4_n
10,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",11.16,2022,nh_eth1y4_n
10,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",88.7,2022,nh_eth2y4_n
10,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.14,2022,nh_eth3y4_n
10,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",20.95,2022,nh_vin1y4_n
10,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",16.18,2022,nh_vin2y4_n
10,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",12.4,2022,nh_vin3y4_n
10,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",25.15,2022,nh_vin4y4_n
10,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",25.33,2022,nh_vin5y4_n
10,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",48.11,2022,nh_sexy4_n
10,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",69.76,2022,nh_modhdy4_n
10,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",27.02,2022,nh_modhhdy4_n
10,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.49,2022,nh_modcapdy4_n
10,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",2.61,2022,nh_modccpdy4_n
10,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.11,2022,nh_modothry4_n
10,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",79.58,2022,nh_allmdcrmy4_n
10,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",9.8,2022,nh_insmdcdmy4_n
10,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",2.38,2022,nh_insempmy4_n
10,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",8.24,2022,nh_insnonothmy4_n
10,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",3.85,2022,nh_mefavfmy4_n
10,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",1.1,2022,nh_mefgraftmy4_n
10,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",92.03,2022,nh_mefcathmy4_n
10,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",3.02,2022,nh_mefoumaccessmy4_n
10,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",7.23,2022,nh_avfpresentmy4_n
10,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",7.33,2022,nh_nephnomy4_n
10,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",16.3,2022,nh_nephy6my4_n
10,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",11.26,2022,nh_nephy612my4_n
10,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",16.48,2022,nh_nephy12my4_n
10,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",48.63,2022,nh_nephunkmissmy4_n
10,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",92.77,2022,nh_ptinfymy4_n
10,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",1.48,2022,alcomy4_n
10,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",7.66,2022,ashdmy4_n
10,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",22.83,2022,othcarmy4_n
10,"N (2728): Incident Patients  - Percent with cancer, 2022",8.03,2022,canmy4_n
10,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",26.71,2022,chfmy4_n
10,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",8.45,2022,cvamy4_n
10,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",42.71,2022,diabimy4_n
10,"N (2728): Incident Patients  - Percent with diabetes, 2022",63.23,2022,diabmy4_n
10,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.2,2022,drugmy4_n
10,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",87.17,2022,hxhtmy4_n
10,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",3.86,2022,ambumy4_n
10,"N (2728): Incident Patients  - Percent inability to transfer, 2022",1.7,2022,transmy4_n
10,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",8.84,2022,copdmy4_n
10,"N (2728): Incident Patients  - Percent with PVD, 2022",5.65,2022,pvdmy4_n
10,"N (2728): Incident Patients  - Percent smoker, 2022",5.91,2022,smokmy4_n
10,"N (2728): Incident Patients  - Percent Hispanic, 2022",15.65,2022,ethmy4_n
10,"N (2728): Incident Patients  - Percent White, 2022",62.05,2022,whitemy4_n
10,"N (2728): Incident Patients  - Percent African American, 2022",32.08,2022,blackmy4_n
10,"N (2728): Incident Patients  - Percent Native American, 2022",0.44,2022,nativmy4_n
10,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",5.26,2022,asianmy4_n
10,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.17,2022,racoummy4_n
10,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",32.33,2022,cempmy4_n
10,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",41.92,2022,pempmy4_n
10,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",43.61,2022,dbprimy4_n
10,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",5.54,2022,gnprimy4_n
10,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",34.98,2022,htprimy4_n
10,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",15.87,2022,omprimy4_n
10,"N (2728): Incident Patients  - Percent female, 2022",42.21,2022,femmy4_n
10,"N (2728): Incident Patients  - Average age, 2022",64.73,2022,agemy4_n
10,"N (2728): Incident Patients  - Average serum albumin, 2022",3.36,2022,salbmy4_n
10,"N (2728): Incident Patients  - Average creatinine, 2022",6.36,2022,creamy4_n
10,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.25,2022,hgmy4_n
10,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",11.07,2022,gfrmy4_n
10,"N (2728): Incident Patients  - Average count of comorbidities, 2022",2.95,2022,cntcomy4_n
10,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",82.85,2022,pdmodMEFHDmy4_n
10,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",17.15,2022,pdmodMEFPDmy4_n
10,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
10,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",44.19,2022,insmdcrmy4_n
10,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",15.45,2022,insmdcdmy4_n
10,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",8.01,2022,insmdcrcdmy4_n
10,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",12.24,2022,insempmy4_n
10,"N (2728): Incident Patients  - Percent with no coverage, 2022",2.01,2022,insnonemy4_n
10,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",11.09,2022,insmdcromy4_n
10,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",7.01,2022,insmedomy4_n
10,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",13.01,2022,preepomy4_n
10,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",10.48,2022,nephnomy4_n
10,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",16.32,2022,nephy6my4_n
10,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",15.93,2022,nephy612my4_n
10,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",30.71,2022,nephy12my4_n
10,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",26.56,2022,nephunkmissmy4_n
10,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",94.76,2022,ptinfymy4_n
10,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",43.75,2022,ptxmedunfitmy4_n
10,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
10,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
10,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",15.0,2022,ptxdeclinemy4_n
10,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",55.42,2022,ptxnotassessmy4_n
10,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",10.22,2022,mefavfmy4_n
10,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",2.63,2022,mefgraftmy4_n
10,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",86.93,2022,mefcathmy4_n
10,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.21,2022,mefoumaccessmy4_n
10,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",16.54,2022,avfpresentmy4_n
10,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",28.04,2022,bmimmy4_n
10,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",29.41,2022,bmifmy4_n
10,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",0.69,2022,ptinfnmy4m_n
10,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",10.91,2022,hemomy4m_n
10,"N (2728): Incident Patients  - Average Number of forms returned, 2022",13.17,2022,nmy4m_n
10,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",72.61,2019,rdsmzm_n
10,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",46.21,2019,dyzm_n
10,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",8.71,2019,deazm_n
10,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",9.5,2019,exdzm_n
10,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.04,2019,dudzm_n
10,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",0.92,2019,smrz_n
10,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",18.83,2019,witz_n
10,"N: All Patient Mortality - % of deaths from infection, 2019-2022",6.35,2019,infz_n
10,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",35.93,2019,cardz_n
10,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",0.69,2019,livz_n
10,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",13.51,2019,fynmzm_n
10,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",8.1,2019,fydyzm_n
10,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.24,2019,fydeazm_n
10,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.23,2019,fyexdzm_n
10,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",1.01,2019,fysmrz_n
10,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",19.79,2019,fywitz_n
10,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",5.31,2019,fyinfz_n
10,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",28.75,2019,fycardiacz_n
10,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",1.07,2019,fylivz_n
10,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",57.69,2019,rdshzm_n
10,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",56.04,2019,htazm_n
10,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",53.15,2019,extzm_n
10,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",426.17,2019,hdzm_n
10,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",436.77,2019,exhdzm_n
10,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",35.76,2019,hdyzm_n
10,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",1.05,2019,shrtz_n
10,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.98,2019,shrdz_n
10,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.3,2019,lenz_n
10,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",7.84,2019,onez_n
10,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",7.41,2019,miiz_n
10,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",13.33,2019,sepiz_n
10,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",32.39,2019,achfz_n
10,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",21.93,2019,acdrz_n
10,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.75,2019,acarz_n
10,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",86.3,2019,ipedz_n
10,"N: ED30 - Average annual index discharges, 2019-22",35.21,2019,ed30indexzm_n
10,"N: ED30- Average annual number of ED visits, 2019-22",5.21,2019,ed30obszm_n
10,"N: ED30 - Average annual expected ED visits, 2019-22",5.61,2019,ed30expzm_n
10,"N: ED30: Standardized Ratio of ED30, 2019-22",0.97,2019,ed30z_n
10,"N SRR -  Standardized Readmission Ratio, 2022",1.09,2022,srry4_n
10,"N: SRR - Average index discharges, 2022",53.63,2022,indexmy4_n
10,"N: SRR - Average number of readmissions, 2022",15.39,2022,readmmy4_n
10,"N: SRR - Average expected readmissions, 2022",15.47,2022,srrexpmy4_n
10,Pt included in SEDR analysis,42.52,2019,rdsezm_n
10,Total number of ED Visits,36.01,2019,hedzm_n
10,Expected number of ED events,38.04,2019,exedzm_n
10,Years at risk for ED visit rate,26.14,2019,edyrzm_n
10,Years at risk for ED visit rate,38483.02,2019,edyrz_n
10,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",0.95,2019,sedrz_n
10,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",51.03,2019,rdstzm_n
10,"N: STR - Average number of patients (per year in average facility), 2019-2022",55.47,2019,rdsalltzm_n
10,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",2.12,2019,txzm_n
10,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",2.39,2019,txallzm_n
10,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",32.5,2019,txyzm_n
10,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.91,2019,cadalltzm_n
10,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.51,2019,livealltzm_n
10,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",1.54,2019,extxzm_n
10,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",1.38,2019,strz_n
10,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",49.3,2022,pppwpty4m_n
10,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",16.78,2022,WLy4_n
10,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",24.56,2022,WLlt40y4_n
10,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",15.92,2022,WL4074y4_n
10,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",17.88,2022,WLmaley4_n
10,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",15.11,2022,WLfemy4_n
10,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",16.35,2022,WLwhhy4_n
10,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",16.51,2022,WLwhnhy4_n
10,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",16.42,2022,WLbly4_n
10,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",23.43,2022,WLasy4_n
10,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",26.83,2022,WLnay4_n
10,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",14.83,2022,WLothy4_n
10,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",14.08,2022,WLDMy4_n
10,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",18.6,2022,WLnodmy4_n
10,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",15.54,2022,WLnotxy4_n
10,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",29.57,2022,WLtxy4_n
10,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",14.03,2022,WLVCat1y4_n
10,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",21.1,2022,WLVCat2y4_n
10,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",16.02,2022,WLVCat3y4_n
10,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",413.33,2022,pppwpmy4m_n
10,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",16.92,2022,pppwy4_n
10,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",7.93,2019,swrptzm_n
10,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",6.39,2019,swrpyzm_n
10,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.67,2019,swrwlzm_n
10,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.64,2019,swrexwlzm_n
10,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",1.04,2019,swrz_n
10,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",79.99,2021,FVfy3_n
10,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",10.38,2021,FVdeclinedfy3_n
10,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.06,2021,FVovndfy3_n
10,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",9.63,2021,FVothrsnfy3_n
10,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",73.83,2022,FVhy4_n
10,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",74.97,2022,FVmcarehy4_n
10,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",74.1,2022,FVmahy4_n
10,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",75.89,2022,FVmpphy4_n
10,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",70.48,2022,FVdualhy4_n
10,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",72.33,2022,FVmsphy4_n
10,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",68.52,2022,FVnonmcarehy4_n
10,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",80.0,2022,FVlt18hy4_n
10,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",64.51,2022,FV1839hy4_n
10,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",71.58,2022,FV4064hy4_n
10,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",74.79,2022,FV6574hy4_n
10,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",78.42,2022,FV75uphy4_n
10,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",74.46,2022,FVmalehy4_n
10,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",72.8,2022,FVfemhy4_n
10,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",80.5,2022,FVashy4_n
10,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",61.54,2022,FVnahy4_n
10,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",77.68,2022,FVwhhy4_n
10,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",50.0,2022,FVrothhy4_n
10,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",67.13,2022,FVblkhy4_n
10,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",80.06,2022,FVhisphy4_n
10,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",63.68,2022,FVVCat1hy4_n
10,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",74.02,2022,FVVCat2hy4_n
10,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",77.96,2022,FVVCat3hy4_n
10,"N: Influenza - Average number of patients treated on 12/31, 2022",52.03,2022,eFVy4m_n
10,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",1.91,2022,medrsnfy4m_N
10,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.64,2022,CWhdavgHGBy4_n
10,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",24.78,2022,CWhdhgb1y4_n
10,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",33.96,2022,CWhdhgb2y4_n
10,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",26.99,2022,CWhdhgb3y4_n
10,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",10.74,2022,CWhdhgb4y4_n
10,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.52,2022,CWhdhgb5y4_n
10,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",75.88,2022,CWhdesarxy4_n
10,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.87,2022,CWpdavgHGBy4_n
10,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",24.26,2022,CWpdhgb1y4_n
10,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",27.72,2022,CWpdhgb2y4_n
10,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",25.08,2022,CWpdhgb3y4_n
10,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",18.93,2022,CWpdhgb4y4_n
10,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",4.0,2022,CWpdhgb5y4_n
10,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",51.89,2022,CWpdesarxy4_n
10,"N: HD HGB (Adult) - Average number of eligible patients, 2022",63.65,2022,CWhdptdenomy4m_n
10,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",526.23,2022,CWhdptmthdenomy4m_n
10,"N: PD HGB (Adult) - Average number of eligible patients, 2022",21.59,2022,CWpdptdenomy4m_n
10,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",168.17,2022,CWpdptmthdenomy4m_n
10,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",30.48,2022,rdstfy4m_n
10,"N: STrR (Adult) - Average Patient Years at Risk, 2022",17.67,2022,tfyy4m_n
10,"N: STrR (Adult) - Average Number of Transfusions, 2022",5.53,2022,tfy4m_n
10,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",5.87,2022,extfy4m_n
10,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.94,2022,strry4_n
10,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.87,2022,CWhdalby4_n
10,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",2.2,2022,CWhdalb1y4_n
10,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",9.47,2022,CWhdalb2y4_n
10,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",40.46,2022,CWhdalb3y4_n
10,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",42.93,2022,CWhdalb4y4_n
10,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",4.93,2022,CWhdalb5y4_n
10,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",52.14,2022,CWhdalblt4y4_n
10,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.78,2022,CWhdavgufry4_n
10,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",85.88,2022,CWhdufr1y4_n
10,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",7.54,2022,CWhdufr2y4_n
10,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",4.64,2022,CWhdufrmissy4_n
10,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",1.94,2022,CWhdufrgt20y4_n
10,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.62,2022,CWpdalby4_n
10,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",6.72,2022,CWpdalb1y4_n
10,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",23.62,2022,CWpdalb2y4_n
10,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",44.17,2022,CWpdalb3y4_n
10,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",21.59,2022,CWpdalb4y4_n
10,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",3.9,2022,CWpdalb5y4_n
10,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",74.51,2022,CWpdalblt4y4_n
10,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",63.65,2022,CWhddenomy4m_n
10,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",526.23,2022,CWhdmthdenomy4m_n
10,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",21.59,2022,CWpddenomy4m_n
10,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",168.17,2022,CWpdmthdenomy4m_n
10,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.24,2022,CWpdavgktvy4_n
10,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",5.48,2022,CWpdktv1y4_n
10,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",66.64,2022,CWpdktv2y4_n
10,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",24.12,2022,CWpdktv3y4_n
10,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",3.76,2022,CWpdktv4y4_n
10,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.63,2022,CWhdavgktvy4_n
10,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",1.69,2022,CWhdktv1y4_n
10,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",70.9,2022,CWhdktv2y4_n
10,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",24.91,2022,CWhdktv3y4_n
10,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",2.5,2022,CWhdktv4y4_n
10,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",63.69,2022,CWhdktvptsy4m_N
10,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",520.82,2022,CWhdktvptmthy4m_N
11,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",3.86,2022,allmcFcovpatPq4_n
11,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",26.65,2022,allmcEcovpatPq4_n
11,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",34.38,2022,allmcEcovDeaPq4_n
11,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",36.07,2022,allmcEcovHosPq4_n
11,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",7.9,2022,nh_mcFcovpatPq4_n
11,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",41.68,2022,nh_mcEcovpatPq4_n
11,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",37.81,2022,nh_mcEcovDeaPq4_n
11,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",44.01,2022,nh_mcEcovHosPq4_n
11,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",63.13,2022,agey4_n
11,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.22,2022,age1y4_n
11,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",48.8,2022,age2y4_n
11,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",50.98,2022,age3y4_n
11,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",42.9,2022,dis1y4_n
11,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",27.83,2022,dis2y4_n
11,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",11.41,2022,dis3y4_n
11,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",17.6,2022,dis4y4_n
11,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.27,2022,dis5y4_n
11,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",17.03,2022,vin1y4_n
11,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",18.42,2022,vin2y4_n
11,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.91,2022,vin3y4_n
11,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.66,2022,vin4y4_n
11,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",25.98,2022,vin5y4_n
11,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",4.03,2022,rac1y4_n
11,"N: Prevalent Patients - Race: % African American, 12/31/2022",31.57,2022,rac2y4_n
11,"N: Prevalent Patients - Race: % Native American, 12/31/2022",3.5,2022,rac3y4_n
11,"N: Prevalent Patients - Race: % White, 12/31/2022",60.6,2022,rac4y4_n
11,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.29,2022,rac5y4_n
11,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",5.99,2022,eth1y4_n
11,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",93.92,2022,eth2y4_n
11,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.09,2022,eth3y4_n
11,"N: Prevalent Patients - Sex: % Female, 12/31/2022",41.84,2022,sexy4_n
11,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",13.7,2022,nrshomey4_n
11,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",5.03,2022,viny4_n
11,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",83.75,2022,modhdy4_n
11,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",3.76,2022,modhhdy4_n
11,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.56,2022,modcapdy4_n
11,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",10.76,2022,modccpdy4_n
11,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.18,2022,modothry4_n
11,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",49.34,2022,pahy4m_n
11,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",19.2,2022,CWunCa1y4_n
11,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",77.35,2022,CWunCa2y4_n
11,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.0,2022,CWunCa3y4_n
11,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",2.44,2022,CWunCamissy4_n
11,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
11,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.88,2022,CWavgUnCay4_n
11,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.43,2022,CWavgPy4_n
11,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.13,2022,CWP1y4_n
11,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",23.44,2022,CWP2y4_n
11,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",29.76,2022,CWP3y4_n
11,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",22.21,2022,CWP4y4_n
11,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",14.69,2022,CWP5y4_n
11,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",2.77,2022,CWPmissy4_n
11,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
11,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",1.53,2022,CWunCagt102y4_n
11,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",68.12,2022,CWptdenomy4m_n
11,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",584.45,2022,CWptmthdenomy4m_n
11,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",72.69,2022,serumphospatsy4m_n
11,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",619.31,2022,serumphospmy4m_n
11,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",68.11,2022,CWhcptdenomy4m_n
11,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",584.41,2022,CWhcptmthdenomy4m_n
11,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",56.02,2022,ppavfy4_n
11,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",18.18,2022,ppavgy4_n
11,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",24.09,2022,ppcathy4_n
11,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",1.71,2022,ppomy4_n
11,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",18.44,2022,ltcy4_n
11,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",12.27,2022,piavfy4_n
11,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",2.91,2022,piavgy4_n
11,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",81.78,2022,picathy4_n
11,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",3.04,2022,piomy4_n
11,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",12.83,2022,pifisty4_n
11,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",65.13,2022,phdvapty4m_n
11,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",550.35,2022,phdy4m_n
11,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",12.5,2022,ihdy4m_n
11,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",58.39,2022,sfry4_n
11,"N: VA infection - Average number of eligible PD patients, 2022",11.41,2022,pdpaty4m_n
11,"N: VA infection - Average number of eligible PD patient-months, 2022",83.23,2022,pdptmoy4m_n
11,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.5,2022,pd2inf100moy4_n
11,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",41.02,2022,ncmy4m_n
11,"N: Prevalent Comorbidities - Average % with Anemia, 2022",3.98,2022,clmanemy4_n
11,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.44,2022,clmhivaidmy4_n
11,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.96,2022,clmalcomy4_n
11,"N: Prevalent Comorbidities - Average % with Cancer, 2022",3.9,2022,clmcanmy4_n
11,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",1.01,2022,clmcamy4_n
11,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",22.23,2022,clmcdmy4_n
11,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",7.9,2022,clmcvdmy4_n
11,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",18.15,2022,clmcopdmy4_n
11,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",35.12,2022,clmchfmy4_n
11,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",36.43,2022,clmdiabmy4_n
11,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",1.56,2022,clmdrugmy4_n
11,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",3.86,2022,clmgtbmy4_n
11,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.53,2022,clmhepbmy4_n
11,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.64,2022,clmhepothmy4_n
11,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",25.81,2022,clmhypthymy4_n
11,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",18.63,2022,clminfmy4_n
11,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",29.28,2022,clmihdmy4_n
11,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",9.71,2022,clmmimy4_n
11,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",18.85,2022,clmpvdmy4_n
11,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",3.59,2022,clmpnemy4_n
11,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.51,2022,clmcntcomy4_n
11,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",4.9,2022,clminfvamy4_n
11,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.75,2022,clmmstinfmy4_n
11,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.26,2022,clmtbmy4_n
11,"N (AFS): Facility Information - Average number of patients, 2022",85.51,2022,allcnty4m_n
11,N (AFS): Facility Information - Average number of all patients on 12/31/2022,54.94,2022,endcnty4m_n
11,"N (AFS): Facility Information - Average % of patients transferred in, 2022",17.33,2022,transiny4_n
11,"N (AFS): Facility Information - Average % of patients transferred out, 2022",17.62,2022,transouty4_n
11,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,84.73,2022,medicarey4_n
11,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,6.11,2022,medpendy4_n
11,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,9.16,2022,nonmedy4_n
11,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.22,2022,cfc_N
11,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,3.66,2022,std_N
11,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",35.09,2022,p_age1y4_n
11,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",19.3,2022,p_age2y4_n
11,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",35.09,2022,p_age3y4_n
11,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",10.53,2022,p_age4y4_n
11,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",1.75,2022,p_dis1y4_n
11,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",1.75,2022,p_dis2y4_n
11,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",33.33,2022,p_dis3y4_n
11,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",29.82,2022,p_dis4y4_n
11,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
11,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
11,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",31.58,2022,p_dis7y4_n
11,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",1.75,2022,p_dis8y4_n
11,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",22.81,2022,p_vin1y4_n
11,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",17.54,2022,p_vin2y4_n
11,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",19.3,2022,p_vin3y4_n
11,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",21.05,2022,p_vin4y4_n
11,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",19.3,2022,p_vin5y4_n
11,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",7.02,2022,p_rac1y4_n
11,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",35.09,2022,p_rac2y4_n
11,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",1.75,2022,p_rac3y4_n
11,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",49.12,2022,p_rac4y4_n
11,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",7.02,2022,p_rac5y4_n
11,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",10.53,2022,p_eth1y4_n
11,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",89.47,2022,p_eth2y4_n
11,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
11,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",22.81,2022,p_sexy4_n
11,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",45.61,2022,p_modhdy4_n
11,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
11,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.0,2022,p_modcapdy4_n
11,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",54.39,2022,p_modccpdy4_n
11,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
11,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",25.71,2022,p_allmdcrmy4_n
11,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",45.71,2022,p_insmdcdmy4_n
11,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",14.29,2022,p_insempmy4_n
11,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",14.29,2022,p_insnonothmy4_n
11,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",2.86,2022,p_nephnomy4_n
11,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",34.29,2022,p_nephy6my4_n
11,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",14.29,2022,p_nephy612my4_n
11,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",37.14,2022,p_nephy12my4_n
11,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",11.43,2022,p_nephunkmissmy4_n
11,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",85.71,2022,p_ptinfymy4_n
11,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",0.0,2022,p_mefavfmy4_n
11,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
11,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",100.0,2022,p_mefcathmy4_n
11,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
11,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",5.56,2022,p_avfpresentmy4_n
11,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",10.72,2022,p_ppavfy4_n
11,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",69.44,2022,p_ltcy4_n
11,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",33.84,2022,p_WLy4_n
11,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",25.91,2022,p_WLlt10y4_n
11,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",42.23,2022,p_WL1017y4_n
11,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.78,2022,p_CWhdavgHGBy4_n
11,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",23.71,2022,p_CWhdhgb1y4_n
11,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",29.71,2022,p_CWhdhgb2y4_n
11,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",30.57,2022,p_CWhdhgb3y4_n
11,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",14.0,2022,p_CWhdhgb4y4_n
11,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.0,2022,p_CWhdhgb5y4_n
11,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.44,2022,p_CWpdavgHGBy4_n
11,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",36.31,2022,p_CWpdhgb1y4_n
11,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",21.43,2022,p_CWpdhgb2y4_n
11,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",20.83,2022,p_CWpdhgb3y4_n
11,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",14.58,2022,p_CWpdhgb4y4_n
11,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",6.85,2022,p_CWpdhgb5y4_n
11,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",3.94,2022,p_CWhdalby4_n
11,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",2.29,2022,p_CWhdalb1y4_n
11,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",15.43,2022,p_CWhdalb2y4_n
11,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",29.71,2022,p_CWhdalb3y4_n
11,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",51.14,2022,p_CWhdalb4y4_n
11,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",1.43,2022,p_CWhdalb5y4_n
11,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.55,2022,p_CWpdalby4_n
11,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",13.69,2022,p_CWpdalb1y4_n
11,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",21.73,2022,p_CWpdalb2y4_n
11,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",30.65,2022,p_CWpdalb3y4_n
11,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",24.4,2022,p_CWpdalb4y4_n
11,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",9.52,2022,p_CWpdalb5y4_n
11,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",72.62,2022,p_CWpdktvge18y4_n
11,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",88.67,2022,p_CWhdktvge12y4_n
11,"N: Patient Placement -  % of incident patients, 2022",17.4,2022,ppidy4_n
11,"N: Patient Placement -  % of patients continuing at facility, 2022",70.57,2022,ppcdy4_n
11,"N: Patient Placement -  % of patients that transfered into facility, 2022",12.03,2022,pptdy4_n
11,"N: End of Year Status - % of patients death attributed to this facility, 2022",14.31,2022,pdhdy4_n
11,"N: End of Year Status - % of patients death attributed to another facility, 2022",2.04,2022,pdody4_n
11,"N: End of Year Status - % of patients that received a transplant, 2022",3.32,2022,ptxdy4_n
11,"N: End of Year Status - % of patients alive in this facility, 2022",68.71,2022,pahdy4_n
11,"N: End of Year Status - % of patients alive in another facility, 2022",8.42,2022,paody4_n
11,"N: End of Year Status - % of patients other, 2022",3.21,2022,potdy4_n
11,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,46.2,2022,iuhemy4m_n
11,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.01,2022,iufreqy4m_n
11,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,46.18,2022,iunonfreqy4m_n
11,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.01,2022,iuothy4m_n
11,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
11,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
11,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,2.03,2022,ihhemy4m_n
11,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.85,2022,ihfreqy4m_n
11,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,1.17,2022,ihnonfreqy4m_n
11,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
11,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.91,2022,ihcapdy4m_n
11,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,5.79,2022,ihccpdy4m_n
11,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",13.12,2022,staffy4m_n
11,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,3.97,2022,nurseFTy4m_n
11,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,4.86,2022,ptcareFTy4m_n
11,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,0.99,2022,dietFTy4m_n
11,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,0.93,2022,socwkFTy4m_n
11,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.88,2022,nursePTy4m_n
11,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.74,2022,ptcarePTy4m_n
11,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.4,2022,dietPTy4m_n
11,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.35,2022,socwkPTy4m_n
11,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,26.62,2022,vocrehaby4m_n
11,"N (AFS): Facility Information - Average % incident patients, 2022",15.85,2022,incpery4_n
11,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,28.98,2022,employedy4_n
11,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.98,2022,schooly4_n
11,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",45.54,2022,nh_ppavfy4_n
11,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",24.59,2022,nh_ltcy4_n
11,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",2.89,2022,nh_CWhdktv1y4_n
11,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",11.45,2022,nh_CWpdktv1y4_n
11,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",30.83,2022,nh_CWhdhgb1y4_n
11,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",82.84,2022,nh_CWhdesarxy4_n
11,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",26.84,2022,nh_CWpdhgb1y4_n
11,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",55.76,2022,nh_CWpdesarxy4_n
11,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",42.74,2022,nh_obdry4_n
11,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.07,2022,nh_smry4_n
11,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",38.18,2022,nh_wity4_n
11,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",278.59,2022,nh_obhtry4_n
11,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.43,2022,nh_shrty4_n
11,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",23.91,2022,nh_sepiy4_n
11,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",15.03,2022,nh_miiy4_n
11,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",52.96,2022,nh_achfy4_n
11,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",38.35,2022,nh_acdry4_n
11,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",4.22,2022,nh_acary4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",0.4,2022,nh_clmhivaidmy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",7.99,2022,nh_clminfvamy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",0.73,2022,nh_clmhepbmy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",2.9,2022,nh_clmhepothmy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",4.82,2022,nh_clmmstinfmy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",9.55,2022,nh_clmpnemy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.18,2022,nh_clmtbmy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",39.62,2022,nh_clminfmy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.44,2022,nh_clmcamy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",43.06,2022,nh_clmcdmy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",18.54,2022,nh_clmcvdmy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",62.15,2022,nh_clmchfmy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",51.54,2022,nh_clmihdmy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",18.88,2022,nh_clmmimy4_n
11,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",38.61,2022,nh_clmpvdmy4_n
11,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
11,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",30.01,2022,nh_age2y4_n
11,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",69.99,2022,nh_age3y4_n
11,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",52.65,2022,nh_dis1y4_n
11,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",26.04,2022,nh_dis2y4_n
11,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",5.91,2022,nh_dis3y4_n
11,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",14.92,2022,nh_dis4y4_n
11,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.48,2022,nh_dis5y4_n
11,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",1.63,2022,nh_rac1y4_n
11,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",30.8,2022,nh_rac2y4_n
11,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",2.84,2022,nh_rac3y4_n
11,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",64.56,2022,nh_rac4y4_n
11,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.17,2022,nh_rac5y4_n
11,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",3.91,2022,nh_eth1y4_n
11,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",95.97,2022,nh_eth2y4_n
11,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.11,2022,nh_eth3y4_n
11,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",21.99,2022,nh_vin1y4_n
11,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",15.85,2022,nh_vin2y4_n
11,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",11.49,2022,nh_vin3y4_n
11,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",26.24,2022,nh_vin4y4_n
11,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",24.44,2022,nh_vin5y4_n
11,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",49.04,2022,nh_sexy4_n
11,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",91.27,2022,nh_modhdy4_n
11,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",6.78,2022,nh_modhhdy4_n
11,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.2,2022,nh_modcapdy4_n
11,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",1.44,2022,nh_modccpdy4_n
11,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.31,2022,nh_modothry4_n
11,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",87.15,2022,nh_allmdcrmy4_n
11,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",8.06,2022,nh_insmdcdmy4_n
11,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",2.11,2022,nh_insempmy4_n
11,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",2.69,2022,nh_insnonothmy4_n
11,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",6.97,2022,nh_mefavfmy4_n
11,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",1.74,2022,nh_mefgraftmy4_n
11,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",89.47,2022,nh_mefcathmy4_n
11,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",1.82,2022,nh_mefoumaccessmy4_n
11,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",13.14,2022,nh_avfpresentmy4_n
11,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",14.16,2022,nh_nephnomy4_n
11,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",22.29,2022,nh_nephy6my4_n
11,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",13.8,2022,nh_nephy612my4_n
11,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",27.52,2022,nh_nephy12my4_n
11,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",22.22,2022,nh_nephunkmissmy4_n
11,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",87.36,2022,nh_ptinfymy4_n
11,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",2.97,2022,alcomy4_n
11,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",12.08,2022,ashdmy4_n
11,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",23.36,2022,othcarmy4_n
11,"N (2728): Incident Patients  - Percent with cancer, 2022",8.2,2022,canmy4_n
11,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",28.67,2022,chfmy4_n
11,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",8.78,2022,cvamy4_n
11,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",42.99,2022,diabimy4_n
11,"N (2728): Incident Patients  - Percent with diabetes, 2022",60.93,2022,diabmy4_n
11,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.97,2022,drugmy4_n
11,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",86.21,2022,hxhtmy4_n
11,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",5.36,2022,ambumy4_n
11,"N (2728): Incident Patients  - Percent inability to transfer, 2022",2.85,2022,transmy4_n
11,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",10.39,2022,copdmy4_n
11,"N (2728): Incident Patients  - Percent with PVD, 2022",8.5,2022,pvdmy4_n
11,"N (2728): Incident Patients  - Percent smoker, 2022",8.56,2022,smokmy4_n
11,"N (2728): Incident Patients  - Percent Hispanic, 2022",5.08,2022,ethmy4_n
11,"N (2728): Incident Patients  - Percent White, 2022",67.33,2022,whitemy4_n
11,"N (2728): Incident Patients  - Percent African American, 2022",25.03,2022,blackmy4_n
11,"N (2728): Incident Patients  - Percent Native American, 2022",3.7,2022,nativmy4_n
11,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",3.4,2022,asianmy4_n
11,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.54,2022,racoummy4_n
11,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",28.41,2022,cempmy4_n
11,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",38.27,2022,pempmy4_n
11,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",42.64,2022,dbprimy4_n
11,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",7.61,2022,gnprimy4_n
11,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",29.46,2022,htprimy4_n
11,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",20.3,2022,omprimy4_n
11,"N (2728): Incident Patients  - Percent female, 2022",41.7,2022,femmy4_n
11,"N (2728): Incident Patients  - Average age, 2022",64.04,2022,agemy4_n
11,"N (2728): Incident Patients  - Average serum albumin, 2022",3.44,2022,salbmy4_n
11,"N (2728): Incident Patients  - Average creatinine, 2022",6.1,2022,creamy4_n
11,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.43,2022,hgmy4_n
11,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",11.14,2022,gfrmy4_n
11,"N (2728): Incident Patients  - Average count of comorbidities, 2022",3.12,2022,cntcomy4_n
11,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",87.38,2022,pdmodMEFHDmy4_n
11,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",12.62,2022,pdmodMEFPDmy4_n
11,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
11,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",48.38,2022,insmdcrmy4_n
11,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",14.36,2022,insmdcdmy4_n
11,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",7.55,2022,insmdcrcdmy4_n
11,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",11.63,2022,insempmy4_n
11,"N (2728): Incident Patients  - Percent with no coverage, 2022",0.98,2022,insnonemy4_n
11,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",10.11,2022,insmdcromy4_n
11,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",6.98,2022,insmedomy4_n
11,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",17.88,2022,preepomy4_n
11,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",12.29,2022,nephnomy4_n
11,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",19.59,2022,nephy6my4_n
11,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",17.68,2022,nephy612my4_n
11,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",36.18,2022,nephy12my4_n
11,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",14.26,2022,nephunkmissmy4_n
11,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",92.14,2022,ptinfymy4_n
11,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",46.84,2022,ptxmedunfitmy4_n
11,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
11,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
11,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",11.52,2022,ptxdeclinemy4_n
11,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",46.28,2022,ptxnotassessmy4_n
11,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",13.16,2022,mefavfmy4_n
11,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",2.68,2022,mefgraftmy4_n
11,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",83.91,2022,mefcathmy4_n
11,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.25,2022,mefoumaccessmy4_n
11,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",20.65,2022,avfpresentmy4_n
11,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",28.41,2022,bmimmy4_n
11,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",29.75,2022,bmifmy4_n
11,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",1.06,2022,ptinfnmy4m_n
11,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",11.75,2022,hemomy4m_n
11,"N (2728): Incident Patients  - Average Number of forms returned, 2022",13.45,2022,nmy4m_n
11,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",68.64,2019,rdsmzm_n
11,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",44.41,2019,dyzm_n
11,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",9.03,2019,deazm_n
11,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",9.92,2019,exdzm_n
11,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.08,2019,dudzm_n
11,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",0.91,2019,smrz_n
11,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",33.28,2019,witz_n
11,"N: All Patient Mortality - % of deaths from infection, 2019-2022",10.84,2019,infz_n
11,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",37.29,2019,cardz_n
11,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.29,2019,livz_n
11,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",13.55,2019,fynmzm_n
11,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",8.16,2019,fydyzm_n
11,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.26,2019,fydeazm_n
11,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.5,2019,fyexdzm_n
11,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",0.9,2019,fysmrz_n
11,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",35.58,2019,fywitz_n
11,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",10.13,2019,fyinfz_n
11,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",34.04,2019,fycardiacz_n
11,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",3.44,2019,fylivz_n
11,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",58.02,2019,rdshzm_n
11,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",56.64,2019,htazm_n
11,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",56.65,2019,extzm_n
11,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",426.12,2019,hdzm_n
11,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",461.78,2019,exhdzm_n
11,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",36.89,2019,hdyzm_n
11,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",1.0,2019,shrtz_n
11,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.92,2019,shrdz_n
11,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.25,2019,lenz_n
11,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",9.15,2019,onez_n
11,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",8.67,2019,miiz_n
11,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",12.96,2019,sepiz_n
11,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",32.33,2019,achfz_n
11,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",22.12,2019,acdrz_n
11,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.56,2019,acarz_n
11,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",82.15,2019,ipedz_n
11,"N: ED30 - Average annual index discharges, 2019-22",33.69,2019,ed30indexzm_n
11,"N: ED30- Average annual number of ED visits, 2019-22",5.68,2019,ed30obszm_n
11,"N: ED30 - Average annual expected ED visits, 2019-22",5.71,2019,ed30expzm_n
11,"N: ED30: Standardized Ratio of ED30, 2019-22",1.03,2019,ed30z_n
11,"N SRR -  Standardized Readmission Ratio, 2022",1.0,2022,srry4_n
11,"N: SRR - Average index discharges, 2022",55.85,2022,indexmy4_n
11,"N: SRR - Average number of readmissions, 2022",14.62,2022,readmmy4_n
11,"N: SRR - Average expected readmissions, 2022",16.03,2022,srrexpmy4_n
11,Pt included in SEDR analysis,39.55,2019,rdsezm_n
11,Total number of ED Visits,39.82,2019,hedzm_n
11,Expected number of ED events,38.95,2019,exedzm_n
11,Years at risk for ED visit rate,25.02,2019,edyrzm_n
11,Years at risk for ED visit rate,55352.57,2019,edyrz_n
11,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",1.02,2019,sedrz_n
11,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",48.47,2019,rdstzm_n
11,"N: STR - Average number of patients (per year in average facility), 2019-2022",53.05,2019,rdsalltzm_n
11,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",1.57,2019,txzm_n
11,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",1.78,2019,txallzm_n
11,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",31.42,2019,txyzm_n
11,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.35,2019,cadalltzm_n
11,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.47,2019,livealltzm_n
11,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",1.5,2019,extxzm_n
11,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",1.04,2019,strz_n
11,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",50.68,2022,pppwpty4m_n
11,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",15.3,2022,WLy4_n
11,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",23.48,2022,WLlt40y4_n
11,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",14.32,2022,WL4074y4_n
11,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",16.12,2022,WLmaley4_n
11,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",14.08,2022,WLfemy4_n
11,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",15.27,2022,WLwhhy4_n
11,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",16.34,2022,WLwhnhy4_n
11,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",12.21,2022,WLbly4_n
11,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",28.43,2022,WLasy4_n
11,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",14.47,2022,WLnay4_n
11,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",16.64,2022,WLothy4_n
11,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",12.35,2022,WLDMy4_n
11,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",17.5,2022,WLnodmy4_n
11,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",14.31,2022,WLnotxy4_n
11,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",24.64,2022,WLtxy4_n
11,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",14.01,2022,WLVCat1y4_n
11,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",19.16,2022,WLVCat2y4_n
11,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",13.34,2022,WLVCat3y4_n
11,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",425.49,2022,pppwpmy4m_n
11,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",15.77,2022,pppwy4_n
11,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",8.45,2019,swrptzm_n
11,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",6.71,2019,swrpyzm_n
11,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.68,2019,swrwlzm_n
11,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.63,2019,swrexwlzm_n
11,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",1.07,2019,swrz_n
11,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",81.12,2021,FVfy3_n
11,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",9.65,2021,FVdeclinedfy3_n
11,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.29,2021,FVovndfy3_n
11,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",9.23,2021,FVothrsnfy3_n
11,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",75.86,2022,FVhy4_n
11,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",76.98,2022,FVmcarehy4_n
11,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",78.23,2022,FVmahy4_n
11,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",76.08,2022,FVmpphy4_n
11,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",73.61,2022,FVdualhy4_n
11,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",76.22,2022,FVmsphy4_n
11,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",67.13,2022,FVnonmcarehy4_n
11,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",13.33,2022,FVlt18hy4_n
11,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",63.4,2022,FV1839hy4_n
11,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",72.88,2022,FV4064hy4_n
11,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",78.36,2022,FV6574hy4_n
11,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",81.73,2022,FV75uphy4_n
11,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",75.41,2022,FVmalehy4_n
11,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",76.07,2022,FVfemhy4_n
11,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",83.43,2022,FVashy4_n
11,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",68.3,2022,FVnahy4_n
11,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",78.61,2022,FVwhhy4_n
11,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",65.43,2022,FVrothhy4_n
11,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",69.87,2022,FVblkhy4_n
11,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",79.83,2022,FVhisphy4_n
11,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",66.22,2022,FVVCat1hy4_n
11,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",76.25,2022,FVVCat2hy4_n
11,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",79.48,2022,FVVCat3hy4_n
11,"N: Influenza - Average number of patients treated on 12/31, 2022",50.57,2022,eFVy4m_n
11,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",1.71,2022,medrsnfy4m_N
11,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.68,2022,CWhdavgHGBy4_n
11,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",24.42,2022,CWhdhgb1y4_n
11,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",33.9,2022,CWhdhgb2y4_n
11,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",28.23,2022,CWhdhgb3y4_n
11,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",11.44,2022,CWhdhgb4y4_n
11,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.01,2022,CWhdhgb5y4_n
11,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",77.84,2022,CWhdesarxy4_n
11,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.98,2022,CWpdavgHGBy4_n
11,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",22.84,2022,CWpdhgb1y4_n
11,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",26.9,2022,CWpdhgb2y4_n
11,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",26.38,2022,CWpdhgb3y4_n
11,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",21.24,2022,CWpdhgb4y4_n
11,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.64,2022,CWpdhgb5y4_n
11,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",51.02,2022,CWpdesarxy4_n
11,"N: HD HGB (Adult) - Average number of eligible patients, 2022",61.62,2022,CWhdptdenomy4m_n
11,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",527.36,2022,CWhdptmthdenomy4m_n
11,"N: PD HGB (Adult) - Average number of eligible patients, 2022",21.65,2022,CWpdptdenomy4m_n
11,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",164.59,2022,CWpdptmthdenomy4m_n
11,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",30.57,2022,rdstfy4m_n
11,"N: STrR (Adult) - Average Patient Years at Risk, 2022",18.47,2022,tfyy4m_n
11,"N: STrR (Adult) - Average Number of Transfusions, 2022",5.71,2022,tfy4m_n
11,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",6.12,2022,extfy4m_n
11,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.93,2022,strry4_n
11,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.88,2022,CWhdalby4_n
11,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",2.17,2022,CWhdalb1y4_n
11,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",9.36,2022,CWhdalb2y4_n
11,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",40.15,2022,CWhdalb3y4_n
11,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",44.88,2022,CWhdalb4y4_n
11,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",3.44,2022,CWhdalb5y4_n
11,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",51.67,2022,CWhdalblt4y4_n
11,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.47,2022,CWhdavgufry4_n
11,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",86.77,2022,CWhdufr1y4_n
11,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",7.75,2022,CWhdufr2y4_n
11,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",2.5,2022,CWhdufrmissy4_n
11,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.98,2022,CWhdufrgt20y4_n
11,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.66,2022,CWpdalby4_n
11,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",5.92,2022,CWpdalb1y4_n
11,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",22.28,2022,CWpdalb2y4_n
11,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",43.61,2022,CWpdalb3y4_n
11,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",25.63,2022,CWpdalb4y4_n
11,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",2.56,2022,CWpdalb5y4_n
11,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",71.8,2022,CWpdalblt4y4_n
11,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",61.62,2022,CWhddenomy4m_n
11,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",527.36,2022,CWhdmthdenomy4m_n
11,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",21.65,2022,CWpddenomy4m_n
11,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",164.59,2022,CWpdmthdenomy4m_n
11,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.23,2022,CWpdavgktvy4_n
11,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",5.43,2022,CWpdktv1y4_n
11,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",67.95,2022,CWpdktv2y4_n
11,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",24.36,2022,CWpdktv3y4_n
11,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",2.25,2022,CWpdktv4y4_n
11,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.58,2022,CWhdavgktvy4_n
11,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",2.26,2022,CWhdktv1y4_n
11,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",77.03,2022,CWhdktv2y4_n
11,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",19.18,2022,CWhdktv3y4_n
11,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.53,2022,CWhdktv4y4_n
11,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",59.94,2022,CWhdktvptsy4m_N
11,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",507.49,2022,CWhdktvptmthy4m_N
12,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",3.7,2022,allmcFcovpatPq4_n
12,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",27.45,2022,allmcEcovpatPq4_n
12,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",37.71,2022,allmcEcovDeaPq4_n
12,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",36.48,2022,allmcEcovHosPq4_n
12,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",7.2,2022,nh_mcFcovpatPq4_n
12,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",44.86,2022,nh_mcEcovpatPq4_n
12,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",48.77,2022,nh_mcEcovDeaPq4_n
12,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",44.77,2022,nh_mcEcovHosPq4_n
12,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",63.02,2022,agey4_n
12,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.28,2022,age1y4_n
12,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",49.44,2022,age2y4_n
12,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",50.29,2022,age3y4_n
12,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",42.94,2022,dis1y4_n
12,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",28.95,2022,dis2y4_n
12,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",10.66,2022,dis3y4_n
12,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",17.0,2022,dis4y4_n
12,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.45,2022,dis5y4_n
12,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",18.75,2022,vin1y4_n
12,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",19.77,2022,vin2y4_n
12,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.32,2022,vin3y4_n
12,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",23.94,2022,vin4y4_n
12,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",24.23,2022,vin5y4_n
12,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",2.29,2022,rac1y4_n
12,"N: Prevalent Patients - Race: % African American, 12/31/2022",28.78,2022,rac2y4_n
12,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.96,2022,rac3y4_n
12,"N: Prevalent Patients - Race: % White, 12/31/2022",67.76,2022,rac4y4_n
12,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.2,2022,rac5y4_n
12,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",7.38,2022,eth1y4_n
12,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",92.53,2022,eth2y4_n
12,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.09,2022,eth3y4_n
12,"N: Prevalent Patients - Sex: % Female, 12/31/2022",42.42,2022,sexy4_n
12,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",15.28,2022,nrshomey4_n
12,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",4.78,2022,viny4_n
12,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",79.32,2022,modhdy4_n
12,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",3.78,2022,modhhdy4_n
12,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.77,2022,modcapdy4_n
12,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",14.78,2022,modccpdy4_n
12,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.35,2022,modothry4_n
12,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",43.52,2022,pahy4m_n
12,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",21.39,2022,CWunCa1y4_n
12,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",74.83,2022,CWunCa2y4_n
12,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",0.96,2022,CWunCa3y4_n
12,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",2.82,2022,CWunCamissy4_n
12,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
12,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.83,2022,CWavgUnCay4_n
12,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.52,2022,CWavgPy4_n
12,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.15,2022,CWP1y4_n
12,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",22.36,2022,CWP2y4_n
12,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",28.24,2022,CWP3y4_n
12,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",22.53,2022,CWP4y4_n
12,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",16.52,2022,CWP5y4_n
12,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",3.2,2022,CWPmissy4_n
12,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
12,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",1.79,2022,CWunCagt102y4_n
12,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",61.07,2022,CWptdenomy4m_n
12,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",510.34,2022,CWptmthdenomy4m_n
12,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",65.58,2022,serumphospatsy4m_n
12,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",543.95,2022,serumphospmy4m_n
12,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",61.07,2022,CWhcptdenomy4m_n
12,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",510.32,2022,CWhcptmthdenomy4m_n
12,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",57.61,2022,ppavfy4_n
12,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",18.1,2022,ppavgy4_n
12,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",21.94,2022,ppcathy4_n
12,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",2.35,2022,ppomy4_n
12,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",16.45,2022,ltcy4_n
12,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",11.24,2022,piavfy4_n
12,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",3.17,2022,piavgy4_n
12,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",82.23,2022,picathy4_n
12,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",3.36,2022,piomy4_n
12,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",11.87,2022,pifisty4_n
12,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",55.78,2022,phdvapty4m_n
12,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",456.1,2022,phdy4m_n
12,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",11.56,2022,ihdy4m_n
12,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",59.08,2022,sfry4_n
12,"N: VA infection - Average number of eligible PD patients, 2022",12.39,2022,pdpaty4m_n
12,"N: VA infection - Average number of eligible PD patient-months, 2022",91.45,2022,pdptmoy4m_n
12,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.25,2022,pd2inf100moy4_n
12,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",36.17,2022,ncmy4m_n
12,"N: Prevalent Comorbidities - Average % with Anemia, 2022",4.05,2022,clmanemy4_n
12,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.53,2022,clmhivaidmy4_n
12,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.55,2022,clmalcomy4_n
12,"N: Prevalent Comorbidities - Average % with Cancer, 2022",3.82,2022,clmcanmy4_n
12,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",1.16,2022,clmcamy4_n
12,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",21.45,2022,clmcdmy4_n
12,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",7.46,2022,clmcvdmy4_n
12,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",17.39,2022,clmcopdmy4_n
12,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",33.0,2022,clmchfmy4_n
12,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",36.88,2022,clmdiabmy4_n
12,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",1.12,2022,clmdrugmy4_n
12,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",3.04,2022,clmgtbmy4_n
12,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.29,2022,clmhepbmy4_n
12,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.57,2022,clmhepothmy4_n
12,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",22.25,2022,clmhypthymy4_n
12,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",19.99,2022,clminfmy4_n
12,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",27.24,2022,clmihdmy4_n
12,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",6.84,2022,clmmimy4_n
12,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",17.39,2022,clmpvdmy4_n
12,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",4.2,2022,clmpnemy4_n
12,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.38,2022,clmcntcomy4_n
12,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",5.21,2022,clminfvamy4_n
12,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.81,2022,clmmstinfmy4_n
12,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.15,2022,clmtbmy4_n
12,"N (AFS): Facility Information - Average number of patients, 2022",78.02,2022,allcnty4m_n
12,N (AFS): Facility Information - Average number of all patients on 12/31/2022,48.51,2022,endcnty4m_n
12,"N (AFS): Facility Information - Average % of patients transferred in, 2022",18.16,2022,transiny4_n
12,"N (AFS): Facility Information - Average % of patients transferred out, 2022",18.47,2022,transouty4_n
12,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,86.67,2022,medicarey4_n
12,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,5.66,2022,medpendy4_n
12,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,7.73,2022,nonmedy4_n
12,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.17,2022,cfc_N
12,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,4.66,2022,std_N
12,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",36.59,2022,p_age1y4_n
12,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",14.63,2022,p_age2y4_n
12,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",26.83,2022,p_age3y4_n
12,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",21.95,2022,p_age4y4_n
12,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",0.0,2022,p_dis1y4_n
12,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",0.0,2022,p_dis2y4_n
12,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",26.83,2022,p_dis3y4_n
12,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",41.46,2022,p_dis4y4_n
12,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
12,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
12,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",24.39,2022,p_dis7y4_n
12,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",7.32,2022,p_dis8y4_n
12,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",19.51,2022,p_vin1y4_n
12,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",31.71,2022,p_vin2y4_n
12,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",7.32,2022,p_vin3y4_n
12,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",17.07,2022,p_vin4y4_n
12,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",24.39,2022,p_vin5y4_n
12,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",0.0,2022,p_rac1y4_n
12,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",26.83,2022,p_rac2y4_n
12,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",0.0,2022,p_rac3y4_n
12,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",68.29,2022,p_rac4y4_n
12,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",4.88,2022,p_rac5y4_n
12,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",12.2,2022,p_eth1y4_n
12,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",82.93,2022,p_eth2y4_n
12,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",4.88,2022,p_eth3y4_n
12,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",46.34,2022,p_sexy4_n
12,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",46.34,2022,p_modhdy4_n
12,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
12,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.0,2022,p_modcapdy4_n
12,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",53.66,2022,p_modccpdy4_n
12,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
12,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",0.0,2022,p_allmdcrmy4_n
12,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",70.0,2022,p_insmdcdmy4_n
12,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",10.0,2022,p_insempmy4_n
12,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",20.0,2022,p_insnonothmy4_n
12,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",10.0,2022,p_nephnomy4_n
12,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",10.0,2022,p_nephy6my4_n
12,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",40.0,2022,p_nephy612my4_n
12,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",40.0,2022,p_nephy12my4_n
12,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",0.0,2022,p_nephunkmissmy4_n
12,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",90.0,2022,p_ptinfymy4_n
12,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",0.0,2022,p_mefavfmy4_n
12,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
12,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",100.0,2022,p_mefcathmy4_n
12,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
12,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",0.0,2022,p_avfpresentmy4_n
12,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",14.55,2022,p_ppavfy4_n
12,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",67.64,2022,p_ltcy4_n
12,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",39.07,2022,p_WLy4_n
12,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",44.04,2022,p_WLlt10y4_n
12,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",34.8,2022,p_WL1017y4_n
12,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.09,2022,p_CWhdavgHGBy4_n
12,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",14.94,2022,p_CWhdhgb1y4_n
12,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",28.35,2022,p_CWhdhgb2y4_n
12,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",29.89,2022,p_CWhdhgb3y4_n
12,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",16.48,2022,p_CWhdhgb4y4_n
12,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",10.34,2022,p_CWhdhgb5y4_n
12,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.69,2022,p_CWpdavgHGBy4_n
12,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",26.32,2022,p_CWpdhgb1y4_n
12,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",28.77,2022,p_CWpdhgb2y4_n
12,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",25.61,2022,p_CWpdhgb3y4_n
12,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",15.44,2022,p_CWpdhgb4y4_n
12,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.86,2022,p_CWpdhgb5y4_n
12,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.03,2022,p_CWhdalby4_n
12,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",0.77,2022,p_CWhdalb1y4_n
12,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",16.09,2022,p_CWhdalb2y4_n
12,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",21.07,2022,p_CWhdalb3y4_n
12,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",52.11,2022,p_CWhdalb4y4_n
12,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",9.96,2022,p_CWhdalb5y4_n
12,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.7,2022,p_CWpdalby4_n
12,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",7.02,2022,p_CWpdalb1y4_n
12,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",24.56,2022,p_CWpdalb2y4_n
12,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",34.39,2022,p_CWpdalb3y4_n
12,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",28.77,2022,p_CWpdalb4y4_n
12,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",5.26,2022,p_CWpdalb5y4_n
12,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",89.12,2022,p_CWpdktvge18y4_n
12,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",90.0,2022,p_CWhdktvge12y4_n
12,"N: Patient Placement -  % of incident patients, 2022",18.56,2022,ppidy4_n
12,"N: Patient Placement -  % of patients continuing at facility, 2022",69.28,2022,ppcdy4_n
12,"N: Patient Placement -  % of patients that transfered into facility, 2022",12.17,2022,pptdy4_n
12,"N: End of Year Status - % of patients death attributed to this facility, 2022",15.16,2022,pdhdy4_n
12,"N: End of Year Status - % of patients death attributed to another facility, 2022",2.09,2022,pdody4_n
12,"N: End of Year Status - % of patients that received a transplant, 2022",3.2,2022,ptxdy4_n
12,"N: End of Year Status - % of patients alive in this facility, 2022",67.36,2022,pahdy4_n
12,"N: End of Year Status - % of patients alive in another facility, 2022",8.71,2022,paody4_n
12,"N: End of Year Status - % of patients other, 2022",3.49,2022,potdy4_n
12,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,38.82,2022,iuhemy4m_n
12,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.01,2022,iufreqy4m_n
12,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,38.8,2022,iunonfreqy4m_n
12,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.02,2022,iuothy4m_n
12,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
12,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
12,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,1.7,2022,ihhemy4m_n
12,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.6,2022,ihfreqy4m_n
12,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,1.09,2022,ihnonfreqy4m_n
12,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
12,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.87,2022,ihcapdy4m_n
12,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,7.1,2022,ihccpdy4m_n
12,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",10.75,2022,staffy4m_n
12,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,3.2,2022,nurseFTy4m_n
12,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,3.97,2022,ptcareFTy4m_n
12,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,0.78,2022,dietFTy4m_n
12,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,0.85,2022,socwkFTy4m_n
12,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.75,2022,nursePTy4m_n
12,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.5,2022,ptcarePTy4m_n
12,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.36,2022,dietPTy4m_n
12,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.33,2022,socwkPTy4m_n
12,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,23.95,2022,vocrehaby4m_n
12,"N (AFS): Facility Information - Average % incident patients, 2022",16.92,2022,incpery4_n
12,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,29.77,2022,employedy4_n
12,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.52,2022,schooly4_n
12,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",49.16,2022,nh_ppavfy4_n
12,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",20.48,2022,nh_ltcy4_n
12,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",1.97,2022,nh_CWhdktv1y4_n
12,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",7.03,2022,nh_CWpdktv1y4_n
12,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",28.31,2022,nh_CWhdhgb1y4_n
12,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",80.98,2022,nh_CWhdesarxy4_n
12,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",29.86,2022,nh_CWpdhgb1y4_n
12,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",58.45,2022,nh_CWpdesarxy4_n
12,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",43.29,2022,nh_obdry4_n
12,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.09,2022,nh_smry4_n
12,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",38.54,2022,nh_wity4_n
12,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",264.31,2022,nh_obhtry4_n
12,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.4,2022,nh_shrty4_n
12,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",22.91,2022,nh_sepiy4_n
12,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",10.4,2022,nh_miiy4_n
12,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",47.61,2022,nh_achfy4_n
12,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",36.19,2022,nh_acdry4_n
12,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",3.66,2022,nh_acary4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",0.33,2022,nh_clmhivaidmy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",7.69,2022,nh_clminfvamy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",0.29,2022,nh_clmhepbmy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",2.82,2022,nh_clmhepothmy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",4.15,2022,nh_clmmstinfmy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",9.31,2022,nh_clmpnemy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.24,2022,nh_clmtbmy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",39.26,2022,nh_clminfmy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.39,2022,nh_clmcamy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",42.12,2022,nh_clmcdmy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",17.62,2022,nh_clmcvdmy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",55.49,2022,nh_clmchfmy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",44.75,2022,nh_clmihdmy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",12.18,2022,nh_clmmimy4_n
12,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",33.91,2022,nh_clmpvdmy4_n
12,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
12,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",32.72,2022,nh_age2y4_n
12,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",67.28,2022,nh_age3y4_n
12,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",52.07,2022,nh_dis1y4_n
12,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",26.9,2022,nh_dis2y4_n
12,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",5.2,2022,nh_dis3y4_n
12,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",14.95,2022,nh_dis4y4_n
12,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.88,2022,nh_dis5y4_n
12,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",1.01,2022,nh_rac1y4_n
12,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",28.17,2022,nh_rac2y4_n
12,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",1.06,2022,nh_rac3y4_n
12,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",69.66,2022,nh_rac4y4_n
12,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.09,2022,nh_rac5y4_n
12,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",3.84,2022,nh_eth1y4_n
12,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",96.08,2022,nh_eth2y4_n
12,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.09,2022,nh_eth3y4_n
12,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",20.94,2022,nh_vin1y4_n
12,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",17.55,2022,nh_vin2y4_n
12,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",11.77,2022,nh_vin3y4_n
12,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",25.57,2022,nh_vin4y4_n
12,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",24.16,2022,nh_vin5y4_n
12,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",51.28,2022,nh_sexy4_n
12,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",92.02,2022,nh_modhdy4_n
12,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",3.53,2022,nh_modhhdy4_n
12,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.31,2022,nh_modcapdy4_n
12,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",3.48,2022,nh_modccpdy4_n
12,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.66,2022,nh_modothry4_n
12,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",86.61,2022,nh_allmdcrmy4_n
12,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",7.99,2022,nh_insmdcdmy4_n
12,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",1.97,2022,nh_insempmy4_n
12,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",3.44,2022,nh_insnonothmy4_n
12,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",6.63,2022,nh_mefavfmy4_n
12,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",3.19,2022,nh_mefgraftmy4_n
12,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",87.71,2022,nh_mefcathmy4_n
12,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",2.46,2022,nh_mefoumaccessmy4_n
12,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",13.51,2022,nh_avfpresentmy4_n
12,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",16.71,2022,nh_nephnomy4_n
12,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",16.22,2022,nh_nephy6my4_n
12,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",18.55,2022,nh_nephy612my4_n
12,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",29.36,2022,nh_nephy12my4_n
12,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",19.16,2022,nh_nephunkmissmy4_n
12,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",88.21,2022,nh_ptinfymy4_n
12,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",2.38,2022,alcomy4_n
12,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",10.91,2022,ashdmy4_n
12,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",21.38,2022,othcarmy4_n
12,"N (2728): Incident Patients  - Percent with cancer, 2022",8.37,2022,canmy4_n
12,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",26.21,2022,chfmy4_n
12,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",9.59,2022,cvamy4_n
12,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",41.8,2022,diabimy4_n
12,"N (2728): Incident Patients  - Percent with diabetes, 2022",61.88,2022,diabmy4_n
12,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.91,2022,drugmy4_n
12,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",84.84,2022,hxhtmy4_n
12,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",5.54,2022,ambumy4_n
12,"N (2728): Incident Patients  - Percent inability to transfer, 2022",2.36,2022,transmy4_n
12,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",10.84,2022,copdmy4_n
12,"N (2728): Incident Patients  - Percent with PVD, 2022",7.61,2022,pvdmy4_n
12,"N (2728): Incident Patients  - Percent smoker, 2022",9.97,2022,smokmy4_n
12,"N (2728): Incident Patients  - Percent Hispanic, 2022",6.15,2022,ethmy4_n
12,"N (2728): Incident Patients  - Percent White, 2022",74.12,2022,whitemy4_n
12,"N (2728): Incident Patients  - Percent African American, 2022",21.43,2022,blackmy4_n
12,"N (2728): Incident Patients  - Percent Native American, 2022",1.86,2022,nativmy4_n
12,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",2.22,2022,asianmy4_n
12,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.38,2022,racoummy4_n
12,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",31.52,2022,cempmy4_n
12,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",41.96,2022,pempmy4_n
12,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",42.72,2022,dbprimy4_n
12,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",7.59,2022,gnprimy4_n
12,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",27.27,2022,htprimy4_n
12,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",22.42,2022,omprimy4_n
12,"N (2728): Incident Patients  - Percent female, 2022",41.56,2022,femmy4_n
12,"N (2728): Incident Patients  - Average age, 2022",64.14,2022,agemy4_n
12,"N (2728): Incident Patients  - Average serum albumin, 2022",3.41,2022,salbmy4_n
12,"N (2728): Incident Patients  - Average creatinine, 2022",6.07,2022,creamy4_n
12,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.48,2022,hgmy4_n
12,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",11.15,2022,gfrmy4_n
12,"N (2728): Incident Patients  - Average count of comorbidities, 2022",3.06,2022,cntcomy4_n
12,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",83.31,2022,pdmodMEFHDmy4_n
12,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",16.69,2022,pdmodMEFPDmy4_n
12,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
12,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",47.74,2022,insmdcrmy4_n
12,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",11.46,2022,insmdcdmy4_n
12,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",7.1,2022,insmdcrcdmy4_n
12,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",13.51,2022,insempmy4_n
12,"N (2728): Incident Patients  - Percent with no coverage, 2022",3.09,2022,insnonemy4_n
12,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",10.56,2022,insmdcromy4_n
12,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",6.55,2022,insmedomy4_n
12,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",14.12,2022,preepomy4_n
12,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",15.16,2022,nephnomy4_n
12,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",16.1,2022,nephy6my4_n
12,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",20.65,2022,nephy612my4_n
12,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",34.3,2022,nephy12my4_n
12,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",13.79,2022,nephunkmissmy4_n
12,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",93.64,2022,ptinfymy4_n
12,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",37.78,2022,ptxmedunfitmy4_n
12,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
12,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
12,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",8.15,2022,ptxdeclinemy4_n
12,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",56.67,2022,ptxnotassessmy4_n
12,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",11.94,2022,mefavfmy4_n
12,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",2.89,2022,mefgraftmy4_n
12,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",84.86,2022,mefcathmy4_n
12,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.31,2022,mefoumaccessmy4_n
12,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",20.57,2022,avfpresentmy4_n
12,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",28.59,2022,bmimmy4_n
12,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",30.04,2022,bmifmy4_n
12,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",0.84,2022,ptinfnmy4m_n
12,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",10.98,2022,hemomy4m_n
12,"N (2728): Incident Patients  - Average Number of forms returned, 2022",13.17,2022,nmy4m_n
12,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",62.23,2019,rdsmzm_n
12,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",39.58,2019,dyzm_n
12,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",8.62,2019,deazm_n
12,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",8.92,2019,exdzm_n
12,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.05,2019,dudzm_n
12,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",0.97,2019,smrz_n
12,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",30.86,2019,witz_n
12,"N: All Patient Mortality - % of deaths from infection, 2019-2022",8.99,2019,infz_n
12,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",39.71,2019,cardz_n
12,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.11,2019,livz_n
12,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",12.76,2019,fynmzm_n
12,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",7.62,2019,fydyzm_n
12,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.25,2019,fydeazm_n
12,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.3,2019,fyexdzm_n
12,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",0.98,2019,fysmrz_n
12,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",31.57,2019,fywitz_n
12,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",9.72,2019,fyinfz_n
12,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",36.35,2019,fycardiacz_n
12,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",2.22,2019,fylivz_n
12,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",52.92,2019,rdshzm_n
12,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",49.37,2019,htazm_n
12,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",50.17,2019,extzm_n
12,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",384.98,2019,hdzm_n
12,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",407.33,2019,exhdzm_n
12,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",32.97,2019,hdyzm_n
12,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",0.98,2019,shrtz_n
12,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.95,2019,shrdz_n
12,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.5,2019,lenz_n
12,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",8.45,2019,onez_n
12,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",6.71,2019,miiz_n
12,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",12.72,2019,sepiz_n
12,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",29.97,2019,achfz_n
12,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",20.92,2019,acdrz_n
12,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.42,2019,acarz_n
12,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",78.5,2019,ipedz_n
12,"N: ED30 - Average annual index discharges, 2019-22",30.29,2019,ed30indexzm_n
12,"N: ED30- Average annual number of ED visits, 2019-22",4.91,2019,ed30obszm_n
12,"N: ED30 - Average annual expected ED visits, 2019-22",4.93,2019,ed30expzm_n
12,"N: ED30: Standardized Ratio of ED30, 2019-22",1.03,2019,ed30z_n
12,"N SRR -  Standardized Readmission Ratio, 2022",1.0,2022,srry4_n
12,"N: SRR - Average index discharges, 2022",48.27,2022,indexmy4_n
12,"N: SRR - Average number of readmissions, 2022",12.24,2022,readmmy4_n
12,"N: SRR - Average expected readmissions, 2022",13.49,2022,srrexpmy4_n
12,Pt included in SEDR analysis,38.93,2019,rdsezm_n
12,Total number of ED Visits,36.65,2019,hedzm_n
12,Expected number of ED events,36.74,2019,exedzm_n
12,Years at risk for ED visit rate,24.16,2019,edyrzm_n
12,Years at risk for ED visit rate,34891.84,2019,edyrz_n
12,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",1.0,2019,sedrz_n
12,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",44.76,2019,rdstzm_n
12,"N: STR - Average number of patients (per year in average facility), 2019-2022",48.7,2019,rdsalltzm_n
12,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",1.62,2019,txzm_n
12,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",1.84,2019,txallzm_n
12,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",28.45,2019,txyzm_n
12,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.56,2019,cadalltzm_n
12,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.3,2019,livealltzm_n
12,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",1.36,2019,extxzm_n
12,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",1.19,2019,strz_n
12,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",46.11,2022,pppwpty4m_n
12,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",12.01,2022,WLy4_n
12,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",20.33,2022,WLlt40y4_n
12,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",11.04,2022,WL4074y4_n
12,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",12.76,2022,WLmaley4_n
12,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",10.92,2022,WLfemy4_n
12,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",10.1,2022,WLwhhy4_n
12,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",12.28,2022,WLwhnhy4_n
12,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",12.0,2022,WLbly4_n
12,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",12.99,2022,WLasy4_n
12,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",8.46,2022,WLnay4_n
12,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",17.05,2022,WLothy4_n
12,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",9.55,2022,WLDMy4_n
12,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",13.88,2022,WLnodmy4_n
12,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",11.06,2022,WLnotxy4_n
12,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",21.94,2022,WLtxy4_n
12,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",11.93,2022,WLVCat1y4_n
12,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",14.71,2022,WLVCat2y4_n
12,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",9.56,2022,WLVCat3y4_n
12,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",373.85,2022,pppwpmy4m_n
12,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",11.9,2022,pppwy4_n
12,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",8.36,2019,swrptzm_n
12,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",6.64,2019,swrpyzm_n
12,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.65,2019,swrwlzm_n
12,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.63,2019,swrexwlzm_n
12,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",1.04,2019,swrz_n
12,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",85.97,2021,FVfy3_n
12,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",7.9,2021,FVdeclinedfy3_n
12,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.12,2021,FVovndfy3_n
12,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",6.13,2021,FVothrsnfy3_n
12,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",68.45,2022,FVhy4_n
12,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",69.4,2022,FVmcarehy4_n
12,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",69.14,2022,FVmahy4_n
12,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",69.71,2022,FVmpphy4_n
12,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",68.64,2022,FVdualhy4_n
12,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",68.46,2022,FVmsphy4_n
12,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",60.21,2022,FVnonmcarehy4_n
12,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",74.42,2022,FVlt18hy4_n
12,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",61.46,2022,FV1839hy4_n
12,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",67.35,2022,FV4064hy4_n
12,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",70.34,2022,FV6574hy4_n
12,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",69.9,2022,FV75uphy4_n
12,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",67.89,2022,FVmalehy4_n
12,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",68.99,2022,FVfemhy4_n
12,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",72.86,2022,FVashy4_n
12,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",60.87,2022,FVnahy4_n
12,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",69.48,2022,FVwhhy4_n
12,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",60.0,2022,FVrothhy4_n
12,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",65.65,2022,FVblkhy4_n
12,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",76.42,2022,FVhisphy4_n
12,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",56.97,2022,FVVCat1hy4_n
12,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",69.32,2022,FVVCat2hy4_n
12,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",73.52,2022,FVVCat3hy4_n
12,"N: Influenza - Average number of patients treated on 12/31, 2022",45.29,2022,eFVy4m_n
12,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",0.78,2022,medrsnfy4m_N
12,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.75,2022,CWhdavgHGBy4_n
12,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",23.14,2022,CWhdhgb1y4_n
12,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",32.81,2022,CWhdhgb2y4_n
12,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",28.73,2022,CWhdhgb3y4_n
12,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",12.84,2022,CWhdhgb4y4_n
12,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.48,2022,CWhdhgb5y4_n
12,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",76.6,2022,CWhdesarxy4_n
12,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.05,2022,CWpdavgHGBy4_n
12,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",20.9,2022,CWpdhgb1y4_n
12,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",26.84,2022,CWpdhgb2y4_n
12,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",26.88,2022,CWpdhgb3y4_n
12,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",22.52,2022,CWpdhgb4y4_n
12,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.86,2022,CWpdhgb5y4_n
12,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",51.92,2022,CWpdesarxy4_n
12,"N: HD HGB (Adult) - Average number of eligible patients, 2022",52.31,2022,CWhdptdenomy4m_n
12,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",435.72,2022,CWhdptmthdenomy4m_n
12,"N: PD HGB (Adult) - Average number of eligible patients, 2022",22.97,2022,CWpdptdenomy4m_n
12,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",172.19,2022,CWpdptmthdenomy4m_n
12,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",29.63,2022,rdstfy4m_n
12,"N: STrR (Adult) - Average Patient Years at Risk, 2022",17.71,2022,tfyy4m_n
12,"N: STrR (Adult) - Average Number of Transfusions, 2022",5.8,2022,tfy4m_n
12,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",5.96,2022,extfy4m_n
12,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.97,2022,strry4_n
12,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.91,2022,CWhdalby4_n
12,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",1.83,2022,CWhdalb1y4_n
12,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",8.53,2022,CWhdalb2y4_n
12,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",38.08,2022,CWhdalb3y4_n
12,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",47.59,2022,CWhdalb4y4_n
12,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",3.98,2022,CWhdalb5y4_n
12,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",48.43,2022,CWhdalblt4y4_n
12,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.77,2022,CWhdavgufry4_n
12,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",84.07,2022,CWhdufr1y4_n
12,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",9.17,2022,CWhdufr2y4_n
12,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",3.64,2022,CWhdufrmissy4_n
12,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",3.12,2022,CWhdufrgt20y4_n
12,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.69,2022,CWpdalby4_n
12,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",5.86,2022,CWpdalb1y4_n
12,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",19.83,2022,CWpdalb2y4_n
12,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",43.38,2022,CWpdalb3y4_n
12,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",28.23,2022,CWpdalb4y4_n
12,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",2.7,2022,CWpdalb5y4_n
12,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",69.07,2022,CWpdalblt4y4_n
12,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",52.31,2022,CWhddenomy4m_n
12,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",435.72,2022,CWhdmthdenomy4m_n
12,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",22.97,2022,CWpddenomy4m_n
12,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",172.19,2022,CWpdmthdenomy4m_n
12,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.27,2022,CWpdavgktvy4_n
12,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",4.22,2022,CWpdktv1y4_n
12,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",67.5,2022,CWpdktv2y4_n
12,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",26.34,2022,CWpdktv3y4_n
12,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.94,2022,CWpdktv4y4_n
12,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.6,2022,CWhdavgktvy4_n
12,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",1.9,2022,CWhdktv1y4_n
12,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",75.16,2022,CWhdktv2y4_n
12,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",21.37,2022,CWhdktv3y4_n
12,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.57,2022,CWhdktv4y4_n
12,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",49.64,2022,CWhdktvptsy4m_N
12,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",407.78,2022,CWhdktvptmthy4m_N
13,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",2.14,2022,allmcFcovpatPq4_n
13,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",26.97,2022,allmcEcovpatPq4_n
13,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",33.6,2022,allmcEcovDeaPq4_n
13,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",32.28,2022,allmcEcovHosPq4_n
13,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",5.53,2022,nh_mcFcovpatPq4_n
13,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",44.71,2022,nh_mcEcovpatPq4_n
13,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",44.86,2022,nh_mcEcovDeaPq4_n
13,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",41.47,2022,nh_mcEcovHosPq4_n
13,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",61.76,2022,agey4_n
13,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.25,2022,age1y4_n
13,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",53.48,2022,age2y4_n
13,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",46.27,2022,age3y4_n
13,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",42.38,2022,dis1y4_n
13,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",37.05,2022,dis2y4_n
13,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",7.59,2022,dis3y4_n
13,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",12.66,2022,dis4y4_n
13,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.32,2022,dis5y4_n
13,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",17.33,2022,vin1y4_n
13,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",18.73,2022,vin2y4_n
13,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.1,2022,vin3y4_n
13,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.68,2022,vin4y4_n
13,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",26.16,2022,vin5y4_n
13,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",1.86,2022,rac1y4_n
13,"N: Prevalent Patients - Race: % African American, 12/31/2022",49.59,2022,rac2y4_n
13,"N: Prevalent Patients - Race: % Native American, 12/31/2022",3.74,2022,rac3y4_n
13,"N: Prevalent Patients - Race: % White, 12/31/2022",44.48,2022,rac4y4_n
13,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.33,2022,rac5y4_n
13,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",5.45,2022,eth1y4_n
13,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",94.49,2022,eth2y4_n
13,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.06,2022,eth3y4_n
13,"N: Prevalent Patients - Sex: % Female, 12/31/2022",44.13,2022,sexy4_n
13,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",11.27,2022,nrshomey4_n
13,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",4.92,2022,viny4_n
13,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",82.79,2022,modhdy4_n
13,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",3.32,2022,modhhdy4_n
13,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.0,2022,modcapdy4_n
13,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",12.66,2022,modccpdy4_n
13,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.24,2022,modothry4_n
13,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",51.72,2022,pahy4m_n
13,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",19.21,2022,CWunCa1y4_n
13,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",77.7,2022,CWunCa2y4_n
13,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",0.93,2022,CWunCa3y4_n
13,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",2.16,2022,CWunCamissy4_n
13,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
13,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.88,2022,CWavgUnCay4_n
13,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.61,2022,CWavgPy4_n
13,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.28,2022,CWP1y4_n
13,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",21.25,2022,CWP2y4_n
13,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",27.04,2022,CWP3y4_n
13,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",23.4,2022,CWP4y4_n
13,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",18.44,2022,CWP5y4_n
13,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",2.58,2022,CWPmissy4_n
13,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
13,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",1.36,2022,CWunCagt102y4_n
13,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",71.17,2022,CWptdenomy4m_n
13,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",602.73,2022,CWptmthdenomy4m_n
13,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",76.27,2022,serumphospatsy4m_n
13,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",639.89,2022,serumphospmy4m_n
13,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",71.15,2022,CWhcptdenomy4m_n
13,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",602.66,2022,CWhcptmthdenomy4m_n
13,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",59.65,2022,ppavfy4_n
13,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",15.91,2022,ppavgy4_n
13,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",22.99,2022,ppcathy4_n
13,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",1.44,2022,ppomy4_n
13,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",16.79,2022,ltcy4_n
13,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",10.89,2022,piavfy4_n
13,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",2.11,2022,piavgy4_n
13,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",83.66,2022,picathy4_n
13,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",3.34,2022,piomy4_n
13,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",11.54,2022,pifisty4_n
13,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",66.19,2022,phdvapty4m_n
13,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",551.46,2022,phdy4m_n
13,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",12.92,2022,ihdy4m_n
13,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",59.46,2022,sfry4_n
13,"N: VA infection - Average number of eligible PD patients, 2022",13.49,2022,pdpaty4m_n
13,"N: VA infection - Average number of eligible PD patient-months, 2022",94.43,2022,pdptmoy4m_n
13,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.56,2022,pd2inf100moy4_n
13,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",43.21,2022,ncmy4m_n
13,"N: Prevalent Comorbidities - Average % with Anemia, 2022",2.75,2022,clmanemy4_n
13,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.8,2022,clmhivaidmy4_n
13,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.1,2022,clmalcomy4_n
13,"N: Prevalent Comorbidities - Average % with Cancer, 2022",2.69,2022,clmcanmy4_n
13,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",0.87,2022,clmcamy4_n
13,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",17.55,2022,clmcdmy4_n
13,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",7.48,2022,clmcvdmy4_n
13,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",13.68,2022,clmcopdmy4_n
13,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",30.19,2022,clmchfmy4_n
13,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",35.74,2022,clmdiabmy4_n
13,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",1.07,2022,clmdrugmy4_n
13,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",2.61,2022,clmgtbmy4_n
13,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.37,2022,clmhepbmy4_n
13,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.75,2022,clmhepothmy4_n
13,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",19.91,2022,clmhypthymy4_n
13,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",18.15,2022,clminfmy4_n
13,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",25.57,2022,clmihdmy4_n
13,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",8.01,2022,clmmimy4_n
13,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",15.74,2022,clmpvdmy4_n
13,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",3.38,2022,clmpnemy4_n
13,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.17,2022,clmcntcomy4_n
13,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",5.46,2022,clminfvamy4_n
13,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.57,2022,clmmstinfmy4_n
13,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.08,2022,clmtbmy4_n
13,"N (AFS): Facility Information - Average number of patients, 2022",90.33,2022,allcnty4m_n
13,N (AFS): Facility Information - Average number of all patients on 12/31/2022,57.91,2022,endcnty4m_n
13,"N (AFS): Facility Information - Average % of patients transferred in, 2022",17.58,2022,transiny4_n
13,"N (AFS): Facility Information - Average % of patients transferred out, 2022",17.86,2022,transouty4_n
13,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,86.97,2022,medicarey4_n
13,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,6.68,2022,medpendy4_n
13,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,6.35,2022,nonmedy4_n
13,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.37,2022,cfc_N
13,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,5.3,2022,std_N
13,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",21.74,2022,p_age1y4_n
13,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",15.22,2022,p_age2y4_n
13,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",23.91,2022,p_age3y4_n
13,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",39.13,2022,p_age4y4_n
13,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",0.0,2022,p_dis1y4_n
13,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",0.0,2022,p_dis2y4_n
13,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",36.96,2022,p_dis3y4_n
13,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",28.26,2022,p_dis4y4_n
13,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
13,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
13,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",23.91,2022,p_dis7y4_n
13,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",10.87,2022,p_dis8y4_n
13,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",23.91,2022,p_vin1y4_n
13,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",17.39,2022,p_vin2y4_n
13,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",19.57,2022,p_vin3y4_n
13,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",19.57,2022,p_vin4y4_n
13,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",19.57,2022,p_vin5y4_n
13,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",2.17,2022,p_rac1y4_n
13,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",47.83,2022,p_rac2y4_n
13,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",4.35,2022,p_rac3y4_n
13,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",43.48,2022,p_rac4y4_n
13,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",2.17,2022,p_rac5y4_n
13,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",15.22,2022,p_eth1y4_n
13,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",84.78,2022,p_eth2y4_n
13,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
13,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",41.3,2022,p_sexy4_n
13,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",47.83,2022,p_modhdy4_n
13,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
13,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",4.35,2022,p_modcapdy4_n
13,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",47.83,2022,p_modccpdy4_n
13,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
13,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",14.29,2022,p_allmdcrmy4_n
13,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",60.71,2022,p_insmdcdmy4_n
13,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",14.29,2022,p_insempmy4_n
13,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",10.71,2022,p_insnonothmy4_n
13,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",14.29,2022,p_nephnomy4_n
13,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",21.43,2022,p_nephy6my4_n
13,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",3.57,2022,p_nephy612my4_n
13,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",42.86,2022,p_nephy12my4_n
13,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",17.86,2022,p_nephunkmissmy4_n
13,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",96.43,2022,p_ptinfymy4_n
13,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",0.0,2022,p_mefavfmy4_n
13,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
13,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",100.0,2022,p_mefcathmy4_n
13,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
13,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",0.0,2022,p_avfpresentmy4_n
13,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",22.97,2022,p_ppavfy4_n
13,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",60.0,2022,p_ltcy4_n
13,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",26.29,2022,p_WLy4_n
13,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",24.1,2022,p_WLlt10y4_n
13,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",32.49,2022,p_WL1017y4_n
13,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.67,2022,p_CWhdavgHGBy4_n
13,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",27.17,2022,p_CWhdhgb1y4_n
13,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",21.68,2022,p_CWhdhgb2y4_n
13,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",28.9,2022,p_CWhdhgb3y4_n
13,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",14.45,2022,p_CWhdhgb4y4_n
13,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",7.8,2022,p_CWhdhgb5y4_n
13,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.68,2022,p_CWpdavgHGBy4_n
13,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",27.27,2022,p_CWpdhgb1y4_n
13,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",24.73,2022,p_CWpdhgb2y4_n
13,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",19.64,2022,p_CWpdhgb3y4_n
13,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",17.09,2022,p_CWpdhgb4y4_n
13,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",11.27,2022,p_CWpdhgb5y4_n
13,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.02,2022,p_CWhdalby4_n
13,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",2.31,2022,p_CWhdalb1y4_n
13,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",6.94,2022,p_CWhdalb2y4_n
13,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",27.17,2022,p_CWhdalb3y4_n
13,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",55.78,2022,p_CWhdalb4y4_n
13,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",7.8,2022,p_CWhdalb5y4_n
13,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.71,2022,p_CWpdalby4_n
13,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",10.55,2022,p_CWpdalb1y4_n
13,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",20.73,2022,p_CWpdalb2y4_n
13,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",25.45,2022,p_CWpdalb3y4_n
13,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",33.09,2022,p_CWpdalb4y4_n
13,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",10.18,2022,p_CWpdalb5y4_n
13,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",78.18,2022,p_CWpdktvge18y4_n
13,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",91.19,2022,p_CWhdktvge12y4_n
13,"N: Patient Placement -  % of incident patients, 2022",17.68,2022,ppidy4_n
13,"N: Patient Placement -  % of patients continuing at facility, 2022",69.71,2022,ppcdy4_n
13,"N: Patient Placement -  % of patients that transfered into facility, 2022",12.62,2022,pptdy4_n
13,"N: End of Year Status - % of patients death attributed to this facility, 2022",14.22,2022,pdhdy4_n
13,"N: End of Year Status - % of patients death attributed to another facility, 2022",2.01,2022,pdody4_n
13,"N: End of Year Status - % of patients that received a transplant, 2022",2.3,2022,ptxdy4_n
13,"N: End of Year Status - % of patients alive in this facility, 2022",68.3,2022,pahdy4_n
13,"N: End of Year Status - % of patients alive in another facility, 2022",9.11,2022,paody4_n
13,"N: End of Year Status - % of patients other, 2022",4.06,2022,potdy4_n
13,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,48.35,2022,iuhemy4m_n
13,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.01,2022,iufreqy4m_n
13,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,48.34,2022,iunonfreqy4m_n
13,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.01,2022,iuothy4m_n
13,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
13,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
13,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,1.76,2022,ihhemy4m_n
13,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.63,2022,ihfreqy4m_n
13,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,1.13,2022,ihnonfreqy4m_n
13,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
13,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.6,2022,ihcapdy4m_n
13,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,7.2,2022,ihccpdy4m_n
13,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",12.86,2022,staffy4m_n
13,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,4.01,2022,nurseFTy4m_n
13,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,4.94,2022,ptcareFTy4m_n
13,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,1.16,2022,dietFTy4m_n
13,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.15,2022,socwkFTy4m_n
13,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.61,2022,nursePTy4m_n
13,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.4,2022,ptcarePTy4m_n
13,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.3,2022,dietPTy4m_n
13,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.29,2022,socwkPTy4m_n
13,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,30.96,2022,vocrehaby4m_n
13,"N (AFS): Facility Information - Average % incident patients, 2022",16.18,2022,incpery4_n
13,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,23.58,2022,employedy4_n
13,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,1.06,2022,schooly4_n
13,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",47.79,2022,nh_ppavfy4_n
13,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",24.01,2022,nh_ltcy4_n
13,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",2.47,2022,nh_CWhdktv1y4_n
13,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",8.55,2022,nh_CWpdktv1y4_n
13,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",29.73,2022,nh_CWhdhgb1y4_n
13,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",80.63,2022,nh_CWhdesarxy4_n
13,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",26.25,2022,nh_CWpdhgb1y4_n
13,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",52.97,2022,nh_CWpdesarxy4_n
13,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",44.44,2022,nh_obdry4_n
13,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.16,2022,nh_smry4_n
13,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",30.13,2022,nh_wity4_n
13,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",269.12,2022,nh_obhtry4_n
13,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.51,2022,nh_shrty4_n
13,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",23.09,2022,nh_sepiy4_n
13,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",12.2,2022,nh_miiy4_n
13,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",47.69,2022,nh_achfy4_n
13,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",31.91,2022,nh_acdry4_n
13,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",4.93,2022,nh_acary4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",0.73,2022,nh_clmhivaidmy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",9.13,2022,nh_clminfvamy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",0.83,2022,nh_clmhepbmy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",3.68,2022,nh_clmhepothmy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",4.05,2022,nh_clmmstinfmy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",7.99,2022,nh_clmpnemy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.05,2022,nh_clmtbmy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",38.33,2022,nh_clminfmy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.39,2022,nh_clmcamy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",36.05,2022,nh_clmcdmy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",19.66,2022,nh_clmcvdmy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",54.56,2022,nh_clmchfmy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",45.18,2022,nh_clmihdmy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",15.15,2022,nh_clmmimy4_n
13,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",32.88,2022,nh_clmpvdmy4_n
13,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
13,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",35.33,2022,nh_age2y4_n
13,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",64.67,2022,nh_age3y4_n
13,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",53.1,2022,nh_dis1y4_n
13,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",32.58,2022,nh_dis2y4_n
13,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",3.05,2022,nh_dis3y4_n
13,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",10.84,2022,nh_dis4y4_n
13,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.44,2022,nh_dis5y4_n
13,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",0.68,2022,nh_rac1y4_n
13,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",45.26,2022,nh_rac2y4_n
13,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",2.81,2022,nh_rac3y4_n
13,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",51.06,2022,nh_rac4y4_n
13,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.19,2022,nh_rac5y4_n
13,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",3.1,2022,nh_eth1y4_n
13,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",96.85,2022,nh_eth2y4_n
13,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.05,2022,nh_eth3y4_n
13,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",22.27,2022,nh_vin1y4_n
13,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",15.83,2022,nh_vin2y4_n
13,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.89,2022,nh_vin3y4_n
13,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.88,2022,nh_vin4y4_n
13,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",23.14,2022,nh_vin5y4_n
13,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",50.0,2022,nh_sexy4_n
13,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",95.45,2022,nh_modhdy4_n
13,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",1.84,2022,nh_modhhdy4_n
13,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.1,2022,nh_modcapdy4_n
13,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",2.23,2022,nh_modccpdy4_n
13,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.39,2022,nh_modothry4_n
13,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",86.48,2022,nh_allmdcrmy4_n
13,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",7.24,2022,nh_insmdcdmy4_n
13,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",2.25,2022,nh_insempmy4_n
13,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",4.03,2022,nh_insnonothmy4_n
13,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",4.03,2022,nh_mefavfmy4_n
13,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",0.95,2022,nh_mefgraftmy4_n
13,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",91.58,2022,nh_mefcathmy4_n
13,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",3.44,2022,nh_mefoumaccessmy4_n
13,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",10.79,2022,nh_avfpresentmy4_n
13,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",23.13,2022,nh_nephnomy4_n
13,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",17.2,2022,nh_nephy6my4_n
13,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",17.56,2022,nh_nephy612my4_n
13,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",20.64,2022,nh_nephy12my4_n
13,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",21.47,2022,nh_nephunkmissmy4_n
13,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",89.8,2022,nh_ptinfymy4_n
13,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",1.85,2022,alcomy4_n
13,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",12.7,2022,ashdmy4_n
13,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",23.43,2022,othcarmy4_n
13,"N (2728): Incident Patients  - Percent with cancer, 2022",6.74,2022,canmy4_n
13,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",28.73,2022,chfmy4_n
13,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",9.63,2022,cvamy4_n
13,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",41.03,2022,diabimy4_n
13,"N (2728): Incident Patients  - Percent with diabetes, 2022",64.39,2022,diabmy4_n
13,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.57,2022,drugmy4_n
13,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",89.83,2022,hxhtmy4_n
13,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",6.22,2022,ambumy4_n
13,"N (2728): Incident Patients  - Percent inability to transfer, 2022",2.65,2022,transmy4_n
13,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",9.73,2022,copdmy4_n
13,"N (2728): Incident Patients  - Percent with PVD, 2022",8.31,2022,pvdmy4_n
13,"N (2728): Incident Patients  - Percent smoker, 2022",10.19,2022,smokmy4_n
13,"N (2728): Incident Patients  - Percent Hispanic, 2022",4.92,2022,ethmy4_n
13,"N (2728): Incident Patients  - Percent White, 2022",53.63,2022,whitemy4_n
13,"N (2728): Incident Patients  - Percent African American, 2022",39.87,2022,blackmy4_n
13,"N (2728): Incident Patients  - Percent Native American, 2022",3.93,2022,nativmy4_n
13,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",2.05,2022,asianmy4_n
13,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.52,2022,racoummy4_n
13,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",22.36,2022,cempmy4_n
13,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",32.14,2022,pempmy4_n
13,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",42.46,2022,dbprimy4_n
13,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",3.77,2022,gnprimy4_n
13,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",37.3,2022,htprimy4_n
13,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",16.47,2022,omprimy4_n
13,"N (2728): Incident Patients  - Percent female, 2022",45.47,2022,femmy4_n
13,"N (2728): Incident Patients  - Average age, 2022",63.16,2022,agemy4_n
13,"N (2728): Incident Patients  - Average serum albumin, 2022",3.33,2022,salbmy4_n
13,"N (2728): Incident Patients  - Average creatinine, 2022",6.33,2022,creamy4_n
13,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.38,2022,hgmy4_n
13,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",10.95,2022,gfrmy4_n
13,"N (2728): Incident Patients  - Average count of comorbidities, 2022",3.17,2022,cntcomy4_n
13,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",84.75,2022,pdmodMEFHDmy4_n
13,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",15.25,2022,pdmodMEFPDmy4_n
13,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
13,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",47.43,2022,insmdcrmy4_n
13,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",15.91,2022,insmdcdmy4_n
13,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",8.85,2022,insmdcrcdmy4_n
13,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",10.37,2022,insempmy4_n
13,"N (2728): Incident Patients  - Percent with no coverage, 2022",1.85,2022,insnonemy4_n
13,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",8.63,2022,insmdcromy4_n
13,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",6.96,2022,insmedomy4_n
13,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",15.65,2022,preepomy4_n
13,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",17.2,2022,nephnomy4_n
13,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",17.98,2022,nephy6my4_n
13,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",20.71,2022,nephy612my4_n
13,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",28.55,2022,nephy12my4_n
13,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",15.57,2022,nephunkmissmy4_n
13,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",93.56,2022,ptinfymy4_n
13,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",41.56,2022,ptxmedunfitmy4_n
13,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
13,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
13,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",8.44,2022,ptxdeclinemy4_n
13,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",58.13,2022,ptxnotassessmy4_n
13,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",11.41,2022,mefavfmy4_n
13,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",2.6,2022,mefgraftmy4_n
13,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",85.67,2022,mefcathmy4_n
13,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.31,2022,mefoumaccessmy4_n
13,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",19.75,2022,avfpresentmy4_n
13,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",28.72,2022,bmimmy4_n
13,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",29.69,2022,bmifmy4_n
13,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",0.93,2022,ptinfnmy4m_n
13,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",12.31,2022,hemomy4m_n
13,"N (2728): Incident Patients  - Average Number of forms returned, 2022",14.53,2022,nmy4m_n
13,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",74.7,2019,rdsmzm_n
13,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",48.15,2019,dyzm_n
13,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",10.01,2019,deazm_n
13,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",9.62,2019,exdzm_n
13,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.08,2019,dudzm_n
13,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",1.04,2019,smrz_n
13,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",21.93,2019,witz_n
13,"N: All Patient Mortality - % of deaths from infection, 2019-2022",9.7,2019,infz_n
13,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",50.12,2019,cardz_n
13,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.35,2019,livz_n
13,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",14.32,2019,fynmzm_n
13,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",8.62,2019,fydyzm_n
13,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.52,2019,fydeazm_n
13,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.44,2019,fyexdzm_n
13,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",1.03,2019,fysmrz_n
13,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",23.63,2019,fywitz_n
13,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",8.77,2019,fyinfz_n
13,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",45.76,2019,fycardiacz_n
13,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",1.83,2019,fylivz_n
13,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",63.19,2019,rdshzm_n
13,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",55.33,2019,htazm_n
13,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",56.44,2019,extzm_n
13,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",454.47,2019,hdzm_n
13,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",457.59,2019,exhdzm_n
13,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",39.97,2019,hdyzm_n
13,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",0.98,2019,shrtz_n
13,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.99,2019,shrdz_n
13,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.91,2019,lenz_n
13,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",9.59,2019,onez_n
13,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",7.0,2019,miiz_n
13,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",12.61,2019,sepiz_n
13,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",28.3,2019,achfz_n
13,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",17.85,2019,acdrz_n
13,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",3.21,2019,acarz_n
13,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",84.22,2019,ipedz_n
13,"N: ED30 - Average annual index discharges, 2019-22",31.98,2019,ed30indexzm_n
13,"N: ED30- Average annual number of ED visits, 2019-22",6.02,2019,ed30obszm_n
13,"N: ED30 - Average annual expected ED visits, 2019-22",5.21,2019,ed30expzm_n
13,"N: ED30: Standardized Ratio of ED30, 2019-22",1.21,2019,ed30z_n
13,"N SRR -  Standardized Readmission Ratio, 2022",1.03,2022,srry4_n
13,"N: SRR - Average index discharges, 2022",51.81,2022,indexmy4_n
13,"N: SRR - Average number of readmissions, 2022",13.2,2022,readmmy4_n
13,"N: SRR - Average expected readmissions, 2022",13.38,2022,srrexpmy4_n
13,Pt included in SEDR analysis,45.44,2019,rdsezm_n
13,Total number of ED Visits,50.67,2019,hedzm_n
13,Expected number of ED events,42.63,2019,exedzm_n
13,Years at risk for ED visit rate,28.3,2019,edyrzm_n
13,Years at risk for ED visit rate,41777.26,2019,edyrz_n
13,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",1.19,2019,sedrz_n
13,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",57.76,2019,rdstzm_n
13,"N: STR - Average number of patients (per year in average facility), 2019-2022",61.51,2019,rdsalltzm_n
13,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",1.42,2019,txzm_n
13,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",1.58,2019,txallzm_n
13,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",37.29,2019,txyzm_n
13,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.36,2019,cadalltzm_n
13,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.25,2019,livealltzm_n
13,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",1.84,2019,extxzm_n
13,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",0.77,2019,strz_n
13,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",58.87,2022,pppwpty4m_n
13,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",11.99,2022,WLy4_n
13,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",20.34,2022,WLlt40y4_n
13,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",11.05,2022,WL4074y4_n
13,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",12.98,2022,WLmaley4_n
13,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",10.67,2022,WLfemy4_n
13,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",11.79,2022,WLwhhy4_n
13,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",10.93,2022,WLwhnhy4_n
13,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",13.17,2022,WLbly4_n
13,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",16.58,2022,WLasy4_n
13,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",5.08,2022,WLnay4_n
13,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",7.53,2022,WLothy4_n
13,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",9.0,2022,WLDMy4_n
13,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",14.15,2022,WLnodmy4_n
13,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",11.11,2022,WLnotxy4_n
13,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",24.67,2022,WLtxy4_n
13,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",9.07,2022,WLVCat1y4_n
13,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",16.93,2022,WLVCat2y4_n
13,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",10.95,2022,WLVCat3y4_n
13,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",483.52,2022,pppwpmy4m_n
13,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",11.74,2022,pppwy4_n
13,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",10.22,2019,swrptzm_n
13,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",8.17,2019,swrpyzm_n
13,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.66,2019,swrwlzm_n
13,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.79,2019,swrexwlzm_n
13,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",0.84,2019,swrz_n
13,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",86.36,2021,FVfy3_n
13,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",7.7,2021,FVdeclinedfy3_n
13,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.09,2021,FVovndfy3_n
13,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",5.94,2021,FVothrsnfy3_n
13,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",77.28,2022,FVhy4_n
13,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",78.04,2022,FVmcarehy4_n
13,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",79.66,2022,FVmahy4_n
13,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",77.25,2022,FVmpphy4_n
13,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",78.03,2022,FVdualhy4_n
13,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",74.79,2022,FVmsphy4_n
13,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",70.68,2022,FVnonmcarehy4_n
13,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",30.0,2022,FVlt18hy4_n
13,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",68.44,2022,FV1839hy4_n
13,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",75.97,2022,FV4064hy4_n
13,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",79.7,2022,FV6574hy4_n
13,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",80.46,2022,FV75uphy4_n
13,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",76.45,2022,FVmalehy4_n
13,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",78.13,2022,FVfemhy4_n
13,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",77.26,2022,FVashy4_n
13,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",74.31,2022,FVnahy4_n
13,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",74.33,2022,FVwhhy4_n
13,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",74.24,2022,FVrothhy4_n
13,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",80.03,2022,FVblkhy4_n
13,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",74.08,2022,FVhisphy4_n
13,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",66.11,2022,FVVCat1hy4_n
13,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",76.42,2022,FVVCat2hy4_n
13,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",82.7,2022,FVVCat3hy4_n
13,"N: Influenza - Average number of patients treated on 12/31, 2022",54.39,2022,eFVy4m_n
13,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",1.16,2022,medrsnfy4m_N
13,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.71,2022,CWhdavgHGBy4_n
13,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",24.01,2022,CWhdhgb1y4_n
13,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",33.5,2022,CWhdhgb2y4_n
13,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",28.6,2022,CWhdhgb3y4_n
13,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",12.18,2022,CWhdhgb4y4_n
13,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",1.71,2022,CWhdhgb5y4_n
13,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",76.58,2022,CWhdesarxy4_n
13,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.01,2022,CWpdavgHGBy4_n
13,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",21.69,2022,CWpdhgb1y4_n
13,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",26.84,2022,CWpdhgb2y4_n
13,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",26.87,2022,CWpdhgb3y4_n
13,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",21.84,2022,CWpdhgb4y4_n
13,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.76,2022,CWpdhgb5y4_n
13,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",52.15,2022,CWpdesarxy4_n
13,"N: HD HGB (Adult) - Average number of eligible patients, 2022",62.33,2022,CWhdptdenomy4m_n
13,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",527.29,2022,CWhdptmthdenomy4m_n
13,"N: PD HGB (Adult) - Average number of eligible patients, 2022",24.7,2022,CWpdptdenomy4m_n
13,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",182.04,2022,CWpdptmthdenomy4m_n
13,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",33.0,2022,rdstfy4m_n
13,"N: STrR (Adult) - Average Patient Years at Risk, 2022",19.51,2022,tfyy4m_n
13,"N: STrR (Adult) - Average Number of Transfusions, 2022",7.28,2022,tfy4m_n
13,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",6.53,2022,extfy4m_n
13,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",1.11,2022,strry4_n
13,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.91,2022,CWhdalby4_n
13,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",1.82,2022,CWhdalb1y4_n
13,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",8.07,2022,CWhdalb2y4_n
13,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",39.0,2022,CWhdalb3y4_n
13,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",48.14,2022,CWhdalb4y4_n
13,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",2.97,2022,CWhdalb5y4_n
13,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",48.9,2022,CWhdalblt4y4_n
13,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.82,2022,CWhdavgufry4_n
13,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",86.05,2022,CWhdufr1y4_n
13,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",8.65,2022,CWhdufr2y4_n
13,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",2.58,2022,CWhdufrmissy4_n
13,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.72,2022,CWhdufrgt20y4_n
13,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.68,2022,CWpdalby4_n
13,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",6.04,2022,CWpdalb1y4_n
13,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",21.17,2022,CWpdalb2y4_n
13,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",43.26,2022,CWpdalb3y4_n
13,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",26.74,2022,CWpdalb4y4_n
13,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",2.78,2022,CWpdalb5y4_n
13,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",70.48,2022,CWpdalblt4y4_n
13,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",62.33,2022,CWhddenomy4m_n
13,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",527.29,2022,CWhdmthdenomy4m_n
13,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",24.7,2022,CWpddenomy4m_n
13,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",182.04,2022,CWpdmthdenomy4m_n
13,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.26,2022,CWpdavgktvy4_n
13,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",4.89,2022,CWpdktv1y4_n
13,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",67.16,2022,CWpdktv2y4_n
13,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",25.83,2022,CWpdktv3y4_n
13,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",2.12,2022,CWpdktv4y4_n
13,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.61,2022,CWhdavgktvy4_n
13,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",1.93,2022,CWhdktv1y4_n
13,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",73.48,2022,CWhdktv2y4_n
13,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",23.32,2022,CWhdktv3y4_n
13,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.27,2022,CWhdktv4y4_n
13,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",60.07,2022,CWhdktvptsy4m_N
13,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",504.75,2022,CWhdktvptmthy4m_N
14,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",2.44,2022,allmcFcovpatPq4_n
14,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",28.42,2022,allmcEcovpatPq4_n
14,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",36.28,2022,allmcEcovDeaPq4_n
14,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",35.23,2022,allmcEcovHosPq4_n
14,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",6.08,2022,nh_mcFcovpatPq4_n
14,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",42.81,2022,nh_mcEcovpatPq4_n
14,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",43.72,2022,nh_mcEcovDeaPq4_n
14,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",41.68,2022,nh_mcEcovHosPq4_n
14,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",61.38,2022,agey4_n
14,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.33,2022,age1y4_n
14,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",54.93,2022,age2y4_n
14,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",44.74,2022,age3y4_n
14,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",52.48,2022,dis1y4_n
14,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",29.55,2022,dis2y4_n
14,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",7.07,2022,dis3y4_n
14,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",10.36,2022,dis4y4_n
14,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.54,2022,dis5y4_n
14,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",17.09,2022,vin1y4_n
14,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",18.01,2022,vin2y4_n
14,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",12.69,2022,vin3y4_n
14,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",25.82,2022,vin4y4_n
14,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",26.39,2022,vin5y4_n
14,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",3.25,2022,rac1y4_n
14,"N: Prevalent Patients - Race: % African American, 12/31/2022",27.81,2022,rac2y4_n
14,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.41,2022,rac3y4_n
14,"N: Prevalent Patients - Race: % White, 12/31/2022",68.27,2022,rac4y4_n
14,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.26,2022,rac5y4_n
14,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",46.19,2022,eth1y4_n
14,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",53.73,2022,eth2y4_n
14,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.08,2022,eth3y4_n
14,"N: Prevalent Patients - Sex: % Female, 12/31/2022",42.99,2022,sexy4_n
14,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",11.14,2022,nrshomey4_n
14,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",4.87,2022,viny4_n
14,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",84.43,2022,modhdy4_n
14,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",2.41,2022,modhhdy4_n
14,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.06,2022,modcapdy4_n
14,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",11.95,2022,modccpdy4_n
14,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.16,2022,modothry4_n
14,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",60.07,2022,pahy4m_n
14,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",21.93,2022,CWunCa1y4_n
14,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",73.69,2022,CWunCa2y4_n
14,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",0.97,2022,CWunCa3y4_n
14,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",3.4,2022,CWunCamissy4_n
14,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
14,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.82,2022,CWavgUnCay4_n
14,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.54,2022,CWavgPy4_n
14,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.38,2022,CWP1y4_n
14,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",22.22,2022,CWP2y4_n
14,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",27.89,2022,CWP3y4_n
14,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",21.78,2022,CWP4y4_n
14,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",17.08,2022,CWP5y4_n
14,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",3.66,2022,CWPmissy4_n
14,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
14,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",2.44,2022,CWunCagt102y4_n
14,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",82.1,2022,CWptdenomy4m_n
14,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",700.23,2022,CWptmthdenomy4m_n
14,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",87.51,2022,serumphospatsy4m_n
14,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",740.91,2022,serumphospmy4m_n
14,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",82.1,2022,CWhcptdenomy4m_n
14,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",700.19,2022,CWhcptmthdenomy4m_n
14,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",59.76,2022,ppavfy4_n
14,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",16.76,2022,ppavgy4_n
14,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",20.93,2022,ppcathy4_n
14,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",2.55,2022,ppomy4_n
14,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",16.05,2022,ltcy4_n
14,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",8.4,2022,piavfy4_n
14,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",2.19,2022,piavgy4_n
14,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",85.02,2022,picathy4_n
14,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",4.39,2022,piomy4_n
14,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",8.8,2022,pifisty4_n
14,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",77.67,2022,phdvapty4m_n
14,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",651.85,2022,phdy4m_n
14,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",14.69,2022,ihdy4m_n
14,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",59.4,2022,sfry4_n
14,"N: VA infection - Average number of eligible PD patients, 2022",10.9,2022,pdpaty4m_n
14,"N: VA infection - Average number of eligible PD patient-months, 2022",75.44,2022,pdptmoy4m_n
14,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.43,2022,pd2inf100moy4_n
14,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",49.29,2022,ncmy4m_n
14,"N: Prevalent Comorbidities - Average % with Anemia, 2022",3.15,2022,clmanemy4_n
14,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.63,2022,clmhivaidmy4_n
14,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.25,2022,clmalcomy4_n
14,"N: Prevalent Comorbidities - Average % with Cancer, 2022",3.12,2022,clmcanmy4_n
14,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",1.1,2022,clmcamy4_n
14,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",17.17,2022,clmcdmy4_n
14,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",7.77,2022,clmcvdmy4_n
14,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",11.94,2022,clmcopdmy4_n
14,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",30.31,2022,clmchfmy4_n
14,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",41.54,2022,clmdiabmy4_n
14,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",0.64,2022,clmdrugmy4_n
14,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",2.74,2022,clmgtbmy4_n
14,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.33,2022,clmhepbmy4_n
14,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.72,2022,clmhepothmy4_n
14,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",16.2,2022,clmhypthymy4_n
14,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",19.66,2022,clminfmy4_n
14,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",27.74,2022,clmihdmy4_n
14,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",8.73,2022,clmmimy4_n
14,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",18.39,2022,clmpvdmy4_n
14,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",3.53,2022,clmpnemy4_n
14,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.24,2022,clmcntcomy4_n
14,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",4.92,2022,clminfvamy4_n
14,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.53,2022,clmmstinfmy4_n
14,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.2,2022,clmtbmy4_n
14,"N (AFS): Facility Information - Average number of patients, 2022",105.12,2022,allcnty4m_n
14,N (AFS): Facility Information - Average number of all patients on 12/31/2022,70.25,2022,endcnty4m_n
14,"N (AFS): Facility Information - Average % of patients transferred in, 2022",16.55,2022,transiny4_n
14,"N (AFS): Facility Information - Average % of patients transferred out, 2022",16.7,2022,transouty4_n
14,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,81.8,2022,medicarey4_n
14,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,8.39,2022,medpendy4_n
14,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,9.81,2022,nonmedy4_n
14,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.47,2022,cfc_N
14,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,4.81,2022,std_N
14,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",31.82,2022,p_age1y4_n
14,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",16.23,2022,p_age2y4_n
14,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",26.62,2022,p_age3y4_n
14,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",25.32,2022,p_age4y4_n
14,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",1.3,2022,p_dis1y4_n
14,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",0.65,2022,p_dis2y4_n
14,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",29.87,2022,p_dis3y4_n
14,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",36.36,2022,p_dis4y4_n
14,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
14,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
14,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",27.92,2022,p_dis7y4_n
14,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",3.9,2022,p_dis8y4_n
14,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",22.08,2022,p_vin1y4_n
14,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",22.73,2022,p_vin2y4_n
14,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",11.04,2022,p_vin3y4_n
14,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",25.32,2022,p_vin4y4_n
14,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",18.83,2022,p_vin5y4_n
14,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",1.3,2022,p_rac1y4_n
14,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",21.43,2022,p_rac2y4_n
14,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",0.0,2022,p_rac3y4_n
14,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",75.32,2022,p_rac4y4_n
14,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",1.95,2022,p_rac5y4_n
14,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",46.75,2022,p_eth1y4_n
14,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",53.25,2022,p_eth2y4_n
14,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
14,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",37.01,2022,p_sexy4_n
14,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",44.81,2022,p_modhdy4_n
14,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
14,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.0,2022,p_modcapdy4_n
14,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",55.19,2022,p_modccpdy4_n
14,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
14,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",6.35,2022,p_allmdcrmy4_n
14,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",47.62,2022,p_insmdcdmy4_n
14,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",30.16,2022,p_insempmy4_n
14,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",15.87,2022,p_insnonothmy4_n
14,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",25.4,2022,p_nephnomy4_n
14,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",28.57,2022,p_nephy6my4_n
14,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",9.52,2022,p_nephy612my4_n
14,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",33.33,2022,p_nephy12my4_n
14,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",3.17,2022,p_nephunkmissmy4_n
14,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",96.83,2022,p_ptinfymy4_n
14,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",3.03,2022,p_mefavfmy4_n
14,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
14,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",96.97,2022,p_mefcathmy4_n
14,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
14,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",3.03,2022,p_avfpresentmy4_n
14,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",11.83,2022,p_ppavfy4_n
14,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",72.8,2022,p_ltcy4_n
14,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",26.12,2022,p_WLy4_n
14,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",21.57,2022,p_WLlt10y4_n
14,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",32.11,2022,p_WL1017y4_n
14,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.77,2022,p_CWhdavgHGBy4_n
14,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",25.72,2022,p_CWhdhgb1y4_n
14,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",24.68,2022,p_CWhdhgb2y4_n
14,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",29.28,2022,p_CWhdhgb3y4_n
14,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",16.42,2022,p_CWhdhgb4y4_n
14,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.9,2022,p_CWhdhgb5y4_n
14,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.08,2022,p_CWpdavgHGBy4_n
14,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",21.04,2022,p_CWpdhgb1y4_n
14,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",21.62,2022,p_CWpdhgb2y4_n
14,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",26.32,2022,p_CWpdhgb3y4_n
14,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",24.66,2022,p_CWpdhgb4y4_n
14,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",6.36,2022,p_CWpdhgb5y4_n
14,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",3.74,2022,p_CWhdalby4_n
14,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",5.4,2022,p_CWhdalb1y4_n
14,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",15.61,2022,p_CWhdalb2y4_n
14,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",42.71,2022,p_CWhdalb3y4_n
14,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",32.26,2022,p_CWhdalb4y4_n
14,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",4.02,2022,p_CWhdalb5y4_n
14,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.4,2022,p_CWpdalby4_n
14,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",21.62,2022,p_CWpdalb1y4_n
14,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",27.4,2022,p_CWpdalb2y4_n
14,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",25.05,2022,p_CWpdalb3y4_n
14,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",19.08,2022,p_CWpdalb4y4_n
14,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",6.85,2022,p_CWpdalb5y4_n
14,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",84.74,2022,p_CWpdktvge18y4_n
14,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",90.75,2022,p_CWhdktvge12y4_n
14,"N: Patient Placement -  % of incident patients, 2022",17.44,2022,ppidy4_n
14,"N: Patient Placement -  % of patients continuing at facility, 2022",70.1,2022,ppcdy4_n
14,"N: Patient Placement -  % of patients that transfered into facility, 2022",12.46,2022,pptdy4_n
14,"N: End of Year Status - % of patients death attributed to this facility, 2022",12.79,2022,pdhdy4_n
14,"N: End of Year Status - % of patients death attributed to another facility, 2022",1.75,2022,pdody4_n
14,"N: End of Year Status - % of patients that received a transplant, 2022",2.73,2022,ptxdy4_n
14,"N: End of Year Status - % of patients alive in this facility, 2022",69.39,2022,pahdy4_n
14,"N: End of Year Status - % of patients alive in another facility, 2022",9.0,2022,paody4_n
14,"N: End of Year Status - % of patients other, 2022",4.34,2022,potdy4_n
14,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,59.84,2022,iuhemy4m_n
14,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.01,2022,iufreqy4m_n
14,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,59.83,2022,iunonfreqy4m_n
14,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.0,2022,iuothy4m_n
14,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
14,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
14,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,1.56,2022,ihhemy4m_n
14,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.56,2022,ihfreqy4m_n
14,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,0.99,2022,ihnonfreqy4m_n
14,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.03,2022,ihothy4m_n
14,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.83,2022,ihcapdy4m_n
14,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,7.98,2022,ihccpdy4m_n
14,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",15.19,2022,staffy4m_n
14,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,5.0,2022,nurseFTy4m_n
14,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,5.99,2022,ptcareFTy4m_n
14,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,1.14,2022,dietFTy4m_n
14,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.16,2022,socwkFTy4m_n
14,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.76,2022,nursePTy4m_n
14,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.49,2022,ptcarePTy4m_n
14,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.35,2022,dietPTy4m_n
14,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.31,2022,socwkPTy4m_n
14,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,39.16,2022,vocrehaby4m_n
14,"N (AFS): Facility Information - Average % incident patients, 2022",15.8,2022,incpery4_n
14,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,26.15,2022,employedy4_n
14,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.76,2022,schooly4_n
14,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",47.53,2022,nh_ppavfy4_n
14,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",21.33,2022,nh_ltcy4_n
14,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",2.32,2022,nh_CWhdktv1y4_n
14,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",10.05,2022,nh_CWpdktv1y4_n
14,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",28.4,2022,nh_CWhdhgb1y4_n
14,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",80.05,2022,nh_CWhdesarxy4_n
14,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",27.6,2022,nh_CWpdhgb1y4_n
14,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",56.37,2022,nh_CWpdesarxy4_n
14,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",44.01,2022,nh_obdry4_n
14,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.37,2022,nh_smry4_n
14,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",28.99,2022,nh_wity4_n
14,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",309.34,2022,nh_obhtry4_n
14,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.66,2022,nh_shrty4_n
14,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",27.18,2022,nh_sepiy4_n
14,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",14.4,2022,nh_miiy4_n
14,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",48.43,2022,nh_achfy4_n
14,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",33.35,2022,nh_acdry4_n
14,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",5.53,2022,nh_acary4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",0.7,2022,nh_clmhivaidmy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",8.18,2022,nh_clminfvamy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",0.55,2022,nh_clmhepbmy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",3.78,2022,nh_clmhepothmy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",4.5,2022,nh_clmmstinfmy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",9.76,2022,nh_clmpnemy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.25,2022,nh_clmtbmy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",43.2,2022,nh_clminfmy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.83,2022,nh_clmcamy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",38.02,2022,nh_clmcdmy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",22.21,2022,nh_clmcvdmy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",57.19,2022,nh_clmchfmy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",51.64,2022,nh_clmihdmy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",18.28,2022,nh_clmmimy4_n
14,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",39.79,2022,nh_clmpvdmy4_n
14,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.08,2022,nh_age1y4_n
14,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",33.84,2022,nh_age2y4_n
14,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",66.08,2022,nh_age3y4_n
14,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",60.02,2022,nh_dis1y4_n
14,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",27.41,2022,nh_dis2y4_n
14,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",3.1,2022,nh_dis3y4_n
14,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",8.93,2022,nh_dis4y4_n
14,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.54,2022,nh_dis5y4_n
14,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",2.19,2022,nh_rac1y4_n
14,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",30.28,2022,nh_rac2y4_n
14,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",0.31,2022,nh_rac3y4_n
14,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",67.08,2022,nh_rac4y4_n
14,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.13,2022,nh_rac5y4_n
14,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",36.17,2022,nh_eth1y4_n
14,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",63.7,2022,nh_eth2y4_n
14,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.13,2022,nh_eth3y4_n
14,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",22.05,2022,nh_vin1y4_n
14,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",16.29,2022,nh_vin2y4_n
14,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",11.08,2022,nh_vin3y4_n
14,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.34,2022,nh_vin4y4_n
14,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",26.24,2022,nh_vin5y4_n
14,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",49.0,2022,nh_sexy4_n
14,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",95.17,2022,nh_modhdy4_n
14,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",2.6,2022,nh_modhhdy4_n
14,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.19,2022,nh_modcapdy4_n
14,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",1.67,2022,nh_modccpdy4_n
14,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.37,2022,nh_modothry4_n
14,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",83.36,2022,nh_allmdcrmy4_n
14,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",4.67,2022,nh_insmdcdmy4_n
14,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",2.99,2022,nh_insempmy4_n
14,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",8.97,2022,nh_insnonothmy4_n
14,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",4.16,2022,nh_mefavfmy4_n
14,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",1.68,2022,nh_mefgraftmy4_n
14,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",90.98,2022,nh_mefcathmy4_n
14,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",3.18,2022,nh_mefoumaccessmy4_n
14,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",12.34,2022,nh_avfpresentmy4_n
14,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",22.94,2022,nh_nephnomy4_n
14,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",20.19,2022,nh_nephy6my4_n
14,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",17.06,2022,nh_nephy612my4_n
14,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",15.61,2022,nh_nephy12my4_n
14,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",24.21,2022,nh_nephunkmissmy4_n
14,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",91.54,2022,nh_ptinfymy4_n
14,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",1.2,2022,alcomy4_n
14,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",9.45,2022,ashdmy4_n
14,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",16.33,2022,othcarmy4_n
14,"N (2728): Incident Patients  - Percent with cancer, 2022",4.49,2022,canmy4_n
14,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",23.77,2022,chfmy4_n
14,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",7.03,2022,cvamy4_n
14,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",44.0,2022,diabimy4_n
14,"N (2728): Incident Patients  - Percent with diabetes, 2022",68.89,2022,diabmy4_n
14,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.17,2022,drugmy4_n
14,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",88.46,2022,hxhtmy4_n
14,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",6.23,2022,ambumy4_n
14,"N (2728): Incident Patients  - Percent inability to transfer, 2022",2.94,2022,transmy4_n
14,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",5.17,2022,copdmy4_n
14,"N (2728): Incident Patients  - Percent with PVD, 2022",7.37,2022,pvdmy4_n
14,"N (2728): Incident Patients  - Percent smoker, 2022",4.45,2022,smokmy4_n
14,"N (2728): Incident Patients  - Percent Hispanic, 2022",43.33,2022,ethmy4_n
14,"N (2728): Incident Patients  - Percent White, 2022",71.74,2022,whitemy4_n
14,"N (2728): Incident Patients  - Percent African American, 2022",23.62,2022,blackmy4_n
14,"N (2728): Incident Patients  - Percent Native American, 2022",1.08,2022,nativmy4_n
14,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",3.12,2022,asianmy4_n
14,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.43,2022,racoummy4_n
14,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",27.64,2022,cempmy4_n
14,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",37.61,2022,pempmy4_n
14,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",52.91,2022,dbprimy4_n
14,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",4.6,2022,gnprimy4_n
14,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",29.24,2022,htprimy4_n
14,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",13.25,2022,omprimy4_n
14,"N (2728): Incident Patients  - Percent female, 2022",42.96,2022,femmy4_n
14,"N (2728): Incident Patients  - Average age, 2022",62.02,2022,agemy4_n
14,"N (2728): Incident Patients  - Average serum albumin, 2022",3.23,2022,salbmy4_n
14,"N (2728): Incident Patients  - Average creatinine, 2022",6.66,2022,creamy4_n
14,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.17,2022,hgmy4_n
14,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",10.36,2022,gfrmy4_n
14,"N (2728): Incident Patients  - Average count of comorbidities, 2022",2.91,2022,cntcomy4_n
14,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",85.75,2022,pdmodMEFHDmy4_n
14,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",14.25,2022,pdmodMEFPDmy4_n
14,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
14,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",45.26,2022,insmdcrmy4_n
14,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",5.8,2022,insmdcdmy4_n
14,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",5.43,2022,insmdcrcdmy4_n
14,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",13.61,2022,insempmy4_n
14,"N (2728): Incident Patients  - Percent with no coverage, 2022",11.88,2022,insnonemy4_n
14,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",6.14,2022,insmdcromy4_n
14,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",11.88,2022,insmedomy4_n
14,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",11.83,2022,preepomy4_n
14,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",20.63,2022,nephnomy4_n
14,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",19.04,2022,nephy6my4_n
14,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",19.13,2022,nephy612my4_n
14,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",21.74,2022,nephy12my4_n
14,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",19.47,2022,nephunkmissmy4_n
14,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",95.22,2022,ptinfymy4_n
14,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",37.14,2022,ptxmedunfitmy4_n
14,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
14,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
14,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",10.9,2022,ptxdeclinemy4_n
14,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",59.63,2022,ptxnotassessmy4_n
14,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",8.5,2022,mefavfmy4_n
14,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",1.95,2022,mefgraftmy4_n
14,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",89.31,2022,mefcathmy4_n
14,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.25,2022,mefoumaccessmy4_n
14,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",17.67,2022,avfpresentmy4_n
14,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",28.25,2022,bmimmy4_n
14,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",28.8,2022,bmifmy4_n
14,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",0.77,2022,ptinfnmy4m_n
14,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",13.75,2022,hemomy4m_n
14,"N (2728): Incident Patients  - Average Number of forms returned, 2022",16.04,2022,nmy4m_n
14,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",84.8,2019,rdsmzm_n
14,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",55.26,2019,dyzm_n
14,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",10.27,2019,deazm_n
14,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",9.78,2019,exdzm_n
14,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.07,2019,dudzm_n
14,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",1.05,2019,smrz_n
14,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",23.33,2019,witz_n
14,"N: All Patient Mortality - % of deaths from infection, 2019-2022",11.83,2019,infz_n
14,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",47.0,2019,cardz_n
14,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.88,2019,livz_n
14,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",15.41,2019,fynmzm_n
14,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",9.46,2019,fydyzm_n
14,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.32,2019,fydeazm_n
14,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",1.96,2019,fyexdzm_n
14,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",1.19,2019,fysmrz_n
14,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",25.2,2019,fywitz_n
14,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",10.26,2019,fyinfz_n
14,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",40.79,2019,fycardiacz_n
14,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",3.38,2019,fylivz_n
14,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",71.7,2019,rdshzm_n
14,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",66.32,2019,htazm_n
14,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",64.97,2019,extzm_n
14,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",555.19,2019,hdzm_n
14,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",531.57,2019,exhdzm_n
14,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",45.81,2019,hdyzm_n
14,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",1.02,2019,shrtz_n
14,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",1.04,2019,shrdz_n
14,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.99,2019,lenz_n
14,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",8.39,2019,onez_n
14,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",7.7,2019,miiz_n
14,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",13.75,2019,sepiz_n
14,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",27.53,2019,achfz_n
14,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",17.22,2019,acdrz_n
14,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",3.35,2019,acarz_n
14,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",84.84,2019,ipedz_n
14,"N: ED30 - Average annual index discharges, 2019-22",33.63,2019,ed30indexzm_n
14,"N: ED30- Average annual number of ED visits, 2019-22",5.55,2019,ed30obszm_n
14,"N: ED30 - Average annual expected ED visits, 2019-22",5.55,2019,ed30expzm_n
14,"N: ED30: Standardized Ratio of ED30, 2019-22",1.04,2019,ed30z_n
14,"N SRR -  Standardized Readmission Ratio, 2022",1.05,2022,srry4_n
14,"N: SRR - Average index discharges, 2022",65.71,2022,indexmy4_n
14,"N: SRR - Average number of readmissions, 2022",17.42,2022,readmmy4_n
14,"N: SRR - Average expected readmissions, 2022",17.18,2022,srrexpmy4_n
14,Pt included in SEDR analysis,45.63,2019,rdsezm_n
14,Total number of ED Visits,43.22,2019,hedzm_n
14,Expected number of ED events,42.62,2019,exedzm_n
14,Years at risk for ED visit rate,28.21,2019,edyrzm_n
14,Years at risk for ED visit rate,90615.81,2019,edyrz_n
14,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",1.01,2019,sedrz_n
14,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",66.79,2019,rdstzm_n
14,"N: STR - Average number of patients (per year in average facility), 2019-2022",70.79,2019,rdsalltzm_n
14,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",1.84,2019,txzm_n
14,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",2.03,2019,txallzm_n
14,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",43.58,2019,txyzm_n
14,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.57,2019,cadalltzm_n
14,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.51,2019,livealltzm_n
14,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",2.15,2019,extxzm_n
14,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",0.86,2019,strz_n
14,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",69.19,2022,pppwpty4m_n
14,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",15.12,2022,WLy4_n
14,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",23.03,2022,WLlt40y4_n
14,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",14.26,2022,WL4074y4_n
14,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",16.42,2022,WLmaley4_n
14,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",13.29,2022,WLfemy4_n
14,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",14.85,2022,WLwhhy4_n
14,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",14.67,2022,WLwhnhy4_n
14,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",15.02,2022,WLbly4_n
14,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",23.07,2022,WLasy4_n
14,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",13.68,2022,WLnay4_n
14,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",17.25,2022,WLothy4_n
14,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",12.89,2022,WLDMy4_n
14,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",17.62,2022,WLnodmy4_n
14,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",14.31,2022,WLnotxy4_n
14,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",27.44,2022,WLtxy4_n
14,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",11.33,2022,WLVCat1y4_n
14,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",21.18,2022,WLVCat2y4_n
14,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",13.9,2022,WLVCat3y4_n
14,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",577.16,2022,pppwpmy4m_n
14,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",14.63,2022,pppwy4_n
14,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",11.31,2019,swrptzm_n
14,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",9.04,2019,swrpyzm_n
14,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.92,2019,swrwlzm_n
14,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",1.0,2019,swrexwlzm_n
14,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",0.92,2019,swrz_n
14,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",85.0,2021,FVfy3_n
14,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",7.04,2021,FVdeclinedfy3_n
14,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.09,2021,FVovndfy3_n
14,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",7.97,2021,FVothrsnfy3_n
14,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",79.3,2022,FVhy4_n
14,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",80.17,2022,FVmcarehy4_n
14,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",81.73,2022,FVmahy4_n
14,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",79.07,2022,FVmpphy4_n
14,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",81.13,2022,FVdualhy4_n
14,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",76.4,2022,FVmsphy4_n
14,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",72.84,2022,FVnonmcarehy4_n
14,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",37.65,2022,FVlt18hy4_n
14,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",70.5,2022,FV1839hy4_n
14,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",77.79,2022,FV4064hy4_n
14,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",81.78,2022,FV6574hy4_n
14,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",83.01,2022,FV75uphy4_n
14,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",78.63,2022,FVmalehy4_n
14,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",79.81,2022,FVfemhy4_n
14,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",78.35,2022,FVashy4_n
14,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",72.52,2022,FVnahy4_n
14,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",81.6,2022,FVwhhy4_n
14,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",55.63,2022,FVrothhy4_n
14,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",73.41,2022,FVblkhy4_n
14,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",84.27,2022,FVhisphy4_n
14,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",70.25,2022,FVVCat1hy4_n
14,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",78.68,2022,FVVCat2hy4_n
14,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",83.19,2022,FVVCat3hy4_n
14,"N: Influenza - Average number of patients treated on 12/31, 2022",63.1,2022,eFVy4m_n
14,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",1.85,2022,medrsnfy4m_N
14,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.77,2022,CWhdavgHGBy4_n
14,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",21.27,2022,CWhdhgb1y4_n
14,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",34.42,2022,CWhdhgb2y4_n
14,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",29.1,2022,CWhdhgb3y4_n
14,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",12.41,2022,CWhdhgb4y4_n
14,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.79,2022,CWhdhgb5y4_n
14,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",76.92,2022,CWhdesarxy4_n
14,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.91,2022,CWpdavgHGBy4_n
14,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",22.12,2022,CWpdhgb1y4_n
14,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",28.96,2022,CWpdhgb2y4_n
14,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",26.37,2022,CWpdhgb3y4_n
14,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",18.43,2022,CWpdhgb4y4_n
14,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",4.12,2022,CWpdhgb5y4_n
14,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",57.95,2022,CWpdesarxy4_n
14,"N: HD HGB (Adult) - Average number of eligible patients, 2022",73.51,2022,CWhdptdenomy4m_n
14,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",625.59,2022,CWhdptmthdenomy4m_n
14,"N: PD HGB (Adult) - Average number of eligible patients, 2022",24.34,2022,CWpdptdenomy4m_n
14,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",186.65,2022,CWpdptmthdenomy4m_n
14,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",32.85,2022,rdstfy4m_n
14,"N: STrR (Adult) - Average Patient Years at Risk, 2022",19.05,2022,tfyy4m_n
14,"N: STrR (Adult) - Average Number of Transfusions, 2022",6.04,2022,tfy4m_n
14,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",6.26,2022,extfy4m_n
14,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.97,2022,strry4_n
14,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.93,2022,CWhdalby4_n
14,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",1.65,2022,CWhdalb1y4_n
14,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",7.42,2022,CWhdalb2y4_n
14,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",36.32,2022,CWhdalb3y4_n
14,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",50.68,2022,CWhdalb4y4_n
14,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",3.92,2022,CWhdalb5y4_n
14,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",45.4,2022,CWhdalblt4y4_n
14,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.91,2022,CWhdavgufry4_n
14,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",86.98,2022,CWhdufr1y4_n
14,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",7.42,2022,CWhdufr2y4_n
14,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",3.71,2022,CWhdufrmissy4_n
14,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",1.89,2022,CWhdufrgt20y4_n
14,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.7,2022,CWpdalby4_n
14,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",5.01,2022,CWpdalb1y4_n
14,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",20.38,2022,CWpdalb2y4_n
14,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",42.85,2022,CWpdalb3y4_n
14,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",27.58,2022,CWpdalb4y4_n
14,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",4.18,2022,CWpdalb5y4_n
14,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",68.23,2022,CWpdalblt4y4_n
14,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",73.51,2022,CWhddenomy4m_n
14,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",625.59,2022,CWhdmthdenomy4m_n
14,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",24.34,2022,CWpddenomy4m_n
14,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",186.65,2022,CWpdmthdenomy4m_n
14,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.2,2022,CWpdavgktvy4_n
14,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",5.56,2022,CWpdktv1y4_n
14,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",68.48,2022,CWpdktv2y4_n
14,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",21.71,2022,CWpdktv3y4_n
14,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",4.25,2022,CWpdktv4y4_n
14,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.66,2022,CWhdavgktvy4_n
14,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",1.47,2022,CWhdktv1y4_n
14,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",67.28,2022,CWhdktv2y4_n
14,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",29.28,2022,CWhdktv3y4_n
14,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.97,2022,CWhdktv4y4_n
14,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",72.0,2022,CWhdktvptsy4m_N
14,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",609.2,2022,CWhdktvptmthy4m_N
15,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",3.65,2022,allmcFcovpatPq4_n
15,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",28.11,2022,allmcEcovpatPq4_n
15,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",35.14,2022,allmcEcovDeaPq4_n
15,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",36.35,2022,allmcEcovHosPq4_n
15,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",8.67,2022,nh_mcFcovpatPq4_n
15,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",42.38,2022,nh_mcEcovpatPq4_n
15,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",47.03,2022,nh_mcEcovDeaPq4_n
15,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",42.4,2022,nh_mcEcovHosPq4_n
15,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",61.96,2022,agey4_n
15,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.26,2022,age1y4_n
15,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",52.71,2022,age2y4_n
15,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",47.03,2022,age3y4_n
15,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",52.56,2022,dis1y4_n
15,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",22.13,2022,dis2y4_n
15,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",10.17,2022,dis3y4_n
15,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",14.51,2022,dis4y4_n
15,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.63,2022,dis5y4_n
15,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",16.7,2022,vin1y4_n
15,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",18.46,2022,vin2y4_n
15,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",14.19,2022,vin3y4_n
15,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",25.21,2022,vin4y4_n
15,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",25.44,2022,vin5y4_n
15,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",7.19,2022,rac1y4_n
15,"N: Prevalent Patients - Race: % African American, 12/31/2022",11.68,2022,rac2y4_n
15,"N: Prevalent Patients - Race: % Native American, 12/31/2022",11.62,2022,rac3y4_n
15,"N: Prevalent Patients - Race: % White, 12/31/2022",69.04,2022,rac4y4_n
15,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.47,2022,rac5y4_n
15,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",32.02,2022,eth1y4_n
15,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",67.85,2022,eth2y4_n
15,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.13,2022,eth3y4_n
15,"N: Prevalent Patients - Sex: % Female, 12/31/2022",41.45,2022,sexy4_n
15,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",11.26,2022,nrshomey4_n
15,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",4.8,2022,viny4_n
15,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",83.15,2022,modhdy4_n
15,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",2.25,2022,modhhdy4_n
15,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.22,2022,modcapdy4_n
15,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",13.24,2022,modccpdy4_n
15,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.13,2022,modothry4_n
15,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",58.92,2022,pahy4m_n
15,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",19.34,2022,CWunCa1y4_n
15,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",77.02,2022,CWunCa2y4_n
15,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.1,2022,CWunCa3y4_n
15,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",2.54,2022,CWunCamissy4_n
15,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
15,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.88,2022,CWavgUnCay4_n
15,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.52,2022,CWavgPy4_n
15,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.7,2022,CWP1y4_n
15,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",22.46,2022,CWP2y4_n
15,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",27.83,2022,CWP3y4_n
15,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",22.26,2022,CWP4y4_n
15,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",16.74,2022,CWP5y4_n
15,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",3.01,2022,CWPmissy4_n
15,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
15,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",1.44,2022,CWunCagt102y4_n
15,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",81.76,2022,CWptdenomy4m_n
15,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",690.72,2022,CWptmthdenomy4m_n
15,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",87.3,2022,serumphospatsy4m_n
15,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",731.34,2022,serumphospmy4m_n
15,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",81.76,2022,CWhcptdenomy4m_n
15,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",690.66,2022,CWhcptmthdenomy4m_n
15,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",65.43,2022,ppavfy4_n
15,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",11.89,2022,ppavgy4_n
15,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",20.8,2022,ppcathy4_n
15,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",1.88,2022,ppomy4_n
15,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",15.7,2022,ltcy4_n
15,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",14.76,2022,piavfy4_n
15,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",2.33,2022,piavgy4_n
15,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",79.01,2022,picathy4_n
15,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",3.9,2022,piomy4_n
15,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",15.18,2022,pifisty4_n
15,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",75.45,2022,phdvapty4m_n
15,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",629.31,2022,phdy4m_n
15,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",13.37,2022,ihdy4m_n
15,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",65.03,2022,sfry4_n
15,"N: VA infection - Average number of eligible PD patients, 2022",13.16,2022,pdpaty4m_n
15,"N: VA infection - Average number of eligible PD patient-months, 2022",95.42,2022,pdptmoy4m_n
15,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",1.92,2022,pd2inf100moy4_n
15,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",45.93,2022,ncmy4m_n
15,"N: Prevalent Comorbidities - Average % with Anemia, 2022",4.03,2022,clmanemy4_n
15,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.28,2022,clmhivaidmy4_n
15,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.66,2022,clmalcomy4_n
15,"N: Prevalent Comorbidities - Average % with Cancer, 2022",3.18,2022,clmcanmy4_n
15,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",0.89,2022,clmcamy4_n
15,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",16.45,2022,clmcdmy4_n
15,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",5.51,2022,clmcvdmy4_n
15,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",11.73,2022,clmcopdmy4_n
15,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",26.22,2022,clmchfmy4_n
15,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",36.83,2022,clmdiabmy4_n
15,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",1.65,2022,clmdrugmy4_n
15,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",2.39,2022,clmgtbmy4_n
15,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.32,2022,clmhepbmy4_n
15,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.43,2022,clmhepothmy4_n
15,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",16.31,2022,clmhypthymy4_n
15,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",18.71,2022,clminfmy4_n
15,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",22.76,2022,clmihdmy4_n
15,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",6.75,2022,clmmimy4_n
15,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",14.32,2022,clmpvdmy4_n
15,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",3.19,2022,clmpnemy4_n
15,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.01,2022,clmcntcomy4_n
15,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",4.24,2022,clminfvamy4_n
15,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.5,2022,clmmstinfmy4_n
15,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.2,2022,clmtbmy4_n
15,"N (AFS): Facility Information - Average number of patients, 2022",106.41,2022,allcnty4m_n
15,N (AFS): Facility Information - Average number of all patients on 12/31/2022,67.33,2022,endcnty4m_n
15,"N (AFS): Facility Information - Average % of patients transferred in, 2022",18.78,2022,transiny4_n
15,"N (AFS): Facility Information - Average % of patients transferred out, 2022",19.29,2022,transouty4_n
15,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,77.98,2022,medicarey4_n
15,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,9.55,2022,medpendy4_n
15,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,12.47,2022,nonmedy4_n
15,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.25,2022,cfc_N
15,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,2.92,2022,std_N
15,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",26.67,2022,p_age1y4_n
15,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",15.0,2022,p_age2y4_n
15,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",31.67,2022,p_age3y4_n
15,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",26.67,2022,p_age4y4_n
15,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",1.67,2022,p_dis1y4_n
15,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",0.0,2022,p_dis2y4_n
15,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",25.0,2022,p_dis3y4_n
15,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",31.67,2022,p_dis4y4_n
15,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
15,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
15,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",33.33,2022,p_dis7y4_n
15,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",8.33,2022,p_dis8y4_n
15,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",30.0,2022,p_vin1y4_n
15,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",13.33,2022,p_vin2y4_n
15,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",25.0,2022,p_vin3y4_n
15,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",15.0,2022,p_vin4y4_n
15,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",16.67,2022,p_vin5y4_n
15,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",8.33,2022,p_rac1y4_n
15,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",6.67,2022,p_rac2y4_n
15,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",6.67,2022,p_rac3y4_n
15,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",75.0,2022,p_rac4y4_n
15,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",3.33,2022,p_rac5y4_n
15,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",38.33,2022,p_eth1y4_n
15,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",61.67,2022,p_eth2y4_n
15,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
15,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",48.33,2022,p_sexy4_n
15,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",45.0,2022,p_modhdy4_n
15,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",1.67,2022,p_modhhdy4_n
15,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.0,2022,p_modcapdy4_n
15,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",53.33,2022,p_modccpdy4_n
15,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
15,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",4.35,2022,p_allmdcrmy4_n
15,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",52.17,2022,p_insmdcdmy4_n
15,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",32.61,2022,p_insempmy4_n
15,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",10.87,2022,p_insnonothmy4_n
15,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",13.04,2022,p_nephnomy4_n
15,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",39.13,2022,p_nephy6my4_n
15,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",10.87,2022,p_nephy612my4_n
15,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",34.78,2022,p_nephy12my4_n
15,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",2.17,2022,p_nephunkmissmy4_n
15,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",100.0,2022,p_ptinfymy4_n
15,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",3.7,2022,p_mefavfmy4_n
15,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
15,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",96.3,2022,p_mefcathmy4_n
15,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
15,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",3.7,2022,p_avfpresentmy4_n
15,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",27.6,2022,p_ppavfy4_n
15,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",55.46,2022,p_ltcy4_n
15,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",37.96,2022,p_WLy4_n
15,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",46.2,2022,p_WLlt10y4_n
15,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",37.5,2022,p_WL1017y4_n
15,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.97,2022,p_CWhdavgHGBy4_n
15,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",16.81,2022,p_CWhdhgb1y4_n
15,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",26.5,2022,p_CWhdhgb2y4_n
15,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",37.61,2022,p_CWhdhgb3y4_n
15,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",17.09,2022,p_CWhdhgb4y4_n
15,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",1.99,2022,p_CWhdhgb5y4_n
15,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.91,2022,p_CWpdavgHGBy4_n
15,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",23.8,2022,p_CWpdhgb1y4_n
15,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",22.19,2022,p_CWpdhgb2y4_n
15,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",20.32,2022,p_CWpdhgb3y4_n
15,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",20.05,2022,p_CWpdhgb4y4_n
15,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",13.64,2022,p_CWpdhgb5y4_n
15,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",3.94,2022,p_CWhdalby4_n
15,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",2.85,2022,p_CWhdalb1y4_n
15,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",18.52,2022,p_CWhdalb2y4_n
15,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",27.64,2022,p_CWhdalb3y4_n
15,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",50.14,2022,p_CWhdalb4y4_n
15,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",0.85,2022,p_CWhdalb5y4_n
15,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.72,2022,p_CWpdalby4_n
15,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",16.84,2022,p_CWpdalb1y4_n
15,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",10.43,2022,p_CWpdalb2y4_n
15,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",19.79,2022,p_CWpdalb3y4_n
15,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",39.84,2022,p_CWpdalb4y4_n
15,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",13.1,2022,p_CWpdalb5y4_n
15,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",80.48,2022,p_CWpdktvge18y4_n
15,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",92.83,2022,p_CWhdktvge12y4_n
15,"N: Patient Placement -  % of incident patients, 2022",16.9,2022,ppidy4_n
15,"N: Patient Placement -  % of patients continuing at facility, 2022",69.84,2022,ppcdy4_n
15,"N: Patient Placement -  % of patients that transfered into facility, 2022",13.26,2022,pptdy4_n
15,"N: End of Year Status - % of patients death attributed to this facility, 2022",13.05,2022,pdhdy4_n
15,"N: End of Year Status - % of patients death attributed to another facility, 2022",1.75,2022,pdody4_n
15,"N: End of Year Status - % of patients that received a transplant, 2022",3.63,2022,ptxdy4_n
15,"N: End of Year Status - % of patients alive in this facility, 2022",68.3,2022,pahdy4_n
15,"N: End of Year Status - % of patients alive in another facility, 2022",9.7,2022,paody4_n
15,"N: End of Year Status - % of patients other, 2022",3.57,2022,potdy4_n
15,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,56.21,2022,iuhemy4m_n
15,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.07,2022,iufreqy4m_n
15,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,56.14,2022,iunonfreqy4m_n
15,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.04,2022,iuothy4m_n
15,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
15,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
15,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,1.37,2022,ihhemy4m_n
15,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.57,2022,ihfreqy4m_n
15,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,0.8,2022,ihnonfreqy4m_n
15,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
15,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.85,2022,ihcapdy4m_n
15,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,8.86,2022,ihccpdy4m_n
15,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",15.05,2022,staffy4m_n
15,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,4.1,2022,nurseFTy4m_n
15,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,6.69,2022,ptcareFTy4m_n
15,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,1.1,2022,dietFTy4m_n
15,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.05,2022,socwkFTy4m_n
15,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.59,2022,nursePTy4m_n
15,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,0.69,2022,ptcarePTy4m_n
15,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.45,2022,dietPTy4m_n
15,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.38,2022,socwkPTy4m_n
15,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,35.85,2022,vocrehaby4m_n
15,"N (AFS): Facility Information - Average % incident patients, 2022",15.08,2022,incpery4_n
15,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,29.13,2022,employedy4_n
15,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.89,2022,schooly4_n
15,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",54.5,2022,nh_ppavfy4_n
15,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",21.33,2022,nh_ltcy4_n
15,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",2.13,2022,nh_CWhdktv1y4_n
15,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",10.34,2022,nh_CWpdktv1y4_n
15,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",28.68,2022,nh_CWhdhgb1y4_n
15,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",77.13,2022,nh_CWhdesarxy4_n
15,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",28.23,2022,nh_CWpdhgb1y4_n
15,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",51.16,2022,nh_CWpdesarxy4_n
15,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",40.06,2022,nh_obdry4_n
15,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.18,2022,nh_smry4_n
15,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",25.45,2022,nh_wity4_n
15,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",271.76,2022,nh_obhtry4_n
15,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.54,2022,nh_shrty4_n
15,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",25.69,2022,nh_sepiy4_n
15,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",11.07,2022,nh_miiy4_n
15,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",43.76,2022,nh_achfy4_n
15,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",32.23,2022,nh_acdry4_n
15,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",4.05,2022,nh_acary4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",0.38,2022,nh_clmhivaidmy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",7.94,2022,nh_clminfvamy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",0.68,2022,nh_clmhepbmy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",2.72,2022,nh_clmhepothmy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",4.84,2022,nh_clmmstinfmy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",8.54,2022,nh_clmpnemy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.25,2022,nh_clmtbmy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",42.17,2022,nh_clminfmy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.29,2022,nh_clmcamy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",37.2,2022,nh_clmcdmy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",14.9,2022,nh_clmcvdmy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",51.97,2022,nh_clmchfmy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",42.85,2022,nh_clmihdmy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",13.84,2022,nh_clmmimy4_n
15,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",33.84,2022,nh_clmpvdmy4_n
15,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
15,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",34.71,2022,nh_age2y4_n
15,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",65.29,2022,nh_age3y4_n
15,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",61.14,2022,nh_dis1y4_n
15,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",19.95,2022,nh_dis2y4_n
15,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",4.83,2022,nh_dis3y4_n
15,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",13.27,2022,nh_dis4y4_n
15,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.81,2022,nh_dis5y4_n
15,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",5.18,2022,nh_rac1y4_n
15,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",12.01,2022,nh_rac2y4_n
15,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",10.47,2022,nh_rac3y4_n
15,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",72.0,2022,nh_rac4y4_n
15,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.35,2022,nh_rac5y4_n
15,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",26.24,2022,nh_eth1y4_n
15,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",73.69,2022,nh_eth2y4_n
15,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.08,2022,nh_eth3y4_n
15,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",21.37,2022,nh_vin1y4_n
15,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",15.77,2022,nh_vin2y4_n
15,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.39,2022,nh_vin3y4_n
15,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",24.66,2022,nh_vin4y4_n
15,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",24.82,2022,nh_vin5y4_n
15,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",45.99,2022,nh_sexy4_n
15,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",96.51,2022,nh_modhdy4_n
15,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",1.11,2022,nh_modhhdy4_n
15,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.12,2022,nh_modcapdy4_n
15,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",2.11,2022,nh_modccpdy4_n
15,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.15,2022,nh_modothry4_n
15,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",82.26,2022,nh_allmdcrmy4_n
15,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",12.0,2022,nh_insmdcdmy4_n
15,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",1.54,2022,nh_insempmy4_n
15,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",4.21,2022,nh_insnonothmy4_n
15,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",6.56,2022,nh_mefavfmy4_n
15,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",1.64,2022,nh_mefgraftmy4_n
15,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",88.62,2022,nh_mefcathmy4_n
15,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",3.18,2022,nh_mefoumaccessmy4_n
15,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",16.0,2022,nh_avfpresentmy4_n
15,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",15.38,2022,nh_nephnomy4_n
15,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",27.79,2022,nh_nephy6my4_n
15,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",13.74,2022,nh_nephy612my4_n
15,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",21.23,2022,nh_nephy12my4_n
15,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",21.85,2022,nh_nephunkmissmy4_n
15,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",91.28,2022,nh_ptinfymy4_n
15,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",1.71,2022,alcomy4_n
15,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",6.4,2022,ashdmy4_n
15,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",13.94,2022,othcarmy4_n
15,"N (2728): Incident Patients  - Percent with cancer, 2022",4.74,2022,canmy4_n
15,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",15.84,2022,chfmy4_n
15,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",5.27,2022,cvamy4_n
15,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",39.55,2022,diabimy4_n
15,"N (2728): Incident Patients  - Percent with diabetes, 2022",66.12,2022,diabmy4_n
15,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.43,2022,drugmy4_n
15,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",84.43,2022,hxhtmy4_n
15,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",3.48,2022,ambumy4_n
15,"N (2728): Incident Patients  - Percent inability to transfer, 2022",1.59,2022,transmy4_n
15,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",4.68,2022,copdmy4_n
15,"N (2728): Incident Patients  - Percent with PVD, 2022",4.73,2022,pvdmy4_n
15,"N (2728): Incident Patients  - Percent smoker, 2022",4.08,2022,smokmy4_n
15,"N (2728): Incident Patients  - Percent Hispanic, 2022",29.19,2022,ethmy4_n
15,"N (2728): Incident Patients  - Percent White, 2022",72.78,2022,whitemy4_n
15,"N (2728): Incident Patients  - Percent African American, 2022",10.16,2022,blackmy4_n
15,"N (2728): Incident Patients  - Percent Native American, 2022",10.21,2022,nativmy4_n
15,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",6.26,2022,asianmy4_n
15,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.6,2022,racoummy4_n
15,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",29.23,2022,cempmy4_n
15,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",39.06,2022,pempmy4_n
15,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",50.69,2022,dbprimy4_n
15,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",7.03,2022,gnprimy4_n
15,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",22.73,2022,htprimy4_n
15,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",19.54,2022,omprimy4_n
15,"N (2728): Incident Patients  - Percent female, 2022",40.43,2022,femmy4_n
15,"N (2728): Incident Patients  - Average age, 2022",62.44,2022,agemy4_n
15,"N (2728): Incident Patients  - Average serum albumin, 2022",3.45,2022,salbmy4_n
15,"N (2728): Incident Patients  - Average creatinine, 2022",6.25,2022,creamy4_n
15,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.65,2022,hgmy4_n
15,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",10.68,2022,gfrmy4_n
15,"N (2728): Incident Patients  - Average count of comorbidities, 2022",2.58,2022,cntcomy4_n
15,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",83.09,2022,pdmodMEFHDmy4_n
15,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",16.91,2022,pdmodMEFPDmy4_n
15,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
15,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",43.93,2022,insmdcrmy4_n
15,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",19.58,2022,insmdcdmy4_n
15,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",5.89,2022,insmdcrcdmy4_n
15,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",11.74,2022,insempmy4_n
15,"N (2728): Incident Patients  - Percent with no coverage, 2022",1.31,2022,insnonemy4_n
15,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",8.24,2022,insmdcromy4_n
15,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",9.3,2022,insmedomy4_n
15,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",17.72,2022,preepomy4_n
15,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",13.89,2022,nephnomy4_n
15,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",22.27,2022,nephy6my4_n
15,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",17.89,2022,nephy612my4_n
15,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",30.41,2022,nephy12my4_n
15,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",15.53,2022,nephunkmissmy4_n
15,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",94.54,2022,ptinfymy4_n
15,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",24.69,2022,ptxmedunfitmy4_n
15,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
15,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
15,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",8.44,2022,ptxdeclinemy4_n
15,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",73.44,2022,ptxnotassessmy4_n
15,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",15.57,2022,mefavfmy4_n
15,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",2.12,2022,mefgraftmy4_n
15,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",81.96,2022,mefcathmy4_n
15,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.35,2022,mefoumaccessmy4_n
15,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",24.34,2022,avfpresentmy4_n
15,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",27.76,2022,bmimmy4_n
15,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",28.3,2022,bmifmy4_n
15,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",0.82,2022,ptinfnmy4m_n
15,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",12.55,2022,hemomy4m_n
15,"N (2728): Incident Patients  - Average Number of forms returned, 2022",15.1,2022,nmy4m_n
15,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",86.23,2019,rdsmzm_n
15,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",55.16,2019,dyzm_n
15,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",10.5,2019,deazm_n
15,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",10.82,2019,exdzm_n
15,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.07,2019,dudzm_n
15,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",0.97,2019,smrz_n
15,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",25.09,2019,witz_n
15,"N: All Patient Mortality - % of deaths from infection, 2019-2022",8.75,2019,infz_n
15,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",42.15,2019,cardz_n
15,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.33,2019,livz_n
15,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",15.77,2019,fynmzm_n
15,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",9.76,2019,fydyzm_n
15,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.22,2019,fydeazm_n
15,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.18,2019,fyexdzm_n
15,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",1.02,2019,fysmrz_n
15,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",27.03,2019,fywitz_n
15,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",7.52,2019,fyinfz_n
15,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",35.4,2019,fycardiacz_n
15,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",2.14,2019,fylivz_n
15,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",69.17,2019,rdshzm_n
15,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",55.93,2019,htazm_n
15,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",60.29,2019,extzm_n
15,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",423.36,2019,hdzm_n
15,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",492.88,2019,exhdzm_n
15,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",43.3,2019,hdyzm_n
15,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",0.93,2019,shrtz_n
15,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.86,2019,shrdz_n
15,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.22,2019,lenz_n
15,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",10.36,2019,onez_n
15,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",6.14,2019,miiz_n
15,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",12.54,2019,sepiz_n
15,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",23.55,2019,achfz_n
15,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",16.54,2019,acdrz_n
15,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.56,2019,acarz_n
15,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",83.19,2019,ipedz_n
15,"N: ED30 - Average annual index discharges, 2019-22",30.43,2019,ed30indexzm_n
15,"N: ED30- Average annual number of ED visits, 2019-22",4.97,2019,ed30obszm_n
15,"N: ED30 - Average annual expected ED visits, 2019-22",4.92,2019,ed30expzm_n
15,"N: ED30: Standardized Ratio of ED30, 2019-22",1.04,2019,ed30z_n
15,"N SRR -  Standardized Readmission Ratio, 2022",0.99,2022,srry4_n
15,"N: SRR - Average index discharges, 2022",53.0,2022,indexmy4_n
15,"N: SRR - Average number of readmissions, 2022",12.88,2022,readmmy4_n
15,"N: SRR - Average expected readmissions, 2022",14.08,2022,srrexpmy4_n
15,Pt included in SEDR analysis,45.35,2019,rdsezm_n
15,Total number of ED Visits,41.2,2019,hedzm_n
15,Expected number of ED events,40.64,2019,exedzm_n
15,Years at risk for ED visit rate,27.97,2019,edyrzm_n
15,Years at risk for ED visit rate,44528.33,2019,edyrz_n
15,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",1.01,2019,sedrz_n
15,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",64.93,2019,rdstzm_n
15,"N: STR - Average number of patients (per year in average facility), 2019-2022",69.52,2019,rdsalltzm_n
15,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",2.28,2019,txzm_n
15,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",2.51,2019,txallzm_n
15,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",41.74,2019,txyzm_n
15,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",2.03,2019,cadalltzm_n
15,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.51,2019,livealltzm_n
15,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",2.05,2019,extxzm_n
15,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",1.11,2019,strz_n
15,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",69.45,2022,pppwpty4m_n
15,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",12.33,2022,WLy4_n
15,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",20.17,2022,WLlt40y4_n
15,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",11.41,2022,WL4074y4_n
15,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",13.35,2022,WLmaley4_n
15,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",10.85,2022,WLfemy4_n
15,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",12.62,2022,WLwhhy4_n
15,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",13.32,2022,WLwhnhy4_n
15,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",12.91,2022,WLbly4_n
15,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",13.62,2022,WLasy4_n
15,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",7.79,2022,WLnay4_n
15,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",10.06,2022,WLothy4_n
15,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",9.77,2022,WLDMy4_n
15,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",15.29,2022,WLnodmy4_n
15,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",11.55,2022,WLnotxy4_n
15,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",23.12,2022,WLtxy4_n
15,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",10.13,2022,WLVCat1y4_n
15,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",15.68,2022,WLVCat2y4_n
15,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",11.8,2022,WLVCat3y4_n
15,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",569.2,2022,pppwpmy4m_n
15,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",12.71,2022,pppwy4_n
15,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",11.0,2019,swrptzm_n
15,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",8.94,2019,swrpyzm_n
15,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.77,2019,swrwlzm_n
15,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",1.01,2019,swrexwlzm_n
15,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",0.77,2019,swrz_n
15,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",87.2,2021,FVfy3_n
15,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",7.34,2021,FVdeclinedfy3_n
15,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.06,2021,FVovndfy3_n
15,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",5.46,2021,FVothrsnfy3_n
15,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",76.96,2022,FVhy4_n
15,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",77.63,2022,FVmcarehy4_n
15,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",79.22,2022,FVmahy4_n
15,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",76.75,2022,FVmpphy4_n
15,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",79.08,2022,FVdualhy4_n
15,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",74.62,2022,FVmsphy4_n
15,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",73.16,2022,FVnonmcarehy4_n
15,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",43.48,2022,FVlt18hy4_n
15,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",69.3,2022,FV1839hy4_n
15,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",76.37,2022,FV4064hy4_n
15,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",77.89,2022,FV6574hy4_n
15,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",79.81,2022,FV75uphy4_n
15,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",76.37,2022,FVmalehy4_n
15,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",77.56,2022,FVfemhy4_n
15,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",80.76,2022,FVashy4_n
15,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",79.82,2022,FVnahy4_n
15,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",77.09,2022,FVwhhy4_n
15,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",60.8,2022,FVrothhy4_n
15,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",70.74,2022,FVblkhy4_n
15,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",81.66,2022,FVhisphy4_n
15,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",65.89,2022,FVVCat1hy4_n
15,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",76.91,2022,FVVCat2hy4_n
15,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",81.6,2022,FVVCat3hy4_n
15,"N: Influenza - Average number of patients treated on 12/31, 2022",62.49,2022,eFVy4m_n
15,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",1.49,2022,medrsnfy4m_N
15,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.86,2022,CWhdavgHGBy4_n
15,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",21.23,2022,CWhdhgb1y4_n
15,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",32.32,2022,CWhdhgb2y4_n
15,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",29.14,2022,CWhdhgb3y4_n
15,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",15.24,2022,CWhdhgb4y4_n
15,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.07,2022,CWhdhgb5y4_n
15,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",71.83,2022,CWhdesarxy4_n
15,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.15,2022,CWpdavgHGBy4_n
15,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",20.17,2022,CWpdhgb1y4_n
15,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",25.46,2022,CWpdhgb2y4_n
15,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",26.48,2022,CWpdhgb3y4_n
15,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",24.58,2022,CWpdhgb4y4_n
15,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.32,2022,CWpdhgb5y4_n
15,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",48.25,2022,CWpdesarxy4_n
15,"N: HD HGB (Adult) - Average number of eligible patients, 2022",71.39,2022,CWhdptdenomy4m_n
15,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",603.4,2022,CWhdptmthdenomy4m_n
15,"N: PD HGB (Adult) - Average number of eligible patients, 2022",29.02,2022,CWpdptdenomy4m_n
15,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",219.38,2022,CWpdptmthdenomy4m_n
15,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",33.63,2022,rdstfy4m_n
15,"N: STrR (Adult) - Average Patient Years at Risk, 2022",19.89,2022,tfyy4m_n
15,"N: STrR (Adult) - Average Number of Transfusions, 2022",5.27,2022,tfy4m_n
15,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",6.55,2022,extfy4m_n
15,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.81,2022,strry4_n
15,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.96,2022,CWhdalby4_n
15,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",1.46,2022,CWhdalb1y4_n
15,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",6.62,2022,CWhdalb2y4_n
15,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",34.54,2022,CWhdalb3y4_n
15,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",53.71,2022,CWhdalb4y4_n
15,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",3.67,2022,CWhdalb5y4_n
15,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",42.61,2022,CWhdalblt4y4_n
15,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.74,2022,CWhdavgufry4_n
15,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",86.09,2022,CWhdufr1y4_n
15,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",8.39,2022,CWhdufr2y4_n
15,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",2.95,2022,CWhdufrmissy4_n
15,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.57,2022,CWhdufrgt20y4_n
15,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.74,2022,CWpdalby4_n
15,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",4.0,2022,CWpdalb1y4_n
15,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",18.51,2022,CWpdalb2y4_n
15,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",43.07,2022,CWpdalb3y4_n
15,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",31.28,2022,CWpdalb4y4_n
15,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",3.13,2022,CWpdalb5y4_n
15,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",65.59,2022,CWpdalblt4y4_n
15,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",71.39,2022,CWhddenomy4m_n
15,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",603.4,2022,CWhdmthdenomy4m_n
15,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",29.02,2022,CWpddenomy4m_n
15,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",219.38,2022,CWpdmthdenomy4m_n
15,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.2,2022,CWpdavgktvy4_n
15,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",6.14,2022,CWpdktv1y4_n
15,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",68.78,2022,CWpdktv2y4_n
15,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",22.71,2022,CWpdktv3y4_n
15,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",2.37,2022,CWpdktv4y4_n
15,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.69,2022,CWhdavgktvy4_n
15,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",1.54,2022,CWhdktv1y4_n
15,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",62.71,2022,CWhdktv2y4_n
15,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",34.01,2022,CWhdktv3y4_n
15,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.74,2022,CWhdktv4y4_n
15,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",68.67,2022,CWhdktvptsy4m_N
15,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",573.73,2022,CWhdktvptmthy4m_N
16,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",2.87,2022,allmcFcovpatPq4_n
16,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",24.47,2022,allmcEcovpatPq4_n
16,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",30.73,2022,allmcEcovDeaPq4_n
16,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",33.14,2022,allmcEcovHosPq4_n
16,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",7.66,2022,nh_mcFcovpatPq4_n
16,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",41.68,2022,nh_mcEcovpatPq4_n
16,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",38.52,2022,nh_mcEcovDeaPq4_n
16,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",41.14,2022,nh_mcEcovHosPq4_n
16,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",62.71,2022,agey4_n
16,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.31,2022,age1y4_n
16,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",49.57,2022,age2y4_n
16,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",50.12,2022,age3y4_n
16,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",47.65,2022,dis1y4_n
16,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",18.35,2022,dis2y4_n
16,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",14.08,2022,dis3y4_n
16,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",19.72,2022,dis4y4_n
16,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.2,2022,dis5y4_n
16,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",16.16,2022,vin1y4_n
16,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",18.27,2022,vin2y4_n
16,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",14.21,2022,vin3y4_n
16,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",25.99,2022,vin4y4_n
16,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",25.38,2022,vin5y4_n
16,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",12.54,2022,rac1y4_n
16,"N: Prevalent Patients - Race: % African American, 12/31/2022",8.77,2022,rac2y4_n
16,"N: Prevalent Patients - Race: % Native American, 12/31/2022",3.23,2022,rac3y4_n
16,"N: Prevalent Patients - Race: % White, 12/31/2022",74.97,2022,rac4y4_n
16,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.48,2022,rac5y4_n
16,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",14.27,2022,eth1y4_n
16,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",85.68,2022,eth2y4_n
16,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.04,2022,eth3y4_n
16,"N: Prevalent Patients - Sex: % Female, 12/31/2022",41.39,2022,sexy4_n
16,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",8.59,2022,nrshomey4_n
16,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",5.02,2022,viny4_n
16,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",79.69,2022,modhdy4_n
16,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",3.07,2022,modhhdy4_n
16,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",2.02,2022,modcapdy4_n
16,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",15.03,2022,modccpdy4_n
16,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.2,2022,modothry4_n
16,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",57.55,2022,pahy4m_n
16,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",15.86,2022,CWunCa1y4_n
16,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",80.61,2022,CWunCa2y4_n
16,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.65,2022,CWunCa3y4_n
16,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",1.87,2022,CWunCamissy4_n
16,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
16,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.98,2022,CWavgUnCay4_n
16,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.65,2022,CWavgPy4_n
16,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",6.65,2022,CWP1y4_n
16,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",21.05,2022,CWP2y4_n
16,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",27.39,2022,CWP3y4_n
16,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",23.97,2022,CWP4y4_n
16,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",18.63,2022,CWP5y4_n
16,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",2.32,2022,CWPmissy4_n
16,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
16,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",1.56,2022,CWunCagt102y4_n
16,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",80.11,2022,CWptdenomy4m_n
16,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",687.53,2022,CWptmthdenomy4m_n
16,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",85.29,2022,serumphospatsy4m_n
16,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",726.38,2022,serumphospmy4m_n
16,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",80.11,2022,CWhcptdenomy4m_n
16,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",687.5,2022,CWhcptmthdenomy4m_n
16,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",64.62,2022,ppavfy4_n
16,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",12.48,2022,ppavgy4_n
16,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",21.78,2022,ppcathy4_n
16,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",1.12,2022,ppomy4_n
16,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",16.34,2022,ltcy4_n
16,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",18.89,2022,piavfy4_n
16,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",2.95,2022,piavgy4_n
16,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",74.01,2022,picathy4_n
16,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",4.15,2022,piomy4_n
16,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",19.66,2022,pifisty4_n
16,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",72.26,2022,phdvapty4m_n
16,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",607.98,2022,phdy4m_n
16,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",12.54,2022,ihdy4m_n
16,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",62.64,2022,sfry4_n
16,"N: VA infection - Average number of eligible PD patients, 2022",12.47,2022,pdpaty4m_n
16,"N: VA infection - Average number of eligible PD patient-months, 2022",90.66,2022,pdptmoy4m_n
16,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.57,2022,pd2inf100moy4_n
16,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",46.08,2022,ncmy4m_n
16,"N: Prevalent Comorbidities - Average % with Anemia, 2022",2.71,2022,clmanemy4_n
16,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.38,2022,clmhivaidmy4_n
16,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.54,2022,clmalcomy4_n
16,"N: Prevalent Comorbidities - Average % with Cancer, 2022",3.04,2022,clmcanmy4_n
16,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",0.81,2022,clmcamy4_n
16,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",18.32,2022,clmcdmy4_n
16,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",5.79,2022,clmcvdmy4_n
16,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",12.85,2022,clmcopdmy4_n
16,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",28.71,2022,clmchfmy4_n
16,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",32.26,2022,clmdiabmy4_n
16,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",3.21,2022,clmdrugmy4_n
16,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",2.81,2022,clmgtbmy4_n
16,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.46,2022,clmhepbmy4_n
16,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.83,2022,clmhepothmy4_n
16,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",23.87,2022,clmhypthymy4_n
16,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",17.33,2022,clminfmy4_n
16,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",22.68,2022,clmihdmy4_n
16,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",7.84,2022,clmmimy4_n
16,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",15.09,2022,clmpvdmy4_n
16,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",3.29,2022,clmpnemy4_n
16,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.11,2022,clmcntcomy4_n
16,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",4.37,2022,clminfvamy4_n
16,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.72,2022,clmmstinfmy4_n
16,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.31,2022,clmtbmy4_n
16,"N (AFS): Facility Information - Average number of patients, 2022",98.09,2022,allcnty4m_n
16,N (AFS): Facility Information - Average number of all patients on 12/31/2022,64.78,2022,endcnty4m_n
16,"N (AFS): Facility Information - Average % of patients transferred in, 2022",16.15,2022,transiny4_n
16,"N (AFS): Facility Information - Average % of patients transferred out, 2022",16.37,2022,transouty4_n
16,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,81.78,2022,medicarey4_n
16,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,8.75,2022,medpendy4_n
16,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,9.47,2022,nonmedy4_n
16,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.28,2022,cfc_N
16,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,3.07,2022,std_N
16,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",48.84,2022,p_age1y4_n
16,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",9.3,2022,p_age2y4_n
16,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",30.23,2022,p_age3y4_n
16,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",11.63,2022,p_age4y4_n
16,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",0.0,2022,p_dis1y4_n
16,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",0.0,2022,p_dis2y4_n
16,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",32.56,2022,p_dis3y4_n
16,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",39.53,2022,p_dis4y4_n
16,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
16,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
16,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",25.58,2022,p_dis7y4_n
16,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",2.33,2022,p_dis8y4_n
16,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",30.23,2022,p_vin1y4_n
16,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",25.58,2022,p_vin2y4_n
16,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.95,2022,p_vin3y4_n
16,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",18.6,2022,p_vin4y4_n
16,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",11.63,2022,p_vin5y4_n
16,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",4.65,2022,p_rac1y4_n
16,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",9.3,2022,p_rac2y4_n
16,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",6.98,2022,p_rac3y4_n
16,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",76.74,2022,p_rac4y4_n
16,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",2.33,2022,p_rac5y4_n
16,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",30.23,2022,p_eth1y4_n
16,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",69.77,2022,p_eth2y4_n
16,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
16,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",48.84,2022,p_sexy4_n
16,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",27.91,2022,p_modhdy4_n
16,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
16,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.0,2022,p_modcapdy4_n
16,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",72.09,2022,p_modccpdy4_n
16,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
16,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",4.35,2022,p_allmdcrmy4_n
16,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",56.52,2022,p_insmdcdmy4_n
16,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",21.74,2022,p_insempmy4_n
16,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",17.39,2022,p_insnonothmy4_n
16,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",21.74,2022,p_nephnomy4_n
16,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",39.13,2022,p_nephy6my4_n
16,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",0.0,2022,p_nephy612my4_n
16,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",34.78,2022,p_nephy12my4_n
16,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",4.35,2022,p_nephunkmissmy4_n
16,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",91.3,2022,p_ptinfymy4_n
16,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",10.0,2022,p_mefavfmy4_n
16,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
16,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",90.0,2022,p_mefcathmy4_n
16,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
16,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",10.0,2022,p_avfpresentmy4_n
16,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",10.18,2022,p_ppavfy4_n
16,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",65.27,2022,p_ltcy4_n
16,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",45.23,2022,p_WLy4_n
16,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",52.65,2022,p_WLlt10y4_n
16,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",37.73,2022,p_WL1017y4_n
16,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.0,2022,p_CWhdavgHGBy4_n
16,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",18.62,2022,p_CWhdhgb1y4_n
16,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",26.21,2022,p_CWhdhgb2y4_n
16,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",38.62,2022,p_CWhdhgb3y4_n
16,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",15.17,2022,p_CWhdhgb4y4_n
16,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",1.38,2022,p_CWhdhgb5y4_n
16,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.04,2022,p_CWpdavgHGBy4_n
16,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",21.99,2022,p_CWpdhgb1y4_n
16,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",18.9,2022,p_CWpdhgb2y4_n
16,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",20.96,2022,p_CWpdhgb3y4_n
16,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",24.74,2022,p_CWpdhgb4y4_n
16,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",13.4,2022,p_CWpdhgb5y4_n
16,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.1,2022,p_CWhdalby4_n
16,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",0.69,2022,p_CWhdalb1y4_n
16,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",4.83,2022,p_CWhdalb2y4_n
16,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",24.83,2022,p_CWhdalb3y4_n
16,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",68.28,2022,p_CWhdalb4y4_n
16,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",1.38,2022,p_CWhdalb5y4_n
16,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.66,2022,p_CWpdalby4_n
16,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",11.34,2022,p_CWpdalb1y4_n
16,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",21.99,2022,p_CWpdalb2y4_n
16,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",22.34,2022,p_CWpdalb3y4_n
16,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",30.58,2022,p_CWpdalb4y4_n
16,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",13.75,2022,p_CWpdalb5y4_n
16,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",82.82,2022,p_CWpdktvge18y4_n
16,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",98.92,2022,p_CWhdktvge12y4_n
16,"N: Patient Placement -  % of incident patients, 2022",16.55,2022,ppidy4_n
16,"N: Patient Placement -  % of patients continuing at facility, 2022",71.21,2022,ppcdy4_n
16,"N: Patient Placement -  % of patients that transfered into facility, 2022",12.24,2022,pptdy4_n
16,"N: End of Year Status - % of patients death attributed to this facility, 2022",15.47,2022,pdhdy4_n
16,"N: End of Year Status - % of patients death attributed to another facility, 2022",1.82,2022,pdody4_n
16,"N: End of Year Status - % of patients that received a transplant, 2022",3.34,2022,ptxdy4_n
16,"N: End of Year Status - % of patients alive in this facility, 2022",67.64,2022,pahdy4_n
16,"N: End of Year Status - % of patients alive in another facility, 2022",8.88,2022,paody4_n
16,"N: End of Year Status - % of patients other, 2022",2.84,2022,potdy4_n
16,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,51.92,2022,iuhemy4m_n
16,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.03,2022,iufreqy4m_n
16,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,51.89,2022,iunonfreqy4m_n
16,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.0,2022,iuothy4m_n
16,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.04,2022,iucapdy4m_n
16,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.01,2022,iuccpdy4m_n
16,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,1.88,2022,ihhemy4m_n
16,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.71,2022,ihfreqy4m_n
16,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,1.17,2022,ihnonfreqy4m_n
16,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
16,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,1.28,2022,ihcapdy4m_n
16,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,9.66,2022,ihccpdy4m_n
16,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",15.23,2022,staffy4m_n
16,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,3.81,2022,nurseFTy4m_n
16,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,6.59,2022,ptcareFTy4m_n
16,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,0.94,2022,dietFTy4m_n
16,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,0.96,2022,socwkFTy4m_n
16,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.81,2022,nursePTy4m_n
16,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,1.17,2022,ptcarePTy4m_n
16,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.54,2022,dietPTy4m_n
16,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.41,2022,socwkPTy4m_n
16,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,32.42,2022,vocrehaby4m_n
16,"N (AFS): Facility Information - Average % incident patients, 2022",15.49,2022,incpery4_n
16,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,28.73,2022,employedy4_n
16,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.97,2022,schooly4_n
16,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",55.51,2022,nh_ppavfy4_n
16,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",21.65,2022,nh_ltcy4_n
16,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",2.86,2022,nh_CWhdktv1y4_n
16,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",5.88,2022,nh_CWpdktv1y4_n
16,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",28.72,2022,nh_CWhdhgb1y4_n
16,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",83.37,2022,nh_CWhdesarxy4_n
16,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",25.88,2022,nh_CWpdhgb1y4_n
16,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",60.98,2022,nh_CWpdesarxy4_n
16,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",42.72,2022,nh_obdry4_n
16,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.14,2022,nh_smry4_n
16,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",49.65,2022,nh_wity4_n
16,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",233.78,2022,nh_obhtry4_n
16,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.34,2022,nh_shrty4_n
16,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",23.03,2022,nh_sepiy4_n
16,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",13.56,2022,nh_miiy4_n
16,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",50.46,2022,nh_achfy4_n
16,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",36.8,2022,nh_acdry4_n
16,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",3.74,2022,nh_acary4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",0.74,2022,nh_clmhivaidmy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",6.45,2022,nh_clminfvamy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",0.46,2022,nh_clmhepbmy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",3.23,2022,nh_clmhepothmy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",5.71,2022,nh_clmmstinfmy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",9.4,2022,nh_clmpnemy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.37,2022,nh_clmtbmy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",39.54,2022,nh_clminfmy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.58,2022,nh_clmcamy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",41.2,2022,nh_clmcdmy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",17.97,2022,nh_clmcvdmy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",59.26,2022,nh_clmchfmy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",47.47,2022,nh_clmihdmy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",16.04,2022,nh_clmmimy4_n
16,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",37.05,2022,nh_clmpvdmy4_n
16,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
16,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",29.34,2022,nh_age2y4_n
16,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",70.66,2022,nh_age3y4_n
16,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",58.59,2022,nh_dis1y4_n
16,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",17.94,2022,nh_dis2y4_n
16,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",7.31,2022,nh_dis3y4_n
16,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",15.99,2022,nh_dis4y4_n
16,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.17,2022,nh_dis5y4_n
16,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",8.42,2022,nh_rac1y4_n
16,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",9.86,2022,nh_rac2y4_n
16,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",3.83,2022,nh_rac3y4_n
16,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",77.64,2022,nh_rac4y4_n
16,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.26,2022,nh_rac5y4_n
16,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",7.91,2022,nh_eth1y4_n
16,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",92.09,2022,nh_eth2y4_n
16,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,nh_eth3y4_n
16,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",18.54,2022,nh_vin1y4_n
16,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",17.26,2022,nh_vin2y4_n
16,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.52,2022,nh_vin3y4_n
16,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",26.62,2022,nh_vin4y4_n
16,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",24.06,2022,nh_vin5y4_n
16,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",50.17,2022,nh_sexy4_n
16,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",97.28,2022,nh_modhdy4_n
16,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",0.77,2022,nh_modhhdy4_n
16,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.09,2022,nh_modcapdy4_n
16,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",1.62,2022,nh_modccpdy4_n
16,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.26,2022,nh_modothry4_n
16,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",86.6,2022,nh_allmdcrmy4_n
16,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",5.67,2022,nh_insmdcdmy4_n
16,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",1.55,2022,nh_insempmy4_n
16,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",6.19,2022,nh_insnonothmy4_n
16,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",10.31,2022,nh_mefavfmy4_n
16,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",2.06,2022,nh_mefgraftmy4_n
16,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",83.76,2022,nh_mefcathmy4_n
16,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",3.87,2022,nh_mefoumaccessmy4_n
16,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",22.68,2022,nh_avfpresentmy4_n
16,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",18.56,2022,nh_nephnomy4_n
16,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",21.91,2022,nh_nephy6my4_n
16,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",12.89,2022,nh_nephy612my4_n
16,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",35.05,2022,nh_nephy12my4_n
16,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",11.6,2022,nh_nephunkmissmy4_n
16,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",80.41,2022,nh_ptinfymy4_n
16,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",2.91,2022,alcomy4_n
16,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",13.53,2022,ashdmy4_n
16,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",29.18,2022,othcarmy4_n
16,"N (2728): Incident Patients  - Percent with cancer, 2022",8.79,2022,canmy4_n
16,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",32.96,2022,chfmy4_n
16,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",9.98,2022,cvamy4_n
16,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",41.75,2022,diabimy4_n
16,"N (2728): Incident Patients  - Percent with diabetes, 2022",61.27,2022,diabmy4_n
16,"N (2728): Incident Patients  - Percent drug dependent, 2022",4.48,2022,drugmy4_n
16,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",85.48,2022,hxhtmy4_n
16,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",4.6,2022,ambumy4_n
16,"N (2728): Incident Patients  - Percent inability to transfer, 2022",2.04,2022,transmy4_n
16,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",8.41,2022,copdmy4_n
16,"N (2728): Incident Patients  - Percent with PVD, 2022",9.22,2022,pvdmy4_n
16,"N (2728): Incident Patients  - Percent smoker, 2022",9.22,2022,smokmy4_n
16,"N (2728): Incident Patients  - Percent Hispanic, 2022",11.9,2022,ethmy4_n
16,"N (2728): Incident Patients  - Percent White, 2022",77.13,2022,whitemy4_n
16,"N (2728): Incident Patients  - Percent African American, 2022",7.45,2022,blackmy4_n
16,"N (2728): Incident Patients  - Percent Native American, 2022",4.39,2022,nativmy4_n
16,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",10.21,2022,asianmy4_n
16,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.81,2022,racoummy4_n
16,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",30.22,2022,cempmy4_n
16,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",42.03,2022,pempmy4_n
16,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",46.7,2022,dbprimy4_n
16,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",11.14,2022,gnprimy4_n
16,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",19.17,2022,htprimy4_n
16,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",22.99,2022,omprimy4_n
16,"N (2728): Incident Patients  - Percent female, 2022",39.28,2022,femmy4_n
16,"N (2728): Incident Patients  - Average age, 2022",62.77,2022,agemy4_n
16,"N (2728): Incident Patients  - Average serum albumin, 2022",3.47,2022,salbmy4_n
16,"N (2728): Incident Patients  - Average creatinine, 2022",6.58,2022,creamy4_n
16,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.48,2022,hgmy4_n
16,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",10.07,2022,gfrmy4_n
16,"N (2728): Incident Patients  - Average count of comorbidities, 2022",3.24,2022,cntcomy4_n
16,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",79.08,2022,pdmodMEFHDmy4_n
16,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",20.92,2022,pdmodMEFPDmy4_n
16,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
16,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",39.98,2022,insmdcrmy4_n
16,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",14.31,2022,insmdcdmy4_n
16,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",8.38,2022,insmdcrcdmy4_n
16,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",11.67,2022,insempmy4_n
16,"N (2728): Incident Patients  - Percent with no coverage, 2022",1.51,2022,insnonemy4_n
16,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",12.02,2022,insmdcromy4_n
16,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",12.13,2022,insmedomy4_n
16,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",20.86,2022,preepomy4_n
16,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",14.2,2022,nephnomy4_n
16,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",19.2,2022,nephy6my4_n
16,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",16.06,2022,nephy612my4_n
16,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",41.66,2022,nephy12my4_n
16,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",8.87,2022,nephunkmissmy4_n
16,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",84.61,2022,ptinfymy4_n
16,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",44.23,2022,ptxmedunfitmy4_n
16,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
16,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
16,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",21.93,2022,ptxdeclinemy4_n
16,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",61.81,2022,ptxnotassessmy4_n
16,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",20.05,2022,mefavfmy4_n
16,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",2.69,2022,mefgraftmy4_n
16,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",76.86,2022,mefcathmy4_n
16,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.4,2022,mefoumaccessmy4_n
16,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",33.89,2022,avfpresentmy4_n
16,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",27.97,2022,bmimmy4_n
16,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",28.57,2022,bmifmy4_n
16,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",2.31,2022,ptinfnmy4m_n
16,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",11.87,2022,hemomy4m_n
16,"N (2728): Incident Patients  - Average Number of forms returned, 2022",15.01,2022,nmy4m_n
16,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",81.54,2019,rdsmzm_n
16,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",52.83,2019,dyzm_n
16,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",10.51,2019,deazm_n
16,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",10.79,2019,exdzm_n
16,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.1,2019,dudzm_n
16,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",0.97,2019,smrz_n
16,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",39.5,2019,witz_n
16,"N: All Patient Mortality - % of deaths from infection, 2019-2022",12.1,2019,infz_n
16,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",39.4,2019,cardz_n
16,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.45,2019,livz_n
16,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",15.83,2019,fynmzm_n
16,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",9.73,2019,fydyzm_n
16,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.38,2019,fydeazm_n
16,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.65,2019,fyexdzm_n
16,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",0.9,2019,fysmrz_n
16,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",42.1,2019,fywitz_n
16,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",11.87,2019,fyinfz_n
16,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",34.97,2019,fycardiacz_n
16,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",2.49,2019,fylivz_n
16,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",66.67,2019,rdshzm_n
16,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",51.0,2019,htazm_n
16,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",59.96,2019,extzm_n
16,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",385.57,2019,hdzm_n
16,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",485.47,2019,exhdzm_n
16,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",42.23,2019,hdyzm_n
16,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",0.85,2019,shrtz_n
16,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.79,2019,shrdz_n
16,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.27,2019,lenz_n
16,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",9.32,2019,onez_n
16,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",7.66,2019,miiz_n
16,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",11.28,2019,sepiz_n
16,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",26.59,2019,achfz_n
16,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",18.59,2019,acdrz_n
16,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.04,2019,acarz_n
16,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",79.48,2019,ipedz_n
16,"N: ED30 - Average annual index discharges, 2019-22",32.57,2019,ed30indexzm_n
16,"N: ED30- Average annual number of ED visits, 2019-22",6.15,2019,ed30obszm_n
16,"N: ED30 - Average annual expected ED visits, 2019-22",5.27,2019,ed30expzm_n
16,"N: ED30: Standardized Ratio of ED30, 2019-22",1.22,2019,ed30z_n
16,"N SRR -  Standardized Readmission Ratio, 2022",0.9,2022,srry4_n
16,"N: SRR - Average index discharges, 2022",51.82,2022,indexmy4_n
16,"N: SRR - Average number of readmissions, 2022",11.42,2022,readmmy4_n
16,"N: SRR - Average expected readmissions, 2022",14.0,2022,srrexpmy4_n
16,Pt included in SEDR analysis,48.41,2019,rdsezm_n
16,Total number of ED Visits,52.23,2019,hedzm_n
16,Expected number of ED events,45.29,2019,exedzm_n
16,Years at risk for ED visit rate,30.78,2019,edyrzm_n
16,Years at risk for ED visit rate,31029.09,2019,edyrz_n
16,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",1.15,2019,sedrz_n
16,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",59.57,2019,rdstzm_n
16,"N: STR - Average number of patients (per year in average facility), 2019-2022",64.16,2019,rdsalltzm_n
16,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",2.09,2019,txzm_n
16,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",2.31,2019,txallzm_n
16,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",38.67,2019,txyzm_n
16,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.88,2019,cadalltzm_n
16,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.49,2019,livealltzm_n
16,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",1.88,2019,extxzm_n
16,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",1.11,2019,strz_n
16,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",62.69,2022,pppwpty4m_n
16,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",12.8,2022,WLy4_n
16,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",19.82,2022,WLlt40y4_n
16,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",11.92,2022,WL4074y4_n
16,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",13.35,2022,WLmaley4_n
16,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",11.98,2022,WLfemy4_n
16,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",13.37,2022,WLwhhy4_n
16,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",12.06,2022,WLwhnhy4_n
16,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",12.99,2022,WLbly4_n
16,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",16.86,2022,WLasy4_n
16,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",7.62,2022,WLnay4_n
16,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",12.46,2022,WLothy4_n
16,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",10.27,2022,WLDMy4_n
16,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",15.17,2022,WLnodmy4_n
16,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",11.87,2022,WLnotxy4_n
16,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",24.62,2022,WLtxy4_n
16,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",11.81,2022,WLVCat1y4_n
16,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",16.22,2022,WLVCat2y4_n
16,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",10.69,2022,WLVCat3y4_n
16,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",523.89,2022,pppwpmy4m_n
16,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",12.09,2022,pppwy4_n
16,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",10.7,2019,swrptzm_n
16,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",8.6,2019,swrpyzm_n
16,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.74,2019,swrwlzm_n
16,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.81,2019,swrexwlzm_n
16,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",0.91,2019,swrz_n
16,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",85.72,2021,FVfy3_n
16,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",8.48,2021,FVdeclinedfy3_n
16,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.09,2021,FVovndfy3_n
16,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",5.81,2021,FVothrsnfy3_n
16,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",68.82,2022,FVhy4_n
16,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",69.98,2022,FVmcarehy4_n
16,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",67.76,2022,FVmahy4_n
16,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",71.92,2022,FVmpphy4_n
16,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",70.33,2022,FVdualhy4_n
16,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",66.67,2022,FVmsphy4_n
16,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",61.92,2022,FVnonmcarehy4_n
16,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",47.83,2022,FVlt18hy4_n
16,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",66.13,2022,FV1839hy4_n
16,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",67.75,2022,FV4064hy4_n
16,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",69.79,2022,FV6574hy4_n
16,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",70.7,2022,FV75uphy4_n
16,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",68.38,2022,FVmalehy4_n
16,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",69.36,2022,FVfemhy4_n
16,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",69.76,2022,FVashy4_n
16,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",64.99,2022,FVnahy4_n
16,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",69.74,2022,FVwhhy4_n
16,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",63.16,2022,FVrothhy4_n
16,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",61.01,2022,FVblkhy4_n
16,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",74.99,2022,FVhisphy4_n
16,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",55.66,2022,FVVCat1hy4_n
16,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",68.02,2022,FVVCat2hy4_n
16,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",74.89,2022,FVVCat3hy4_n
16,"N: Influenza - Average number of patients treated on 12/31, 2022",58.76,2022,eFVy4m_n
16,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",0.72,2022,medrsnfy4m_N
16,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.76,2022,CWhdavgHGBy4_n
16,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",22.6,2022,CWhdhgb1y4_n
16,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",33.84,2022,CWhdhgb2y4_n
16,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",29.8,2022,CWhdhgb3y4_n
16,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",12.39,2022,CWhdhgb4y4_n
16,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",1.37,2022,CWhdhgb5y4_n
16,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",77.93,2022,CWhdesarxy4_n
16,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.03,2022,CWpdavgHGBy4_n
16,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",20.56,2022,CWpdhgb1y4_n
16,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",27.82,2022,CWpdhgb2y4_n
16,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",27.85,2022,CWpdhgb3y4_n
16,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",21.51,2022,CWpdhgb4y4_n
16,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.26,2022,CWpdhgb5y4_n
16,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",54.47,2022,CWpdesarxy4_n
16,"N: HD HGB (Adult) - Average number of eligible patients, 2022",68.4,2022,CWhdptdenomy4m_n
16,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",585.75,2022,CWhdptmthdenomy4m_n
16,"N: PD HGB (Adult) - Average number of eligible patients, 2022",23.56,2022,CWpdptdenomy4m_n
16,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",178.85,2022,CWpdptmthdenomy4m_n
16,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",38.86,2022,rdstfy4m_n
16,"N: STrR (Adult) - Average Patient Years at Risk, 2022",23.73,2022,tfyy4m_n
16,"N: STrR (Adult) - Average Number of Transfusions, 2022",6.21,2022,tfy4m_n
16,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",7.59,2022,extfy4m_n
16,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.82,2022,strry4_n
16,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.95,2022,CWhdalby4_n
16,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",1.51,2022,CWhdalb1y4_n
16,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",6.86,2022,CWhdalb2y4_n
16,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",35.53,2022,CWhdalb3y4_n
16,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",53.35,2022,CWhdalb4y4_n
16,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",2.75,2022,CWhdalb5y4_n
16,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",43.9,2022,CWhdalblt4y4_n
16,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",7.11,2022,CWhdavgufry4_n
16,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",88.73,2022,CWhdufr1y4_n
16,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",5.72,2022,CWhdufr2y4_n
16,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",2.56,2022,CWhdufrmissy4_n
16,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.99,2022,CWhdufrgt20y4_n
16,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.74,2022,CWpdalby4_n
16,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",4.13,2022,CWpdalb1y4_n
16,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",17.79,2022,CWpdalb2y4_n
16,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",43.83,2022,CWpdalb3y4_n
16,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",32.15,2022,CWpdalb4y4_n
16,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",2.1,2022,CWpdalb5y4_n
16,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",65.75,2022,CWpdalblt4y4_n
16,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",68.4,2022,CWhddenomy4m_n
16,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",585.75,2022,CWhdmthdenomy4m_n
16,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",23.56,2022,CWpddenomy4m_n
16,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",178.85,2022,CWpdmthdenomy4m_n
16,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.24,2022,CWpdavgktvy4_n
16,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",5.07,2022,CWpdktv1y4_n
16,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",69.4,2022,CWpdktv2y4_n
16,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",23.86,2022,CWpdktv3y4_n
16,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.67,2022,CWpdktv4y4_n
16,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.67,2022,CWhdavgktvy4_n
16,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",2.22,2022,CWhdktv1y4_n
16,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",64.64,2022,CWhdktv2y4_n
16,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",31.83,2022,CWhdktv3y4_n
16,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.32,2022,CWhdktv4y4_n
16,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",64.9,2022,CWhdktvptsy4m_N
16,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",547.4,2022,CWhdktvptmthy4m_N
17,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",3.43,2022,allmcFcovpatPq4_n
17,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",25.13,2022,allmcEcovpatPq4_n
17,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",33.13,2022,allmcEcovDeaPq4_n
17,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",35.54,2022,allmcEcovHosPq4_n
17,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",10.39,2022,nh_mcFcovpatPq4_n
17,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",45.12,2022,nh_mcEcovpatPq4_n
17,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",41.63,2022,nh_mcEcovDeaPq4_n
17,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",44.9,2022,nh_mcEcovHosPq4_n
17,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",63.87,2022,agey4_n
17,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.23,2022,age1y4_n
17,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",47.91,2022,age2y4_n
17,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",51.86,2022,age3y4_n
17,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",53.55,2022,dis1y4_n
17,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",23.39,2022,dis2y4_n
17,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",9.22,2022,dis3y4_n
17,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",13.36,2022,dis4y4_n
17,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.48,2022,dis5y4_n
17,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",14.86,2022,vin1y4_n
17,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",17.22,2022,vin2y4_n
17,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.63,2022,vin3y4_n
17,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",27.73,2022,vin4y4_n
17,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",26.57,2022,vin5y4_n
17,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",37.1,2022,rac1y4_n
17,"N: Prevalent Patients - Race: % African American, 12/31/2022",12.82,2022,rac2y4_n
17,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.96,2022,rac3y4_n
17,"N: Prevalent Patients - Race: % White, 12/31/2022",48.13,2022,rac4y4_n
17,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.99,2022,rac5y4_n
17,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",25.0,2022,eth1y4_n
17,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",74.89,2022,eth2y4_n
17,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.11,2022,eth3y4_n
17,"N: Prevalent Patients - Sex: % Female, 12/31/2022",41.26,2022,sexy4_n
17,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",9.66,2022,nrshomey4_n
17,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",4.95,2022,viny4_n
17,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",82.98,2022,modhdy4_n
17,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",2.16,2022,modhhdy4_n
17,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",2.18,2022,modcapdy4_n
17,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",12.53,2022,modccpdy4_n
17,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.14,2022,modothry4_n
17,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",78.09,2022,pahy4m_n
17,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",17.24,2022,CWunCa1y4_n
17,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",78.59,2022,CWunCa2y4_n
17,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.21,2022,CWunCa3y4_n
17,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",2.96,2022,CWunCamissy4_n
17,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
17,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.92,2022,CWavgUnCay4_n
17,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.5,2022,CWavgPy4_n
17,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.29,2022,CWP1y4_n
17,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",22.22,2022,CWP2y4_n
17,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",28.01,2022,CWP3y4_n
17,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",22.69,2022,CWP4y4_n
17,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",15.92,2022,CWP5y4_n
17,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",3.86,2022,CWPmissy4_n
17,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
17,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",1.9,2022,CWunCagt102y4_n
17,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",103.1,2022,CWptdenomy4m_n
17,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",916.72,2022,CWptmthdenomy4m_n
17,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",108.54,2022,serumphospatsy4m_n
17,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",964.81,2022,serumphospmy4m_n
17,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",103.1,2022,CWhcptdenomy4m_n
17,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",916.7,2022,CWhcptmthdenomy4m_n
17,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",64.65,2022,ppavfy4_n
17,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",14.51,2022,ppavgy4_n
17,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",18.88,2022,ppcathy4_n
17,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",1.95,2022,ppomy4_n
17,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",14.75,2022,ltcy4_n
17,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",16.61,2022,piavfy4_n
17,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",3.95,2022,piavgy4_n
17,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",76.22,2022,picathy4_n
17,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",3.23,2022,piomy4_n
17,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",17.12,2022,pifisty4_n
17,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",95.02,2022,phdvapty4m_n
17,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",841.07,2022,phdy4m_n
17,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",16.09,2022,ihdy4m_n
17,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",63.53,2022,sfry4_n
17,"N: VA infection - Average number of eligible PD patients, 2022",14.42,2022,pdpaty4m_n
17,"N: VA infection - Average number of eligible PD patient-months, 2022",111.3,2022,pdptmoy4m_n
17,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.27,2022,pd2inf100moy4_n
17,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",58.24,2022,ncmy4m_n
17,"N: Prevalent Comorbidities - Average % with Anemia, 2022",2.32,2022,clmanemy4_n
17,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.2,2022,clmhivaidmy4_n
17,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.11,2022,clmalcomy4_n
17,"N: Prevalent Comorbidities - Average % with Cancer, 2022",2.92,2022,clmcanmy4_n
17,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",0.72,2022,clmcamy4_n
17,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",18.36,2022,clmcdmy4_n
17,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",6.65,2022,clmcvdmy4_n
17,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",11.58,2022,clmcopdmy4_n
17,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",27.16,2022,clmchfmy4_n
17,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",34.25,2022,clmdiabmy4_n
17,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",1.04,2022,clmdrugmy4_n
17,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",2.89,2022,clmgtbmy4_n
17,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.73,2022,clmhepbmy4_n
17,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.27,2022,clmhepothmy4_n
17,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",18.94,2022,clmhypthymy4_n
17,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",17.32,2022,clminfmy4_n
17,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",22.53,2022,clmihdmy4_n
17,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",7.4,2022,clmmimy4_n
17,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",16.61,2022,clmpvdmy4_n
17,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",2.74,2022,clmpnemy4_n
17,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.02,2022,clmcntcomy4_n
17,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",3.8,2022,clminfvamy4_n
17,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.07,2022,clmmstinfmy4_n
17,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.4,2022,clmtbmy4_n
17,"N (AFS): Facility Information - Average number of patients, 2022",130.82,2022,allcnty4m_n
17,N (AFS): Facility Information - Average number of all patients on 12/31/2022,89.32,2022,endcnty4m_n
17,"N (AFS): Facility Information - Average % of patients transferred in, 2022",15.02,2022,transiny4_n
17,"N (AFS): Facility Information - Average % of patients transferred out, 2022",15.05,2022,transouty4_n
17,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,73.47,2022,medicarey4_n
17,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,12.0,2022,medpendy4_n
17,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,14.53,2022,nonmedy4_n
17,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.37,2022,cfc_N
17,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,6.15,2022,std_N
17,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",26.23,2022,p_age1y4_n
17,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",8.2,2022,p_age2y4_n
17,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",39.34,2022,p_age3y4_n
17,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",26.23,2022,p_age4y4_n
17,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",1.64,2022,p_dis1y4_n
17,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",0.0,2022,p_dis2y4_n
17,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",19.67,2022,p_dis3y4_n
17,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",32.79,2022,p_dis4y4_n
17,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
17,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
17,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",29.51,2022,p_dis7y4_n
17,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",16.39,2022,p_dis8y4_n
17,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",37.7,2022,p_vin1y4_n
17,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",21.31,2022,p_vin2y4_n
17,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",13.11,2022,p_vin3y4_n
17,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",13.11,2022,p_vin4y4_n
17,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",14.75,2022,p_vin5y4_n
17,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",19.67,2022,p_rac1y4_n
17,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",3.28,2022,p_rac2y4_n
17,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",6.56,2022,p_rac3y4_n
17,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",62.3,2022,p_rac4y4_n
17,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",8.2,2022,p_rac5y4_n
17,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",37.7,2022,p_eth1y4_n
17,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",60.66,2022,p_eth2y4_n
17,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",1.64,2022,p_eth3y4_n
17,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",50.82,2022,p_sexy4_n
17,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",32.79,2022,p_modhdy4_n
17,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
17,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.64,2022,p_modcapdy4_n
17,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",65.57,2022,p_modccpdy4_n
17,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
17,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",31.37,2022,p_allmdcrmy4_n
17,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",35.29,2022,p_insmdcdmy4_n
17,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",11.76,2022,p_insempmy4_n
17,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",21.57,2022,p_insnonothmy4_n
17,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",19.61,2022,p_nephnomy4_n
17,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",27.45,2022,p_nephy6my4_n
17,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",19.61,2022,p_nephy612my4_n
17,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",25.49,2022,p_nephy12my4_n
17,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",7.84,2022,p_nephunkmissmy4_n
17,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",84.31,2022,p_ptinfymy4_n
17,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",2.94,2022,p_mefavfmy4_n
17,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
17,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",97.06,2022,p_mefcathmy4_n
17,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
17,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",2.94,2022,p_avfpresentmy4_n
17,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",9.24,2022,p_ppavfy4_n
17,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",73.09,2022,p_ltcy4_n
17,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",51.41,2022,p_WLy4_n
17,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",52.04,2022,p_WLlt10y4_n
17,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",68.98,2022,p_WL1017y4_n
17,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.56,2022,p_CWhdavgHGBy4_n
17,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",28.0,2022,p_CWhdhgb1y4_n
17,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",24.0,2022,p_CWhdhgb2y4_n
17,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",27.11,2022,p_CWhdhgb3y4_n
17,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",10.22,2022,p_CWhdhgb4y4_n
17,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",10.67,2022,p_CWhdhgb5y4_n
17,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",11.02,2022,p_CWpdavgHGBy4_n
17,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",20.57,2022,p_CWpdhgb1y4_n
17,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",25.12,2022,p_CWpdhgb2y4_n
17,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",26.79,2022,p_CWpdhgb3y4_n
17,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",19.62,2022,p_CWpdhgb4y4_n
17,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",7.89,2022,p_CWpdhgb5y4_n
17,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.16,2022,p_CWhdalby4_n
17,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",0.0,2022,p_CWhdalb1y4_n
17,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",3.11,2022,p_CWhdalb2y4_n
17,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",16.89,2022,p_CWhdalb3y4_n
17,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",74.22,2022,p_CWhdalb4y4_n
17,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",5.78,2022,p_CWhdalb5y4_n
17,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",4.02,2022,p_CWpdalby4_n
17,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",4.55,2022,p_CWpdalb1y4_n
17,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",8.37,2022,p_CWpdalb2y4_n
17,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",20.81,2022,p_CWpdalb3y4_n
17,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",56.46,2022,p_CWpdalb4y4_n
17,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",9.81,2022,p_CWpdalb5y4_n
17,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",59.33,2022,p_CWpdktvge18y4_n
17,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",92.77,2022,p_CWhdktvge12y4_n
17,"N: Patient Placement -  % of incident patients, 2022",15.81,2022,ppidy4_n
17,"N: Patient Placement -  % of patients continuing at facility, 2022",73.86,2022,ppcdy4_n
17,"N: Patient Placement -  % of patients that transfered into facility, 2022",10.33,2022,pptdy4_n
17,"N: End of Year Status - % of patients death attributed to this facility, 2022",13.0,2022,pdhdy4_n
17,"N: End of Year Status - % of patients death attributed to another facility, 2022",1.41,2022,pdody4_n
17,"N: End of Year Status - % of patients that received a transplant, 2022",2.42,2022,ptxdy4_n
17,"N: End of Year Status - % of patients alive in this facility, 2022",72.3,2022,pahdy4_n
17,"N: End of Year Status - % of patients alive in another facility, 2022",8.0,2022,paody4_n
17,"N: End of Year Status - % of patients other, 2022",2.87,2022,potdy4_n
17,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,74.45,2022,iuhemy4m_n
17,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.08,2022,iufreqy4m_n
17,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,74.37,2022,iunonfreqy4m_n
17,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.0,2022,iuothy4m_n
17,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
17,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.01,2022,iuccpdy4m_n
17,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,1.78,2022,ihhemy4m_n
17,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.62,2022,ihfreqy4m_n
17,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,1.16,2022,ihnonfreqy4m_n
17,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
17,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,1.82,2022,ihcapdy4m_n
17,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,11.27,2022,ihccpdy4m_n
17,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",18.25,2022,staffy4m_n
17,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,5.09,2022,nurseFTy4m_n
17,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,8.22,2022,ptcareFTy4m_n
17,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,1.07,2022,dietFTy4m_n
17,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.11,2022,socwkFTy4m_n
17,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,0.96,2022,nursePTy4m_n
17,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,1.11,2022,ptcarePTy4m_n
17,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.38,2022,dietPTy4m_n
17,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.31,2022,socwkPTy4m_n
17,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,43.71,2022,vocrehaby4m_n
17,"N (AFS): Facility Information - Average % incident patients, 2022",14.5,2022,incpery4_n
17,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,31.08,2022,employedy4_n
17,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.88,2022,schooly4_n
17,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",52.89,2022,nh_ppavfy4_n
17,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",21.21,2022,nh_ltcy4_n
17,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",3.22,2022,nh_CWhdktv1y4_n
17,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",12.55,2022,nh_CWpdktv1y4_n
17,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",28.42,2022,nh_CWhdhgb1y4_n
17,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",67.78,2022,nh_CWhdesarxy4_n
17,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",26.87,2022,nh_CWpdhgb1y4_n
17,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",53.84,2022,nh_CWpdesarxy4_n
17,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",41.95,2022,nh_obdry4_n
17,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.28,2022,nh_smry4_n
17,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",22.7,2022,nh_wity4_n
17,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",266.17,2022,nh_obhtry4_n
17,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.5,2022,nh_shrty4_n
17,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",28.06,2022,nh_sepiy4_n
17,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",13.39,2022,nh_miiy4_n
17,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",50.16,2022,nh_achfy4_n
17,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",37.19,2022,nh_acdry4_n
17,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",4.53,2022,nh_acary4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",0.62,2022,nh_clmhivaidmy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",7.55,2022,nh_clminfvamy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",1.32,2022,nh_clmhepbmy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",3.53,2022,nh_clmhepothmy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",4.19,2022,nh_clmmstinfmy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",8.96,2022,nh_clmpnemy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.44,2022,nh_clmtbmy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",41.15,2022,nh_clminfmy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",2.16,2022,nh_clmcamy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",41.94,2022,nh_clmcdmy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",19.16,2022,nh_clmcvdmy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",55.58,2022,nh_clmchfmy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",45.34,2022,nh_clmihdmy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",15.23,2022,nh_clmmimy4_n
17,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",39.21,2022,nh_clmpvdmy4_n
17,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
17,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",29.13,2022,nh_age2y4_n
17,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",70.87,2022,nh_age3y4_n
17,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",61.27,2022,nh_dis1y4_n
17,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",20.94,2022,nh_dis2y4_n
17,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",4.68,2022,nh_dis3y4_n
17,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",12.71,2022,nh_dis4y4_n
17,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.39,2022,nh_dis5y4_n
17,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",25.2,2022,nh_rac1y4_n
17,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",18.17,2022,nh_rac2y4_n
17,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",1.21,2022,nh_rac3y4_n
17,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",54.95,2022,nh_rac4y4_n
17,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.47,2022,nh_rac5y4_n
17,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",22.31,2022,nh_eth1y4_n
17,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",77.65,2022,nh_eth2y4_n
17,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.04,2022,nh_eth3y4_n
17,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",18.84,2022,nh_vin1y4_n
17,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",14.94,2022,nh_vin2y4_n
17,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",10.84,2022,nh_vin3y4_n
17,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",26.56,2022,nh_vin4y4_n
17,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",28.82,2022,nh_vin5y4_n
17,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",44.85,2022,nh_sexy4_n
17,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",97.43,2022,nh_modhdy4_n
17,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",0.78,2022,nh_modhhdy4_n
17,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.16,2022,nh_modcapdy4_n
17,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",1.44,2022,nh_modccpdy4_n
17,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.2,2022,nh_modothry4_n
17,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",79.16,2022,nh_allmdcrmy4_n
17,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",11.55,2022,nh_insmdcdmy4_n
17,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",2.72,2022,nh_insempmy4_n
17,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",6.57,2022,nh_insnonothmy4_n
17,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",9.17,2022,nh_mefavfmy4_n
17,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",4.53,2022,nh_mefgraftmy4_n
17,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",84.26,2022,nh_mefcathmy4_n
17,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",2.04,2022,nh_mefoumaccessmy4_n
17,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",16.31,2022,nh_avfpresentmy4_n
17,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",20.95,2022,nh_nephnomy4_n
17,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",23.33,2022,nh_nephy6my4_n
17,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",14.61,2022,nh_nephy612my4_n
17,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",22.88,2022,nh_nephy12my4_n
17,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",18.23,2022,nh_nephunkmissmy4_n
17,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",82.56,2022,nh_ptinfymy4_n
17,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",0.97,2022,alcomy4_n
17,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",9.73,2022,ashdmy4_n
17,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",13.41,2022,othcarmy4_n
17,"N (2728): Incident Patients  - Percent with cancer, 2022",4.38,2022,canmy4_n
17,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",22.33,2022,chfmy4_n
17,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",6.09,2022,cvamy4_n
17,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",37.63,2022,diabimy4_n
17,"N (2728): Incident Patients  - Percent with diabetes, 2022",65.91,2022,diabmy4_n
17,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.57,2022,drugmy4_n
17,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",84.86,2022,hxhtmy4_n
17,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",4.31,2022,ambumy4_n
17,"N (2728): Incident Patients  - Percent inability to transfer, 2022",2.38,2022,transmy4_n
17,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",4.21,2022,copdmy4_n
17,"N (2728): Incident Patients  - Percent with PVD, 2022",4.37,2022,pvdmy4_n
17,"N (2728): Incident Patients  - Percent smoker, 2022",3.14,2022,smokmy4_n
17,"N (2728): Incident Patients  - Percent Hispanic, 2022",22.54,2022,ethmy4_n
17,"N (2728): Incident Patients  - Percent White, 2022",50.57,2022,whitemy4_n
17,"N (2728): Incident Patients  - Percent African American, 2022",11.1,2022,blackmy4_n
17,"N (2728): Incident Patients  - Percent Native American, 2022",2.74,2022,nativmy4_n
17,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",33.69,2022,asianmy4_n
17,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",1.9,2022,racoummy4_n
17,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",32.46,2022,cempmy4_n
17,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",43.49,2022,pempmy4_n
17,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",53.37,2022,dbprimy4_n
17,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",6.04,2022,gnprimy4_n
17,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",22.78,2022,htprimy4_n
17,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",17.81,2022,omprimy4_n
17,"N (2728): Incident Patients  - Percent female, 2022",41.28,2022,femmy4_n
17,"N (2728): Incident Patients  - Average age, 2022",64.22,2022,agemy4_n
17,"N (2728): Incident Patients  - Average serum albumin, 2022",3.41,2022,salbmy4_n
17,"N (2728): Incident Patients  - Average creatinine, 2022",6.58,2022,creamy4_n
17,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.38,2022,hgmy4_n
17,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",10.15,2022,gfrmy4_n
17,"N (2728): Incident Patients  - Average count of comorbidities, 2022",2.65,2022,cntcomy4_n
17,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",82.65,2022,pdmodMEFHDmy4_n
17,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",17.35,2022,pdmodMEFPDmy4_n
17,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
17,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",40.3,2022,insmdcrmy4_n
17,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",19.09,2022,insmdcdmy4_n
17,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",8.01,2022,insmdcrcdmy4_n
17,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",11.96,2022,insempmy4_n
17,"N (2728): Incident Patients  - Percent with no coverage, 2022",1.09,2022,insnonemy4_n
17,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",8.58,2022,insmdcromy4_n
17,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",10.98,2022,insmedomy4_n
17,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",21.56,2022,preepomy4_n
17,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",16.29,2022,nephnomy4_n
17,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",19.69,2022,nephy6my4_n
17,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",19.07,2022,nephy612my4_n
17,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",31.33,2022,nephy12my4_n
17,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",13.62,2022,nephunkmissmy4_n
17,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",88.25,2022,ptinfymy4_n
17,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",38.09,2022,ptxmedunfitmy4_n
17,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
17,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
17,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",12.06,2022,ptxdeclinemy4_n
17,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",51.76,2022,ptxnotassessmy4_n
17,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",16.79,2022,mefavfmy4_n
17,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",3.97,2022,mefgraftmy4_n
17,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",78.97,2022,mefcathmy4_n
17,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.27,2022,mefoumaccessmy4_n
17,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",25.4,2022,avfpresentmy4_n
17,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",26.64,2022,bmimmy4_n
17,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",27.75,2022,bmifmy4_n
17,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",2.07,2022,ptinfnmy4m_n
17,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",14.6,2022,hemomy4m_n
17,"N (2728): Incident Patients  - Average Number of forms returned, 2022",17.66,2022,nmy4m_n
17,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",106.61,2019,rdsmzm_n
17,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",72.03,2019,dyzm_n
17,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",12.11,2019,deazm_n
17,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",13.07,2019,exdzm_n
17,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.06,2019,dudzm_n
17,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",0.93,2019,smrz_n
17,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",20.11,2019,witz_n
17,"N: All Patient Mortality - % of deaths from infection, 2019-2022",11.4,2019,infz_n
17,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",43.53,2019,cardz_n
17,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",0.99,2019,livz_n
17,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",18.34,2019,fynmzm_n
17,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",11.65,2019,fydyzm_n
17,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.26,2019,fydeazm_n
17,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.52,2019,fyexdzm_n
17,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",0.9,2019,fysmrz_n
17,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",21.9,2019,fywitz_n
17,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",10.58,2019,fyinfz_n
17,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",38.72,2019,fycardiacz_n
17,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",2.05,2019,fylivz_n
17,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",81.7,2019,rdshzm_n
17,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",62.16,2019,htazm_n
17,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",72.58,2019,extzm_n
17,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",456.05,2019,hdzm_n
17,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",595.2,2019,exhdzm_n
17,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",53.88,2019,hdyzm_n
17,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",0.86,2019,shrtz_n
17,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.77,2019,shrdz_n
17,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.03,2019,lenz_n
17,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",9.2,2019,onez_n
17,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",6.7,2019,miiz_n
17,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",13.21,2019,sepiz_n
17,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",25.98,2019,achfz_n
17,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",18.61,2019,acdrz_n
17,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.34,2019,acarz_n
17,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",77.85,2019,ipedz_n
17,"N: ED30 - Average annual index discharges, 2019-22",37.05,2019,ed30indexzm_n
17,"N: ED30- Average annual number of ED visits, 2019-22",5.95,2019,ed30obszm_n
17,"N: ED30 - Average annual expected ED visits, 2019-22",5.61,2019,ed30expzm_n
17,"N: ED30: Standardized Ratio of ED30, 2019-22",1.1,2019,ed30z_n
17,"N SRR -  Standardized Readmission Ratio, 2022",1.01,2022,srry4_n
17,"N: SRR - Average index discharges, 2022",63.88,2022,indexmy4_n
17,"N: SRR - Average number of readmissions, 2022",15.34,2022,readmmy4_n
17,"N: SRR - Average expected readmissions, 2022",16.54,2022,srrexpmy4_n
17,Pt included in SEDR analysis,54.0,2019,rdsezm_n
17,Total number of ED Visits,50.75,2019,hedzm_n
17,Expected number of ED events,47.92,2019,exedzm_n
17,Years at risk for ED visit rate,35.37,2019,edyrzm_n
17,Years at risk for ED visit rate,48817.44,2019,edyrz_n
17,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",1.06,2019,sedrz_n
17,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",77.41,2019,rdstzm_n
17,"N: STR - Average number of patients (per year in average facility), 2019-2022",82.2,2019,rdsalltzm_n
17,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",2.01,2019,txzm_n
17,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",2.27,2019,txallzm_n
17,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",52.44,2019,txyzm_n
17,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",1.86,2019,cadalltzm_n
17,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.46,2019,livealltzm_n
17,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",2.49,2019,extxzm_n
17,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",0.81,2019,strz_n
17,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",80.71,2022,pppwpty4m_n
17,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",28.02,2022,WLy4_n
17,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",40.82,2022,WLlt40y4_n
17,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",26.71,2022,WL4074y4_n
17,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",29.16,2022,WLmaley4_n
17,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",26.27,2022,WLfemy4_n
17,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",33.71,2022,WLwhhy4_n
17,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",26.42,2022,WLwhnhy4_n
17,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",27.18,2022,WLbly4_n
17,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",25.74,2022,WLasy4_n
17,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",19.26,2022,WLnay4_n
17,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",19.24,2022,WLothy4_n
17,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",23.49,2022,WLDMy4_n
17,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",33.32,2022,WLnodmy4_n
17,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",27.12,2022,WLnotxy4_n
17,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",42.97,2022,WLtxy4_n
17,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",18.54,2022,WLVCat1y4_n
17,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",32.86,2022,WLVCat2y4_n
17,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",33.26,2022,WLVCat3y4_n
17,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",704.78,2022,pppwpmy4m_n
17,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",30.53,2022,pppwy4_n
17,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",11.8,2019,swrptzm_n
17,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",9.41,2019,swrpyzm_n
17,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",1.2,2019,swrwlzm_n
17,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",0.96,2019,swrexwlzm_n
17,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",1.25,2019,swrz_n
17,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",87.4,2021,FVfy3_n
17,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",5.63,2021,FVdeclinedfy3_n
17,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.05,2021,FVovndfy3_n
17,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",6.97,2021,FVothrsnfy3_n
17,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",67.62,2022,FVhy4_n
17,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",68.63,2022,FVmcarehy4_n
17,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",69.33,2022,FVmahy4_n
17,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",68.27,2022,FVmpphy4_n
17,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",69.43,2022,FVdualhy4_n
17,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",67.74,2022,FVmsphy4_n
17,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",62.96,2022,FVnonmcarehy4_n
17,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",25.0,2022,FVlt18hy4_n
17,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",60.29,2022,FV1839hy4_n
17,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",66.49,2022,FV4064hy4_n
17,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",68.62,2022,FV6574hy4_n
17,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",69.97,2022,FV75uphy4_n
17,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",66.82,2022,FVmalehy4_n
17,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",68.35,2022,FVfemhy4_n
17,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",72.37,2022,FVashy4_n
17,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",56.74,2022,FVnahy4_n
17,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",65.58,2022,FVwhhy4_n
17,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",67.82,2022,FVrothhy4_n
17,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",60.86,2022,FVblkhy4_n
17,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",68.63,2022,FVhisphy4_n
17,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",54.53,2022,FVVCat1hy4_n
17,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",65.81,2022,FVVCat2hy4_n
17,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",73.02,2022,FVVCat3hy4_n
17,"N: Influenza - Average number of patients treated on 12/31, 2022",80.52,2022,eFVy4m_n
17,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",1.22,2022,medrsnfy4m_N
17,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.75,2022,CWhdavgHGBy4_n
17,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",21.17,2022,CWhdhgb1y4_n
17,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",35.31,2022,CWhdhgb2y4_n
17,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",28.72,2022,CWhdhgb3y4_n
17,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",11.47,2022,CWhdhgb4y4_n
17,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.33,2022,CWhdhgb5y4_n
17,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",66.55,2022,CWhdesarxy4_n
17,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.78,2022,CWpdavgHGBy4_n
17,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",23.97,2022,CWpdhgb1y4_n
17,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",31.78,2022,CWpdhgb2y4_n
17,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",25.86,2022,CWpdhgb3y4_n
17,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",14.63,2022,CWpdhgb4y4_n
17,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",3.77,2022,CWpdhgb5y4_n
17,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",51.78,2022,CWpdesarxy4_n
17,"N: HD HGB (Adult) - Average number of eligible patients, 2022",91.1,2022,CWhdptdenomy4m_n
17,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",809.31,2022,CWhdptmthdenomy4m_n
17,"N: PD HGB (Adult) - Average number of eligible patients, 2022",38.14,2022,CWpdptdenomy4m_n
17,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",323.08,2022,CWpdptmthdenomy4m_n
17,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",43.95,2022,rdstfy4m_n
17,"N: STrR (Adult) - Average Patient Years at Risk, 2022",28.53,2022,tfyy4m_n
17,"N: STrR (Adult) - Average Number of Transfusions, 2022",6.63,2022,tfy4m_n
17,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",9.22,2022,extfy4m_n
17,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.72,2022,strry4_n
17,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.95,2022,CWhdalby4_n
17,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",1.47,2022,CWhdalb1y4_n
17,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",6.74,2022,CWhdalb2y4_n
17,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",34.83,2022,CWhdalb3y4_n
17,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",52.83,2022,CWhdalb4y4_n
17,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",4.13,2022,CWhdalb5y4_n
17,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",43.04,2022,CWhdalblt4y4_n
17,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",8.14,2022,CWhdavgufry4_n
17,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",83.51,2022,CWhdufr1y4_n
17,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",10.04,2022,CWhdufr2y4_n
17,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",4.42,2022,CWhdufrmissy4_n
17,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.03,2022,CWhdufrgt20y4_n
17,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.74,2022,CWpdalby4_n
17,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",3.99,2022,CWpdalb1y4_n
17,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",17.69,2022,CWpdalb2y4_n
17,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",43.57,2022,CWpdalb3y4_n
17,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",31.19,2022,CWpdalb4y4_n
17,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",3.56,2022,CWpdalb5y4_n
17,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",65.25,2022,CWpdalblt4y4_n
17,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",91.1,2022,CWhddenomy4m_n
17,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",809.31,2022,CWhdmthdenomy4m_n
17,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",38.14,2022,CWpddenomy4m_n
17,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",323.08,2022,CWpdmthdenomy4m_n
17,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.17,2022,CWpdavgktvy4_n
17,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",5.66,2022,CWpdktv1y4_n
17,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",71.65,2022,CWpdktv2y4_n
17,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",18.91,2022,CWpdktv3y4_n
17,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",3.78,2022,CWpdktv4y4_n
17,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.63,2022,CWhdavgktvy4_n
17,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",2.09,2022,CWhdktv1y4_n
17,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",70.89,2022,CWhdktv2y4_n
17,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",24.98,2022,CWhdktv3y4_n
17,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",2.04,2022,CWhdktv4y4_n
17,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",89.02,2022,CWhdktvptsy4m_N
17,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",780.91,2022,CWhdktvptmthy4m_N
18,"NETWORK: COVID - % of Medicare patients initially infected with COVID, 2022-Q4",3.76,2022,allmcFcovpatPq4_n
18,"NETWORK: COVID - % of Medicare patients ever infected with COVID, 2022-Q4",27.82,2022,allmcEcovpatPq4_n
18,"NETWORK: COVID - % of deaths with patients ever infected with COVID, 2022-Q4",35.67,2022,allmcEcovDeaPq4_n
18,"NETWORK: COVID - % of hospitalizations with patients ever infected with COVID, 2022-Q4",37.43,2022,allmcEcovHosPq4_n
18,"NETWORK: COVID Nursing Home - % of Medicare patients initially infected with COVID, 2022-Q4",9.36,2022,nh_mcFcovpatPq4_n
18,"NETWORK: COVID Nursing Home - % of Medicare patients ever infected with COVID, 2022-Q4",49.44,2022,nh_mcEcovpatPq4_n
18,"NETWORK: COVID Nursing Home - % of deaths with patients ever infected with COVID, 2022-Q4",49.08,2022,nh_mcEcovDeaPq4_n
18,"NETWORK: COVID Nursing Home - % of hospitalizations with patients ever infected with COVID, 2022-Q4",48.74,2022,nh_mcEcovHosPq4_n
18,"N: Prevalent Patients - Age: Average patient age, 12/31/2022",63.49,2022,agey4_n
18,"N: Prevalent Patients - Age: % Less than 18 years, 12/31/2022",0.15,2022,age1y4_n
18,"N: Prevalent Patients - Age: % Between 18-64 years, 12/31/2022",49.28,2022,age2y4_n
18,"N: Prevalent Patients - Age: % Greater than or equal to 65 years, 12/31/2022",50.57,2022,age3y4_n
18,"N: Prevalent Patients - Primary Cause of ESRD: % Diabetes, 12/31/2022",52.83,2022,dis1y4_n
18,"N: Prevalent Patients - Primary Cause of ESRD: % Hypertension, 12/31/2022",26.75,2022,dis2y4_n
18,"N: Prevalent Patients - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",8.1,2022,dis3y4_n
18,"N: Prevalent Patients - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",11.89,2022,dis4y4_n
18,"N: Prevalent Patients - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.43,2022,dis5y4_n
18,"N: Prevalent Patients - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",14.44,2022,vin1y4_n
18,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",16.95,2022,vin2y4_n
18,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",12.86,2022,vin3y4_n
18,"N: Prevalent Patients - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",27.07,2022,vin4y4_n
18,"N: Prevalent Patients - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",28.68,2022,vin5y4_n
18,"N: Prevalent Patients - Race: % Asian/Pacific Islander, 12/31/2022",15.44,2022,rac1y4_n
18,"N: Prevalent Patients - Race: % African American, 12/31/2022",13.19,2022,rac2y4_n
18,"N: Prevalent Patients - Race: % Native American, 12/31/2022",0.57,2022,rac3y4_n
18,"N: Prevalent Patients - Race: % White, 12/31/2022",70.42,2022,rac4y4_n
18,"N: Prevalent Patients - Race: % Other/Unknown/Missing Race, 12/31/2022",0.38,2022,rac5y4_n
18,"N: Prevalent Patients - Ethnicity: % Hispanic, 12/31/2022",51.18,2022,eth1y4_n
18,"N: Prevalent Patients - Ethnicity: % Non-Hispanic, 12/31/2022",48.73,2022,eth2y4_n
18,"N: Prevalent Patients - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.08,2022,eth3y4_n
18,"N: Prevalent Patients - Sex: % Female, 12/31/2022",40.85,2022,sexy4_n
18,"N: Prevalent Patients - Nursing Home: % of Nursing Home Facility Patients During Year, 12/31/2022",9.72,2022,nrshomey4_n
18,"N: Prevalent Patients - Vintage: Average Years of Prior ESRD Therapy, 12/31/2022",5.17,2022,viny4_n
18,"N: Prevalent Patients - Modality: % on Hemodialysis, 12/31/2022",84.73,2022,modhdy4_n
18,"N: Prevalent Patients - Modality: % on Home Hemodialysis, 12/31/2022",1.33,2022,modhhdy4_n
18,"N: Prevalent Patients - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",1.51,2022,modcapdy4_n
18,"N: Prevalent Patients - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",12.32,2022,modccpdy4_n
18,"N: Prevalent Patients - Modality: % Other Modality, 12/31/2022",0.1,2022,modothry4_n
18,"N: Prevalent Patients - End of Year Status: Average number of patients alive in facility, 2022",84.94,2022,pahy4m_n
18,"N: Calcium (Adult) - % of patient-months with uncorrected calcium < 8.4 mg/dL, 2022",17.39,2022,CWunCa1y4_n
18,"N: Calcium (Adult) - % of patient-months with uncorrected calcium 8.4-10.2 mg/dL, 2022",78.35,2022,CWunCa2y4_n
18,"N: Calcium (Adult) - % of patient-months with uncorrected calcium > 10.2 mg/dL, 2022",1.05,2022,CWunCa3y4_n
18,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Missing, 2022",3.21,2022,CWunCamissy4_n
18,"N: Calcium (Adult) - % of patient-months with uncorrected calcium Out of Range, 2022",0.0,2022,CWunCaOoRy4_n
18,"N: Calcium (Adult) - Average uncorrected calcium in mg/dL, out of valid in range patient-months, 2022",8.91,2022,CWavgUnCay4_n
18,"N: Phosphorus (Adult) - Average serum phosphorus in mg/dL, out of valid in range patient-months, 2022",5.4,2022,CWavgPy4_n
18,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus < 3.5 mg/dL, 2022",7.98,2022,CWP1y4_n
18,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 3.5-4.5 mg/dL, 2022",23.85,2022,CWP2y4_n
18,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 4.6-5.5 mg/dL, 2022",29.27,2022,CWP3y4_n
18,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus 5.6-7.0 mg/dL, 2022",20.63,2022,CWP4y4_n
18,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus > 7.0 mg/dL, 2022",14.62,2022,CWP5y4_n
18,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Missing, 2022",3.65,2022,CWPmissy4_n
18,"N: Phosphorus (Adult) - % of patient-months with serum phosphorus Out of Range, 2022",0.0,2022,CWPOoRy4_n
18,"N: Hypercalcemia (Adult) - Average uncorrected calcium > 10.2 mg/dL, out of valid in range patient-months, 2022",2.1,2022,CWunCagt102y4_n
18,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patients, 2022",111.24,2022,CWptdenomy4m_n
18,"N: Calcium (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",998.39,2022,CWptmthdenomy4m_n
18,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patients, 2022",117.39,2022,serumphospatsy4m_n
18,"N: Phosphorus (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",1049.75,2022,serumphospmy4m_n
18,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patients, 2022",111.24,2022,CWhcptdenomy4m_n
18,"N: Hypercalcemia (Adult) - Average Number of Eligible Dialysis Patient-months, 2022",998.38,2022,CWhcptmthdenomy4m_n
18,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",64.08,2022,ppavfy4_n
18,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with grafts, 2022",13.68,2022,ppavgy4_n
18,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with catheters, 2022",19.98,2022,ppcathy4_n
18,"N: Prevalent VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",2.26,2022,ppomy4_n
18,"N: Prevalent VA Type (Adult) - Long-Term Catheter Rate, 2022",16.02,2022,ltcy4_n
18,"N: Incident VA Type (Adult) - % of patients receiving treatment with fistulae, 2022",13.32,2022,piavfy4_n
18,"N: Incident VA Type (Adult) - % of patients receiving treatment with grafts, 2022",3.05,2022,piavgy4_n
18,"N: Incident VA Type (Adult) - % of patients receiving treatment with catheters, 2022",79.0,2022,picathy4_n
18,"N: Incident VA Type (Adult) - % of patients receiving treatment with other or unknown access type., 2022",4.63,2022,piomy4_n
18,"N: Incident VA Type (Adult) - % of patients with fistulae placed, 2022",13.95,2022,pifisty4_n
18,"N: Prevalent VA Type (Adult) - Average number of HD patients, 2022",106.59,2022,phdvapty4m_n
18,"N: Prevalent VA Type (Adult) - Average number of HD patient-months, 2022",947.68,2022,phdy4m_n
18,"N: Incident VA Type (Adult) - Average number of HD patients, 2022",18.64,2022,ihdy4m_n
18,"N: Prevalent VA Type (Adult) - Standardized Fistula Rate (SFR), 2022",63.04,2022,sfry4_n
18,"N: VA infection - Average number of eligible PD patients, 2022",13.07,2022,pdpaty4m_n
18,"N: VA infection - Average number of eligible PD patient-months, 2022",101.67,2022,pdptmoy4m_n
18,"N: VA infection - PD catheter infection rate per 100 PD patient-months, 2022",2.3,2022,pd2inf100moy4_n
18,"N: Prevalent Comorbidities - Average Number of Medicare Dialysis Patients Alive on December 31, 2022",64.61,2022,ncmy4m_n
18,"N: Prevalent Comorbidities - Average % with Anemia, 2022",2.47,2022,clmanemy4_n
18,"N: Prevalent Comorbidities - Average % with AIDS, 2022",0.29,2022,clmhivaidmy4_n
18,"N: Prevalent Comorbidities - Average % with Alcohol Dependence, 2022",1.39,2022,clmalcomy4_n
18,"N: Prevalent Comorbidities - Average % with Cancer, 2022",3.05,2022,clmcanmy4_n
18,"N: Prevalent Comorbidities - Average % with Cardiac Arrest, 2022",0.97,2022,clmcamy4_n
18,"N: Prevalent Comorbidities - Average % with Cardiac Dysrythmias, 2022",17.32,2022,clmcdmy4_n
18,"N: Prevalent Comorbidities - Average % with Cerebrovascular Disease, 2022",6.89,2022,clmcvdmy4_n
18,"N: Prevalent Comorbidities - Average % with Chronic Observedtructive Pulmonary Disease, 2022",9.66,2022,clmcopdmy4_n
18,"N: Prevalent Comorbidities - Average % with Congestive Heart Failure, 2022",27.67,2022,clmchfmy4_n
18,"N: Prevalent Comorbidities - Average % with Diabetes, 2022",36.87,2022,clmdiabmy4_n
18,"N: Prevalent Comorbidities - Average % with Drug Dependence, 2022",1.0,2022,clmdrugmy4_n
18,"N: Prevalent Comorbidities - Average % with Gastro-Intestinal Tract Bleeding, 2022",2.72,2022,clmgtbmy4_n
18,"N: Prevalent Comorbidities - Average % with Hepatitis B, 2022",0.46,2022,clmhepbmy4_n
18,"N: Prevalent Comorbidities - Average % with Hepatitis Other, 2022",1.3,2022,clmhepothmy4_n
18,"N: Prevalent Comorbidities - Average % with Hyperparathyearoidism, 2022",18.26,2022,clmhypthymy4_n
18,"N: Prevalent Comorbidities - Average % with Non-Vascular Access-Related Infection, 2022",17.11,2022,clminfmy4_n
18,"N: Prevalent Comorbidities - Average % with Ischemic Heart Disease, 2022",22.7,2022,clmihdmy4_n
18,"N: Prevalent Comorbidities - Average % with Myocardial Infarction, 2022",8.12,2022,clmmimy4_n
18,"N: Prevalent Comorbidities - Average % with Peripheral Vascular Disease, 2022",17.58,2022,clmpvdmy4_n
18,"N: Prevalent Comorbidities - Average % with Pneumonia, 2022",3.28,2022,clmpnemy4_n
18,"N: Prevalent Comorbidities - Average Number of Comorbid Conditions, 2022",2.05,2022,clmcntcomy4_n
18,"N: Prevalent Comorbidities - Average % with Vascular Access-Related Infection, 2022",4.06,2022,clminfvamy4_n
18,"N: Prevalent Comorbidities - Average % with Metastatic Infection, 2022",1.19,2022,clmmstinfmy4_n
18,"N: Prevalent Comorbidities - Average % with Tuberculosis, 2022",0.48,2022,clmtbmy4_n
18,"N (AFS): Facility Information - Average number of patients, 2022",145.75,2022,allcnty4m_n
18,N (AFS): Facility Information - Average number of all patients on 12/31/2022,102.04,2022,endcnty4m_n
18,"N (AFS): Facility Information - Average % of patients transferred in, 2022",13.61,2022,transiny4_n
18,"N (AFS): Facility Information - Average % of patients transferred out, 2022",14.51,2022,transouty4_n
18,N (AFS): Facility Information - Average % Medicare patients on 12/31/2022,70.28,2022,medicarey4_n
18,N (AFS): Facility Information - Average % Medicare pending on 12/31/2022,11.23,2022,medpendy4_n
18,N (AFS): Facility Information - Average % Non-Medicare on 12/31/2022,18.5,2022,nonmedy4_n
18,N (QIES): Facility Information Â Average number of Condition-Level Citations/Survey,0.4,2022,cfc_N
18,N (QIES): Facility Information Â Average number of Standard-Level Citations/Survey,8.06,2022,std_N
18,"N: Prevalent Patients (Pediatric) - Age: % under 5 years, 12/31/2022",18.03,2022,p_age1y4_n
18,"N: Prevalent Patients (Pediatric) - Age: % between 5-9 years, 12/31/2022",19.67,2022,p_age2y4_n
18,"N: Prevalent Patients (Pediatric) - Age: % between 10-14 years, 12/31/2022",31.15,2022,p_age3y4_n
18,"N: Prevalent Patients (Pediatric) - Age: % between 15-17 years, 12/31/2022",31.15,2022,p_age4y4_n
18,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Diabetes, 12/31/2022",9.84,2022,p_dis1y4_n
18,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hypertension, 12/31/2022",4.92,2022,p_dis2y4_n
18,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",21.31,2022,p_dis3y4_n
18,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Cystic Kidney, 12/31/2022",22.95,2022,p_dis4y4_n
18,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Congenital/Hereditary, 12/31/2022",0.0,2022,p_dis5y4_n
18,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Hemolytic Uremic Syndrome, 12/31/2022",0.0,2022,p_dis6y4_n
18,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Other Cause, 12/31/2022",36.07,2022,p_dis7y4_n
18,"N: Prevalent Patients (Pediatric) - Primary Cause of ESRD: % Missing/Unknown Cause, 12/31/2022",4.92,2022,p_dis8y4_n
18,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",22.95,2022,p_vin1y4_n
18,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",21.31,2022,p_vin2y4_n
18,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",8.2,2022,p_vin3y4_n
18,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",26.23,2022,p_vin4y4_n
18,"N: Prevalent Patients (Pediatric) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",21.31,2022,p_vin5y4_n
18,"N: Prevalent Patients (Pediatric) - Race: % Asian/Pacific Islander, 12/31/2022",4.92,2022,p_rac1y4_n
18,"N: Prevalent Patients (Pediatric) - Race: % African American, 12/31/2022",13.11,2022,p_rac2y4_n
18,"N: Prevalent Patients (Pediatric) - Race: % Native American, 12/31/2022",0.0,2022,p_rac3y4_n
18,"N: Prevalent Patients (Pediatric) - Race: % White, 12/31/2022",78.69,2022,p_rac4y4_n
18,"N: Prevalent Patients (Pediatric) - Race: % Other/Unk/Missing race, 12/31/2022",3.28,2022,p_rac5y4_n
18,"N: Prevalent Patients (Pediatric) - Ethnicity: % Hispanic, 12/31/2022",62.3,2022,p_eth1y4_n
18,"N: Prevalent Patients (Pediatric) - Ethnicity: % Non-Hispanic, 12/31/2022",37.7,2022,p_eth2y4_n
18,"N: Prevalent Patients (Pediatric) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.0,2022,p_eth3y4_n
18,"N: Prevalent Patients (Pediatric) - Sex: % Female, 12/31/2022",45.9,2022,p_sexy4_n
18,"N: Prevalent Patients (Pediatric) - Modality: % on Hemodialysis, 12/31/2022",57.38,2022,p_modhdy4_n
18,"N: Prevalent Patients (Pediatric) - Modality: % on Home Hemodialysis, 12/31/2022",0.0,2022,p_modhhdy4_n
18,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",4.92,2022,p_modcapdy4_n
18,"N: Prevalent Patients (Pediatric) - Modality: % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",37.7,2022,p_modccpdy4_n
18,"N: Prevalent Patients (Pediatric) - Modality: % on Other Modality, 12/31/2022",0.0,2022,p_modothry4_n
18,"N (2728): Incident Patients  (Pediatric) - Percent with Medicare coverage, 2022",45.28,2022,p_allmdcrmy4_n
18,"N (2728): Incident Patients  (Pediatric) - Percent with Medicaid coverage only, 2022",33.96,2022,p_insmdcdmy4_n
18,"N (2728): Incident Patients  (Pediatric) - Percent with employer group coverage only, 2022",11.32,2022,p_insempmy4_n
18,"N (2728): Incident Patients  (Pediatric) - Percent with None, other or unknown coverage only, 2022",9.43,2022,p_insnonothmy4_n
18,"N (2728): Incident Patients  (Pediatric) - No Pre-ESRD Nephrologist Care, 2022",18.87,2022,p_nephnomy4_n
18,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",18.87,2022,p_nephy6my4_n
18,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",22.64,2022,p_nephy612my4_n
18,"N (2728): Incident Patients  (Pediatric) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",28.3,2022,p_nephy12my4_n
18,"N (2728): Incident Patients  (Pediatric) - Unknown Pre-ESRD Nephrologist Care, 2022",11.32,2022,p_nephunkmissmy4_n
18,"N (2728): Incident Patients  (Pediatric) - Percent of Patients Informed of Transplant Options, 2022",84.91,2022,p_ptinfymy4_n
18,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Fistula, 2022",0.0,2022,p_mefavfmy4_n
18,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: AV Graft, 2022",0.0,2022,p_mefgraftmy4_n
18,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Catheter, 2022",100.0,2022,p_mefcathmy4_n
18,"N (2728): Incident Patients  (Pediatric) - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.0,2022,p_mefoumaccessmy4_n
18,"N (2728): Incident Patients  (Pediatric) - Percent of Incident Patients with Fistulae placed, 2022",0.0,2022,p_avfpresentmy4_n
18,"N: Prevalent VA Type (Pediatric) - % of patients receiving treatment with fistulae, 2022",3.78,2022,p_ppavfy4_n
18,"N: Prevalent VA Type (Pediatric) - Long-Term Catheter Rate, 2022",82.89,2022,p_ltcy4_n
18,"N: Prevalent Waitlist (Pediatric) - % of patient-months (<18 only) on waitlist, 2022",37.32,2022,p_WLy4_n
18,"N: Prevalent Waitlist (Pediatric) - % of patient-months <10 years on waitlist, 2022",47.21,2022,p_WLlt10y4_n
18,"N: Prevalent Waitlist (Pediatric) - % of patient-months aged 10-17 on waitlist, 2022",39.05,2022,p_WL1017y4_n
18,"N: HD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.97,2022,p_CWhdavgHGBy4_n
18,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",19.08,2022,p_CWhdhgb1y4_n
18,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",20.77,2022,p_CWhdhgb2y4_n
18,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",31.4,2022,p_CWhdhgb3y4_n
18,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",17.63,2022,p_CWhdhgb4y4_n
18,"N: HD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",11.11,2022,p_CWhdhgb5y4_n
18,"N: PD HGB (Pediatric) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.83,2022,p_CWpdavgHGBy4_n
18,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin < 10 g/dL, 2022",22.69,2022,p_CWpdhgb1y4_n
18,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",29.13,2022,p_CWpdhgb2y4_n
18,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",30.25,2022,p_CWpdhgb3y4_n
18,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin > 12 g/dL, 2022",15.41,2022,p_CWpdhgb4y4_n
18,"N: PD HGB (Pediatric) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.52,2022,p_CWpdhgb5y4_n
18,"N: Albumin (Pediatric) - Average serum albumin (g/dL), of valid in range HD patient-months, 2022",4.09,2022,p_CWhdalby4_n
18,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin < 3 g/dL, 2022",2.42,2022,p_CWhdalb1y4_n
18,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",3.38,2022,p_CWhdalb2y4_n
18,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",22.71,2022,p_CWhdalb3y4_n
18,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin >= 4 g/dL, 2022",58.45,2022,p_CWhdalb4y4_n
18,"N: Albumin (Pediatric) - % of HD patient-months with Serum Albumin Missing, 2022",13.04,2022,p_CWhdalb5y4_n
18,"N:  Albumin (Pediatric) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.94,2022,p_CWpdalby4_n
18,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin < 3 g/dL, 2022",3.64,2022,p_CWpdalb1y4_n
18,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3 - < 3.5 g/dL, 2022",8.4,2022,p_CWpdalb2y4_n
18,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin 3.5 - < 4 g/dL, 2022",36.69,2022,p_CWpdalb3y4_n
18,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin >= 4 g/dL, 2022",48.74,2022,p_CWpdalb4y4_n
18,"N:  Albumin (Pediatric) - % of PD patient-months with Serum Albumin Missing, 2022",2.52,2022,p_CWpdalb5y4_n
18,"N: PD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.8, 2022",71.15,2022,p_CWpdktvge18y4_n
18,"N: HD Kt/V (Pediatric)- % of patient-months with Kt/V >= 1.2, 2022",83.01,2022,p_CWhdktvge12y4_n
18,"N: Patient Placement -  % of incident patients, 2022",15.56,2022,ppidy4_n
18,"N: Patient Placement -  % of patients continuing at facility, 2022",74.09,2022,ppcdy4_n
18,"N: Patient Placement -  % of patients that transfered into facility, 2022",10.36,2022,pptdy4_n
18,"N: End of Year Status - % of patients death attributed to this facility, 2022",12.27,2022,pdhdy4_n
18,"N: End of Year Status - % of patients death attributed to another facility, 2022",1.46,2022,pdody4_n
18,"N: End of Year Status - % of patients that received a transplant, 2022",2.8,2022,ptxdy4_n
18,"N: End of Year Status - % of patients alive in this facility, 2022",72.61,2022,pahdy4_n
18,"N: End of Year Status - % of patients alive in another facility, 2022",7.93,2022,paody4_n
18,"N: End of Year Status - % of patients other, 2022",2.95,2022,potdy4_n
18,N (AFS): Facility Information - Average number of in-center HD patients on 12/31/2022,86.88,2022,iuhemy4m_n
18,N (AFS): Facility Information - Average number of in-center frequent HD patients on 12/31/2022,0.05,2022,iufreqy4m_n
18,N (AFS): Facility Information - Average number of in-center non-frequent HD patients on 12/31/2022,86.83,2022,iunonfreqy4m_n
18,N (AFS): Facility Information - Average number of in-center patients with other modality on 12/31/2022,0.01,2022,iuothy4m_n
18,N (AFS): Facility Information - Average number of in-center Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iucapdy4m_n
18,N (AFS): Facility Information - Average number of in-center Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,0.0,2022,iuccpdy4m_n
18,N (AFS): Facility Information - Average number of home HD patients on 12/31/2022,1.35,2022,ihhemy4m_n
18,N (AFS): Facility Information - Average number of home frequent HD patients on 12/31/2022,0.41,2022,ihfreqy4m_n
18,N (AFS): Facility Information - Average number of home non-frequent HD patients on 12/31/2022,0.95,2022,ihnonfreqy4m_n
18,N (AFS): Facility Information - Average number of home patients with other modality on 12/31/2022,0.0,2022,ihothy4m_n
18,N (AFS): Facility Information - Average number of home Continuous Ambulatory Peritoneal Dialysis patients on 12/31/2022,1.61,2022,ihcapdy4m_n
18,N (AFS): Facility Information - Average number of home Continuous Cycling Peritoneal Dialysis patients on 12/31/2022,12.18,2022,ihccpdy4m_n
18,"N (AFS): Facility Information - Average number of total staff positions on Dec 31 (full & part time), 2022",20.06,2022,staffy4m_n
18,N (AFS): Facility Information - Average number of full time nurses on 12/31/2022,5.64,2022,nurseFTy4m_n
18,N (AFS): Facility Information - Average number of full time patient care technicians on 12/31/2022,9.14,2022,ptcareFTy4m_n
18,N (AFS): Facility Information - Average number of full time renal dieticians on 12/31/2022,1.18,2022,dietFTy4m_n
18,N (AFS): Facility Information - Average number of full time social workers on 12/31/2022,1.32,2022,socwkFTy4m_n
18,N (AFS): Facility Information - Average number of part time nurses on 12/31/2022,1.09,2022,nursePTy4m_n
18,N (AFS): Facility Information - Average number of part time patient care technicians on 12/31/2022,1.05,2022,ptcarePTy4m_n
18,N (AFS): Facility Information - Average number of part time renal dieticians on 12/31/2022,0.32,2022,dietPTy4m_n
18,N (AFS): Facility Information -  Average number of part time social workers on 12/31/2022,0.32,2022,socwkPTy4m_n
18,F (AFS): Facility Information - Vocational Rehab number of Patients 18-54 on 12/31/2022,53.03,2022,vocrehaby4m_n
18,"N (AFS): Facility Information - Average % incident patients, 2022",14.88,2022,incpery4_n
18,N (AFS): Facility Information - % Patients 18-54 who are employed on 12/31/2022,25.34,2022,employedy4_n
18,N (AFS): Facility Information - % Patients 18-54 who are school on 12/31/2022,0.87,2022,schooly4_n
18,"N: Prevalent VA Type (Nursing Home) - % of Patients Receiving Treatment with Fistulae, 2022",51.88,2022,nh_ppavfy4_n
18,"N: Prevalent VA Type (Nursing Home) - Long-Term Catheter Rate, 2022",22.31,2022,nh_ltcy4_n
18,"N: HD Kt/V (Nursing Home)- % of Patient-months with Kt/V < 1.2, 2022",2.46,2022,nh_CWhdktv1y4_n
18,"N: PD Kt/V (Nursing Home) - % of Patient-months with with Kt/V < 1.7, 2022",10.02,2022,nh_CWpdktv1y4_n
18,"N: HD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",29.9,2022,nh_CWhdhgb1y4_n
18,"N: HD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",83.71,2022,nh_CWhdesarxy4_n
18,"N: PD HGB (Nursing Home) - % of Patient-months with Hemoglobin < 10 g/dL, 2022",30.98,2022,nh_CWpdhgb1y4_n
18,"N: PD HGB (Nursing Home) - % of Patient-months with ESA Prescribed, 2022",58.08,2022,nh_CWpdesarxy4_n
18,"N: All Patient Mortality (Nursing Home) - Observed death rate (per 100 patient-years), 2022",40.53,2022,nh_obdry4_n
18,"N: All Patient Mortality (Nursing Home) - Standardized Mortality Ratio (SMR), 2022",1.27,2022,nh_smry4_n
18,"N: All Patient Mortality (Nursing Home) - % of deaths from withdrawal, 2022",14.34,2022,nh_wity4_n
18,"N: SHR (Nursing Home Admissions) - Observed Admission Rate (per patient-year in average facility), 2022",282.07,2022,nh_obhtry4_n
18,"N: SHR (Nursing Home Admissions) - Standardized Hospitalization Ratio for Admissions, 2022",1.56,2022,nh_shrty4_n
18,"N: Hospitalization (Nursing Home) - Diagnosis: % with Septicemia, 2022",30.35,2022,nh_sepiy4_n
18,"N: Hospitalization (Nursing Home) - Diagnosis: % with Acute Myocardial Infarction, 2022",14.92,2022,nh_miiy4_n
18,"N: Hospitalization (Nursing Home) - Diagnosis: % with Congestive Heart Failure, 2022",50.54,2022,nh_achfy4_n
18,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Dysrhythmia, 2022",35.21,2022,nh_acdry4_n
18,"N: Hospitalization (Nursing Home) - Diagnosis: % with Cardiac Arrest, 2022",5.5,2022,nh_acary4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with AIDS, 2022",0.59,2022,nh_clmhivaidmy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Vascular Access-Related Infection, 2022",9.07,2022,nh_clminfvamy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis B, 2022",0.99,2022,nh_clmhepbmy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Hepatitis Other, 2022",3.09,2022,nh_clmhepothmy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Metastatic Infection, 2022",4.31,2022,nh_clmmstinfmy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Pneumonia, 2022",11.25,2022,nh_clmpnemy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Tuberculosis, 2022",0.4,2022,nh_clmtbmy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Non-Vascular Access-Related Infection, 2022",43.51,2022,nh_clminfmy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Arrest, 2022",3.14,2022,nh_clmcamy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Cardiac Dysrythmias, 2022",39.09,2022,nh_clmcdmy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Cerebrovascular Disease, 2022",19.01,2022,nh_clmcvdmy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Congestive Heart Failure, 2022",56.86,2022,nh_clmchfmy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Ischemic Heart Disease, 2022",45.44,2022,nh_clmihdmy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Myocardial Infarction, 2022",17.22,2022,nh_clmmimy4_n
18,"N: Prevalent Comorbidities (Nursing Home) - % with Peripheral Vascular Disease, 2022",40.57,2022,nh_clmpvdmy4_n
18,"N: Prevalent Patients (Nursing Home) - Age: % Less than 18 years, 12/31/2022",0.0,2022,nh_age1y4_n
18,"N: Prevalent Patients (Nursing Home) - Age: % Between 18-64 years, 12/31/2022",30.39,2022,nh_age2y4_n
18,"N: Prevalent Patients (Nursing Home) - Age: % Greater than or equal to 65 years, 12/31/2022",69.61,2022,nh_age3y4_n
18,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Diabetes, 12/31/2022",60.05,2022,nh_dis1y4_n
18,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Hypertension, 12/31/2022",24.88,2022,nh_dis2y4_n
18,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Glomerulonephritis, 12/31/2022",3.26,2022,nh_dis3y4_n
18,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Other/Unknown Cause, 12/31/2022",11.18,2022,nh_dis4y4_n
18,"N: Prevalent Patients (Nursing Home) - Primary Cause of ESRD: % Missing Cause, 12/31/2022",0.62,2022,nh_dis5y4_n
18,"N: Prevalent Patients (Nursing Home) - Race: % Asian/Pacific Islander, 12/31/2022",13.26,2022,nh_rac1y4_n
18,"N: Prevalent Patients (Nursing Home) - Race: % African American, 12/31/2022",16.3,2022,nh_rac2y4_n
18,"N: Prevalent Patients (Nursing Home) - Race: % Native American, 12/31/2022",0.64,2022,nh_rac3y4_n
18,"N: Prevalent Patients (Nursing Home) - Race: % White, 12/31/2022",69.38,2022,nh_rac4y4_n
18,"N: Prevalent Patients (Nursing Home) - Race: % Other/Unknown/Missing race, 12/31/2022",0.41,2022,nh_rac5y4_n
18,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Hispanic, 12/31/2022",42.31,2022,nh_eth1y4_n
18,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Non-Hispanic, 12/31/2022",57.53,2022,nh_eth2y4_n
18,"N: Prevalent Patients (Nursing Home) - Ethnicity: % Unknown Ethnicity, 12/31/2022",0.15,2022,nh_eth3y4_n
18,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy less than 1 year, 12/31/2022",18.71,2022,nh_vin1y4_n
18,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 1-2 years, 12/31/2022",15.55,2022,nh_vin2y4_n
18,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 2-3 years, 12/31/2022",10.26,2022,nh_vin3y4_n
18,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for 3-6 years, 12/31/2022",25.53,2022,nh_vin4y4_n
18,"N: Prevalent Patients (Nursing Home) - Vintage: % on ESRD Therapy for over 6 years, 12/31/2022",29.95,2022,nh_vin5y4_n
18,"N: Prevalent Patients (Nursing Home) - Sex: % Female, 12/31/2022",44.52,2022,nh_sexy4_n
18,"N: Prevalent Patients (Nursing Home) - Modality: % on Hemodialysis, 12/31/2022",96.97,2022,nh_modhdy4_n
18,"N: Prevalent Patients (Nursing Home) - Modality: % on Home Hemodialysis, 12/31/2022",1.67,2022,nh_modhhdy4_n
18,"N: Prevalent Patients (Nursing Home) - % on Continuous Ambulatory Peritoneal Dialysis, 12/31/2022",0.1,2022,nh_modcapdy4_n
18,"N: Prevalent Patients (Nursing Home) - % on Continuous Cycling Peritoneal Dialysis, 12/31/2022",0.95,2022,nh_modccpdy4_n
18,"N: Prevalent Patients (Nursing Home) - % on Other Modality, 12/31/2022",0.31,2022,nh_modothry4_n
18,"N: Incident Patients (Nursing Home) - Percent with Medicare alone or with other insurance, 2022",82.8,2022,nh_allmdcrmy4_n
18,"N: Incident Patients (Nursing Home) - Percent with Medicaid coverage only, 2022",11.25,2022,nh_insmdcdmy4_n
18,"N: Incident Patients (Nursing Home) - Percent with employer group coverage only, 2022",1.65,2022,nh_insempmy4_n
18,"N: Incident Patients (Nursing Home) -  Percent with Other/Unknown/No insurance, 2022",4.3,2022,nh_insnonothmy4_n
18,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Fistula, 2022",4.95,2022,nh_mefavfmy4_n
18,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Arteriovenous Graft, 2022",2.22,2022,nh_mefgraftmy4_n
18,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Catheter, 2022",91.33,2022,nh_mefcathmy4_n
18,"N: Incident Patients (Nursing Home) - Percent of hemodialysis patients.: Other/Unknown/Missing Access, 2022",1.51,2022,nh_mefoumaccessmy4_n
18,"N: Incident Patients (Nursing Home) - Percent of patients with Arteriovenous fistulae placed, 2022",9.96,2022,nh_avfpresentmy4_n
18,"N: Incident Patients (Nursing Home) - No Pre-ESRD Nephrologist Care, 2022",24.52,2022,nh_nephnomy4_n
18,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",20.93,2022,nh_nephy6my4_n
18,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",15.84,2022,nh_nephy612my4_n
18,"N: Incident Patients (Nursing Home) - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",13.69,2022,nh_nephy12my4_n
18,"N: Incident Patients (Nursing Home) - Unknown Pre-ESRD Nephrologist Care, 2022",25.02,2022,nh_nephunkmissmy4_n
18,"N: Incident Patients (Nursing Home) - Percent of Patients Informed of Transplant Options, 2022",84.23,2022,nh_ptinfymy4_n
18,"N (2728): Incident Patients  - Percent alcohol dependent, 2022",1.41,2022,alcomy4_n
18,"N (2728): Incident Patients  - Percent with atherosclerotic heart disease, 2022",9.15,2022,ashdmy4_n
18,"N (2728): Incident Patients  - Percent with other cardiac disorder, 2022",16.5,2022,othcarmy4_n
18,"N (2728): Incident Patients  - Percent with cancer, 2022",5.02,2022,canmy4_n
18,"N (2728): Incident Patients  - Percent with congestive heart failure, 2022",20.71,2022,chfmy4_n
18,"N (2728): Incident Patients  - Percent with cardiovascular disease, cerebral vascular incident, and transient ischemic attack, 2022",6.02,2022,cvamy4_n
18,"N (2728): Incident Patients  - Percent with diabetes on insulin, 2022",38.35,2022,diabimy4_n
18,"N (2728): Incident Patients  - Percent with diabetes, 2022",67.57,2022,diabmy4_n
18,"N (2728): Incident Patients  - Percent drug dependent, 2022",1.13,2022,drugmy4_n
18,"N (2728): Incident Patients  - Percent with history of hypertension, 2022",85.73,2022,hxhtmy4_n
18,"N (2728): Incident Patients  - Percent inability to ambulate, 2022",7.12,2022,ambumy4_n
18,"N (2728): Incident Patients  - Percent inability to transfer, 2022",5.02,2022,transmy4_n
18,"N (2728): Incident Patients  - Percent with chronic obstructive pulmonary disease, 2022",4.32,2022,copdmy4_n
18,"N (2728): Incident Patients  - Percent with PVD, 2022",5.25,2022,pvdmy4_n
18,"N (2728): Incident Patients  - Percent smoker, 2022",2.9,2022,smokmy4_n
18,"N (2728): Incident Patients  - Percent Hispanic, 2022",44.83,2022,ethmy4_n
18,"N (2728): Incident Patients  - Percent White, 2022",68.62,2022,whitemy4_n
18,"N (2728): Incident Patients  - Percent African American, 2022",12.52,2022,blackmy4_n
18,"N (2728): Incident Patients  - Percent Native American, 2022",1.92,2022,nativmy4_n
18,"N (2728): Incident Patients  - Percent Asian/Pacific Islander, 2022",16.33,2022,asianmy4_n
18,"N (2728): Incident Patients  - Percent other/unknown/missing race, 2022",0.61,2022,racoummy4_n
18,"N (2728): Incident Patients  - Percent currently employed FT/PT/student, 2022",27.32,2022,cempmy4_n
18,"N (2728): Incident Patients  - Percent previously employed FT/PT/student, 2022",38.66,2022,pempmy4_n
18,"N (2728): Incident Patients  - Percent diabetes as primary cause ESRD, 2022",52.29,2022,dbprimy4_n
18,"N (2728): Incident Patients  - Percent glomerulonephritis as primary cause of ESRD, 2022",5.04,2022,gnprimy4_n
18,"N (2728): Incident Patients  - Percent hypertension as primary cause ESRD, 2022",25.9,2022,htprimy4_n
18,"N (2728): Incident Patients  - Percent other/missing primary cause of ESRD, 2022",16.77,2022,omprimy4_n
18,"N (2728): Incident Patients  - Percent female, 2022",39.51,2022,femmy4_n
18,"N (2728): Incident Patients  - Average age, 2022",64.36,2022,agemy4_n
18,"N (2728): Incident Patients  - Average serum albumin, 2022",3.45,2022,salbmy4_n
18,"N (2728): Incident Patients  - Average creatinine, 2022",6.4,2022,creamy4_n
18,"N (2728): Incident Patients  - Average hemoglobin, 2022",9.4,2022,hgmy4_n
18,"N (2728): Incident Patients  - GFR by MDRD formula, 2022",10.51,2022,gfrmy4_n
18,"N (2728): Incident Patients  - Average count of comorbidities, 2022",2.76,2022,cntcomy4_n
18,"N (2728): Incident Patients  - Primary Modality: Hemodialysis, 2022",85.7,2022,pdmodMEFHDmy4_n
18,"N (2728): Incident Patients  - Primary Modality: Peritoneal Dialysis, 2022",14.3,2022,pdmodMEFPDmy4_n
18,"N (2728): Incident Patients  -Primary Modality: Other/Unknown/Missing, 2022",0.0,2022,pdmodMEFOTHUNKmy4_n
18,"N (2728): Incident Patients  - Percent with Medicare coverage only, 2022",40.64,2022,insmdcrmy4_n
18,"N (2728): Incident Patients  - Percent with Medicaid coverage only, 2022",22.4,2022,insmdcdmy4_n
18,"N (2728): Incident Patients  - Percent with Medicare and Medicaid coverage only, 2022",11.18,2022,insmdcrcdmy4_n
18,"N (2728): Incident Patients  - Percent with employer group coverage only, 2022",9.83,2022,insempmy4_n
18,"N (2728): Incident Patients  - Percent with no coverage, 2022",0.81,2022,insnonemy4_n
18,"N (2728): Incident Patients  - Percent with Medicare and other coverage, 2022",6.35,2022,insmdcromy4_n
18,"N (2728): Incident Patients  - Percent with other or unknown coverage, 2022",8.79,2022,insmedomy4_n
18,"N (2728): Incident Patients  - Percent of Patients Received ESA prior to ESRD, 2022",18.73,2022,preepomy4_n
18,"N (2728): Incident Patients  - No Pre-ESRD Nephrologist Care, 2022",20.4,2022,nephnomy4_n
18,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Less Than 6 months, 2022",20.16,2022,nephy6my4_n
18,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Between 6 and 12 months, 2022",18.09,2022,nephy612my4_n
18,"N (2728): Incident Patients  - Pre-ESRD Nephrologist Care Greater Than 12 months, 2022",23.76,2022,nephy12my4_n
18,"N (2728): Incident Patients  - Unknown Pre-ESRD Nephrologist Care, 2022",17.59,2022,nephunkmissmy4_n
18,"N (2728): Incident Patients  - Percent of Patients Informed of Transplant Options, 2022",90.84,2022,ptinfymy4_n
18,"N (2728): Incident Patients  - Reason Not Informed: Patient Medically Unfit, 2022",38.74,2022,ptxmedunfitmy4_n
18,"N (2728): Incident Patients  - Reason Not Informed: Unsuitable Due to Age, 2022",0.0,2022,ptxagedmy4_n
18,"N (2728): Incident Patients  - Reason Not Informed: Patient Psychologically Unfit, 2022",0.0,2022,ptxpsyunfitmy4_n
18,"N (2728): Incident Patients  - Reason Not Informed: Patient Declined Information, 2022",13.12,2022,ptxdeclinemy4_n
18,"N (2728): Incident Patients  - Reason Not Informed: Patient Has Not Been Assessed, 2022",59.78,2022,ptxnotassessmy4_n
18,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Fistula, 2022",13.56,2022,mefavfmy4_n
18,"N (2728): Incident Patients  - Percent of Incident HD Patients: Arteriovenous Graft, 2022",2.46,2022,mefgraftmy4_n
18,"N (2728): Incident Patients  - Percent of Incident HD Patients: Catheter, 2022",83.86,2022,mefcathmy4_n
18,"N (2728): Incident Patients  - Percent of Incident HD Patients: Other/Unknown/Missing, 2022",0.12,2022,mefoumaccessmy4_n
18,"N (2728): Incident Patients  - Percent of Incident Patients with Arteriovenous fistulae placed, 2022",21.09,2022,avfpresentmy4_n
18,"N (2728): Incident Patients  - Median BMI for males >= 20 yrs, 2022",26.85,2022,bmimmy4_n
18,"N (2728): Incident Patients  - Median BMI for females >= 20 yrs, 2022",26.69,2022,bmifmy4_n
18,"N (2728): Incident Patients  - Average Patients Not Informed of Transplant Options, 2022",1.76,2022,ptinfnmy4m_n
18,"N (2728): Incident Patients  - Average Number of incident hemodialysis patients (n),2022",16.46,2022,hemomy4m_n
18,"N (2728): Incident Patients  - Average Number of forms returned, 2022",19.21,2022,nmy4m_n
18,"N: All Patient Mortality - Average number of patients (per year in average facility), 2019-2022",118.35,2019,rdsmzm_n
18,"N: All Patient Mortality - Average years at risk for mortality (per year in average facility), 2019-2022",79.85,2019,dyzm_n
18,"N: All Patient Mortality - Average number of deaths (per year in average facility), 2019-2022",13.5,2019,deazm_n
18,"N: All Patient Mortality - Average expected deaths (per year in average facility), 2019-2022",13.87,2019,exdzm_n
18,"N: All Patient Mortality - Average number deaths from dialysis, unrelated deaths (per year in average facility), 2019-2022",0.06,2019,dudzm_n
18,"N: All Patient Mortality - Standardized Mortality Ratio (SMR), 2019-2022",0.97,2019,smrz_n
18,"N: All Patient Mortality - % of deaths from withdrawl, 2019-2022",14.17,2019,witz_n
18,"N: All Patient Mortality - % of deaths from infection, 2019-2022",9.09,2019,infz_n
18,"N: All Patient Mortality - % of deaths from cardiac causes, 2019-2022",51.14,2019,cardz_n
18,"N: All Patient Mortality - % of deaths from liver disease, 2019-2022",1.09,2019,livz_n
18,"N: First-Year Mortality - Average number of new patients, 2019 - 2021",20.29,2019,fynmzm_n
18,"N: First-Year Mortality - Average Years at risk , 2019 - 2021",12.72,2019,fydyzm_n
18,"N: First-Year Mortality - Average number of deaths, 2019 - 2021",2.73,2019,fydeazm_n
18,"N: First-Year Mortality - Average number of expected deaths, 2019 - 2021",2.8,2019,fyexdzm_n
18,"N: First-Year Mortality - Standardized First-Year Mortality Ratio, 2019 - 2021",0.97,2019,fysmrz_n
18,"N: First-Year Mortality - Percent of deaths from withdrawal, 2019 - 2021",14.99,2019,fywitz_n
18,"N: First-Year Mortality - Percent of deaths from infection, 2019 - 2021",8.85,2019,fyinfz_n
18,"N: First-Year Mortality - Percent of deaths from cardiac causes, 2019 - 2021",44.99,2019,fycardiacz_n
18,"N: First-Year Mortality - Percent of deaths from liver disease, 2019 - 2021",2.13,2019,fylivz_n
18,"N: Hospitalization - Average Number of Patients (per year in average facility), 2019-2022",92.2,2019,rdshzm_n
18,"N: SHR (Admissions) - Average Number of Hospital Admissions (per year in average facility), 2019-2022",73.5,2019,htazm_n
18,"N: SHR (Admissions) - Average Expected Number of Hospital Admissions (per year in average facility), 2019-2022",80.98,2019,extzm_n
18,"N: SHR (Days) - Average Days Hospitalized (per year in average facility), 2019-2022",548.7,2019,hdzm_n
18,"N: SHR (Days) - Average Expected Days Hospitalized (per year in average facility), 2019-2022",666.92,2019,exhdzm_n
18,"N: Hospitalization - Average Years at Risk (per year in average facility), 2019-2022",60.82,2019,hdyzm_n
18,"N: SHR (Admissions) - Average Standardized Hospitalization Ratio for Admissions (per year in average facility), 2019-2022",0.91,2019,shrtz_n
18,"N: SHR (Days) - Average Standardized Hospitalization Ratio for Days (per year in average facility), 2019-2022",0.82,2019,shrdz_n
18,"N: SHR (Days) - Average Length of Stay (days per admission, per year in average facility), 2019-2022",7.12,2019,lenz_n
18,"N: SHR (Admissions) - Average % One Day Admissions (per year in average facility), 2019-2022",10.01,2019,onez_n
18,"N: Hospitalization - Diagnosis: Average % with Acute Myocardial Infarction (per year in average facility), 2019-2022",7.67,2019,miiz_n
18,"N: Hospitalization - Diagnosis: Average % with Septicemia (per year in average facility), 2019-2022",13.55,2019,sepiz_n
18,"N: Hospitalization - Diagnosis: Average % with Congestive Heart Failure (per year in average facility), 2019-2022",25.91,2019,achfz_n
18,"N: Hospitalization - Diagnosis: Average % with Cardiac Dysrhythmia (per year in average facility), 2019-2022",17.36,2019,acdrz_n
18,"N: Hospitalization - Diagnosis: Average % with Cardiac Arrest (per year in average facility), 2019-2022",2.81,2019,acarz_n
18,"N: SHR (Admissions) -Average % Inpatient Admissions Originating in ED (per year in average facility), 2019-2022",83.03,2019,ipedz_n
18,"N: ED30 - Average annual index discharges, 2019-22",39.07,2019,ed30indexzm_n
18,"N: ED30- Average annual number of ED visits, 2019-22",5.29,2019,ed30obszm_n
18,"N: ED30 - Average annual expected ED visits, 2019-22",6.34,2019,ed30expzm_n
18,"N: ED30: Standardized Ratio of ED30, 2019-22",0.87,2019,ed30z_n
18,"N SRR -  Standardized Readmission Ratio, 2022",1.07,2022,srry4_n
18,"N: SRR - Average index discharges, 2022",74.44,2022,indexmy4_n
18,"N: SRR - Average number of readmissions, 2022",18.95,2022,readmmy4_n
18,"N: SRR - Average expected readmissions, 2022",18.69,2022,srrexpmy4_n
18,Pt included in SEDR analysis,54.36,2019,rdsezm_n
18,Total number of ED Visits,42.6,2019,hedzm_n
18,Expected number of ED events,50.0,2019,exedzm_n
18,Years at risk for ED visit rate,35.02,2019,edyrzm_n
18,Years at risk for ED visit rate,66684.59,2019,edyrz_n
18,"N: SEDR - Standardized Emergency Department Encounter Ratio, 2019-2022",0.85,2019,sedrz_n
18,"N: STR - Average number of eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",86.55,2019,rdstzm_n
18,"N: STR - Average number of patients (per year in average facility), 2019-2022",91.76,2019,rdsalltzm_n
18,"N: STR - Average number of 1st transplant (per year in average facility), 2019-2022",2.48,2019,txzm_n
18,"N: Transplantation - Average number of transplants (per year in average facility), 2019-2022",2.77,2019,txallzm_n
18,"N: STR - Average number of years at risk for eligible patients (age<75) with no previous transplant (per year in average facility), 2019-2022",58.73,2019,txyzm_n
18,"N: STR - Average number of deceased donor transplant (per year in average facility), 2019-2022",2.25,2019,cadalltzm_n
18,"N: STR - Average number of living donor transplant (per year in average facility), 2019-2022",0.55,2019,livealltzm_n
18,"N: STR - Average number of expected 1st transplant (per year in average facility), 2019-2022",2.83,2019,extxzm_n
18,"N: STR - Standardized 1st Transplant Ratio, 2019-2022",0.88,2019,strz_n
18,"N: Prevalent Waitlist - Average number of eligible dialysis patients (age<75), 2022",87.56,2022,pppwpty4m_n
18,"N: Prevalent Waitlist - % of patient-months (age<75) on waitlist, 2022",20.45,2022,WLy4_n
18,"N: Prevalent Waitlist - % of patient-months < 40 years on waitlist, 2022",33.29,2022,WLlt40y4_n
18,"N: Prevalent Waitlist - % of patient-months aged 40-74 on waitlist, 2022",19.05,2022,WL4074y4_n
18,"N: Prevalent Waitlist - % of male patient-months (age<75) on waitlist, 2022",21.35,2022,WLmaley4_n
18,"N: Prevalent Waitlist - % of female patient-months (age<75) on waitlist, 2022",19.01,2022,WLfemy4_n
18,"N: Prevalent Waitlist - % Hispanic White patient-months (age<75)on waitlist, 2022",20.61,2022,WLwhhy4_n
18,"N: Prevalent Waitlist - % Non-Hispanic White patient-months (age<75) on waitlist, 2022",19.4,2022,WLwhnhy4_n
18,"N: Prevalent Waitlist - % of African American patient-months (age<75) on waitlist, 2022",16.37,2022,WLbly4_n
18,"N: Prevalent Waitlist - % of Asian patient-months (age<75) on waitlist, 2022",25.3,2022,WLasy4_n
18,"N: Prevalent Waitlist - % of Native American patient-months (age<75) on waitlist, 2022",12.53,2022,WLnay4_n
18,"N: Prevalent Waitlist - % of other/unknown race patient-months (age<75) on waitlist, 2022",20.9,2022,WLothy4_n
18,"N: Prevalent Waitlist - % of diabetic patient-months (age<75) on waitlist, 2022",16.4,2022,WLDMy4_n
18,"N: Prevalent Waitlist - % of non-diabetic patient-months (age<75) on waitlist, 2022",24.99,2022,WLnodmy4_n
18,"N: Prevalent Waitlist - % of patient-months (age<75) without previous transplant on waitlist, 2022",19.86,2022,WLnotxy4_n
18,"N: Prevalent Waitlist - % of patient-months (age<75) with prev KI transplant on waitlist, 2022",30.23,2022,WLtxy4_n
18,"N: Prevalent Waitlist - % of patient-months (age<75) with <2 years of prior ESRD therapy on waitlist, 2022",10.15,2022,WLVCat1y4_n
18,"N: Prevalent Waitlist - % of patient-months (age<75) with 2-4 years of prior ESRD therapy on waitlist, 2022",25.9,2022,WLVCat2y4_n
18,"N: Prevalent Waitlist - % of patient-months (age<75) with 5+ years of prior ESRD therapy on waitlist, 2022",25.4,2022,WLVCat3y4_n
18,"N: Prevalent Waitlist - Average number of patient-months (age<75) at risk, 2022",769.17,2022,pppwpmy4m_n
18,"N: Prevalent Waitlist - Age-adjusted percentage of patient-months waitlisted (age<75), 2022",20.58,2022,pppwy4_n
18,"N: Incident Waitlist - Average number of patients (per year in average facility), 2019-2021",13.39,2019,swrptzm_n
18,"N: Incident Waitlist - Average number of of patient-years at risk (per year in average facility), 2019-2021",10.99,2019,swrpyzm_n
18,"N: Incident Waitlist - Average number of waitlisting or receipt of a living-donor transplant for SWR (per year in average facility), 2019-2021",0.8,2019,swrwlzm_n
18,"N: Incident Waitlist - Average number of expected transplant waitlisting or receipt of a living-donor transplant (per year in average facility), 2019-2021",1.17,2019,swrexwlzm_n
18,"N: Incident Waitlist - Standardized Waitlist Ratio, 2019 - 2021",0.69,2019,swrz_n
18,"N: Influenza - % of patients vaccinated, 8/1-3/31, 2021",83.45,2021,FVfy3_n
18,"N: Influenza - % of patients that declined vaccination, 8/1-3/31, 2021",6.28,2021,FVdeclinedfy3_n
18,"N: Influenza - % of patients without vaccination due to outside vaccination reported but no documentation, 8/1-3/31, 2021",0.13,2021,FVovndfy3_n
18,"N: Influenza - % of patients without vaccination due to other reason or vaccine data not available, 8/1-3/31, 2021",10.27,2021,FVothrsnfy3_n
18,"N: Influenza - % of patients vaccinated, 8/1-12/31, 2022",74.16,2022,FVhy4_n
18,"N: Influenza - % of Medicare patients vaccinated, 8/1-12/31, 2022",75.12,2022,FVmcarehy4_n
18,"N: Influenza - % of Medicare Advantage patients vaccinated, 8/1-12/31, 2022",76.78,2022,FVmahy4_n
18,"N: Influenza - % of patients with Medicare as primary insurer vaccinated, 8/1-12/31, 2022",74.18,2022,FVmpphy4_n
18,"N: Influenza - % of dual Medicare/Medicaid eligible patients vaccinated, 8/1-12/31, 2022",74.69,2022,FVdualhy4_n
18,"N: Influenza - % of patients with Medicare as secondary insurer vaccinated, 8/1-12/31, 2022",70.69,2022,FVmsphy4_n
18,"N: Influenza - % of Non-Medicare patients vaccinated, 8/1-12/31, 2022",68.75,2022,FVnonmcarehy4_n
18,"N: Influenza - % of dialysis patients <18 vaccinated, 8/1-12/31, 2022",44.62,2022,FVlt18hy4_n
18,"N: Influenza - % of dialysis patients 18-39 vaccinated, 8/1-12/31, 2022",62.63,2022,FV1839hy4_n
18,"N: Influenza - % of dialysis patients 40-64 vaccinated, 8/1-12/31, 2022",71.51,2022,FV4064hy4_n
18,"N: Influenza - % of dialysis patients 65-74 vaccinated, 8/1-12/31, 2022",76.0,2022,FV6574hy4_n
18,"N: Influenza - % of dialysis patients 75+ vaccinated, 8/1-12/31, 2022",78.66,2022,FV75uphy4_n
18,"N: Influenza - % of male dialysis patients vaccinated, 8/1-12/31, 2022",73.67,2022,FVmalehy4_n
18,"N: Influenza - % of female dialysis patients vaccinated, 8/1-12/31, 2022",73.96,2022,FVfemhy4_n
18,"N: Influenza - % of Asian dialysis patients vaccinated, 8/1-12/31, 2022",78.9,2022,FVashy4_n
18,"N: Influenza - % of Native American dialysis patients vaccinated, 8/1-12/31, 2022",63.28,2022,FVnahy4_n
18,"N: Influenza - % of white dialysis patients vaccinated, 8/1-12/31, 2022",74.25,2022,FVwhhy4_n
18,"N: Influenza - % of Other race dialysis patients vaccinated, 8/1-12/31, 2022",44.44,2022,FVrothhy4_n
18,"N: Influenza - % of black dialysis patients vaccinated, 8/1-12/31, 2022",66.47,2022,FVblkhy4_n
18,"N: Influenza - % of Hispanic dialysis patients vaccinated, 8/1-12/31, 2022",74.79,2022,FVhisphy4_n
18,"N: Influenza - % of dialysis patients with <1 year of prior ESRD therapy vaccinated, 8/1-12/31, 2022",63.03,2022,FVVCat1hy4_n
18,"N: Influenza - % of dialysis patients with 1-2 years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",72.83,2022,FVVCat2hy4_n
18,"N: Influenza - % of dialysis patients with 3+ years of prior ESRD therapy vaccinated, 8/1-12/31, 2022",77.95,2022,FVVCat3hy4_n
18,"N: Influenza - Average number of patients treated on 12/31, 2022",88.16,2022,eFVy4m_n
18,"N: Influenza - Average number of patients not vaccinated due to medical contraindication, 8/1-3/31, 2022",3.58,2022,medrsnfy4m_N
18,"N: HD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.72,2022,CWhdavgHGBy4_n
18,"N: HD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",22.43,2022,CWhdhgb1y4_n
18,"N: HD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",35.05,2022,CWhdhgb2y4_n
18,"N: HD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",28.69,2022,CWhdhgb3y4_n
18,"N: HD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",11.45,2022,CWhdhgb4y4_n
18,"N: HD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",2.38,2022,CWhdhgb5y4_n
18,"N: HD HGB (Adult) - % of patient-months with ESA prescribed, 2022",80.65,2022,CWhdesarxy4_n
18,"N: PD HGB (Adult) - Average hemoglobin levels (g/dL), of valid in-range patient-months, 2022",10.69,2022,CWpdavgHGBy4_n
18,"N: PD HGB (Adult) - % of patient-months with hemoglobin < 10 g/dL, 2022",26.17,2022,CWpdhgb1y4_n
18,"N: PD HGB (Adult) - % of patient-months with hemoglobin 10 - <11 g/dL, 2022",29.79,2022,CWpdhgb2y4_n
18,"N: PD HGB (Adult) - % of patient-months with hemoglobin 11 - 12 g/dL, 2022",23.65,2022,CWpdhgb3y4_n
18,"N: PD HGB (Adult) - % of patient-months with hemoglobin > 12 g/dL, 2022",13.81,2022,CWpdhgb4y4_n
18,"N: PD HGB (Adult) - % of patient-months with hemoglobin Missing or Out of Range, 2022",6.58,2022,CWpdhgb5y4_n
18,"N: PD HGB (Adult) - % of patient-months with ESA prescribed, 2022",61.13,2022,CWpdesarxy4_n
18,"N: HD HGB (Adult) - Average number of eligible patients, 2022",102.15,2022,CWhdptdenomy4m_n
18,"N: HD HGB (Adult) - Average number of eligible patient-months, 2022",914.36,2022,CWhdptmthdenomy4m_n
18,"N: PD HGB (Adult) - Average number of eligible patients, 2022",33.76,2022,CWpdptdenomy4m_n
18,"N: PD HGB (Adult) - Average number of eligible patient-months, 2022",287.19,2022,CWpdptmthdenomy4m_n
18,"N: STrR (Adult) - Average Number of Medicare Patients, 2022",44.5,2022,rdstfy4m_n
18,"N: STrR (Adult) - Average Patient Years at Risk, 2022",28.22,2022,tfyy4m_n
18,"N: STrR (Adult) - Average Number of Transfusions, 2022",7.74,2022,tfy4m_n
18,"N: STrR (Adult) - Average Expected Total Number of Transfusions, 2022",9.34,2022,extfy4m_n
18,"N: STrR (Adult) - Standardized Transfusion Ratio, 2022",0.83,2022,strry4_n
18,"N: Albumin (Adult) - Average Serum Albumin, of valid in range HD patient-months, 2022",3.98,2022,CWhdalby4_n
18,"N: Albumin (Adult) - % of HD patient-months with serum albumin < 3 g/dL, 2022",1.34,2022,CWhdalb1y4_n
18,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",5.98,2022,CWhdalb2y4_n
18,"N: Albumin (Adult) - % of HD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",32.96,2022,CWhdalb3y4_n
18,"N: Albumin (Adult) - % of HD patient-months with serum albumin >= 4 g/dL, 2022",56.04,2022,CWhdalb4y4_n
18,"N: Albumin (Adult) - % of HD patient-months with serum albumin Missing, 2022",3.69,2022,CWhdalb5y4_n
18,"N: Albumin (Adult) - % of HD patient-months with Serum Albumin  < 4.0 g/dL, 2022",40.27,2022,CWhdalblt4y4_n
18,"N: UFR (Adult) - Average UFR, of valid in range HD patient-months, 2022",8.0,2022,CWhdavgufry4_n
18,"N: UFR (Adult) - % of HD patient-months with UFR <= 13 ml/kg/hr, 2022",85.32,2022,CWhdufr1y4_n
18,"N: UFR (Adult) - % of HD patient-months with UFR > 13 ml/kg/hr, 2022",9.58,2022,CWhdufr2y4_n
18,"N: UFR (Adult) - % of HD patient-months with UFR Missing, 2022",2.97,2022,CWhdufrmissy4_n
18,"N: UFR (Adult) - % of HD patient-months with UFR Out of Range (> 20 ml/kg/hr), 2022",2.13,2022,CWhdufrgt20y4_n
18,"N: Albumin (Adult) - Average Serum Albumin, of valid in range PD patient-months, 2022",3.73,2022,CWpdalby4_n
18,"N: Albumin (Adult) - % of PD patient-months with serum albumin < 3 g/dL, 2022",4.27,2022,CWpdalb1y4_n
18,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3 - < 3.5 g/dL, 2022",18.32,2022,CWpdalb2y4_n
18,"N: Albumin (Adult) - % of PD patient-months with serum albumin 3.5 - < 4 g/dL, 2022",41.18,2022,CWpdalb3y4_n
18,"N: Albumin (Adult) - % of PD patient-months with serum albumin >= 4 g/dL, 2022",29.19,2022,CWpdalb4y4_n
18,"N: Albumin (Adult) - % of PD patient-months with serum albumin Missing, 2022",7.04,2022,CWpdalb5y4_n
18,"N: Albumin (Adult) - % of PD patient-months with Serum Albumin  < 4.0 g/dL, 2022",63.77,2022,CWpdalblt4y4_n
18,"N: HD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",102.15,2022,CWhddenomy4m_n
18,"N: HD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",914.36,2022,CWhdmthdenomy4m_n
18,"N: PD Dialysis Adequacy (Adult)- Average number of eligible patients, 2022",33.76,2022,CWpddenomy4m_n
18,"N: PD Dialysis Adequacy (Adult) - Average number of Eligible Dialysis Patient-months, 2022",287.19,2022,CWpdmthdenomy4m_n
18,"N: PD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",2.18,2022,CWpdavgktvy4_n
18,"N: PD Kt/V (Adult)- % of patient-months with Kt/V < 1.7, 2022",5.79,2022,CWpdktv1y4_n
18,"N: PD Kt/V (Adult)- % of patient-months with Kt/V 1.7-<2.5, 2022",67.26,2022,CWpdktv2y4_n
18,"N: PD Kt/V (Adult)- % of patient-months with Kt/V >= 2.5, 2022",19.93,2022,CWpdktv3y4_n
18,"N: PD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",7.03,2022,CWpdktv4y4_n
18,"N: HD Kt/V (Adult)- Average Kt/V, of valid in-range values, 2022",1.62,2022,CWhdavgktvy4_n
18,"N: HD Kt/V (Adult)- % of patient-months with Kt/V < 1.2, 2022",1.48,2022,CWhdktv1y4_n
18,"N: HD Kt/V (Adult)- % of patient-months with Kt/V 1.2-<1.8, 2022",71.74,2022,CWhdktv2y4_n
18,"N: HD Kt/V (Adult)- % of patient-months with Kt/V >= 1.8, 2022",25.15,2022,CWhdktv3y4_n
18,"N: HD Kt/V (Adult)- % of patient-months with Kt/V missing or out of range, 2022",1.63,2022,CWhdktv4y4_n
18,"N: HD Kt/V (Adult)- Average number of eligible patients, 2022",97.93,2022,CWhdktvptsy4m_N
18,"N: HD Kt/V (Adult)- Average number of eligible patient-months, 2022",864.15,2022,CWhdktvptmthy4m_N
